400	Laboratory Tests Response to  <e0>Plenaxis</e0>  should be monitored by measuring serum total  <e1>testosterone</e1>  concentrations just prior to administration on Day 29 and every 8 weeks thereafter."
Other
Comment:


200	Population pharmacokinetic analyses revealed that  <e0>MTX</e0> ,  <e1>NSAIDs</e1> ,  corticosteroids , and  TNF blocking agents  did not influence  abatacept  clearance."
Other
Comment:

201	Population pharmacokinetic analyses revealed that  <e0>MTX</e0> ,  NSAIDs ,  <e1>corticosteroids</e1> , and  TNF blocking agents  did not influence  abatacept  clearance."
Other
Comment:

202	Population pharmacokinetic analyses revealed that  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids , and  <e1>TNF blocking agents</e1>  did not influence  abatacept  clearance."
Other
Comment:

203	Population pharmacokinetic analyses revealed that  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids , and  TNF blocking agents  did not influence  <e1>abatacept</e1>  clearance."
Other
Comment:

204	Population pharmacokinetic analyses revealed that  MTX ,  <e0>NSAIDs</e0> ,  <e1>corticosteroids</e1> , and  TNF blocking agents  did not influence  abatacept  clearance."
Other
Comment:

205	Population pharmacokinetic analyses revealed that  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids , and  <e1>TNF blocking agents</e1>  did not influence  abatacept  clearance."
Other
Comment:

206	Population pharmacokinetic analyses revealed that  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids , and  TNF blocking agents  did not influence  <e1>abatacept</e1>  clearance."
Other
Comment:

207	Population pharmacokinetic analyses revealed that  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> , and  <e1>TNF blocking agents</e1>  did not influence  abatacept  clearance."
Other
Comment:

208	Population pharmacokinetic analyses revealed that  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> , and  TNF blocking agents  did not influence  <e1>abatacept</e1>  clearance."
Other
Comment:

209	Population pharmacokinetic analyses revealed that  MTX ,  NSAIDs ,  corticosteroids , and  <e0>TNF blocking agents</e0>  did not influence  <e1>abatacept</e1>  clearance."
Other
Comment:

300	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  <e1>MTX</e1> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

301	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  <e1>NSAIDs</e1> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

302	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  <e1>corticosteroids</e1> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

303	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  <e1>TNF blocking agents</e1> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

304	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e1>azathioprine</e1> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

305	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

306	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

307	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

308	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

309	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

310	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  <e0>ORENCIA</e0> :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

311	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  <e1>NSAIDs</e1> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

312	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  <e1>corticosteroids</e1> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

313	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  <e1>TNF blocking agents</e1> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

314	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e1>azathioprine</e1> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

315	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

316	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

317	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

318	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

319	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

320	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  <e0>MTX</e0> ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

321	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  <e1>corticosteroids</e1> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

322	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  <e1>TNF blocking agents</e1> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

323	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  <e1>azathioprine</e1> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

324	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

325	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

326	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

327	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

328	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

329	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  <e0>NSAIDs</e0> ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

330	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  <e1>TNF blocking agents</e1> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

331	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  <e1>azathioprine</e1> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

332	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

333	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

334	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

335	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

336	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

337	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  <e0>corticosteroids</e0> ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

338	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  <e1>azathioprine</e1> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

339	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

340	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

341	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

342	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

343	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

344	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  <e0>TNF blocking agents</e0> ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

345	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  <e1>chloroquine</e1> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

346	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  chloroquine ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

347	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  chloroquine ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

348	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

349	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

350	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  <e0>azathioprine</e0> ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

351	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e0>chloroquine</e0> ,  <e1>gold</e1> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

352	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e0>chloroquine</e0> ,  gold ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

353	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e0>chloroquine</e0> ,  gold ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

354	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e0>chloroquine</e0> ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

355	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  <e0>chloroquine</e0> ,  gold ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

356	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e0>gold</e0> ,  <e1>hydroxychloroquine</e1> ,  leflunomide ,  sulfasalazine , and  anakinra ."
Other
Comment:

357	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e0>gold</e0> ,  hydroxychloroquine ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

358	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e0>gold</e0> ,  hydroxychloroquine ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

359	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  <e0>gold</e0> ,  hydroxychloroquine ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

360	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e0>hydroxychloroquine</e0> ,  <e1>leflunomide</e1> ,  sulfasalazine , and  anakinra ."
Other
Comment:

361	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e0>hydroxychloroquine</e0> ,  leflunomide ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

362	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  <e0>hydroxychloroquine</e0> ,  leflunomide ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

363	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e0>leflunomide</e0> ,  <e1>sulfasalazine</e1> , and  anakinra ."
Other
Comment:

364	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  <e0>leflunomide</e0> ,  sulfasalazine , and  <e1>anakinra</e1> ."
Other
Comment:

365	The majority of patients in RA clinical studies received one or more of the following concomitant medications with  ORENCIA :  MTX ,  NSAIDs ,  corticosteroids ,  TNF blocking agents ,  azathioprine ,  chloroquine ,  gold ,  hydroxychloroquine ,  leflunomide ,  <e0>sulfasalazine</e0> , and  <e1>anakinra</e1> ."
Other
Comment:

400	Concurrent administration of a  <e0>TNF antagonist</e0>  with  <e1>ORENCIA</e1>  has been associated with an increased risk of serious infections and no significant additional efficacy over use of the  TNF antagonists  alone."
effect(e0,e1)Comment:

401	Concurrent administration of a  <e0>TNF antagonist</e0>  with  ORENCIA  has been associated with an increased risk of serious infections and no significant additional efficacy over use of the  <e1>TNF antagonists</e1>  alone."
Other
Comment:

402	Concurrent administration of a  TNF antagonist  with  <e0>ORENCIA</e0>  has been associated with an increased risk of serious infections and no significant additional efficacy over use of the  <e1>TNF antagonists</e1>  alone."
Other
Comment:

500	Concurrent therapy with  <e0>ORENCIA</e0>  and  <e1>TNF antagonists</e1>  is not recommended."
advise(e0,e1)Comment:

600	There is insufficient experience to assess the safety and efficacy of  <e0>ORENCIA</e0>  administered concurrently with  <e1>anakinra</e1> , and therefore such use is not recommended."
advise(e0,e1)Comment:


300	These medications have included  <e0>heparin</e0> ,  <e1>warfarin</e1> ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

301	These medications have included  <e0>heparin</e0> ,  warfarin ,  <e1>beta-adrenergic receptor blockers</e1> ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

302	These medications have included  <e0>heparin</e0> ,  warfarin ,  beta-adrenergic receptor blockers ,  <e1>calcium channel antagonists</e1> ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

303	These medications have included  <e0>heparin</e0> ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  <e1>angiotensin converting enzyme inhibitors</e1> , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

304	These medications have included  <e0>heparin</e0> ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e1>nitrates</e1> ,  ticlopidine , and  aspirin ."
Other
Comment:

305	These medications have included  <e0>heparin</e0> ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

306	These medications have included  <e0>heparin</e0> ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

307	These medications have included  heparin ,  <e0>warfarin</e0> ,  <e1>beta-adrenergic receptor blockers</e1> ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

308	These medications have included  heparin ,  <e0>warfarin</e0> ,  beta-adrenergic receptor blockers ,  <e1>calcium channel antagonists</e1> ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

309	These medications have included  heparin ,  <e0>warfarin</e0> ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  <e1>angiotensin converting enzyme inhibitors</e1> , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

310	These medications have included  heparin ,  <e0>warfarin</e0> ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e1>nitrates</e1> ,  ticlopidine , and  aspirin ."
Other
Comment:

311	These medications have included  heparin ,  <e0>warfarin</e0> ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

312	These medications have included  heparin ,  <e0>warfarin</e0> ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

313	These medications have included  heparin ,  warfarin ,  <e0>beta-adrenergic receptor blockers</e0> ,  <e1>calcium channel antagonists</e1> ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

314	These medications have included  heparin ,  warfarin ,  <e0>beta-adrenergic receptor blockers</e0> ,  calcium channel antagonists ,  <e1>angiotensin converting enzyme inhibitors</e1> , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

315	These medications have included  heparin ,  warfarin ,  <e0>beta-adrenergic receptor blockers</e0> ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e1>nitrates</e1> ,  ticlopidine , and  aspirin ."
Other
Comment:

316	These medications have included  heparin ,  warfarin ,  <e0>beta-adrenergic receptor blockers</e0> ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

317	These medications have included  heparin ,  warfarin ,  <e0>beta-adrenergic receptor blockers</e0> ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

318	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  <e0>calcium channel antagonists</e0> ,  <e1>angiotensin converting enzyme inhibitors</e1> , intravenous and oral  nitrates ,  ticlopidine , and  aspirin ."
Other
Comment:

319	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  <e0>calcium channel antagonists</e0> ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e1>nitrates</e1> ,  ticlopidine , and  aspirin ."
Other
Comment:

320	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  <e0>calcium channel antagonists</e0> ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

321	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  <e0>calcium channel antagonists</e0> ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

322	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  <e0>angiotensin converting enzyme inhibitors</e0> , intravenous and oral  <e1>nitrates</e1> ,  ticlopidine , and  aspirin ."
Other
Comment:

323	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  <e0>angiotensin converting enzyme inhibitors</e0> , intravenous and oral  nitrates ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

324	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  <e0>angiotensin converting enzyme inhibitors</e0> , intravenous and oral  nitrates ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

325	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e0>nitrates</e0> ,  <e1>ticlopidine</e1> , and  aspirin ."
Other
Comment:

326	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  <e0>nitrates</e0> ,  ticlopidine , and  <e1>aspirin</e1> ."
Other
Comment:

327	These medications have included  heparin ,  warfarin ,  beta-adrenergic receptor blockers ,  calcium channel antagonists ,  angiotensin converting enzyme inhibitors , intravenous and oral  nitrates ,  <e0>ticlopidine</e0> , and  <e1>aspirin</e1> ."
Other
Comment:

400	 <e0>Heparin</e0> , other  <e1>anticoagulants</e1> ,  thrombolytics , and  anti platelet agents  are associated with an increase in bleeding."
Other
Comment:

401	 <e0>Heparin</e0> , other  anticoagulants ,  <e1>thrombolytics</e1> , and  anti platelet agents  are associated with an increase in bleeding."
Other
Comment:

402	 <e0>Heparin</e0> , other  anticoagulants ,  thrombolytics , and  <e1>anti platelet agents</e1>  are associated with an increase in bleeding."
Other
Comment:

403	 Heparin , other  <e0>anticoagulants</e0> ,  <e1>thrombolytics</e1> , and  anti platelet agents  are associated with an increase in bleeding."
Other
Comment:

404	 Heparin , other  <e0>anticoagulants</e0> ,  thrombolytics , and  <e1>anti platelet agents</e1>  are associated with an increase in bleeding."
Other
Comment:

405	 Heparin , other  anticoagulants ,  <e0>thrombolytics</e0> , and  <e1>anti platelet agents</e1>  are associated with an increase in bleeding."
Other
Comment:

500	Patients with HACA titers may have allergic or hypersensitivity reactions when treated with other  <e0>diagnostic monoclonal antibodies</e0>  or  <e1>therapeutic monoclonal antibodies</e1> ."
Other
Comment:


100	The concomitant intake of  <e0>alcohol</e0>  and  <e1>Acamprosate</e1>  does not affect the pharmacokinetics of either  alcohol  or  acamprosate ."
Other
Comment:

101	The concomitant intake of  <e0>alcohol</e0>  and  Acamprosate  does not affect the pharmacokinetics of either  <e1>alcohol</e1>  or  acamprosate ."
Other
Comment:

102	The concomitant intake of  <e0>alcohol</e0>  and  Acamprosate  does not affect the pharmacokinetics of either  alcohol  or  <e1>acamprosate</e1> ."
Other
Comment:

103	The concomitant intake of  alcohol  and  <e0>Acamprosate</e0>  does not affect the pharmacokinetics of either  <e1>alcohol</e1>  or  acamprosate ."
Other
Comment:

104	The concomitant intake of  alcohol  and  <e0>Acamprosate</e0>  does not affect the pharmacokinetics of either  alcohol  or  <e1>acamprosate</e1> ."
Other
Comment:

105	The concomitant intake of  alcohol  and  Acamprosate  does not affect the pharmacokinetics of either  <e0>alcohol</e0>  or  <e1>acamprosate</e1> ."
Other
Comment:

200	Pharmacokinetic studies indicate that administration of  <e0>disulfiram</e0>  or  <e1>diazepam</e1>  does not affect the pharmacokinetics of  acamprosate ."
Other
Comment:

201	Pharmacokinetic studies indicate that administration of  <e0>disulfiram</e0>  or  diazepam  does not affect the pharmacokinetics of  <e1>acamprosate</e1> ."
Other
Comment:

202	Pharmacokinetic studies indicate that administration of  disulfiram  or  <e0>diazepam</e0>  does not affect the pharmacokinetics of  <e1>acamprosate</e1> ."
Other
Comment:

300	Co-administration of  <e0>naltrexone</e0>  with  <e1>Acamprosate</e1>  produced a 25% increase in AUC and a 33% increase in the Cmax of  acamprosate ."
mechanism(e0,e1)Comment:

301	Co-administration of  <e0>naltrexone</e0>  with  Acamprosate  produced a 25% increase in AUC and a 33% increase in the Cmax of  <e1>acamprosate</e1> ."
Other
Comment:

302	Co-administration of  naltrexone  with  <e0>Acamprosate</e0>  produced a 25% increase in AUC and a 33% increase in the Cmax of  <e1>acamprosate</e1> ."
Other
Comment:

500	The pharmacokinetics of  <e0>naltrexone</e0>  and its major metabolite  <e1>6-beta-naltrexol</e1>  were unaffected following co-administration with  Acamprosate ."
Other
Comment:

501	The pharmacokinetics of  <e0>naltrexone</e0>  and its major metabolite  6-beta-naltrexol  were unaffected following co-administration with  <e1>Acamprosate</e1> ."
Other
Comment:

502	The pharmacokinetics of  naltrexone  and its major metabolite  <e0>6-beta-naltrexol</e0>  were unaffected following co-administration with  <e1>Acamprosate</e1> ."
Other
Comment:

600	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  <e0>Acamprosate</e0>  concomitantly with  <e1>anxiolytics</e1> ,  hypnotics  and  sedatives  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

601	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  <e0>Acamprosate</e0>  concomitantly with  anxiolytics ,  <e1>hypnotics</e1>  and  sedatives  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

602	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  <e0>Acamprosate</e0>  concomitantly with  anxiolytics ,  hypnotics  and  <e1>sedatives</e1>  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

603	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  <e0>Acamprosate</e0>  concomitantly with  anxiolytics ,  hypnotics  and  sedatives  (including  <e1>benzodiazepines</e1> ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

604	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  <e0>Acamprosate</e0>  concomitantly with  anxiolytics ,  hypnotics  and  sedatives  (including  benzodiazepines ), or  <e1>non-opioid analgesics</e1>  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

605	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  <e0>anxiolytics</e0> ,  <e1>hypnotics</e1>  and  sedatives  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

606	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  <e0>anxiolytics</e0> ,  hypnotics  and  <e1>sedatives</e1>  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

607	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  <e0>anxiolytics</e0> ,  hypnotics  and  sedatives  (including  <e1>benzodiazepines</e1> ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

608	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  <e0>anxiolytics</e0> ,  hypnotics  and  sedatives  (including  benzodiazepines ), or  <e1>non-opioid analgesics</e1>  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

609	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  <e0>hypnotics</e0>  and  <e1>sedatives</e1>  (including  benzodiazepines ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

610	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  <e0>hypnotics</e0>  and  sedatives  (including  <e1>benzodiazepines</e1> ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

611	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  <e0>hypnotics</e0>  and  sedatives  (including  benzodiazepines ), or  <e1>non-opioid analgesics</e1>  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

612	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  hypnotics  and  <e0>sedatives</e0>  (including  <e1>benzodiazepines</e1> ), or  non-opioid analgesics  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

613	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  hypnotics  and  <e0>sedatives</e0>  (including  benzodiazepines ), or  <e1>non-opioid analgesics</e1>  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

614	Other concomitant therapies: In clinical trials, the safety profile in subjects treated with  Acamprosate  concomitantly with  anxiolytics ,  hypnotics  and  sedatives  (including  <e0>benzodiazepines</e0> ), or  <e1>non-opioid analgesics</e1>  was similar to that of subjects taking placebo with these concomitant medications."
Other
Comment:

700	Patients taking  <e0>Acamprosate</e0>  concomitantly with  <e1>antidepressants</e1>  more commonly reported both weight gain and weight loss, compared with patients taking either medication alone."
effect(e0,e1)Comment:


200	These drugs include the  <e0>thiazides</e0>  and other  <e1>diuretics</e1> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

201	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  <e1>corticosteroids</e1> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

202	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  <e1>phenothiazines</e1> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

203	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e1>thyroid products</e1> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

204	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e1>estrogens</e1> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

205	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

206	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

207	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

208	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

209	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

210	These drugs include the  <e0>thiazides</e0>  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

211	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  <e1>corticosteroids</e1> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

212	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  <e1>phenothiazines</e1> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

213	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  <e1>thyroid products</e1> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

214	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e1>estrogens</e1> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

215	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

216	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

217	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

218	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

219	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

220	These drugs include the  thiazides  and other  <e0>diuretics</e0> ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

221	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  <e1>phenothiazines</e1> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

222	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  <e1>thyroid products</e1> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

223	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  <e1>estrogens</e1> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

224	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

225	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

226	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

227	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

228	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

229	These drugs include the  thiazides  and other  diuretics ,  <e0>corticosteroids</e0> ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

230	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  <e1>thyroid products</e1> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

231	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  <e1>estrogens</e1> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

232	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

233	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

234	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

235	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

236	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

237	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  <e0>phenothiazines</e0> ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

238	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  <e1>estrogens</e1> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

239	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

240	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

241	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

242	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

243	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

244	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  <e0>thyroid products</e0> ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

245	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  <e1>contraceptives</e1> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

246	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  contraceptives ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

247	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  contraceptives ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

248	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

249	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

250	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  <e0>estrogens</e0> , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

251	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e0>contraceptives</e0> ,  <e1>phenytoin</e1> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

252	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e0>contraceptives</e0> ,  phenytoin ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

253	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e0>contraceptives</e0> ,  phenytoin ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

254	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e0>contraceptives</e0> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

255	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  <e0>contraceptives</e0> ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

256	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e0>phenytoin</e0> ,  <e1>nicotinic acid</e1> ,  sympathomimetics ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

257	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e0>phenytoin</e0> ,  nicotinic acid ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

258	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e0>phenytoin</e0> ,  nicotinic acid ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

259	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  <e0>phenytoin</e0> ,  nicotinic acid ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

260	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e0>nicotinic acid</e0> ,  <e1>sympathomimetics</e1> ,  calcium channel-blocking drugs , and  isoniazid ."
Other
Comment:

261	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e0>nicotinic acid</e0> ,  sympathomimetics ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

262	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  <e0>nicotinic acid</e0> ,  sympathomimetics ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

263	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e0>sympathomimetics</e0> ,  <e1>calcium channel-blocking drugs</e1> , and  isoniazid ."
Other
Comment:

264	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  <e0>sympathomimetics</e0> ,  calcium channel-blocking drugs , and  <e1>isoniazid</e1> ."
Other
Comment:

265	These drugs include the  thiazides  and other  diuretics ,  corticosteroids ,  phenothiazines ,  thyroid products ,  estrogens , oral  contraceptives ,  phenytoin ,  nicotinic acid ,  sympathomimetics ,  <e0>calcium channel-blocking drugs</e0> , and  <e1>isoniazid</e1> ."
Other
Comment:

400	When such drugs are withdrawn from patients receiving  <e0>Acarbose</e0>  in combination with  <e1>sulfonylureas</e1>  or  insulin , patients should be observed closely for any evidence of hypoglycemia."
Other
Comment:

401	When such drugs are withdrawn from patients receiving  <e0>Acarbose</e0>  in combination with  sulfonylureas  or  <e1>insulin</e1> , patients should be observed closely for any evidence of hypoglycemia."
Other
Comment:

402	When such drugs are withdrawn from patients receiving  Acarbose  in combination with  <e0>sulfonylureas</e0>  or  <e1>insulin</e1> , patients should be observed closely for any evidence of hypoglycemia."
Other
Comment:

500	 <e0>Intestinal adsorbents</e0>  (e. g.,  <e1>charcoal</e1> ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

501	 <e0>Intestinal adsorbents</e0>  (e. g.,  charcoal ) and  <e1>digestive enzyme preparations</e1>  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

502	 <e0>Intestinal adsorbents</e0>  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  <e1>amylase</e1> ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

503	 <e0>Intestinal adsorbents</e0>  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  <e1>pancreatin</e1> ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

504	 <e0>Intestinal adsorbents</e0>  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  <e1>Acarbose</e1>  and should not be taken concomitantly."
mechanism(e0,e1)Comment:

505	 Intestinal adsorbents  (e. g.,  <e0>charcoal</e0> ) and  <e1>digestive enzyme preparations</e1>  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

506	 Intestinal adsorbents  (e. g.,  <e0>charcoal</e0> ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  <e1>amylase</e1> ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

507	 Intestinal adsorbents  (e. g.,  <e0>charcoal</e0> ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  <e1>pancreatin</e1> ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

508	 Intestinal adsorbents  (e. g.,  <e0>charcoal</e0> ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  <e1>Acarbose</e1>  and should not be taken concomitantly."
mechanism(e0,e1)Comment:

509	 Intestinal adsorbents  (e. g.,  charcoal ) and  <e0>digestive enzyme preparations</e0>  containing carbohydrate-splitting enzymes (e. g.,  <e1>amylase</e1> ,  pancreatin ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

510	 Intestinal adsorbents  (e. g.,  charcoal ) and  <e0>digestive enzyme preparations</e0>  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  <e1>pancreatin</e1> ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

511	 Intestinal adsorbents  (e. g.,  charcoal ) and  <e0>digestive enzyme preparations</e0>  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  pancreatin ) may reduce the effect of  <e1>Acarbose</e1>  and should not be taken concomitantly."
Other
Comment:

512	 Intestinal adsorbents  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  <e0>amylase</e0> ,  <e1>pancreatin</e1> ) may reduce the effect of  Acarbose  and should not be taken concomitantly."
Other
Comment:

513	 Intestinal adsorbents  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  <e0>amylase</e0> ,  pancreatin ) may reduce the effect of  <e1>Acarbose</e1>  and should not be taken concomitantly."
mechanism(e0,e1)Comment:

514	 Intestinal adsorbents  (e. g.,  charcoal ) and  digestive enzyme preparations  containing carbohydrate-splitting enzymes (e. g.,  amylase ,  <e0>pancreatin</e0> ) may reduce the effect of  <e1>Acarbose</e1>  and should not be taken concomitantly."
mechanism(e0,e1)Comment:

600	 <e0>Acarbose</e0>  has been shown to change the bioavailabillty  <e1>digoxin</e1>  when they are co-administered, which may require  digoxin  dose adjustment."
mechanism(e0,e1)Comment:

601	 <e0>Acarbose</e0>  has been shown to change the bioavailabillty  digoxin  when they are co-administered, which may require  <e1>digoxin</e1>  dose adjustment."
Other
Comment:

602	 Acarbose  has been shown to change the bioavailabillty  <e0>digoxin</e0>  when they are co-administered, which may require  <e1>digoxin</e1>  dose adjustment."
Other
Comment:

700	Studies in healthy volunteers have shown that  <e0>Acarbose</e0>  has no effect on either the pharmacokinetics or pharmacodynamics of  <e1>digoxin</e1> ,  nifedipine ,  propranolol , or  ranitidine ."
Other
Comment:

701	Studies in healthy volunteers have shown that  <e0>Acarbose</e0>  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  <e1>nifedipine</e1> ,  propranolol , or  ranitidine ."
Other
Comment:

702	Studies in healthy volunteers have shown that  <e0>Acarbose</e0>  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  nifedipine ,  <e1>propranolol</e1> , or  ranitidine ."
Other
Comment:

703	Studies in healthy volunteers have shown that  <e0>Acarbose</e0>  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  nifedipine ,  propranolol , or  <e1>ranitidine</e1> ."
Other
Comment:

704	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  <e0>digoxin</e0> ,  <e1>nifedipine</e1> ,  propranolol , or  ranitidine ."
Other
Comment:

705	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  <e0>digoxin</e0> ,  nifedipine ,  <e1>propranolol</e1> , or  ranitidine ."
Other
Comment:

706	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  <e0>digoxin</e0> ,  nifedipine ,  propranolol , or  <e1>ranitidine</e1> ."
Other
Comment:

707	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  <e0>nifedipine</e0> ,  <e1>propranolol</e1> , or  ranitidine ."
Other
Comment:

708	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  <e0>nifedipine</e0> ,  propranolol , or  <e1>ranitidine</e1> ."
Other
Comment:

709	Studies in healthy volunteers have shown that  Acarbose  has no effect on either the pharmacokinetics or pharmacodynamics of  digoxin ,  nifedipine ,  <e0>propranolol</e0> , or  <e1>ranitidine</e1> ."
Other
Comment:

800	 <e0>Acarbose</e0>  did not interfere with the absorption or disposition of the  <e1>sulfonylurea</e1>   glyburide  in diabetic patients."
Other
Comment:

801	 <e0>Acarbose</e0>  did not interfere with the absorption or disposition of the  sulfonylurea   <e1>glyburide</e1>  in diabetic patients."
Other
Comment:

802	 Acarbose  did not interfere with the absorption or disposition of the  <e0>sulfonylurea</e0>   <e1>glyburide</e1>  in diabetic patients."
Other
Comment:

900	 <e0>Acarbose</e0>  may affect  <e1>digoxin</e1>  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

901	 <e0>Acarbose</e0>  may affect  digoxin  bioavailabillty and may require dose adjustment of  <e1>digoxin</e1>  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

902	 <e0>Acarbose</e0>  may affect  digoxin  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  <e1>digoxin</e1>  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

903	 <e0>Acarbose</e0>  may affect  digoxin  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  <e1>digoxin</e1>  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

904	 Acarbose  may affect  <e0>digoxin</e0>  bioavailabillty and may require dose adjustment of  <e1>digoxin</e1>  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

905	 Acarbose  may affect  <e0>digoxin</e0>  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  <e1>digoxin</e1>  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

906	 Acarbose  may affect  <e0>digoxin</e0>  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  <e1>digoxin</e1>  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

907	 Acarbose  may affect  digoxin  bioavailabillty and may require dose adjustment of  <e0>digoxin</e0>  by 16% (90% confidence interval: 8-23%), decrease mean C max  <e1>digoxin</e1>  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  digoxin  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

908	 Acarbose  may affect  digoxin  bioavailabillty and may require dose adjustment of  <e0>digoxin</e0>  by 16% (90% confidence interval: 8-23%), decrease mean C max  digoxin  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  <e1>digoxin</e1>  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

909	 Acarbose  may affect  digoxin  bioavailabillty and may require dose adjustment of  digoxin  by 16% (90% confidence interval: 8-23%), decrease mean C max  <e0>digoxin</e0>  by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of  <e1>digoxin</e1>  by 9% (90% confidence limit: 19% decrease to 2% increase)."
Other
Comment:

1000	The amount of  <e0>metformin</e0>  absorbed while taking  <e1>Acarbose</e1>  was bioequivalent to the amount absorbed when taking placebo, as indicated by the plasma AUC values."
Other
Comment:

1100	However, the peak plasma level of  <e0>metformin</e0>  was reduced by approximately 20% when taking  <e1>Acarbose</e1>  due to a slight delay in the absorption of  metformin ."
mechanism(e0,e1)Comment:

1101	However, the peak plasma level of  <e0>metformin</e0>  was reduced by approximately 20% when taking  Acarbose  due to a slight delay in the absorption of  <e1>metformin</e1> ."
Other
Comment:

1102	However, the peak plasma level of  metformin  was reduced by approximately 20% when taking  <e0>Acarbose</e0>  due to a slight delay in the absorption of  <e1>metformin</e1> ."
mechanism(e0,e1)Comment:

1200	There is little if any clinically significant interaction between  <e0>Acarbose</e0>  and  <e1>metformin</e1> ."
Other
Comment:


100	 <e0>Catecholamine-depleting drugs</e0> , such as  <e1>reserpine</e1> , may have an additive effect when given with  beta-blocking agents ."
Other
Comment:

101	 <e0>Catecholamine-depleting drugs</e0> , such as  reserpine , may have an additive effect when given with  <e1>beta-blocking agents</e1> ."
effect(e0,e1)Comment:

102	 Catecholamine-depleting drugs , such as  <e0>reserpine</e0> , may have an additive effect when given with  <e1>beta-blocking agents</e1> ."
effect(e0,e1)Comment:

200	Patients treated with  <e0>acebutolol</e0>  plus  <e1>catecholamine depletors</e1>  should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure without compensatory tachycardia."
advise(e0,e1)Comment:

300	Exaggerated hypertensive responses have been reported from the combined use of  <e0>beta-adrenergic antagonists</e0>  and  <e1>alpha-adrenergic stimulants</e1> , including those contained in proprietary cold remedies and vasoconstrictive nasal drops."
effect(e0,e1)Comment:

500	Blunting of the antihypertensive effect of  <e0>beta-adrenoceptor blocking agents</e0>  by  <e1>nonsteroidal anti-inflammatory drugs</e1>  has been reported."
effect(e0,e1)Comment:

600	No significant interactions with  <e0>digoxin</e0> ,  <e1>hydrochlorothiazide</e1> ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

601	No significant interactions with  <e0>digoxin</e0> ,  hydrochlorothiazide ,  <e1>hydralazine</e1> ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

602	No significant interactions with  <e0>digoxin</e0> ,  hydrochlorothiazide ,  hydralazine ,  <e1>sulfinpyrazone</e1> , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

603	No significant interactions with  <e0>digoxin</e0> ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  <e1>contraceptives</e1> ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

604	No significant interactions with  <e0>digoxin</e0> ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  <e1>tolbutamide</e1> , or  warfarin  have been observed."
Other
Comment:

605	No significant interactions with  <e0>digoxin</e0> ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  <e1>warfarin</e1>  have been observed."
Other
Comment:

606	No significant interactions with  digoxin ,  <e0>hydrochlorothiazide</e0> ,  <e1>hydralazine</e1> ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

607	No significant interactions with  digoxin ,  <e0>hydrochlorothiazide</e0> ,  hydralazine ,  <e1>sulfinpyrazone</e1> , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

608	No significant interactions with  digoxin ,  <e0>hydrochlorothiazide</e0> ,  hydralazine ,  sulfinpyrazone , oral  <e1>contraceptives</e1> ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

609	No significant interactions with  digoxin ,  <e0>hydrochlorothiazide</e0> ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  <e1>tolbutamide</e1> , or  warfarin  have been observed."
Other
Comment:

610	No significant interactions with  digoxin ,  <e0>hydrochlorothiazide</e0> ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  <e1>warfarin</e1>  have been observed."
Other
Comment:

611	No significant interactions with  digoxin ,  hydrochlorothiazide ,  <e0>hydralazine</e0> ,  <e1>sulfinpyrazone</e1> , oral  contraceptives ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

612	No significant interactions with  digoxin ,  hydrochlorothiazide ,  <e0>hydralazine</e0> ,  sulfinpyrazone , oral  <e1>contraceptives</e1> ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

613	No significant interactions with  digoxin ,  hydrochlorothiazide ,  <e0>hydralazine</e0> ,  sulfinpyrazone , oral  contraceptives ,  <e1>tolbutamide</e1> , or  warfarin  have been observed."
Other
Comment:

614	No significant interactions with  digoxin ,  hydrochlorothiazide ,  <e0>hydralazine</e0> ,  sulfinpyrazone , oral  contraceptives ,  tolbutamide , or  <e1>warfarin</e1>  have been observed."
Other
Comment:

615	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  <e0>sulfinpyrazone</e0> , oral  <e1>contraceptives</e1> ,  tolbutamide , or  warfarin  have been observed."
Other
Comment:

616	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  <e0>sulfinpyrazone</e0> , oral  contraceptives ,  <e1>tolbutamide</e1> , or  warfarin  have been observed."
Other
Comment:

617	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  <e0>sulfinpyrazone</e0> , oral  contraceptives ,  tolbutamide , or  <e1>warfarin</e1>  have been observed."
Other
Comment:

618	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  <e0>contraceptives</e0> ,  <e1>tolbutamide</e1> , or  warfarin  have been observed."
Other
Comment:

619	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  <e0>contraceptives</e0> ,  tolbutamide , or  <e1>warfarin</e1>  have been observed."
Other
Comment:

620	No significant interactions with  digoxin ,  hydrochlorothiazide ,  hydralazine ,  sulfinpyrazone , oral  contraceptives ,  <e0>tolbutamide</e0> , or  <e1>warfarin</e1>  have been observed."
Other
Comment:


100	 <e0>DIAMOX</e0>  modifies  <e1>phenytoin</e1>  metabolism with increased serum levels of  phenytoin ."
mechanism(e0,e1)Comment:

101	 <e0>DIAMOX</e0>  modifies  phenytoin  metabolism with increased serum levels of  <e1>phenytoin</e1> ."
mechanism(e0,e1)Comment:

102	 DIAMOX  modifies  <e0>phenytoin</e0>  metabolism with increased serum levels of  <e1>phenytoin</e1> ."
Other
Comment:

400	By decreasing the gastrointestinal absorption of  <e0>primidone</e0> ,  <e1>DIAMOX</e1>  may decrease serum concentrations of  primidone  and its metabolites, with a consequent possible decrease in anticonvulsant effect."
Other
Comment:

401	By decreasing the gastrointestinal absorption of  <e0>primidone</e0> ,  DIAMOX  may decrease serum concentrations of  <e1>primidone</e1>  and its metabolites, with a consequent possible decrease in anticonvulsant effect."
Other
Comment:

402	By decreasing the gastrointestinal absorption of  primidone ,  <e0>DIAMOX</e0>  may decrease serum concentrations of  <e1>primidone</e1>  and its metabolites, with a consequent possible decrease in anticonvulsant effect."
mechanism(e0,e1)Comment:

500	Caution is advised when beginning, discontinuing, or changing the dose of  <e0>DIAMOX</e0>  in patients receiving  <e1>primidone</e1> ."
advise(e0,e1)Comment:

700	 <e0>Acetazolamide</e0>  may increase the effects of other  <e1>folic acid antagonists</e1> ."
effect(e0,e1)Comment:

1000	 <e0>Acetazolamide</e0>  decreases urinary excretion of  <e1>amphetamine</e1>  and may enhance the magnitude and duration of their effect."
mechanism(e0,e1)Comment:

1100	 <e0>Acetazolamide</e0>  reduces urinary excretion of  <e1>quinidine</e1>  and may enhance its effect."
mechanism(e0,e1)Comment:

1200	 <e0>Acetazolamide</e0>  may prevent the urinary antiseptic effect of  <e1>methenamine</e1> ."
effect(e0,e1)Comment:

1300	 <e0>Acetazolamide</e0>  increases  <e1>lithium</e1>  excretion and the  lithium  may be decreased."
mechanism(e0,e1)Comment:

1301	 <e0>Acetazolamide</e0>  increases  lithium  excretion and the  <e1>lithium</e1>  may be decreased."
Other
Comment:

1302	 Acetazolamide  increases  <e0>lithium</e0>  excretion and the  <e1>lithium</e1>  may be decreased."
Other
Comment:

1400	 <e0>Acetazolamide</e0>  and  <e1>sodium bicarbonate</e1>  used concurrently increases the risk of renal calculus formation."
effect(e0,e1)Comment:

1500	 <e0>Acetazolamide</e0>  may elevate  <e1>cyclosporine</e1>  levels."
mechanism(e0,e1)Comment:


100	Concomitant use with  <e0>iron supplement</e0> s may result in the reduced absorption of  <e1>iron</e1> ."
Other
Comment:


100	Co-administration of  <e0>probenecid</e0>  with  <e1>acyclovir</e1>  has been shown to increase the mean half-life and the area under the concentration-time curve."
mechanism(e0,e1)Comment:


100	 <e0>Ethanol</e0> :Clinical evidence has shown that  <e1>etretinate</e1>  can be formed with concurrent ingestion of  acitretin  and  ethanol ."
Other
Comment:

101	 <e0>Ethanol</e0> :Clinical evidence has shown that  etretinate  can be formed with concurrent ingestion of  <e1>acitretin</e1>  and  ethanol ."
Other
Comment:

102	 <e0>Ethanol</e0> :Clinical evidence has shown that  etretinate  can be formed with concurrent ingestion of  acitretin  and  <e1>ethanol</e1> ."
Other
Comment:

103	 Ethanol :Clinical evidence has shown that  <e0>etretinate</e0>  can be formed with concurrent ingestion of  <e1>acitretin</e1>  and  ethanol ."
Other
Comment:

104	 Ethanol :Clinical evidence has shown that  <e0>etretinate</e0>  can be formed with concurrent ingestion of  acitretin  and  <e1>ethanol</e1> ."
Other
Comment:

105	 Ethanol :Clinical evidence has shown that  etretinate  can be formed with concurrent ingestion of  <e0>acitretin</e0>  and  <e1>ethanol</e1> ."
mechanism(e0,e1)Comment:

200	 <e0>Glibenclamide</e0> : In a study of 7 healthy male volunteers,  <e1>acitretin</e1>  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  sulfonylurea  similar to  chlorpropamide ) in 3 of the 7 subjects."
Other
Comment:

201	 <e0>Glibenclamide</e0> : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  <e1>glibenclamide</e1>  (a  sulfonylurea  similar to  chlorpropamide ) in 3 of the 7 subjects."
Other
Comment:

202	 <e0>Glibenclamide</e0> : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  <e1>sulfonylurea</e1>  similar to  chlorpropamide ) in 3 of the 7 subjects."
Other
Comment:

203	 <e0>Glibenclamide</e0> : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  sulfonylurea  similar to  <e1>chlorpropamide</e1> ) in 3 of the 7 subjects."
Other
Comment:

204	 Glibenclamide : In a study of 7 healthy male volunteers,  <e0>acitretin</e0>  treatment potentiated the blood glucose lowering effect of  <e1>glibenclamide</e1>  (a  sulfonylurea  similar to  chlorpropamide ) in 3 of the 7 subjects."
effect(e0,e1)Comment:

205	 Glibenclamide : In a study of 7 healthy male volunteers,  <e0>acitretin</e0>  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  <e1>sulfonylurea</e1>  similar to  chlorpropamide ) in 3 of the 7 subjects."
Other
Comment:

206	 Glibenclamide : In a study of 7 healthy male volunteers,  <e0>acitretin</e0>  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  sulfonylurea  similar to  <e1>chlorpropamide</e1> ) in 3 of the 7 subjects."
Other
Comment:

207	 Glibenclamide : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  <e0>glibenclamide</e0>  (a  <e1>sulfonylurea</e1>  similar to  chlorpropamide ) in 3 of the 7 subjects."
Other
Comment:

208	 Glibenclamide : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  <e0>glibenclamide</e0>  (a  sulfonylurea  similar to  <e1>chlorpropamide</e1> ) in 3 of the 7 subjects."
Other
Comment:

209	 Glibenclamide : In a study of 7 healthy male volunteers,  acitretin  treatment potentiated the blood glucose lowering effect of  glibenclamide  (a  <e0>sulfonylurea</e0>  similar to  <e1>chlorpropamide</e1> ) in 3 of the 7 subjects."
Other
Comment:

300	Repeating the study with 6 healthy male volunteers in the absence of  <e0>glibenclamide</e0>  did not detect an effect of  <e1>acitretin</e1>  on glucose tolerance."
Other
Comment:

500	 <e0>Hormonal Contraceptives</e0> : It has not been established if there is a pharmacokinetic interaction between  <e1>acitretin</e1>  and  combined oral contraceptives ."
Other
Comment:

501	 <e0>Hormonal Contraceptives</e0> : It has not been established if there is a pharmacokinetic interaction between  acitretin  and  <e1>combined oral contraceptives</e1> ."
Other
Comment:

502	 Hormonal Contraceptives : It has not been established if there is a pharmacokinetic interaction between  <e0>acitretin</e0>  and  <e1>combined oral contraceptives</e1> ."
Other
Comment:

600	However, it has been established that  <e0>acitretin</e0>  interferes with the contraceptive effect of microdosed  <e1>progestin</e1>  minipill preparations."
effect(e0,e1)Comment:

700	Microdosed minipill  <e0>progestin</e0>  preparations are not recommended for use with  <e1>Soriatane</e1> ."
advise(e0,e1)Comment:

800	It is not known whether other  <e0>progestational contraceptives</e0> , such as implants and injectables, are adequate methods of contraception during  <e1>acitretin</e1>  therapy."
Other
Comment:

900	 <e0>Methotrexate</e0> : An increased risk of hepatitis has been reported to result from combined use of  <e1>methotrexate</e1>  and  etretinate ."
Other
Comment:

901	 <e0>Methotrexate</e0> : An increased risk of hepatitis has been reported to result from combined use of  methotrexate  and  <e1>etretinate</e1> ."
Other
Comment:

902	 Methotrexate : An increased risk of hepatitis has been reported to result from combined use of  <e0>methotrexate</e0>  and  <e1>etretinate</e1> ."
effect(e0,e1)Comment:

1000	Consequently, the combination of  <e0>methotrexate</e0>  with  <e1>acitretin</e1>  is also contraindicated."
advise(e0,e1)Comment:

1100	 <e0>Phenytoin</e0> : If  <e1>acitretin</e1>  is given concurrently with  phenytoin , the protein binding of  phenytoin  may be reduced."
Other
Comment:

1101	 <e0>Phenytoin</e0> : If  acitretin  is given concurrently with  <e1>phenytoin</e1> , the protein binding of  phenytoin  may be reduced."
Other
Comment:

1102	 <e0>Phenytoin</e0> : If  acitretin  is given concurrently with  phenytoin , the protein binding of  <e1>phenytoin</e1>  may be reduced."
Other
Comment:

1103	 Phenytoin : If  <e0>acitretin</e0>  is given concurrently with  <e1>phenytoin</e1> , the protein binding of  phenytoin  may be reduced."
mechanism(e0,e1)Comment:

1104	 Phenytoin : If  <e0>acitretin</e0>  is given concurrently with  phenytoin , the protein binding of  <e1>phenytoin</e1>  may be reduced."
Other
Comment:

1105	 Phenytoin : If  acitretin  is given concurrently with  <e0>phenytoin</e0> , the protein binding of  <e1>phenytoin</e1>  may be reduced."
Other
Comment:

1200	 <e0>Tetracyclines</e0> : Since both  <e1>acitretin</e1>  and  tetracyclines  can cause increased intracranial pressure, their combined use is contraindicated."
Other
Comment:

1201	 <e0>Tetracyclines</e0> : Since both  acitretin  and  <e1>tetracyclines</e1>  can cause increased intracranial pressure, their combined use is contraindicated."
Other
Comment:

1202	 Tetracyclines : Since both  <e0>acitretin</e0>  and  <e1>tetracyclines</e1>  can cause increased intracranial pressure, their combined use is contraindicated."
effect(e0,e1)Comment:

1300	 <e0>Vitamin A</e0>  and oral  <e1>retinoids</e1> : Concomitant administration of  vitamin A  and/or other oral  retinoids  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1301	 <e0>Vitamin A</e0>  and oral  retinoids : Concomitant administration of  <e1>vitamin A</e1>  and/or other oral  retinoids  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1302	 <e0>Vitamin A</e0>  and oral  retinoids : Concomitant administration of  vitamin A  and/or other oral  <e1>retinoids</e1>  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1303	 <e0>Vitamin A</e0>  and oral  retinoids : Concomitant administration of  vitamin A  and/or other oral  retinoids  with  <e1>acitretin</e1>  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1304	 Vitamin A  and oral  <e0>retinoids</e0> : Concomitant administration of  <e1>vitamin A</e1>  and/or other oral  retinoids  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1305	 Vitamin A  and oral  <e0>retinoids</e0> : Concomitant administration of  vitamin A  and/or other oral  <e1>retinoids</e1>  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1306	 Vitamin A  and oral  <e0>retinoids</e0> : Concomitant administration of  vitamin A  and/or other oral  retinoids  with  <e1>acitretin</e1>  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1307	 Vitamin A  and oral  retinoids : Concomitant administration of  <e0>vitamin A</e0>  and/or other oral  <e1>retinoids</e1>  with  acitretin  must be avoided because of the risk of hypervitaminosis A."
Other
Comment:

1308	 Vitamin A  and oral  retinoids : Concomitant administration of  <e0>vitamin A</e0>  and/or other oral  retinoids  with  <e1>acitretin</e1>  must be avoided because of the risk of hypervitaminosis A."
advise(e0,e1)Comment:

1309	 Vitamin A  and oral  retinoids : Concomitant administration of  vitamin A  and/or other oral  <e0>retinoids</e0>  with  <e1>acitretin</e1>  must be avoided because of the risk of hypervitaminosis A."
advise(e0,e1)Comment:

1400	Other: There appears to be no pharmacokinetic interaction between  <e0>acitretin</e0>  and  <e1>cimetidine</e1> ,  digoxin , or  glyburide ."
Other
Comment:

1401	Other: There appears to be no pharmacokinetic interaction between  <e0>acitretin</e0>  and  cimetidine ,  <e1>digoxin</e1> , or  glyburide ."
Other
Comment:

1402	Other: There appears to be no pharmacokinetic interaction between  <e0>acitretin</e0>  and  cimetidine ,  digoxin , or  <e1>glyburide</e1> ."
Other
Comment:

1403	Other: There appears to be no pharmacokinetic interaction between  acitretin  and  <e0>cimetidine</e0> ,  <e1>digoxin</e1> , or  glyburide ."
Other
Comment:

1404	Other: There appears to be no pharmacokinetic interaction between  acitretin  and  <e0>cimetidine</e0> ,  digoxin , or  <e1>glyburide</e1> ."
Other
Comment:

1405	Other: There appears to be no pharmacokinetic interaction between  acitretin  and  cimetidine ,  <e0>digoxin</e0> , or  <e1>glyburide</e1> ."
Other
Comment:

1500	Investigations into the effect of  <e0>acitretin</e0>  on the protein binding of  <e1>anticoagulants of the coumarin type</e1>  ( warfarin ) revealed no interaction."
Other
Comment:

1501	Investigations into the effect of  <e0>acitretin</e0>  on the protein binding of  anticoagulants of the coumarin type  ( <e1>warfarin</e1> ) revealed no interaction."
Other
Comment:

1502	Investigations into the effect of  acitretin  on the protein binding of  <e0>anticoagulants of the coumarin type</e0>  ( <e1>warfarin</e1> ) revealed no interaction."
Other
Comment:


100	 <e0>Methotrexate</e0> :  <e1>HUMIRA</e1>  has been studied in rheumatoid arthritis patients taking concomitant  MTX ."
Other
Comment:

101	 <e0>Methotrexate</e0> :  HUMIRA  has been studied in rheumatoid arthritis patients taking concomitant  <e1>MTX</e1> ."
Other
Comment:

102	 Methotrexate :  <e0>HUMIRA</e0>  has been studied in rheumatoid arthritis patients taking concomitant  <e1>MTX</e1> ."
Other
Comment:

200	The data do not suggest the need for dose adjustment of either  <e0>HUMIRA</e0>  or  <e1>MTX</e1> ."
Other
Comment:

300	 <e0>Anakinra</e0> : Concurrent administration of  <e1>anakinra</e1>  (an  interleukin-1 antagonist ) and another  TNF-blocking agent  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
Other
Comment:

301	 <e0>Anakinra</e0> : Concurrent administration of  anakinra  (an  <e1>interleukin-1 antagonist</e1> ) and another  TNF-blocking agent  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
Other
Comment:

302	 <e0>Anakinra</e0> : Concurrent administration of  anakinra  (an  interleukin-1 antagonist ) and another  <e1>TNF-blocking agent</e1>  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
Other
Comment:

303	 Anakinra : Concurrent administration of  <e0>anakinra</e0>  (an  <e1>interleukin-1 antagonist</e1> ) and another  TNF-blocking agent  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
Other
Comment:

304	 Anakinra : Concurrent administration of  <e0>anakinra</e0>  (an  interleukin-1 antagonist ) and another  <e1>TNF-blocking agent</e1>  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
effect(e0,e1)Comment:

305	 Anakinra : Concurrent administration of  anakinra  (an  <e0>interleukin-1 antagonist</e0> ) and another  <e1>TNF-blocking agent</e1>  has been associated with an increased risk of serious infections, an increased risk of neutropenia and no additional benefit compared to these medicinal products alone."
effect(e0,e1)Comment:

400	The safety and efficacy of  <e0>anakinra</e0>  used in combination with  <e1>HUMIRA</e1>  has not been studied."
Other
Comment:

500	Therefore the, combination of  <e0>anakinra</e0>  with other  <e1>TNF-blocking agents</e1> , including  HUMIRA , may also result i n similar toxicities."
effect(e0,e1)Comment:

501	Therefore the, combination of  <e0>anakinra</e0>  with other  TNF-blocking agents , including  <e1>HUMIRA</e1> , may also result i n similar toxicities."
effect(e0,e1)Comment:

502	Therefore the, combination of  anakinra  with other  <e0>TNF-blocking agents</e0> , including  <e1>HUMIRA</e1> , may also result i n similar toxicities."
Other
Comment:


200	Particular caution should be exercised in using preparations containing  <e0>sulfur</e0> ,  <e1>resorcinol</e1> , or  salicylic acid  in combination with  DIFFERIN  Gel."
Other
Comment:

201	Particular caution should be exercised in using preparations containing  <e0>sulfur</e0> ,  resorcinol , or  <e1>salicylic acid</e1>  in combination with  DIFFERIN  Gel."
Other
Comment:

202	Particular caution should be exercised in using preparations containing  <e0>sulfur</e0> ,  resorcinol , or  salicylic acid  in combination with  <e1>DIFFERIN</e1>  Gel."
Other
Comment:

203	Particular caution should be exercised in using preparations containing  sulfur ,  <e0>resorcinol</e0> , or  <e1>salicylic acid</e1>  in combination with  DIFFERIN  Gel."
Other
Comment:

204	Particular caution should be exercised in using preparations containing  sulfur ,  <e0>resorcinol</e0> , or  salicylic acid  in combination with  <e1>DIFFERIN</e1>  Gel."
Other
Comment:

205	Particular caution should be exercised in using preparations containing  sulfur ,  resorcinol , or  <e0>salicylic acid</e0>  in combination with  <e1>DIFFERIN</e1>  Gel."
Other
Comment:


100	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  <e1>gentamicin</e1> ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

101	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  <e1>amikacin</e1> ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

102	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  <e1>amphotericin B</e1> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

103	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  <e1>cyclosporine</e1> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

104	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  <e1>non-steroidal anti-inflammatory</e1>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

105	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

106	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

107	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  <e0>aminoglycosides</e0>  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

108	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  <e1>amikacin</e1> ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

109	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  <e1>amphotericin B</e1> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

110	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  amphotericin B ,  <e1>cyclosporine</e1> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

111	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  amphotericin B ,  cyclosporine ,  <e1>non-steroidal anti-inflammatory</e1>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

112	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

113	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

114	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  <e0>gentamicin</e0> ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

115	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  <e1>amphotericin B</e1> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

116	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  amphotericin B ,  <e1>cyclosporine</e1> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

117	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  amphotericin B ,  cyclosporine ,  <e1>non-steroidal anti-inflammatory</e1>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

118	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

119	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

120	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  <e0>amikacin</e0> ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

121	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  <e0>amphotericin B</e0> ,  <e1>cyclosporine</e1> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

122	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  <e0>amphotericin B</e0> ,  cyclosporine ,  <e1>non-steroidal anti-inflammatory</e1>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

123	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  <e0>amphotericin B</e0> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

124	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  <e0>amphotericin B</e0> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

125	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  <e0>amphotericin B</e0> ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

126	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  <e0>cyclosporine</e0> ,  <e1>non-steroidal anti-inflammatory</e1>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  vancomycin ."
Other
Comment:

127	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  <e0>cyclosporine</e0> ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

128	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  <e0>cyclosporine</e0> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

129	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  <e0>cyclosporine</e0> ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

130	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  <e0>non-steroidal anti-inflammatory</e0>  drugs (e.g.,  <e1>ibuprofen</e1> ),  tacrolimus ,  vancomycin ."
Other
Comment:

131	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  <e0>non-steroidal anti-inflammatory</e0>  drugs (e.g.,  ibuprofen ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

132	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  <e0>non-steroidal anti-inflammatory</e0>  drugs (e.g.,  ibuprofen ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

133	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e0>ibuprofen</e0> ),  <e1>tacrolimus</e1> ,  vancomycin ."
Other
Comment:

134	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  <e0>ibuprofen</e0> ),  tacrolimus ,  <e1>vancomycin</e1> ."
Other
Comment:

135	Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of:  aminoglycosides  (e.g.,  gentamicin ,  amikacin ),  amphotericin B ,  cyclosporine ,  non-steroidal anti-inflammatory  drugs (e.g.,  ibuprofen ),  <e0>tacrolimus</e0> ,  <e1>vancomycin</e1> ."
Other
Comment:


100	Intravenous  <e0>Adenocard</e0>  ( <e1>adenosine</e1> ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

101	Intravenous  <e0>Adenocard</e0>  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  <e1>quinidine</e1> ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

102	Intravenous  <e0>Adenocard</e0>  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  <e1>beta-adrenergic blocking agents</e1> ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

103	Intravenous  <e0>Adenocard</e0>  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  <e1>calcium channel blocking agents</e1> , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

104	Intravenous  <e0>Adenocard</e0>  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  <e1>angiotensin converting enzyme inhibitors</e1> , without any change in the adverse reaction profile."
Other
Comment:

105	Intravenous  Adenocard  ( <e0>adenosine</e0> ) has been effectively administered in the presence of other cardioactive drugs, such as  <e1>quinidine</e1> ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

106	Intravenous  Adenocard  ( <e0>adenosine</e0> ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  <e1>beta-adrenergic blocking agents</e1> ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

107	Intravenous  Adenocard  ( <e0>adenosine</e0> ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  <e1>calcium channel blocking agents</e1> , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

108	Intravenous  Adenocard  ( <e0>adenosine</e0> ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  <e1>angiotensin converting enzyme inhibitors</e1> , without any change in the adverse reaction profile."
Other
Comment:

109	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  <e0>quinidine</e0> ,  <e1>beta-adrenergic blocking agents</e1> ,  calcium channel blocking agents , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

110	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  <e0>quinidine</e0> ,  beta-adrenergic blocking agents ,  <e1>calcium channel blocking agents</e1> , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

111	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  <e0>quinidine</e0> ,  beta-adrenergic blocking agents ,  calcium channel blocking agents , and  <e1>angiotensin converting enzyme inhibitors</e1> , without any change in the adverse reaction profile."
Other
Comment:

112	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  <e0>beta-adrenergic blocking agents</e0> ,  <e1>calcium channel blocking agents</e1> , and  angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile."
Other
Comment:

113	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  <e0>beta-adrenergic blocking agents</e0> ,  calcium channel blocking agents , and  <e1>angiotensin converting enzyme inhibitors</e1> , without any change in the adverse reaction profile."
Other
Comment:

114	Intravenous  Adenocard  ( adenosine ) has been effectively administered in the presence of other cardioactive drugs, such as  quinidine ,  beta-adrenergic blocking agents ,  <e0>calcium channel blocking agents</e0> , and  <e1>angiotensin converting enzyme inhibitors</e1> , without any change in the adverse reaction profile."
Other
Comment:

200	 <e0>Digoxin</e0>  and  <e1>verapamil</e1>  use may be rarely associated with ventricular fibrillation when combined with  Adenocard ."
Other
Comment:

201	 <e0>Digoxin</e0>  and  verapamil  use may be rarely associated with ventricular fibrillation when combined with  <e1>Adenocard</e1> ."
effect(e0,e1)Comment:

202	 Digoxin  and  <e0>verapamil</e0>  use may be rarely associated with ventricular fibrillation when combined with  <e1>Adenocard</e1> ."
effect(e0,e1)Comment:

400	The use of  <e0>Adenocard</e0>  in patients receiving  <e1>digitalis</e1>  may be rarely associated with ventricular fibrillation."
effect(e0,e1)Comment:

500	The effects of  <e0>adenosine</e0>  are antagonized by  <e1>methylxanthines</e1>  such as  caffeine  and  theophylline ."
effect(e0,e1)Comment:

501	The effects of  <e0>adenosine</e0>  are antagonized by  methylxanthines  such as  <e1>caffeine</e1>  and  theophylline ."
effect(e0,e1)Comment:

502	The effects of  <e0>adenosine</e0>  are antagonized by  methylxanthines  such as  caffeine  and  <e1>theophylline</e1> ."
effect(e0,e1)Comment:

503	The effects of  adenosine  are antagonized by  <e0>methylxanthines</e0>  such as  <e1>caffeine</e1>  and  theophylline ."
Other
Comment:

504	The effects of  adenosine  are antagonized by  <e0>methylxanthines</e0>  such as  caffeine  and  <e1>theophylline</e1> ."
Other
Comment:

505	The effects of  adenosine  are antagonized by  methylxanthines  such as  <e0>caffeine</e0>  and  <e1>theophylline</e1> ."
Other
Comment:

600	In the presence of these  <e0>methylxanthines</e0> , larger doses of  <e1>adenosine</e1>  may be required or  adenosine  may not be effective."
advise(e0,e1)Comment:

601	In the presence of these  <e0>methylxanthines</e0> , larger doses of  adenosine  may be required or  <e1>adenosine</e1>  may not be effective."
advise(e0,e1)Comment:

602	In the presence of these  methylxanthines , larger doses of  <e0>adenosine</e0>  may be required or  <e1>adenosine</e1>  may not be effective."
Other
Comment:

700	 <e0>Adenosine</e0>  effects are potentiated by  <e1>dipyridamole</e1> ."
effect(e0,e1)Comment:

800	Thus, smaller doses of  <e0>adenosine</e0>  may be effective in the presence of  <e1>dipyridamole</e1> ."
effect(e0,e1)Comment:

1000	As the primary effect of  <e0>adenosine</e0>  is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of  <e1>carbamazepine</e1> ."
effect(e0,e1)Comment:


100	Co-administration with  <e0>antifungal agents</e0>  such as  <e1>ketoconazole</e1>  or  itraconazole  is not recommended."
Other
Comment:

101	Co-administration with  <e0>antifungal agents</e0>  such as  ketoconazole  or  <e1>itraconazole</e1>  is not recommended."
Other
Comment:

102	Co-administration with  antifungal agents  such as  <e0>ketoconazole</e0>  or  <e1>itraconazole</e1>  is not recommended."
Other
Comment:

200	 <e0>Nafazodone</e0> ,  <e1>fluvoxamine</e1> ,  cimetidine  (consider  Xanax  dose reduction)."
Other
Comment:

201	 <e0>Nafazodone</e0> ,  fluvoxamine ,  <e1>cimetidine</e1>  (consider  Xanax  dose reduction)."
Other
Comment:

202	 <e0>Nafazodone</e0> ,  fluvoxamine ,  cimetidine  (consider  <e1>Xanax</e1>  dose reduction)."
advise(e0,e1)Comment:

203	 Nafazodone ,  <e0>fluvoxamine</e0> ,  <e1>cimetidine</e1>  (consider  Xanax  dose reduction)."
Other
Comment:

204	 Nafazodone ,  <e0>fluvoxamine</e0> ,  cimetidine  (consider  <e1>Xanax</e1>  dose reduction)."
advise(e0,e1)Comment:

205	 Nafazodone ,  fluvoxamine ,  <e0>cimetidine</e0>  (consider  <e1>Xanax</e1>  dose reduction)."
advise(e0,e1)Comment:

300	 <e0>Fluoxetine</e0> ,  <e1>OCs</e1> ,  sertraline ,  diltiazem ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

301	 <e0>Fluoxetine</e0> ,  OCs ,  <e1>sertraline</e1> ,  diltiazem ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

302	 <e0>Fluoxetine</e0> ,  OCs ,  sertraline ,  <e1>diltiazem</e1> ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

303	 <e0>Fluoxetine</e0> ,  OCs ,  sertraline ,  diltiazem ,  <e1>macrolide antibiotics</e1>  (exercise caution)."
Other
Comment:

304	 Fluoxetine ,  <e0>OCs</e0> ,  <e1>sertraline</e1> ,  diltiazem ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

305	 Fluoxetine ,  <e0>OCs</e0> ,  sertraline ,  <e1>diltiazem</e1> ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

306	 Fluoxetine ,  <e0>OCs</e0> ,  sertraline ,  diltiazem ,  <e1>macrolide antibiotics</e1>  (exercise caution)."
Other
Comment:

307	 Fluoxetine ,  OCs ,  <e0>sertraline</e0> ,  <e1>diltiazem</e1> ,  macrolide antibiotics  (exercise caution)."
Other
Comment:

308	 Fluoxetine ,  OCs ,  <e0>sertraline</e0> ,  diltiazem ,  <e1>macrolide antibiotics</e1>  (exercise caution)."
Other
Comment:

309	 Fluoxetine ,  OCs ,  sertraline ,  <e0>diltiazem</e0> ,  <e1>macrolide antibiotics</e1>  (exercise caution)."
Other
Comment:



100	 <e0>Dexamethasone</e0> : Steady-state trough concentrations of  <e1>albendazole sulfoxide</e1>  were about 56% higher when 8 mg  dexamethasone  was coadministered with each dose of  albendazole  (15 mg/kg/day) in eight neurocysticercosis patients."
Other
Comment:

101	 <e0>Dexamethasone</e0> : Steady-state trough concentrations of  albendazole sulfoxide  were about 56% higher when 8 mg  <e1>dexamethasone</e1>  was coadministered with each dose of  albendazole  (15 mg/kg/day) in eight neurocysticercosis patients."
Other
Comment:

102	 <e0>Dexamethasone</e0> : Steady-state trough concentrations of  albendazole sulfoxide  were about 56% higher when 8 mg  dexamethasone  was coadministered with each dose of  <e1>albendazole</e1>  (15 mg/kg/day) in eight neurocysticercosis patients."
Other
Comment:

103	 Dexamethasone : Steady-state trough concentrations of  <e0>albendazole sulfoxide</e0>  were about 56% higher when 8 mg  <e1>dexamethasone</e1>  was coadministered with each dose of  albendazole  (15 mg/kg/day) in eight neurocysticercosis patients."
Other
Comment:

104	 Dexamethasone : Steady-state trough concentrations of  <e0>albendazole sulfoxide</e0>  were about 56% higher when 8 mg  dexamethasone  was coadministered with each dose of  <e1>albendazole</e1>  (15 mg/kg/day) in eight neurocysticercosis patients."
Other
Comment:

105	 Dexamethasone : Steady-state trough concentrations of  albendazole sulfoxide  were about 56% higher when 8 mg  <e0>dexamethasone</e0>  was coadministered with each dose of  <e1>albendazole</e1>  (15 mg/kg/day) in eight neurocysticercosis patients."
mechanism(e0,e1)Comment:

200	 <e0>Praziquantel</e0> : In the fed state,  <e1>praziquantel</e1>  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  albendazole sulfoxide  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  albendazole  alone."
Other
Comment:

201	 <e0>Praziquantel</e0> : In the fed state,  praziquantel  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  <e1>albendazole sulfoxide</e1>  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  albendazole  alone."
Other
Comment:

202	 <e0>Praziquantel</e0> : In the fed state,  praziquantel  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  albendazole sulfoxide  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  <e1>albendazole</e1>  alone."
Other
Comment:

203	 Praziquantel : In the fed state,  <e0>praziquantel</e0>  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  <e1>albendazole sulfoxide</e1>  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  albendazole  alone."
mechanism(e0,e1)Comment:

204	 Praziquantel : In the fed state,  <e0>praziquantel</e0>  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  albendazole sulfoxide  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  <e1>albendazole</e1>  alone."
Other
Comment:

205	 Praziquantel : In the fed state,  praziquantel  (40 mg/kg) increased mean maximum plasma concentration and area under the curve of  <e0>albendazole sulfoxide</e0>  by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given  <e1>albendazole</e1>  alone."
Other
Comment:

400	The pharmacokinetics of  <e0>praziquantel</e0>  were unchanged following coadministration with  <e1>albendazole</e1>  (400 mg)."
Other
Comment:

500	 <e0>Cimetidine</e0> :  <e1>Albendazole sulfoxide</e1>  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  cimetidine  (10 mg/kg/day) (n=7) compared with  albendazole  (20 mg/kg/day) alone (n=12)."
Other
Comment:

501	 <e0>Cimetidine</e0> :  Albendazole sulfoxide  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  <e1>cimetidine</e1>  (10 mg/kg/day) (n=7) compared with  albendazole  (20 mg/kg/day) alone (n=12)."
Other
Comment:

502	 <e0>Cimetidine</e0> :  Albendazole sulfoxide  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  cimetidine  (10 mg/kg/day) (n=7) compared with  <e1>albendazole</e1>  (20 mg/kg/day) alone (n=12)."
Other
Comment:

503	 Cimetidine :  <e0>Albendazole sulfoxide</e0>  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  <e1>cimetidine</e1>  (10 mg/kg/day) (n=7) compared with  albendazole  (20 mg/kg/day) alone (n=12)."
mechanism(e0,e1)Comment:

504	 Cimetidine :  <e0>Albendazole sulfoxide</e0>  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  cimetidine  (10 mg/kg/day) (n=7) compared with  <e1>albendazole</e1>  (20 mg/kg/day) alone (n=12)."
Other
Comment:

505	 Cimetidine :  Albendazole sulfoxide  concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with  <e0>cimetidine</e0>  (10 mg/kg/day) (n=7) compared with  <e1>albendazole</e1>  (20 mg/kg/day) alone (n=12)."
Other
Comment:

700	 <e0>Theophylline</e0> : The pharmacokinetics of  <e1>theophylline</e1>  ( aminophylline  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  albendazole  (400 mg) in 6 healthy subjects."
Other
Comment:

701	 <e0>Theophylline</e0> : The pharmacokinetics of  theophylline  ( <e1>aminophylline</e1>  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  albendazole  (400 mg) in 6 healthy subjects."
Other
Comment:

702	 <e0>Theophylline</e0> : The pharmacokinetics of  theophylline  ( aminophylline  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  <e1>albendazole</e1>  (400 mg) in 6 healthy subjects."
Other
Comment:

703	 Theophylline : The pharmacokinetics of  <e0>theophylline</e0>  ( <e1>aminophylline</e1>  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  albendazole  (400 mg) in 6 healthy subjects."
Other
Comment:

704	 Theophylline : The pharmacokinetics of  <e0>theophylline</e0>  ( aminophylline  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  <e1>albendazole</e1>  (400 mg) in 6 healthy subjects."
Other
Comment:

705	 Theophylline : The pharmacokinetics of  theophylline  ( <e0>aminophylline</e0>  5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of  <e1>albendazole</e1>  (400 mg) in 6 healthy subjects."
Other
Comment:



200	Therefore, interactions could occur following concomitant administration of  <e0>psychotropic drugs</e0>  (e.g.,  <e1>narcotics</e1> ,  analgesics ,  antiemetics ,  sedatives ,  tranquilizers )."
Other
Comment:

201	Therefore, interactions could occur following concomitant administration of  <e0>psychotropic drugs</e0>  (e.g.,  narcotics ,  <e1>analgesics</e1> ,  antiemetics ,  sedatives ,  tranquilizers )."
Other
Comment:

202	Therefore, interactions could occur following concomitant administration of  <e0>psychotropic drugs</e0>  (e.g.,  narcotics ,  analgesics ,  <e1>antiemetics</e1> ,  sedatives ,  tranquilizers )."
Other
Comment:

203	Therefore, interactions could occur following concomitant administration of  <e0>psychotropic drugs</e0>  (e.g.,  narcotics ,  analgesics ,  antiemetics ,  <e1>sedatives</e1> ,  tranquilizers )."
Other
Comment:

204	Therefore, interactions could occur following concomitant administration of  <e0>psychotropic drugs</e0>  (e.g.,  narcotics ,  analgesics ,  antiemetics ,  sedatives ,  <e1>tranquilizers</e1> )."
Other
Comment:

205	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  <e0>narcotics</e0> ,  <e1>analgesics</e1> ,  antiemetics ,  sedatives ,  tranquilizers )."
Other
Comment:

206	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  <e0>narcotics</e0> ,  analgesics ,  <e1>antiemetics</e1> ,  sedatives ,  tranquilizers )."
Other
Comment:

207	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  <e0>narcotics</e0> ,  analgesics ,  antiemetics ,  <e1>sedatives</e1> ,  tranquilizers )."
Other
Comment:

208	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  <e0>narcotics</e0> ,  analgesics ,  antiemetics ,  sedatives ,  <e1>tranquilizers</e1> )."
Other
Comment:

209	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  <e0>analgesics</e0> ,  <e1>antiemetics</e1> ,  sedatives ,  tranquilizers )."
Other
Comment:

210	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  <e0>analgesics</e0> ,  antiemetics ,  <e1>sedatives</e1> ,  tranquilizers )."
Other
Comment:

211	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  <e0>analgesics</e0> ,  antiemetics ,  sedatives ,  <e1>tranquilizers</e1> )."
Other
Comment:

212	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  analgesics ,  <e0>antiemetics</e0> ,  <e1>sedatives</e1> ,  tranquilizers )."
Other
Comment:

213	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  analgesics ,  <e0>antiemetics</e0> ,  sedatives ,  <e1>tranquilizers</e1> )."
Other
Comment:

214	Therefore, interactions could occur following concomitant administration of  psychotropic drugs  (e.g.,  narcotics ,  analgesics ,  antiemetics ,  <e0>sedatives</e0> ,  <e1>tranquilizers</e1> )."
Other
Comment:

300	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  <e1>indomethacin</e1> ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

301	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  indomethacin ), myelotoxic (e.g.,  <e1>cytotoxic</e1>  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

302	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  <e1>doxorubicin</e1> ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

303	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  <e1>methotrexate</e1> ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

304	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  <e1>asparaginase</e1> ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

305	Concurrent administration of drugs possessing nephrotoxic (e.g.,  <e0>aminoglycosides</e0> ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

306	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  <e0>indomethacin</e0> ), myelotoxic (e.g.,  <e1>cytotoxic</e1>  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

307	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  <e0>indomethacin</e0> ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  <e1>doxorubicin</e1> ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

308	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  <e0>indomethacin</e0> ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  <e1>methotrexate</e1> ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

309	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  <e0>indomethacin</e0> ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  <e1>asparaginase</e1> ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

310	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  <e0>indomethacin</e0> ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

311	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  <e0>cytotoxic</e0>  chemotherapy), cardiotoxic (e.g.,  <e1>doxorubicin</e1> ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

312	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  <e0>cytotoxic</e0>  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  <e1>methotrexate</e1> ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

313	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  <e0>cytotoxic</e0>  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  <e1>asparaginase</e1> ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

314	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  <e0>cytotoxic</e0>  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

315	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  <e0>doxorubicin</e0> ) or hepatotoxic (e.g.,  <e1>methotrexate</e1> ,  asparaginase ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

316	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  <e0>doxorubicin</e0> ) or hepatotoxic (e.g.,  methotrexate ,  <e1>asparaginase</e1> ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

317	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  <e0>doxorubicin</e0> ) or hepatotoxic (e.g.,  methotrexate ,  asparaginase ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

318	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  <e0>methotrexate</e0> ,  <e1>asparaginase</e1> ) effects with  PROLEUKIN  may increase toxicity in these organ systems."
Other
Comment:

319	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  <e0>methotrexate</e0> ,  asparaginase ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

320	Concurrent administration of drugs possessing nephrotoxic (e.g.,  aminoglycosides ,  indomethacin ), myelotoxic (e.g.,  cytotoxic  chemotherapy), cardiotoxic (e.g.,  doxorubicin ) or hepatotoxic (e.g.,  methotrexate ,  <e0>asparaginase</e0> ) effects with  <e1>PROLEUKIN</e1>  may increase toxicity in these organ systems."
effect(e0,e1)Comment:

400	The safety and efficacy of  <e0>PROLEUKIN</e0>  in combination with any  <e1>antineoplastic agents</e1>  have not been established."
Other
Comment:

600	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  <e0>PROLEUKIN</e0>  and  <e1>antineoplastic agents</e1> , specifically,  dacarbazine ,  cis-platinum ,  tamoxifen  and  interferon-alfa ."
effect(e0,e1)Comment:

601	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  <e0>PROLEUKIN</e0>  and  antineoplastic agents , specifically,  <e1>dacarbazine</e1> ,  cis-platinum ,  tamoxifen  and  interferon-alfa ."
effect(e0,e1)Comment:

602	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  <e0>PROLEUKIN</e0>  and  antineoplastic agents , specifically,  dacarbazine ,  <e1>cis-platinum</e1> ,  tamoxifen  and  interferon-alfa ."
effect(e0,e1)Comment:

603	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  <e0>PROLEUKIN</e0>  and  antineoplastic agents , specifically,  dacarbazine ,  cis-platinum ,  <e1>tamoxifen</e1>  and  interferon-alfa ."
effect(e0,e1)Comment:

604	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  <e0>PROLEUKIN</e0>  and  antineoplastic agents , specifically,  dacarbazine ,  cis-platinum ,  tamoxifen  and  <e1>interferon-alfa</e1> ."
effect(e0,e1)Comment:

605	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  <e0>antineoplastic agents</e0> , specifically,  <e1>dacarbazine</e1> ,  cis-platinum ,  tamoxifen  and  interferon-alfa ."
Other
Comment:

606	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  <e0>antineoplastic agents</e0> , specifically,  dacarbazine ,  <e1>cis-platinum</e1> ,  tamoxifen  and  interferon-alfa ."
Other
Comment:

607	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  <e0>antineoplastic agents</e0> , specifically,  dacarbazine ,  cis-platinum ,  <e1>tamoxifen</e1>  and  interferon-alfa ."
Other
Comment:

608	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  <e0>antineoplastic agents</e0> , specifically,  dacarbazine ,  cis-platinum ,  tamoxifen  and  <e1>interferon-alfa</e1> ."
Other
Comment:

609	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  <e0>dacarbazine</e0> ,  <e1>cis-platinum</e1> ,  tamoxifen  and  interferon-alfa ."
Other
Comment:

610	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  <e0>dacarbazine</e0> ,  cis-platinum ,  <e1>tamoxifen</e1>  and  interferon-alfa ."
Other
Comment:

611	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  <e0>dacarbazine</e0> ,  cis-platinum ,  tamoxifen  and  <e1>interferon-alfa</e1> ."
Other
Comment:

612	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  dacarbazine ,  <e0>cis-platinum</e0> ,  <e1>tamoxifen</e1>  and  interferon-alfa ."
Other
Comment:

613	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  dacarbazine ,  <e0>cis-platinum</e0> ,  tamoxifen  and  <e1>interferon-alfa</e1> ."
Other
Comment:

614	Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose  PROLEUKIN  and  antineoplastic agents , specifically,  dacarbazine ,  cis-platinum ,  <e0>tamoxifen</e0>  and  <e1>interferon-alfa</e1> ."
Other
Comment:

900	Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving  <e0>PROLEUKIN</e0>  and  <e1>interferon-alfa</e1>  concurrently."
effect(e0,e1)Comment:

1000	Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of  <e0>interferon-alfa</e0>  and  <e1>PROLEUKIN</e1> , including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome."
effect(e0,e1)Comment:

1100	Although  <e0>glucocorticoids</e0>  have been shown to reduce  <e1>PROLEUKIN</e1> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
effect(e0,e1)Comment:

1101	Although  <e0>glucocorticoids</e0>  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e1>PROLEUKIN</e1>  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1102	Although  <e0>glucocorticoids</e0>  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  <e1>PROLEUKIN</e1>  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1103	Although  <e0>glucocorticoids</e0>  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  <e1>Beta-blockers</e1>  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1104	Although  <e0>glucocorticoids</e0>  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  <e1>antihypertensives</e1>  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1105	Although  <e0>glucocorticoids</e0>  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
Other
Comment:

1106	Although  glucocorticoids  have been shown to reduce  <e0>PROLEUKIN</e0> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e1>PROLEUKIN</e1>  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1107	Although  glucocorticoids  have been shown to reduce  <e0>PROLEUKIN</e0> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  <e1>PROLEUKIN</e1>  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1108	Although  glucocorticoids  have been shown to reduce  <e0>PROLEUKIN</e0> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  <e1>Beta-blockers</e1>  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1109	Although  glucocorticoids  have been shown to reduce  <e0>PROLEUKIN</e0> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  <e1>antihypertensives</e1>  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1110	Although  glucocorticoids  have been shown to reduce  <e0>PROLEUKIN</e0> -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
Other
Comment:

1111	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e0>PROLEUKIN</e0>  may reduce the antitumor effectiveness of  <e1>PROLEUKIN</e1>  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1112	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e0>PROLEUKIN</e0>  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  <e1>Beta-blockers</e1>  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1113	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e0>PROLEUKIN</e0>  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  <e1>antihypertensives</e1>  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1114	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  <e0>PROLEUKIN</e0>  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
Other
Comment:

1115	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  <e0>PROLEUKIN</e0>  and thus should be avoided. 12  <e1>Beta-blockers</e1>  and other  antihypertensives  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1116	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  <e0>PROLEUKIN</e0>  and thus should be avoided. 12  Beta-blockers  and other  <e1>antihypertensives</e1>  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1117	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  <e0>PROLEUKIN</e0>  and thus should be avoided. 12  Beta-blockers  and other  antihypertensives  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
Other
Comment:

1118	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  <e0>Beta-blockers</e0>  and other  <e1>antihypertensives</e1>  may potentiate the hypotension seen with  PROLEUKIN ."
Other
Comment:

1119	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  <e0>Beta-blockers</e0>  and other  antihypertensives  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
effect(e0,e1)Comment:

1120	Although  glucocorticoids  have been shown to reduce  PROLEUKIN -induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with  PROLEUKIN  may reduce the antitumor effectiveness of  PROLEUKIN  and thus should be avoided. 12  Beta-blockers  and other  <e0>antihypertensives</e0>  may potentiate the hypotension seen with  <e1>PROLEUKIN</e1> ."
effect(e0,e1)Comment:

1200	Delayed Adverse Reactions to  <e0>Iodinated Contrast Media</e0> : A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various  <e1>interleukin-2</e1>  containing regimens who were subsequently administered  radiographic iodinated contrast media  experienced acute, atypical adverse reactions."
Other
Comment:

1201	Delayed Adverse Reactions to  <e0>Iodinated Contrast Media</e0> : A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various  interleukin-2  containing regimens who were subsequently administered  <e1>radiographic iodinated contrast media</e1>  experienced acute, atypical adverse reactions."
Other
Comment:

1202	Delayed Adverse Reactions to  Iodinated Contrast Media : A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various  <e0>interleukin-2</e0>  containing regimens who were subsequently administered  <e1>radiographic iodinated contrast media</e1>  experienced acute, atypical adverse reactions."
effect(e0,e1)Comment:


200	The duration of the period following treatment with  <e0>AMEVIVE</e0>   before one should consider starting other  <e1>immunosuppressive</e1>  therapy has not been evaluated."
Other
Comment:

1700	Since the effect of  <e0>AMEVIVE</e0>  on pregnancy and fetal development, including immune system development, is not known, health care providers are encouraged to enroll patients currently taking  <e1>AMEVIVE</e1>  who become pregnant into the Biogen Pregnancy Registry by calling 1-866- AMEVIVE  (1-866-263-8483)."
Other
Comment:

1701	Since the effect of  <e0>AMEVIVE</e0>  on pregnancy and fetal development, including immune system development, is not known, health care providers are encouraged to enroll patients currently taking  AMEVIVE  who become pregnant into the Biogen Pregnancy Registry by calling 1-866- <e1>AMEVIVE</e1>  (1-866-263-8483)."
Other
Comment:

1702	Since the effect of  AMEVIVE  on pregnancy and fetal development, including immune system development, is not known, health care providers are encouraged to enroll patients currently taking  <e0>AMEVIVE</e0>  who become pregnant into the Biogen Pregnancy Registry by calling 1-866- <e1>AMEVIVE</e1>  (1-866-263-8483)."
Other
Comment:


200	An immune response to  <e0>Campath</e0>  may interfere with subsequent diagnostic serum tests that utilize  <e1>antibodies</e1> "
Other
Comment:


100	Intravenous  <e0>ranitidine</e0>  was shown to double the bioavailability of oral  <e1>alendronate</e1> ."
mechanism(e0,e1)Comment:

400	Products containing  <e0>calcium</e0>  and other  <e1>multivalent cations</e1>  likely will interfere with absorption of  alendronate ."
Other
Comment:

401	Products containing  <e0>calcium</e0>  and other  multivalent cations  likely will interfere with absorption of  <e1>alendronate</e1> ."
mechanism(e0,e1)Comment:

402	Products containing  calcium  and other  <e0>multivalent cations</e0>  likely will interfere with absorption of  <e1>alendronate</e1> ."
mechanism(e0,e1)Comment:


100	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  <e0>ALFENTA</e0>  is administered in combination with other  <e1>CNS depressants</e1>  such as  barbiturates ,  tranquilizers ,  opioids , or inhalation general  anesthetics ."
effect(e0,e1)Comment:

101	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  <e0>ALFENTA</e0>  is administered in combination with other  CNS depressants  such as  <e1>barbiturates</e1> ,  tranquilizers ,  opioids , or inhalation general  anesthetics ."
effect(e0,e1)Comment:

102	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  <e0>ALFENTA</e0>  is administered in combination with other  CNS depressants  such as  barbiturates ,  <e1>tranquilizers</e1> ,  opioids , or inhalation general  anesthetics ."
effect(e0,e1)Comment:

103	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  <e0>ALFENTA</e0>  is administered in combination with other  CNS depressants  such as  barbiturates ,  tranquilizers ,  <e1>opioids</e1> , or inhalation general  anesthetics ."
effect(e0,e1)Comment:

104	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  <e0>ALFENTA</e0>  is administered in combination with other  CNS depressants  such as  barbiturates ,  tranquilizers ,  opioids , or inhalation general  <e1>anesthetics</e1> ."
effect(e0,e1)Comment:

105	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  <e0>CNS depressants</e0>  such as  <e1>barbiturates</e1> ,  tranquilizers ,  opioids , or inhalation general  anesthetics ."
Other
Comment:

106	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  <e0>CNS depressants</e0>  such as  barbiturates ,  <e1>tranquilizers</e1> ,  opioids , or inhalation general  anesthetics ."
Other
Comment:

107	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  <e0>CNS depressants</e0>  such as  barbiturates ,  tranquilizers ,  <e1>opioids</e1> , or inhalation general  anesthetics ."
Other
Comment:

108	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  <e0>CNS depressants</e0>  such as  barbiturates ,  tranquilizers ,  opioids , or inhalation general  <e1>anesthetics</e1> ."
Other
Comment:

109	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  <e0>barbiturates</e0> ,  <e1>tranquilizers</e1> ,  opioids , or inhalation general  anesthetics ."
Other
Comment:

110	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  <e0>barbiturates</e0> ,  tranquilizers ,  <e1>opioids</e1> , or inhalation general  anesthetics ."
Other
Comment:

111	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  <e0>barbiturates</e0> ,  tranquilizers ,  opioids , or inhalation general  <e1>anesthetics</e1> ."
Other
Comment:

112	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  barbiturates ,  <e0>tranquilizers</e0> ,  <e1>opioids</e1> , or inhalation general  anesthetics ."
Other
Comment:

113	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  barbiturates ,  <e0>tranquilizers</e0> ,  opioids , or inhalation general  <e1>anesthetics</e1> ."
Other
Comment:

114	Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when  ALFENTA  is administered in combination with other  CNS depressants  such as  barbiturates ,  tranquilizers ,  <e0>opioids</e0> , or inhalation general  <e1>anesthetics</e1> ."
Other
Comment:

400	Limited clinical experience indicates that requirements for  <e0>volatile inhalation anesthetics</e0>  are reduced by 30 to 50% for the first sixty (60) minutes following  <e1>ALFENTA</e1>  induction The concomitant use of  erythromycin  with  ALFENTA  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
mechanism(e0,e1)Comment:

401	Limited clinical experience indicates that requirements for  <e0>volatile inhalation anesthetics</e0>  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  <e1>erythromycin</e1>  with  ALFENTA  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

402	Limited clinical experience indicates that requirements for  <e0>volatile inhalation anesthetics</e0>  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  erythromycin  with  <e1>ALFENTA</e1>  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

403	Limited clinical experience indicates that requirements for  <e0>volatile inhalation anesthetics</e0>  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  erythromycin  with  ALFENTA  can significantly inhibit  <e1>ALFENTA</e1>  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

404	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  <e0>ALFENTA</e0>  induction The concomitant use of  <e1>erythromycin</e1>  with  ALFENTA  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

405	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  <e0>ALFENTA</e0>  induction The concomitant use of  erythromycin  with  <e1>ALFENTA</e1>  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

406	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  <e0>ALFENTA</e0>  induction The concomitant use of  erythromycin  with  ALFENTA  can significantly inhibit  <e1>ALFENTA</e1>  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

407	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  <e0>erythromycin</e0>  with  <e1>ALFENTA</e1>  can significantly inhibit  ALFENTA  clearance and may increase the risk of prolonged or delayed respiratory depression."
mechanism(e0,e1)Comment:

408	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  <e0>erythromycin</e0>  with  ALFENTA  can significantly inhibit  <e1>ALFENTA</e1>  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

409	Limited clinical experience indicates that requirements for  volatile inhalation anesthetics  are reduced by 30 to 50% for the first sixty (60) minutes following  ALFENTA  induction The concomitant use of  erythromycin  with  <e0>ALFENTA</e0>  can significantly inhibit  <e1>ALFENTA</e1>  clearance and may increase the risk of prolonged or delayed respiratory depression."
Other
Comment:

500	 <e0>Cimetidine</e0>  reduces the clearance of  <e1>ALFENTA</e1> ."
mechanism(e0,e1)Comment:

600	Therefore smaller  <e0>ALFENTA</e0>  doses will be required with prolonged administration and the duration of action of  <e1>ALFENTA</e1>  my be extended."
Other
Comment:


100	Drug-Drug Interactions: The pharmacokinetic and pharmacodynamic interactions between  <e0>UROXATRAL</e0>  and other  <e1>alpha-blockers</e1>  have not been determined."
Other
Comment:

200	However, interactions may be expected, and  <e0>UROXATRAL</e0>  should NOT be used in combination with other  <e1>alpha-blockers</e1> ."
advise(e0,e1)Comment:



100	Effects of Other Drugs on  <e0>Aliskiren</e0>  Based on in-vitro studies,  <e1>aliskiren</e1>  is metabolized by CYP 3A4."
Other
Comment:

200	Co-administration of  <e0>lovastatin</e0> ,  <e1>atenolol</e1> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

201	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  <e1>warfarin</e1> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

202	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  <e1>furosemide</e1> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

203	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  <e1>digoxin</e1> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

204	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e1>celecoxib</e1> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

205	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

206	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

207	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

208	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

209	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

210	Co-administration of  <e0>lovastatin</e0> ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

211	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  <e1>warfarin</e1> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

212	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  <e1>furosemide</e1> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

213	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  <e1>digoxin</e1> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

214	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  <e1>celecoxib</e1> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

215	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

216	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

217	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

218	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

219	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

220	Co-administration of  lovastatin ,  <e0>atenolol</e0> ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

221	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  <e1>furosemide</e1> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

222	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  <e1>digoxin</e1> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

223	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  <e1>celecoxib</e1> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

224	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

225	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

226	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

227	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

228	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

229	Co-administration of  lovastatin ,  atenolol ,  <e0>warfarin</e0> ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

230	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  <e1>digoxin</e1> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

231	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  <e1>celecoxib</e1> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

232	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

233	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

234	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

235	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

236	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

237	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  <e0>furosemide</e0> ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

238	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  <e1>celecoxib</e1> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

239	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

240	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

241	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

242	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

243	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

244	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  <e0>digoxin</e0> ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

245	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  <e1>hydrochlorothiazide</e1> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

246	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  hydrochlorothiazide ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

247	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  hydrochlorothiazide ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

248	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

249	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

250	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  <e0>celecoxib</e0> ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

251	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e0>hydrochlorothiazide</e0> ,  <e1>ramipril</e1> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

252	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e0>hydrochlorothiazide</e0> ,  ramipril ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

253	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e0>hydrochlorothiazide</e0> ,  ramipril ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

254	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e0>hydrochlorothiazide</e0> ,  ramipril ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

255	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  <e0>hydrochlorothiazide</e0> ,  ramipril ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

256	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e0>ramipril</e0> ,  <e1>valsartan</e1> ,  metformin  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

257	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e0>ramipril</e0> ,  valsartan ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

258	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e0>ramipril</e0> ,  valsartan ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

259	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  <e0>ramipril</e0> ,  valsartan ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

260	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e0>valsartan</e0> ,  <e1>metformin</e1>  and  amlodipine  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

261	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e0>valsartan</e0> ,  metformin  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

262	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  <e0>valsartan</e0> ,  metformin  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

263	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e0>metformin</e0>  and  <e1>amlodipine</e1>  did not result in clinically significant increases in  aliskiren  exposure."
Other
Comment:

264	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  <e0>metformin</e0>  and  amlodipine  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

265	Co-administration of  lovastatin ,  atenolol ,  warfarin ,  furosemide ,  digoxin ,  celecoxib ,  hydrochlorothiazide ,  ramipril ,  valsartan ,  metformin  and  <e0>amlodipine</e0>  did not result in clinically significant increases in  <e1>aliskiren</e1>  exposure."
Other
Comment:

300	Co-administration of  <e0>irbesartan</e0>  reduced  <e1>aliskiren</e1>  Cmax up to 50% after multiple dosing."
mechanism(e0,e1)Comment:

400	Co-administration of  <e0>atorvastatin</e0>  resulted in about a 50% increase in  <e1>aliskiren</e1>  Cmax and AUC after multiple dosing."
mechanism(e0,e1)Comment:

500	 <e0>Ketoconazole</e0> : Co-administration of 200 mg twice-daily  <e1>ketoconazole</e1>  with  aliskiren  resulted in an approximate 80% increase in plasma levels of  aliskiren ."
Other
Comment:

501	 <e0>Ketoconazole</e0> : Co-administration of 200 mg twice-daily  ketoconazole  with  <e1>aliskiren</e1>  resulted in an approximate 80% increase in plasma levels of  aliskiren ."
Other
Comment:

502	 <e0>Ketoconazole</e0> : Co-administration of 200 mg twice-daily  ketoconazole  with  aliskiren  resulted in an approximate 80% increase in plasma levels of  <e1>aliskiren</e1> ."
Other
Comment:

503	 Ketoconazole : Co-administration of 200 mg twice-daily  <e0>ketoconazole</e0>  with  <e1>aliskiren</e1>  resulted in an approximate 80% increase in plasma levels of  aliskiren ."
mechanism(e0,e1)Comment:

504	 Ketoconazole : Co-administration of 200 mg twice-daily  <e0>ketoconazole</e0>  with  aliskiren  resulted in an approximate 80% increase in plasma levels of  <e1>aliskiren</e1> ."
Other
Comment:

505	 Ketoconazole : Co-administration of 200 mg twice-daily  ketoconazole  with  <e0>aliskiren</e0>  resulted in an approximate 80% increase in plasma levels of  <e1>aliskiren</e1> ."
Other
Comment:

700	Effects of  <e0>Aliskiren</e0>  on Other Drugs  <e1>Aliskiren</e1>  does not inhibit the CYP450 isoenzymes (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and CYP 3A) or induce CYP 3A4."
Other
Comment:

800	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  <e1>lovastatin</e1> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

801	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  <e1>digoxin</e1> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

802	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e1>valsartan</e1> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

803	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e1>amlodipine</e1> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

804	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e1>metformin</e1> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

805	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

806	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

807	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

808	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

809	Co-administration of  <e0>aliskiren</e0>  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

810	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  <e1>digoxin</e1> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

811	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  <e1>valsartan</e1> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

812	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  <e1>amlodipine</e1> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

813	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  <e1>metformin</e1> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

814	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

815	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

816	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

817	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

818	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  <e0>lovastatin</e0> ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

819	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  <e1>valsartan</e1> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

820	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  <e1>amlodipine</e1> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

821	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  <e1>metformin</e1> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

822	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  metformin ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

823	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

824	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

825	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

826	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  <e0>digoxin</e0> ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

827	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  <e1>amlodipine</e1> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

828	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  <e1>metformin</e1> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

829	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  metformin ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

830	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  metformin ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

831	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

832	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

833	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  <e0>valsartan</e0> ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

834	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  <e1>metformin</e1> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

835	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  metformin ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

836	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  metformin ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

837	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  metformin ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

838	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

839	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  <e0>amlodipine</e0> ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

840	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e0>metformin</e0> ,  <e1>celecoxib</e1> ,  atenolol ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

841	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e0>metformin</e0> ,  celecoxib ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

842	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e0>metformin</e0> ,  celecoxib ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

843	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e0>metformin</e0> ,  celecoxib ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

844	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  <e0>metformin</e0> ,  celecoxib ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

845	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e0>celecoxib</e0> ,  <e1>atenolol</e1> ,  atorvastatin ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

846	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e0>celecoxib</e0> ,  atenolol ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

847	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e0>celecoxib</e0> ,  atenolol ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

848	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  <e0>celecoxib</e0> ,  atenolol ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

849	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e0>atenolol</e0> ,  <e1>atorvastatin</e1> ,  ramipril  or  hydrochlorothiazide ."
Other
Comment:

850	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e0>atenolol</e0> ,  atorvastatin ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

851	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  <e0>atenolol</e0> ,  atorvastatin ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

852	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e0>atorvastatin</e0> ,  <e1>ramipril</e1>  or  hydrochlorothiazide ."
Other
Comment:

853	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  <e0>atorvastatin</e0> ,  ramipril  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

854	Co-administration of  aliskiren  did not significantly affect the pharmacokinetics of  lovastatin ,  digoxin ,  valsartan ,  amlodipine ,  metformin ,  celecoxib ,  atenolol ,  atorvastatin ,  <e0>ramipril</e0>  or  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

900	 <e0>Warfarin</e0> : The effects of  <e1>aliskiren</e1>  on  warfarin  pharmacokinetics have not been evaluated in a well-controlled clinical trial."
Other
Comment:

901	 <e0>Warfarin</e0> : The effects of  aliskiren  on  <e1>warfarin</e1>  pharmacokinetics have not been evaluated in a well-controlled clinical trial."
Other
Comment:

902	 Warfarin : The effects of  <e0>aliskiren</e0>  on  <e1>warfarin</e1>  pharmacokinetics have not been evaluated in a well-controlled clinical trial."
Other
Comment:

1000	 <e0>Furosemide</e0> : When  <e1>aliskiren</e1>  was co-administered with  furosemide , the AUC and Cmax of  furosemide  were reduced by about 30% and 50%, respectively."
Other
Comment:

1001	 <e0>Furosemide</e0> : When  aliskiren  was co-administered with  <e1>furosemide</e1> , the AUC and Cmax of  furosemide  were reduced by about 30% and 50%, respectively."
Other
Comment:

1002	 <e0>Furosemide</e0> : When  aliskiren  was co-administered with  furosemide , the AUC and Cmax of  <e1>furosemide</e1>  were reduced by about 30% and 50%, respectively."
Other
Comment:

1003	 Furosemide : When  <e0>aliskiren</e0>  was co-administered with  <e1>furosemide</e1> , the AUC and Cmax of  furosemide  were reduced by about 30% and 50%, respectively."
mechanism(e0,e1)Comment:

1004	 Furosemide : When  <e0>aliskiren</e0>  was co-administered with  furosemide , the AUC and Cmax of  <e1>furosemide</e1>  were reduced by about 30% and 50%, respectively."
Other
Comment:

1005	 Furosemide : When  aliskiren  was co-administered with  <e0>furosemide</e0> , the AUC and Cmax of  <e1>furosemide</e1>  were reduced by about 30% and 50%, respectively."
Other
Comment:


100	Patients who are applying  <e0>Panretin</e0>  gel should not concurrently use products that contain  <e1>DEET</e1>  (N,  N-diethyl-m-toluamide ), a common component of insect repellent products."
advise(e0,e1)Comment:

101	Patients who are applying  <e0>Panretin</e0>  gel should not concurrently use products that contain  DEET  (N,  <e1>N-diethyl-m-toluamide</e1> ), a common component of insect repellent products."
advise(e0,e1)Comment:

102	Patients who are applying  Panretin  gel should not concurrently use products that contain  <e0>DEET</e0>  (N,  <e1>N-diethyl-m-toluamide</e1> ), a common component of insect repellent products."
Other
Comment:

200	Animal toxicology studies showed increased  <e0>DEET</e0>  toxicity when  <e1>DEET</e1>  was included as proof of the formulation."
Other
Comment:

300	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  <e0>antiretroviral agents</e0> , including  <e1>protease inhibitors</e1> ,  macrolide antibiotics , and  azole antifungals , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

301	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  <e0>antiretroviral agents</e0> , including  protease inhibitors ,  <e1>macrolide antibiotics</e1> , and  azole antifungals , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

302	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  <e0>antiretroviral agents</e0> , including  protease inhibitors ,  macrolide antibiotics , and  <e1>azole antifungals</e1> , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

303	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  <e0>antiretroviral agents</e0> , including  protease inhibitors ,  macrolide antibiotics , and  azole antifungals , the effect of  <e1>Panretin</e1>  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

304	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  <e0>protease inhibitors</e0> ,  <e1>macrolide antibiotics</e1> , and  azole antifungals , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

305	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  <e0>protease inhibitors</e0> ,  macrolide antibiotics , and  <e1>azole antifungals</e1> , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

306	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  <e0>protease inhibitors</e0> ,  macrolide antibiotics , and  azole antifungals , the effect of  <e1>Panretin</e1>  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

307	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  protease inhibitors ,  <e0>macrolide antibiotics</e0> , and  <e1>azole antifungals</e1> , the effect of  Panretin  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

308	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  protease inhibitors ,  <e0>macrolide antibiotics</e0> , and  azole antifungals , the effect of  <e1>Panretin</e1>  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:

309	Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic  antiretroviral agents , including  protease inhibitors ,  macrolide antibiotics , and  <e0>azole antifungals</e0> , the effect of  <e1>Panretin</e1>  gel on the steady-state concentrations of these drugs is not known."
Other
Comment:


300	 <e0>Mercaptopurine</e0> / <e1>Azathioprine</e1> :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  6-thiouric acid ."
Other
Comment:

301	 <e0>Mercaptopurine</e0> / Azathioprine :  <e1>Allopurinol</e1>  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  6-thiouric acid ."
Other
Comment:

302	 <e0>Mercaptopurine</e0> / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  <e1>mercaptopurine</e1>  and  azathioprine  to  6-thiouric acid ."
Other
Comment:

303	 <e0>Mercaptopurine</e0> / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  <e1>azathioprine</e1>  to  6-thiouric acid ."
Other
Comment:

304	 <e0>Mercaptopurine</e0> / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  <e1>6-thiouric acid</e1> ."
Other
Comment:

305	 Mercaptopurine / <e0>Azathioprine</e0> :  <e1>Allopurinol</e1>  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  6-thiouric acid ."
Other
Comment:

306	 Mercaptopurine / <e0>Azathioprine</e0> :  Allopurinol  inhibits the enzymatic oxidation of  <e1>mercaptopurine</e1>  and  azathioprine  to  6-thiouric acid ."
Other
Comment:

307	 Mercaptopurine / <e0>Azathioprine</e0> :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  <e1>azathioprine</e1>  to  6-thiouric acid ."
Other
Comment:

308	 Mercaptopurine / <e0>Azathioprine</e0> :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  <e1>6-thiouric acid</e1> ."
Other
Comment:

309	 Mercaptopurine / Azathioprine :  <e0>Allopurinol</e0>  inhibits the enzymatic oxidation of  <e1>mercaptopurine</e1>  and  azathioprine  to  6-thiouric acid ."
mechanism(e0,e1)Comment:

310	 Mercaptopurine / Azathioprine :  <e0>Allopurinol</e0>  inhibits the enzymatic oxidation of  mercaptopurine  and  <e1>azathioprine</e1>  to  6-thiouric acid ."
mechanism(e0,e1)Comment:

311	 Mercaptopurine / Azathioprine :  <e0>Allopurinol</e0>  inhibits the enzymatic oxidation of  mercaptopurine  and  azathioprine  to  <e1>6-thiouric acid</e1> ."
Other
Comment:

312	 Mercaptopurine / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  <e0>mercaptopurine</e0>  and  <e1>azathioprine</e1>  to  6-thiouric acid ."
Other
Comment:

313	 Mercaptopurine / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  <e0>mercaptopurine</e0>  and  azathioprine  to  <e1>6-thiouric acid</e1> ."
Other
Comment:

314	 Mercaptopurine / Azathioprine :  Allopurinol  inhibits the enzymatic oxidation of  mercaptopurine  and  <e0>azathioprine</e0>  to  <e1>6-thiouric acid</e1> ."
Other
Comment:

500	In patients receiving  <e0>mercaptopurine</e0>  ( <e1>Purinethol</e1> ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

501	In patients receiving  <e0>mercaptopurine</e0>  ( Purinethol ) or  <e1>azathioprine</e1>  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

502	In patients receiving  <e0>mercaptopurine</e0>  ( Purinethol ) or  azathioprine  ( <e1>Imuran</e1> ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

503	In patients receiving  <e0>mercaptopurine</e0>  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  <e1>allopurinol</e1>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

504	In patients receiving  <e0>mercaptopurine</e0>  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e1>mercaptopurine</e1>  or  azathioprine ."
Other
Comment:

505	In patients receiving  <e0>mercaptopurine</e0>  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  <e1>azathioprine</e1> ."
Other
Comment:

506	In patients receiving  mercaptopurine  ( <e0>Purinethol</e0> ) or  <e1>azathioprine</e1>  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

507	In patients receiving  mercaptopurine  ( <e0>Purinethol</e0> ) or  azathioprine  ( <e1>Imuran</e1> ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

508	In patients receiving  mercaptopurine  ( <e0>Purinethol</e0> ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  <e1>allopurinol</e1>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

509	In patients receiving  mercaptopurine  ( <e0>Purinethol</e0> ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e1>mercaptopurine</e1>  or  azathioprine ."
Other
Comment:

510	In patients receiving  mercaptopurine  ( <e0>Purinethol</e0> ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  <e1>azathioprine</e1> ."
Other
Comment:

511	In patients receiving  mercaptopurine  ( Purinethol ) or  <e0>azathioprine</e0>  ( <e1>Imuran</e1> ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

512	In patients receiving  mercaptopurine  ( Purinethol ) or  <e0>azathioprine</e0>  ( Imuran ), the concomitant administration of 300-600 mg of  <e1>allopurinol</e1>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

513	In patients receiving  mercaptopurine  ( Purinethol ) or  <e0>azathioprine</e0>  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e1>mercaptopurine</e1>  or  azathioprine ."
Other
Comment:

514	In patients receiving  mercaptopurine  ( Purinethol ) or  <e0>azathioprine</e0>  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  <e1>azathioprine</e1> ."
Other
Comment:

515	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( <e0>Imuran</e0> ), the concomitant administration of 300-600 mg of  <e1>allopurinol</e1>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  azathioprine ."
Other
Comment:

516	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( <e0>Imuran</e0> ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e1>mercaptopurine</e1>  or  azathioprine ."
Other
Comment:

517	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( <e0>Imuran</e0> ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  <e1>azathioprine</e1> ."
Other
Comment:

518	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  <e0>allopurinol</e0>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e1>mercaptopurine</e1>  or  azathioprine ."
advise(e0,e1)Comment:

519	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  <e0>allopurinol</e0>  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  mercaptopurine  or  <e1>azathioprine</e1> ."
advise(e0,e1)Comment:

520	In patients receiving  mercaptopurine  ( Purinethol ) or  azathioprine  ( Imuran ), the concomitant administration of 300-600 mg of  allopurinol  per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of  <e0>mercaptopurine</e0>  or  <e1>azathioprine</e1> ."
Other
Comment:

600	Subsequent adjustment of doses of  <e0>mercaptopurine</e0>  or  <e1>azathioprine</e1>  should be made on the basis of therapeutic response and the appearance of toxic effects."
Other
Comment:

700	 <e0>Dicumarol</e0> : It has been reported that  <e1>allopurinol</e1>  prolongs the half-life of the  anticoagulant ,  dicumarol ."
Other
Comment:

701	 <e0>Dicumarol</e0> : It has been reported that  allopurinol  prolongs the half-life of the  <e1>anticoagulant</e1> ,  dicumarol ."
Other
Comment:

702	 <e0>Dicumarol</e0> : It has been reported that  allopurinol  prolongs the half-life of the  anticoagulant ,  <e1>dicumarol</e1> ."
Other
Comment:

703	 Dicumarol : It has been reported that  <e0>allopurinol</e0>  prolongs the half-life of the  <e1>anticoagulant</e1> ,  dicumarol ."
Other
Comment:

704	 Dicumarol : It has been reported that  <e0>allopurinol</e0>  prolongs the half-life of the  anticoagulant ,  <e1>dicumarol</e1> ."
mechanism(e0,e1)Comment:

705	 Dicumarol : It has been reported that  allopurinol  prolongs the half-life of the  <e0>anticoagulant</e0> ,  <e1>dicumarol</e1> ."
Other
Comment:

800	The clinical basis of this drug interaction has not been established but should be noted when  <e0>allopurinol</e0>  is given to patients already on  <e1>dicumarol</e1>  therapy."
Other
Comment:

1000	 <e0>Uricosuric Agents</e0> : Since the excretion of  <e1>oxipurinol</e1>  is similar to that of urate,  uricosuric agents , which increase the excretion of urate, are also likely to increase the excretion of  oxipurinol  and thus lower the degree of inhibition of xanthine oxidase."
Other
Comment:

1001	 <e0>Uricosuric Agents</e0> : Since the excretion of  oxipurinol  is similar to that of urate,  <e1>uricosuric agents</e1> , which increase the excretion of urate, are also likely to increase the excretion of  oxipurinol  and thus lower the degree of inhibition of xanthine oxidase."
Other
Comment:

1002	 <e0>Uricosuric Agents</e0> : Since the excretion of  oxipurinol  is similar to that of urate,  uricosuric agents , which increase the excretion of urate, are also likely to increase the excretion of  <e1>oxipurinol</e1>  and thus lower the degree of inhibition of xanthine oxidase."
Other
Comment:

1003	 Uricosuric Agents : Since the excretion of  <e0>oxipurinol</e0>  is similar to that of urate,  <e1>uricosuric agents</e1> , which increase the excretion of urate, are also likely to increase the excretion of  oxipurinol  and thus lower the degree of inhibition of xanthine oxidase."
Other
Comment:

1004	 Uricosuric Agents : Since the excretion of  <e0>oxipurinol</e0>  is similar to that of urate,  uricosuric agents , which increase the excretion of urate, are also likely to increase the excretion of  <e1>oxipurinol</e1>  and thus lower the degree of inhibition of xanthine oxidase."
Other
Comment:

1005	 Uricosuric Agents : Since the excretion of  oxipurinol  is similar to that of urate,  <e0>uricosuric agents</e0> , which increase the excretion of urate, are also likely to increase the excretion of  <e1>oxipurinol</e1>  and thus lower the degree of inhibition of xanthine oxidase."
mechanism(e0,e1)Comment:

1100	The concomitant administration of  <e0>uricosuric agents</e0>  and  <e1>allopurinol</e1>  has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with  allopurinol  alone."
mechanism(e0,e1)Comment:

1101	The concomitant administration of  <e0>uricosuric agents</e0>  and  allopurinol  has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with  <e1>allopurinol</e1>  alone."
Other
Comment:

1102	The concomitant administration of  uricosuric agents  and  <e0>allopurinol</e0>  has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with  <e1>allopurinol</e1>  alone."
Other
Comment:

1200	Although clinical evidence to date has not demonstrated renal precipitation of oxypurines in patients either on  <e0>allopurinol</e0>  alone or in combination with  <e1>uricosuric agents</e1> , the possibility should be kept in mind."
Other
Comment:

1300	 <e0>Thiazide Diuretics</e0> : The reports that the concomitant use of  <e1>allopurinol</e1>  and  thiazide diuretics  may contribute to the enhancement of  allopurinol  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
Other
Comment:

1301	 <e0>Thiazide Diuretics</e0> : The reports that the concomitant use of  allopurinol  and  <e1>thiazide diuretics</e1>  may contribute to the enhancement of  allopurinol  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
Other
Comment:

1302	 <e0>Thiazide Diuretics</e0> : The reports that the concomitant use of  allopurinol  and  thiazide diuretics  may contribute to the enhancement of  <e1>allopurinol</e1>  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
Other
Comment:

1303	 Thiazide Diuretics : The reports that the concomitant use of  <e0>allopurinol</e0>  and  <e1>thiazide diuretics</e1>  may contribute to the enhancement of  allopurinol  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
effect(e0,e1)Comment:

1304	 Thiazide Diuretics : The reports that the concomitant use of  <e0>allopurinol</e0>  and  thiazide diuretics  may contribute to the enhancement of  <e1>allopurinol</e1>  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
Other
Comment:

1305	 Thiazide Diuretics : The reports that the concomitant use of  allopurinol  and  <e0>thiazide diuretics</e0>  may contribute to the enhancement of  <e1>allopurinol</e1>  toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation."
Other
Comment:

1600	Although a causal mechanism and a cause-and-effect relationship have not been established, current evidence suggests that renal function should be monitored in patients on  <e0>thiazide diuretics</e0>  and  <e1>allopurinol</e1>  even in the absence of renal failure, and dosage levels should be even more conservatively adjusted in those patients on such combined therapy if diminished renal function is detected.."
advise(e0,e1)Comment:

1700	 <e0>Ampicillin</e0> / <e1>Amoxicillin</e1> : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  amoxicillin  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1701	 <e0>Ampicillin</e0> / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  <e1>ampicillin</e1>  or  amoxicillin  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1702	 <e0>Ampicillin</e0> / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  <e1>amoxicillin</e1>  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1703	 <e0>Ampicillin</e0> / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  amoxicillin  concurrently with  <e1>allopurinol</e1>  compared to patients who are not receiving both drugs."
Other
Comment:

1704	 Ampicillin / <e0>Amoxicillin</e0> : An increase in the frequency of skin rash has been reported among patients receiving  <e1>ampicillin</e1>  or  amoxicillin  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1705	 Ampicillin / <e0>Amoxicillin</e0> : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  <e1>amoxicillin</e1>  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1706	 Ampicillin / <e0>Amoxicillin</e0> : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  amoxicillin  concurrently with  <e1>allopurinol</e1>  compared to patients who are not receiving both drugs."
Other
Comment:

1707	 Ampicillin / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  <e0>ampicillin</e0>  or  <e1>amoxicillin</e1>  concurrently with  allopurinol  compared to patients who are not receiving both drugs."
Other
Comment:

1708	 Ampicillin / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  <e0>ampicillin</e0>  or  amoxicillin  concurrently with  <e1>allopurinol</e1>  compared to patients who are not receiving both drugs."
effect(e0,e1)Comment:

1709	 Ampicillin / Amoxicillin : An increase in the frequency of skin rash has been reported among patients receiving  ampicillin  or  <e0>amoxicillin</e0>  concurrently with  <e1>allopurinol</e1>  compared to patients who are not receiving both drugs."
effect(e0,e1)Comment:

1900	 <e0>Cytotoxic Agents</e0> : Enhanced bone marrow suppression by  <e1>cyclophosphamide</e1>  and other  cytotoxic agents  has been reported among patients with neoplastic disease, except leukemia, in the presence of  allopurinol ."
Other
Comment:

1901	 <e0>Cytotoxic Agents</e0> : Enhanced bone marrow suppression by  cyclophosphamide  and other  <e1>cytotoxic agents</e1>  has been reported among patients with neoplastic disease, except leukemia, in the presence of  allopurinol ."
Other
Comment:

1902	 <e0>Cytotoxic Agents</e0> : Enhanced bone marrow suppression by  cyclophosphamide  and other  cytotoxic agents  has been reported among patients with neoplastic disease, except leukemia, in the presence of  <e1>allopurinol</e1> ."
Other
Comment:

1903	 Cytotoxic Agents : Enhanced bone marrow suppression by  <e0>cyclophosphamide</e0>  and other  <e1>cytotoxic agents</e1>  has been reported among patients with neoplastic disease, except leukemia, in the presence of  allopurinol ."
Other
Comment:

1904	 Cytotoxic Agents : Enhanced bone marrow suppression by  <e0>cyclophosphamide</e0>  and other  cytotoxic agents  has been reported among patients with neoplastic disease, except leukemia, in the presence of  <e1>allopurinol</e1> ."
effect(e0,e1)Comment:

1905	 Cytotoxic Agents : Enhanced bone marrow suppression by  cyclophosphamide  and other  <e0>cytotoxic agents</e0>  has been reported among patients with neoplastic disease, except leukemia, in the presence of  <e1>allopurinol</e1> ."
effect(e0,e1)Comment:

2000	However, in a well-controlled study of patients with lymphoma on combination therapy,  <e0>allopurinol</e0>  did not increase the marrow toxicity of patients treated with  <e1>cyclophosphamide</e1> ,  doxorubicin ,  bleomycin ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2001	However, in a well-controlled study of patients with lymphoma on combination therapy,  <e0>allopurinol</e0>  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  <e1>doxorubicin</e1> ,  bleomycin ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2002	However, in a well-controlled study of patients with lymphoma on combination therapy,  <e0>allopurinol</e0>  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  <e1>bleomycin</e1> ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2003	However, in a well-controlled study of patients with lymphoma on combination therapy,  <e0>allopurinol</e0>  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  bleomycin ,  <e1>procarbazine</e1>  and/or  mechlorethamine ."
Other
Comment:

2004	However, in a well-controlled study of patients with lymphoma on combination therapy,  <e0>allopurinol</e0>  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  bleomycin ,  procarbazine  and/or  <e1>mechlorethamine</e1> ."
Other
Comment:

2005	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  <e0>cyclophosphamide</e0> ,  <e1>doxorubicin</e1> ,  bleomycin ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2006	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  <e0>cyclophosphamide</e0> ,  doxorubicin ,  <e1>bleomycin</e1> ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2007	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  <e0>cyclophosphamide</e0> ,  doxorubicin ,  bleomycin ,  <e1>procarbazine</e1>  and/or  mechlorethamine ."
Other
Comment:

2008	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  <e0>cyclophosphamide</e0> ,  doxorubicin ,  bleomycin ,  procarbazine  and/or  <e1>mechlorethamine</e1> ."
Other
Comment:

2009	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  <e0>doxorubicin</e0> ,  <e1>bleomycin</e1> ,  procarbazine  and/or  mechlorethamine ."
Other
Comment:

2010	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  <e0>doxorubicin</e0> ,  bleomycin ,  <e1>procarbazine</e1>  and/or  mechlorethamine ."
Other
Comment:

2011	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  <e0>doxorubicin</e0> ,  bleomycin ,  procarbazine  and/or  <e1>mechlorethamine</e1> ."
Other
Comment:

2012	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  <e0>bleomycin</e0> ,  <e1>procarbazine</e1>  and/or  mechlorethamine ."
Other
Comment:

2013	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  <e0>bleomycin</e0> ,  procarbazine  and/or  <e1>mechlorethamine</e1> ."
Other
Comment:

2014	However, in a well-controlled study of patients with lymphoma on combination therapy,  allopurinol  did not increase the marrow toxicity of patients treated with  cyclophosphamide ,  doxorubicin ,  bleomycin ,  <e0>procarbazine</e0>  and/or  <e1>mechlorethamine</e1> ."
Other
Comment:

2100	 <e0>Chlorpropamide</e0> :  <e1>Chlorpropamide</e1> s plasma half-life may be prolonged by  allopurinol , since  allopurinol  and  chlorpropamide  may compete for excretion in the renal tubule."
Other
Comment:

2101	 <e0>Chlorpropamide</e0> :  Chlorpropamide s plasma half-life may be prolonged by  <e1>allopurinol</e1> , since  allopurinol  and  chlorpropamide  may compete for excretion in the renal tubule."
Other
Comment:

2102	 <e0>Chlorpropamide</e0> :  Chlorpropamide s plasma half-life may be prolonged by  allopurinol , since  <e1>allopurinol</e1>  and  chlorpropamide  may compete for excretion in the renal tubule."
Other
Comment:

2103	 <e0>Chlorpropamide</e0> :  Chlorpropamide s plasma half-life may be prolonged by  allopurinol , since  allopurinol  and  <e1>chlorpropamide</e1>  may compete for excretion in the renal tubule."
Other
Comment:

2104	 Chlorpropamide :  <e0>Chlorpropamide</e0> s plasma half-life may be prolonged by  <e1>allopurinol</e1> , since  allopurinol  and  chlorpropamide  may compete for excretion in the renal tubule."
mechanism(e0,e1)Comment:

2105	 Chlorpropamide :  <e0>Chlorpropamide</e0> s plasma half-life may be prolonged by  allopurinol , since  <e1>allopurinol</e1>  and  chlorpropamide  may compete for excretion in the renal tubule."
Other
Comment:

2106	 Chlorpropamide :  <e0>Chlorpropamide</e0> s plasma half-life may be prolonged by  allopurinol , since  allopurinol  and  <e1>chlorpropamide</e1>  may compete for excretion in the renal tubule."
Other
Comment:

2107	 Chlorpropamide :  Chlorpropamide s plasma half-life may be prolonged by  <e0>allopurinol</e0> , since  <e1>allopurinol</e1>  and  chlorpropamide  may compete for excretion in the renal tubule."
Other
Comment:

2108	 Chlorpropamide :  Chlorpropamide s plasma half-life may be prolonged by  <e0>allopurinol</e0> , since  allopurinol  and  <e1>chlorpropamide</e1>  may compete for excretion in the renal tubule."
Other
Comment:

2109	 Chlorpropamide :  Chlorpropamide s plasma half-life may be prolonged by  allopurinol , since  <e0>allopurinol</e0>  and  <e1>chlorpropamide</e1>  may compete for excretion in the renal tubule."
mechanism(e0,e1)Comment:

2200	The risk of hypoglycemia secondary to this mechanism may be increased if  <e0>allopurinol</e0>  and  <e1>chlorpropamide</e1>  are given concomitantly in the presence of renal insufficiency."
effect(e0,e1)Comment:

2300	 <e0>Cyclosporin</e0> : Reports indicate that  <e1>cyclosporine</e1>  levels may be increased during concomitant treatment with  allopurinol sodium  for injection."
Other
Comment:

2301	 <e0>Cyclosporin</e0> : Reports indicate that  cyclosporine  levels may be increased during concomitant treatment with  <e1>allopurinol sodium</e1>  for injection."
Other
Comment:

2302	 Cyclosporin : Reports indicate that  <e0>cyclosporine</e0>  levels may be increased during concomitant treatment with  <e1>allopurinol sodium</e1>  for injection."
mechanism(e0,e1)Comment:

2400	Monitoring of  <e0>cyclosporine</e0>  levels and possible adjustment of  <e1>cyclosporine</e1>  dosage should be considered when these drugs are co-administered."
Other
Comment:


200	Because there is a theoretical basis that these effects may be additive, use of  <e0>ergotamine</e0> -containing or  <e1>ergot-type medications</e1>  (like  dihydroergotamine  or  methysergide ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

201	Because there is a theoretical basis that these effects may be additive, use of  <e0>ergotamine</e0> -containing or  ergot-type medications  (like  <e1>dihydroergotamine</e1>  or  methysergide ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

202	Because there is a theoretical basis that these effects may be additive, use of  <e0>ergotamine</e0> -containing or  ergot-type medications  (like  dihydroergotamine  or  <e1>methysergide</e1> ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

203	Because there is a theoretical basis that these effects may be additive, use of  <e0>ergotamine</e0> -containing or  ergot-type medications  (like  dihydroergotamine  or  methysergide ) and  <e1>AXERT</e1>  within 24 hours of each other should be avoided."
advise(e0,e1)Comment:

204	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  <e0>ergot-type medications</e0>  (like  <e1>dihydroergotamine</e1>  or  methysergide ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

205	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  <e0>ergot-type medications</e0>  (like  dihydroergotamine  or  <e1>methysergide</e1> ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

206	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  <e0>ergot-type medications</e0>  (like  dihydroergotamine  or  methysergide ) and  <e1>AXERT</e1>  within 24 hours of each other should be avoided."
advise(e0,e1)Comment:

207	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  ergot-type medications  (like  <e0>dihydroergotamine</e0>  or  <e1>methysergide</e1> ) and  AXERT  within 24 hours of each other should be avoided."
Other
Comment:

208	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  ergot-type medications  (like  <e0>dihydroergotamine</e0>  or  methysergide ) and  <e1>AXERT</e1>  within 24 hours of each other should be avoided."
advise(e0,e1)Comment:

209	Because there is a theoretical basis that these effects may be additive, use of  ergotamine -containing or  ergot-type medications  (like  dihydroergotamine  or  <e0>methysergide</e0> ) and  <e1>AXERT</e1>  within 24 hours of each other should be avoided."
advise(e0,e1)Comment:

300	 <e0>Monoamine Oxidase Inhibitors</e0> : Coadministration of  <e1>moclobemide</e1>  resulted in a 27% decrease in  almotriptan  clearance and an increase in Cmax of approximately 6%."
Other
Comment:

301	 <e0>Monoamine Oxidase Inhibitors</e0> : Coadministration of  moclobemide  resulted in a 27% decrease in  <e1>almotriptan</e1>  clearance and an increase in Cmax of approximately 6%."
Other
Comment:

302	 Monoamine Oxidase Inhibitors : Coadministration of  <e0>moclobemide</e0>  resulted in a 27% decrease in  <e1>almotriptan</e1>  clearance and an increase in Cmax of approximately 6%."
mechanism(e0,e1)Comment:

500	Other  <e0>5-HT1B/1D Agonists</e0>  Concomitant use of other  <e1>5-HT1B/1D agonists</e1>  within 24 hours of treatment with  AXERT  is contraindicated."
Other
Comment:

501	Other  <e0>5-HT1B/1D Agonists</e0>  Concomitant use of other  5-HT1B/1D agonists  within 24 hours of treatment with  <e1>AXERT</e1>  is contraindicated."
Other
Comment:

502	Other  5-HT1B/1D Agonists  Concomitant use of other  <e0>5-HT1B/1D agonists</e0>  within 24 hours of treatment with  <e1>AXERT</e1>  is contraindicated."
advise(e0,e1)Comment:

600	 <e0>Propanolol</e0> : The pharmacokinetics of  <e1>almotriptan</e1>  were not affected by coadministration of  propranolol ."
Other
Comment:

601	 <e0>Propanolol</e0> : The pharmacokinetics of  almotriptan  were not affected by coadministration of  <e1>propranolol</e1> ."
Other
Comment:

602	 Propanolol : The pharmacokinetics of  <e0>almotriptan</e0>  were not affected by coadministration of  <e1>propranolol</e1> ."
Other
Comment:

700	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( <e1>SSRIs</e1> ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

701	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  <e1>SSRIs</e1>  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

702	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  SSRIs  (e.g.,  <e1>fluoxetine</e1> ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

703	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  <e1>fluvoxamine</e1> ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

704	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  <e1>paroxetine</e1> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

705	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

706	 <e0>Selective Serotonin Reuptake Inhibitors</e0>  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
Other
Comment:

707	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  <e1>SSRIs</e1>  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

708	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  SSRIs  (e.g.,  <e1>fluoxetine</e1> ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

709	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  SSRIs  (e.g.,  fluoxetine ,  <e1>fluvoxamine</e1> ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

710	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  <e1>paroxetine</e1> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

711	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

712	 Selective Serotonin Reuptake Inhibitors  ( <e0>SSRIs</e0> ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
Other
Comment:

713	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  <e0>SSRIs</e0>  (e.g.,  <e1>fluoxetine</e1> ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

714	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  <e0>SSRIs</e0>  (e.g.,  fluoxetine ,  <e1>fluvoxamine</e1> ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

715	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  <e0>SSRIs</e0>  (e.g.,  fluoxetine ,  fluvoxamine ,  <e1>paroxetine</e1> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

716	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  <e0>SSRIs</e0>  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

717	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  <e0>SSRIs</e0>  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
effect(e0,e1)Comment:

718	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  <e0>fluoxetine</e0> ,  <e1>fluvoxamine</e1> ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

719	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  <e0>fluoxetine</e0> ,  fluvoxamine ,  <e1>paroxetine</e1> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

720	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  <e0>fluoxetine</e0> ,  fluvoxamine ,  paroxetine ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

721	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  <e0>fluoxetine</e0> ,  fluvoxamine ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
effect(e0,e1)Comment:

722	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  <e0>fluvoxamine</e0> ,  <e1>paroxetine</e1> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

723	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  <e0>fluvoxamine</e0> ,  paroxetine ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

724	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  <e0>fluvoxamine</e0> ,  paroxetine ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
effect(e0,e1)Comment:

725	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  <e0>paroxetine</e0> ,  <e1>sertraline</e1> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  5-HT1 agonists ."
Other
Comment:

726	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  <e0>paroxetine</e0> ,  sertraline ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
effect(e0,e1)Comment:

727	 Selective Serotonin Reuptake Inhibitors  ( SSRIs ):  SSRIs  (e.g.,  fluoxetine ,  fluvoxamine ,  paroxetine ,  <e0>sertraline</e0> ) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with  <e1>5-HT1 agonists</e1> ."
effect(e0,e1)Comment:

800	If concomitant treatment with  <e0>AXERT</e0>  and an  <e1>SSRI</e1>  is clinically warranted, appropriate observation of the patient is advised."
advise(e0,e1)Comment:

900	 <e0>Verapamil</e0> : Coadministration of  <e1>almotriptan</e1>  and  verapamil  resulted in a 24% increase in plasma concentrations of  almotriptan ."
Other
Comment:

901	 <e0>Verapamil</e0> : Coadministration of  almotriptan  and  <e1>verapamil</e1>  resulted in a 24% increase in plasma concentrations of  almotriptan ."
Other
Comment:

902	 <e0>Verapamil</e0> : Coadministration of  almotriptan  and  verapamil  resulted in a 24% increase in plasma concentrations of  <e1>almotriptan</e1> ."
Other
Comment:

903	 Verapamil : Coadministration of  <e0>almotriptan</e0>  and  <e1>verapamil</e1>  resulted in a 24% increase in plasma concentrations of  almotriptan ."
mechanism(e0,e1)Comment:

904	 Verapamil : Coadministration of  <e0>almotriptan</e0>  and  verapamil  resulted in a 24% increase in plasma concentrations of  <e1>almotriptan</e1> ."
Other
Comment:

905	 Verapamil : Coadministration of  almotriptan  and  <e0>verapamil</e0>  resulted in a 24% increase in plasma concentrations of  <e1>almotriptan</e1> ."
Other
Comment:

1100	Coadministration of  <e0>almotriptan</e0>  and the potent CYP3A4 inhibitor  <e1>ketoconazole</e1>  (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of  almotriptan ."
mechanism(e0,e1)Comment:

1101	Coadministration of  <e0>almotriptan</e0>  and the potent CYP3A4 inhibitor  ketoconazole  (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of  <e1>almotriptan</e1> ."
Other
Comment:

1102	Coadministration of  almotriptan  and the potent CYP3A4 inhibitor  <e0>ketoconazole</e0>  (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of  <e1>almotriptan</e1> ."
Other
Comment:

1200	Although the interaction between  <e0>almotriptan</e0>  and other potent CYP3A4 inhibitors (e.g.,  <e1>itraconazole</e1> ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1201	Although the interaction between  <e0>almotriptan</e0>  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  <e1>ritonavir</e1> , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1202	Although the interaction between  <e0>almotriptan</e0>  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  <e1>erythromycin</e1> ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1203	Although the interaction between  <e0>almotriptan</e0>  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  <e1>almotriptan</e1>  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1204	Although the interaction between  <e0>almotriptan</e0>  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  <e1>almotriptan</e1>  is used concomitantly with these medications."
Other
Comment:

1205	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  <e0>itraconazole</e0> ,  <e1>ritonavir</e1> , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1206	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  <e0>itraconazole</e0> ,  ritonavir , and  <e1>erythromycin</e1> ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1207	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  <e0>itraconazole</e0> ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  <e1>almotriptan</e1>  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1208	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  <e0>itraconazole</e0> ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  <e1>almotriptan</e1>  is used concomitantly with these medications."
advise(e0,e1)Comment:

1209	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  <e0>ritonavir</e0> , and  <e1>erythromycin</e1> ) has not been studied, increased exposures to  almotriptan  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1210	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  <e0>ritonavir</e0> , and  erythromycin ) has not been studied, increased exposures to  <e1>almotriptan</e1>  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1211	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  <e0>ritonavir</e0> , and  erythromycin ) has not been studied, increased exposures to  almotriptan  may be expected when  <e1>almotriptan</e1>  is used concomitantly with these medications."
advise(e0,e1)Comment:

1212	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  <e0>erythromycin</e0> ) has not been studied, increased exposures to  <e1>almotriptan</e1>  may be expected when  almotriptan  is used concomitantly with these medications."
Other
Comment:

1213	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  <e0>erythromycin</e0> ) has not been studied, increased exposures to  almotriptan  may be expected when  <e1>almotriptan</e1>  is used concomitantly with these medications."
advise(e0,e1)Comment:

1214	Although the interaction between  almotriptan  and other potent CYP3A4 inhibitors (e.g.,  itraconazole ,  ritonavir , and  erythromycin ) has not been studied, increased exposures to  <e0>almotriptan</e0>  may be expected when  <e1>almotriptan</e1>  is used concomitantly with these medications."
Other
Comment:


100	Because  <e0>alosetron</e0>  is metabolized by a variety of hepatic CYP drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance of  <e1>alosetron</e1> ."
Other
Comment:

300	In a pharmacokinetic study, 40 healthy female subjects received  <e0>fluvoxamine</e0>  in escalating doses from 50 to 200 mg per day for 16 days, with coadministration of  <e1>alosetron</e1>  1 mg on the last day."
Other
Comment:

400	 <e0>Fluvoxamine</e0>  increased mean  <e1>alosetron</e1>  plasma concentrations (AUC) approximately 6-fold and prolonged the half-life by approximately 3-fold."
mechanism(e0,e1)Comment:

500	Concomitant administration of  <e0>alosetron</e0>  and  <e1>fluvoxamine</e1>  is contraindicated."
advise(e0,e1)Comment:

600	Concomitant administration of  <e0>alosetron</e0>  and moderate CYP1A2 inhibitors, including  <e1>quinolone antibiotics</e1>  and  cimetidine , has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions."
advise(e0,e1)Comment:

601	Concomitant administration of  <e0>alosetron</e0>  and moderate CYP1A2 inhibitors, including  quinolone antibiotics  and  <e1>cimetidine</e1> , has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions."
advise(e0,e1)Comment:

602	Concomitant administration of  alosetron  and moderate CYP1A2 inhibitors, including  <e0>quinolone antibiotics</e0>  and  <e1>cimetidine</e1> , has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions."
Other
Comment:

800	In a pharmacokinetic study, 38 healthy female subjects received  <e0>ketoconazole</e0>  200 mg twice daily for 7 days, with coadministration of  <e1>alosetron</e1>  1 mg on the last day."
Other
Comment:

900	 <e0>Ketoconazole</e0>  increased mean  <e1>alosetron</e1>  plasma concentrations (AUC) by 29%."
mechanism(e0,e1)Comment:

1000	Caution should be used when  <e0>alosetron</e0>  and  <e1>ketoconazole</e1>  are administered concomitantly."
advise(e0,e1)Comment:

1100	Coadministration of  <e0>alosetron</e0>  and strong CYP3A4 inhibitors, such as  <e1>clarithromycin</e1> ,  telithromycin ,  protease inhibitors ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
advise(e0,e1)Comment:

1101	Coadministration of  <e0>alosetron</e0>  and strong CYP3A4 inhibitors, such as  clarithromycin ,  <e1>telithromycin</e1> ,  protease inhibitors ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
advise(e0,e1)Comment:

1102	Coadministration of  <e0>alosetron</e0>  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  <e1>protease inhibitors</e1> ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
advise(e0,e1)Comment:

1103	Coadministration of  <e0>alosetron</e0>  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  protease inhibitors ,  <e1>voriconazole</e1> , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
advise(e0,e1)Comment:

1104	Coadministration of  <e0>alosetron</e0>  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  protease inhibitors ,  voriconazole , and  <e1>itraconazole</e1>  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
advise(e0,e1)Comment:

1105	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  <e0>clarithromycin</e0> ,  <e1>telithromycin</e1> ,  protease inhibitors ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1106	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  <e0>clarithromycin</e0> ,  telithromycin ,  <e1>protease inhibitors</e1> ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1107	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  <e0>clarithromycin</e0> ,  telithromycin ,  protease inhibitors ,  <e1>voriconazole</e1> , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1108	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  <e0>clarithromycin</e0> ,  telithromycin ,  protease inhibitors ,  voriconazole , and  <e1>itraconazole</e1>  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1109	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  <e0>telithromycin</e0> ,  <e1>protease inhibitors</e1> ,  voriconazole , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1110	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  <e0>telithromycin</e0> ,  protease inhibitors ,  <e1>voriconazole</e1> , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1111	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  <e0>telithromycin</e0> ,  protease inhibitors ,  voriconazole , and  <e1>itraconazole</e1>  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1112	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  <e0>protease inhibitors</e0> ,  <e1>voriconazole</e1> , and  itraconazole  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1113	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  <e0>protease inhibitors</e0> ,  voriconazole , and  <e1>itraconazole</e1>  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1114	Coadministration of  alosetron  and strong CYP3A4 inhibitors, such as  clarithromycin ,  telithromycin ,  protease inhibitors ,  <e0>voriconazole</e0> , and  <e1>itraconazole</e1>  has not been evaluated but should be undertaken with caution because of similar potential drug interactions."
Other
Comment:

1600	Although not studied with  <e0>alosetron</e0> , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  <e1>isoniazid</e1> ,  procainamide , and  hydralazine ."
effect(e0,e1)Comment:

1601	Although not studied with  <e0>alosetron</e0> , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  isoniazid ,  <e1>procainamide</e1> , and  hydralazine ."
effect(e0,e1)Comment:

1602	Although not studied with  <e0>alosetron</e0> , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  isoniazid ,  procainamide , and  <e1>hydralazine</e1> ."
effect(e0,e1)Comment:

1603	Although not studied with  alosetron , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  <e0>isoniazid</e0> ,  <e1>procainamide</e1> , and  hydralazine ."
Other
Comment:

1604	Although not studied with  alosetron , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  <e0>isoniazid</e0> ,  procainamide , and  <e1>hydralazine</e1> ."
Other
Comment:

1605	Although not studied with  alosetron , inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as  isoniazid ,  <e0>procainamide</e0> , and  <e1>hydralazine</e1> ."
Other
Comment:

1800	Another study showed that  <e0>alosetron</e0>  had no clinically significant effect on plasma concentrations of the oral  <e1>contraceptive agents</e1>   ethinyl estradiol  and  levonorgestrel  (CYP3A4 substrates)."
Other
Comment:

1801	Another study showed that  <e0>alosetron</e0>  had no clinically significant effect on plasma concentrations of the oral  contraceptive agents   <e1>ethinyl estradiol</e1>  and  levonorgestrel  (CYP3A4 substrates)."
Other
Comment:

1802	Another study showed that  <e0>alosetron</e0>  had no clinically significant effect on plasma concentrations of the oral  contraceptive agents   ethinyl estradiol  and  <e1>levonorgestrel</e1>  (CYP3A4 substrates)."
Other
Comment:

1803	Another study showed that  alosetron  had no clinically significant effect on plasma concentrations of the oral  <e0>contraceptive agents</e0>   <e1>ethinyl estradiol</e1>  and  levonorgestrel  (CYP3A4 substrates)."
Other
Comment:

1804	Another study showed that  alosetron  had no clinically significant effect on plasma concentrations of the oral  <e0>contraceptive agents</e0>   ethinyl estradiol  and  <e1>levonorgestrel</e1>  (CYP3A4 substrates)."
Other
Comment:

1805	Another study showed that  alosetron  had no clinically significant effect on plasma concentrations of the oral  contraceptive agents   <e0>ethinyl estradiol</e0>  and  <e1>levonorgestrel</e1>  (CYP3A4 substrates)."
Other
Comment:

1900	A clinical interaction study was also conducted with  <e0>alosetron</e0>  and the CYP3A4 substrate  <e1>cisapride</e1> ."
Other
Comment:


100	The  <e0>benzodiazepines</e0> , including  <e1>alprazolam</e1> , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
Other
Comment:

101	The  <e0>benzodiazepines</e0> , including  alprazolam , produce additive CNS depressant effects when co-administered with other  <e1>psychotropic medications</e1> ,  anticonvulsants ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

102	The  <e0>benzodiazepines</e0> , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  <e1>anticonvulsants</e1> ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

103	The  <e0>benzodiazepines</e0> , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  <e1>antihistaminics</e1> ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

104	The  <e0>benzodiazepines</e0> , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  antihistaminics ,  <e1>ethanol</e1> , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

105	The  benzodiazepines , including  <e0>alprazolam</e0> , produce additive CNS depressant effects when co-administered with other  <e1>psychotropic medications</e1> ,  anticonvulsants ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

106	The  benzodiazepines , including  <e0>alprazolam</e0> , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  <e1>anticonvulsants</e1> ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

107	The  benzodiazepines , including  <e0>alprazolam</e0> , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  <e1>antihistaminics</e1> ,  ethanol , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

108	The  benzodiazepines , including  <e0>alprazolam</e0> , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  antihistaminics ,  <e1>ethanol</e1> , and other drugs which themselves produce CNS depression."
effect(e0,e1)Comment:

109	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  <e0>psychotropic medications</e0> ,  <e1>anticonvulsants</e1> ,  antihistaminics ,  ethanol , and other drugs which themselves produce CNS depression."
Other
Comment:

110	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  <e0>psychotropic medications</e0> ,  anticonvulsants ,  <e1>antihistaminics</e1> ,  ethanol , and other drugs which themselves produce CNS depression."
Other
Comment:

111	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  <e0>psychotropic medications</e0> ,  anticonvulsants ,  antihistaminics ,  <e1>ethanol</e1> , and other drugs which themselves produce CNS depression."
Other
Comment:

112	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  <e0>anticonvulsants</e0> ,  <e1>antihistaminics</e1> ,  ethanol , and other drugs which themselves produce CNS depression."
Other
Comment:

113	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  <e0>anticonvulsants</e0> ,  antihistaminics ,  <e1>ethanol</e1> , and other drugs which themselves produce CNS depression."
Other
Comment:

114	The  benzodiazepines , including  alprazolam , produce additive CNS depressant effects when co-administered with other  psychotropic medications ,  anticonvulsants ,  <e0>antihistaminics</e0> ,  <e1>ethanol</e1> , and other drugs which themselves produce CNS depression."
Other
Comment:

200	The steady state plasma concentrations of  <e0>imipramine</e0>  and  <e1>desipramine</e1>  have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of  alprazolam  tablets in doses up to 4 mg/day."
Other
Comment:

201	The steady state plasma concentrations of  <e0>imipramine</e0>  and  desipramine  have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of  <e1>alprazolam</e1>  tablets in doses up to 4 mg/day."
mechanism(e0,e1)Comment:

202	The steady state plasma concentrations of  imipramine  and  <e0>desipramine</e0>  have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of  <e1>alprazolam</e1>  tablets in doses up to 4 mg/day."
mechanism(e0,e1)Comment:

400	Drugs That Inhibit  <e0>Alprazolam</e0>  Metabolism Via Cytochrome P450 3A: The initial step in  <e1>alprazolam</e1>  metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A)."
Other
Comment:

600	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  <e0>Alprazolam</e0>  (caution is recommended during coadministration with  <e1>alprazolam</e1> ): Coadministration of  fluoxetine  with  alprazolam  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

601	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  <e0>Alprazolam</e0>  (caution is recommended during coadministration with  alprazolam ): Coadministration of  <e1>fluoxetine</e1>  with  alprazolam  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

602	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  <e0>Alprazolam</e0>  (caution is recommended during coadministration with  alprazolam ): Coadministration of  fluoxetine  with  <e1>alprazolam</e1>  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

603	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  <e0>Alprazolam</e0>  (caution is recommended during coadministration with  alprazolam ): Coadministration of  fluoxetine  with  alprazolam  increased the maximum plasma concentration of  <e1>alprazolam</e1>  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

604	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Coadministration of  <e1>fluoxetine</e1>  with  alprazolam  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

605	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Coadministration of  fluoxetine  with  <e1>alprazolam</e1>  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

606	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Coadministration of  fluoxetine  with  alprazolam  increased the maximum plasma concentration of  <e1>alprazolam</e1>  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

607	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  alprazolam ): Coadministration of  <e0>fluoxetine</e0>  with  <e1>alprazolam</e1>  increased the maximum plasma concentration of  alprazolam  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
mechanism(e0,e1)Comment:

608	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  alprazolam ): Coadministration of  <e0>fluoxetine</e0>  with  alprazolam  increased the maximum plasma concentration of  <e1>alprazolam</e1>  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

609	Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving  Alprazolam  (caution is recommended during coadministration with  alprazolam ): Coadministration of  fluoxetine  with  <e0>alprazolam</e0>  increased the maximum plasma concentration of  <e1>alprazolam</e1>  by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance."
Other
Comment:

700	Coadministration of  <e0>propoxyphene</e0>  decreased the maximum plasma concentration of  <e1>alprazolam</e1>  by 6%, decreased clearance by 38%, and increased half-life by 58%."
mechanism(e0,e1)Comment:

800	Coadministration of oral  <e0>contraceptives</e0>  increased the maximum plasma concentration of  <e1>alprazolam</e1>  by 18%, decreased clearance by 22%, and increased half-life by 29%."
mechanism(e0,e1)Comment:

900	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  <e1>alprazolam</e1>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

901	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e1>alprazolam</e1>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

902	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e1>benzodiazepines</e1>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

903	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e1>alprazolam</e1> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

904	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e1>benzodiazepines</e1>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

905	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

906	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

907	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

908	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

909	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

910	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

911	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  <e0>benzodiazepines</e0>  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

912	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  <e1>alprazolam</e1>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

913	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  <e1>benzodiazepines</e1>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

914	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e1>alprazolam</e1> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

915	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e1>benzodiazepines</e1>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

916	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

917	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

918	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

919	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

920	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

921	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

922	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  <e0>alprazolam</e0>  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

923	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  <e1>benzodiazepines</e1>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

924	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  <e1>alprazolam</e1> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

925	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e1>benzodiazepines</e1>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

926	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

927	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

928	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

929	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

930	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

931	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

932	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  <e0>alprazolam</e0>  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

933	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  <e1>alprazolam</e1> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

934	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e1>benzodiazepines</e1>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

935	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

936	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

937	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

938	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

939	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

940	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

941	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  <e0>benzodiazepines</e0>  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

942	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  <e1>benzodiazepines</e1>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

943	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

944	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

945	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

946	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

947	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

948	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

949	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  <e0>alprazolam</e0> ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

950	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  <e1>alprazolam</e1>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

951	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

952	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

953	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

954	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

955	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

956	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

957	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

958	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

959	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

960	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

961	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

962	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

963	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  <e1>diltiazem</e1> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
int(e0,e1)Comment:

964	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  diltiazem ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
int(e0,e1)Comment:

965	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  diltiazem ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
int(e0,e1)Comment:

966	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
int(e0,e1)Comment:

967	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
int(e0,e1)Comment:

968	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e0>diltiazem</e0> ,  <e1>isoniazid</e1> ,  macrolide antibiotics  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

969	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e0>diltiazem</e0> ,  isoniazid ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

970	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e0>diltiazem</e0> ,  isoniazid ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

971	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e0>diltiazem</e0> ,  isoniazid ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

972	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e0>isoniazid</e0> ,  <e1>macrolide antibiotics</e1>  such as  erythromycin  and  clarithromycin , and grapefruit juice."
Other
Comment:

973	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e0>isoniazid</e0> ,  macrolide antibiotics  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

974	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  <e0>isoniazid</e0> ,  macrolide antibiotics  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

975	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e0>macrolide antibiotics</e0>  such as  <e1>erythromycin</e1>  and  clarithromycin , and grapefruit juice."
Other
Comment:

976	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  <e0>macrolide antibiotics</e0>  such as  erythromycin  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

977	Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving  benzodiazepines  metabolized similarly to  alprazolam  or on the basis of in vitro studies with  alprazolam  or other  benzodiazepines  (caution is recommended during coadministration with  alprazolam ): Available data from clinical studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  diltiazem ,  isoniazid ,  macrolide antibiotics  such as  <e0>erythromycin</e0>  and  <e1>clarithromycin</e1> , and grapefruit juice."
Other
Comment:

1000	Data from in vitro studies of  <e0>alprazolam</e0>  suggest a possible drug interaction with  <e1>alprazolam</e1>  for the following:  sertraline  and  paroxetine ."
Other
Comment:

1001	Data from in vitro studies of  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  <e1>sertraline</e1>  and  paroxetine ."
Other
Comment:

1002	Data from in vitro studies of  <e0>alprazolam</e0>  suggest a possible drug interaction with  alprazolam  for the following:  sertraline  and  <e1>paroxetine</e1> ."
Other
Comment:

1003	Data from in vitro studies of  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  <e1>sertraline</e1>  and  paroxetine ."
int(e0,e1)Comment:

1004	Data from in vitro studies of  alprazolam  suggest a possible drug interaction with  <e0>alprazolam</e0>  for the following:  sertraline  and  <e1>paroxetine</e1> ."
int(e0,e1)Comment:

1005	Data from in vitro studies of  alprazolam  suggest a possible drug interaction with  alprazolam  for the following:  <e0>sertraline</e0>  and  <e1>paroxetine</e1> ."
Other
Comment:

1100	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  <e1>alprazolam</e1>  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  nicardipine , and  nifedipine ."
Other
Comment:

1101	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction for the following:  <e1>ergotamine</e1> ,  cyclosporine ,  amiodarone ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1102	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  <e1>cyclosporine</e1> ,  amiodarone ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1103	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  <e1>amiodarone</e1> ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1104	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  <e1>nicardipine</e1> , and  nifedipine ."
int(e0,e1)Comment:

1105	Data from in vitro studies of  <e0>benzodiazepines</e0>  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  nicardipine , and  <e1>nifedipine</e1> ."
int(e0,e1)Comment:

1106	Data from in vitro studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction for the following:  <e1>ergotamine</e1> ,  cyclosporine ,  amiodarone ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1107	Data from in vitro studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction for the following:  ergotamine ,  <e1>cyclosporine</e1> ,  amiodarone ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1108	Data from in vitro studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  <e1>amiodarone</e1> ,  nicardipine , and  nifedipine ."
int(e0,e1)Comment:

1109	Data from in vitro studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  <e1>nicardipine</e1> , and  nifedipine ."
int(e0,e1)Comment:

1110	Data from in vitro studies of  benzodiazepines  other than  <e0>alprazolam</e0>  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  nicardipine , and  <e1>nifedipine</e1> ."
int(e0,e1)Comment:

1111	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  <e0>ergotamine</e0> ,  <e1>cyclosporine</e1> ,  amiodarone ,  nicardipine , and  nifedipine ."
Other
Comment:

1112	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  <e0>ergotamine</e0> ,  cyclosporine ,  <e1>amiodarone</e1> ,  nicardipine , and  nifedipine ."
Other
Comment:

1113	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  <e0>ergotamine</e0> ,  cyclosporine ,  amiodarone ,  <e1>nicardipine</e1> , and  nifedipine ."
Other
Comment:

1114	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  <e0>ergotamine</e0> ,  cyclosporine ,  amiodarone ,  nicardipine , and  <e1>nifedipine</e1> ."
Other
Comment:

1115	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  <e0>cyclosporine</e0> ,  <e1>amiodarone</e1> ,  nicardipine , and  nifedipine ."
Other
Comment:

1116	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  <e0>cyclosporine</e0> ,  amiodarone ,  <e1>nicardipine</e1> , and  nifedipine ."
Other
Comment:

1117	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  <e0>cyclosporine</e0> ,  amiodarone ,  nicardipine , and  <e1>nifedipine</e1> ."
Other
Comment:

1118	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  <e0>amiodarone</e0> ,  <e1>nicardipine</e1> , and  nifedipine ."
Other
Comment:

1119	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  <e0>amiodarone</e0> ,  nicardipine , and  <e1>nifedipine</e1> ."
Other
Comment:

1120	Data from in vitro studies of  benzodiazepines  other than  alprazolam  suggest a possible drug interaction for the following:  ergotamine ,  cyclosporine ,  amiodarone ,  <e0>nicardipine</e0> , and  <e1>nifedipine</e1> ."
Other
Comment:


200	Standard therapy includes  <e0>antibiotics</e0> , such as  <e1>penicillin</e1>  and  gentamicin ;"
Other
Comment:

201	Standard therapy includes  <e0>antibiotics</e0> , such as  penicillin  and  <e1>gentamicin</e1> ;"
Other
Comment:

202	Standard therapy includes  antibiotics , such as  <e0>penicillin</e0>  and  <e1>gentamicin</e1> ;"
Other
Comment:

300	 <e0>vasopressors</e0> , such as  <e1>dopamine</e1>  and  isoproterenol ;"
Other
Comment:

301	 <e0>vasopressors</e0> , such as  dopamine  and  <e1>isoproterenol</e1> ;"
Other
Comment:

302	 vasopressors , such as  <e0>dopamine</e0>  and  <e1>isoproterenol</e1> ;"
Other
Comment:

500	and  <e0>diuretics</e0> , such as  <e1>furosemide</e1> ."
Other
Comment:

600	 <e0>Caverject</e0> : The potential for pharmacokinetic drug-drug interactions between  <e1>alprostadil</e1>  and other agents has not been formally studied."
Other
Comment:


200	In addition to bleeding associated with  <e0>heparin</e0>  and  <e1>vitamin K antagonists</e1> , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

201	In addition to bleeding associated with  <e0>heparin</e0>  and  vitamin K antagonists , drugs that alter platelet function (such as  <e1>acetylsalicylic acid</e1> ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

202	In addition to bleeding associated with  <e0>heparin</e0>  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  <e1>dipyridamole</e1>  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

203	In addition to bleeding associated with  <e0>heparin</e0>  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  <e1>Abciximab</e1> ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

204	In addition to bleeding associated with  <e0>heparin</e0>  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  <e1>Activase</e1>  therapy."
effect(e0,e1)Comment:

205	In addition to bleeding associated with  heparin  and  <e0>vitamin K antagonists</e0> , drugs that alter platelet function (such as  <e1>acetylsalicylic acid</e1> ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

206	In addition to bleeding associated with  heparin  and  <e0>vitamin K antagonists</e0> , drugs that alter platelet function (such as  acetylsalicylic acid ,  <e1>dipyridamole</e1>  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

207	In addition to bleeding associated with  heparin  and  <e0>vitamin K antagonists</e0> , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  <e1>Abciximab</e1> ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

208	In addition to bleeding associated with  heparin  and  <e0>vitamin K antagonists</e0> , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  <e1>Activase</e1>  therapy."
effect(e0,e1)Comment:

209	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  <e0>acetylsalicylic acid</e0> ,  <e1>dipyridamole</e1>  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

210	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  <e0>acetylsalicylic acid</e0> ,  dipyridamole  and  <e1>Abciximab</e1> ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

211	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  <e0>acetylsalicylic acid</e0> ,  dipyridamole  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  <e1>Activase</e1>  therapy."
int(e0,e1)Comment:

212	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  <e0>dipyridamole</e0>  and  <e1>Abciximab</e1> ) may increase the risk of bleeding if administered prior to, during, or after  Activase  therapy."
Other
Comment:

213	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  <e0>dipyridamole</e0>  and  Abciximab ) may increase the risk of bleeding if administered prior to, during, or after  <e1>Activase</e1>  therapy."
effect(e0,e1)Comment:

214	In addition to bleeding associated with  heparin  and  vitamin K antagonists , drugs that alter platelet function (such as  acetylsalicylic acid ,  dipyridamole  and  <e0>Abciximab</e0> ) may increase the risk of bleeding if administered prior to, during, or after  <e1>Activase</e1>  therapy."
effect(e0,e1)Comment:

300	Use of  <e0>Antithrombotics</e0>   <e1>Aspirin</e1>  and  heparin  have been administered concomitantly with and following infusions of  Activase  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

301	Use of  <e0>Antithrombotics</e0>   Aspirin  and  <e1>heparin</e1>  have been administered concomitantly with and following infusions of  Activase  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

302	Use of  <e0>Antithrombotics</e0>   Aspirin  and  heparin  have been administered concomitantly with and following infusions of  <e1>Activase</e1>  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

303	Use of  Antithrombotics   <e0>Aspirin</e0>  and  <e1>heparin</e1>  have been administered concomitantly with and following infusions of  Activase  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

304	Use of  Antithrombotics   <e0>Aspirin</e0>  and  heparin  have been administered concomitantly with and following infusions of  <e1>Activase</e1>  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

305	Use of  Antithrombotics   Aspirin  and  <e0>heparin</e0>  have been administered concomitantly with and following infusions of  <e1>Activase</e1>  in the management of acute myocardial infarction or pulmonary embolism."
Other
Comment:

400	Because  <e0>heparin</e0> ,  <e1>aspirin</e1> , or  Activase  may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites."
Other
Comment:

401	Because  <e0>heparin</e0> ,  aspirin , or  <e1>Activase</e1>  may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites."
Other
Comment:

402	Because  heparin ,  <e0>aspirin</e0> , or  <e1>Activase</e1>  may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites."
Other
Comment:

500	The concomitant use of  <e0>heparin</e0>  or  <e1>aspirin</e1>  during the first 24 hours following symptom onset were prohibited in The NINDS t-PA Stroke Trial."
Other
Comment:


100	Concurrent administration of  <e0>HEXALEN</e0>  and  <e1>antidepressants of the MAO inhibitor class</e1>  may cause severe orthostatic hypotension. Cimetidine , an inhibitor of microsomal drug metabolism, increased  altretamine s half-life and toxicity in a rat model."
effect(e0,e1)Comment:

101	Concurrent administration of  <e0>HEXALEN</e0>  and  antidepressants of the MAO inhibitor class  may cause severe orthostatic hypotension. <e1>Cimetidine</e1> , an inhibitor of microsomal drug metabolism, increased  altretamine s half-life and toxicity in a rat model."
Other
Comment:

102	Concurrent administration of  <e0>HEXALEN</e0>  and  antidepressants of the MAO inhibitor class  may cause severe orthostatic hypotension. Cimetidine , an inhibitor of microsomal drug metabolism, increased  <e1>altretamine</e1> s half-life and toxicity in a rat model."
Other
Comment:

103	Concurrent administration of  HEXALEN  and  <e0>antidepressants of the MAO inhibitor class</e0>  may cause severe orthostatic hypotension. <e1>Cimetidine</e1> , an inhibitor of microsomal drug metabolism, increased  altretamine s half-life and toxicity in a rat model."
Other
Comment:

104	Concurrent administration of  HEXALEN  and  <e0>antidepressants of the MAO inhibitor class</e0>  may cause severe orthostatic hypotension. Cimetidine , an inhibitor of microsomal drug metabolism, increased  <e1>altretamine</e1> s half-life and toxicity in a rat model."
Other
Comment:

105	Concurrent administration of  HEXALEN  and  antidepressants of the MAO inhibitor class  may cause severe orthostatic hypotension. <e0>Cimetidine</e0> , an inhibitor of microsomal drug metabolism, increased  <e1>altretamine</e1> s half-life and toxicity in a rat model."
mechanism(e0,e1)Comment:

200	Data from a randomized trial of  <e0>HEXALEN</e0>  and  <e1>cisplatin</e1>  plus or minus  pyridoxine  in ovarian cancer indicated that  pyridoxine  significantly reduced neurotoxicity;"
effect(e0,e1)Comment:

201	Data from a randomized trial of  <e0>HEXALEN</e0>  and  cisplatin  plus or minus  <e1>pyridoxine</e1>  in ovarian cancer indicated that  pyridoxine  significantly reduced neurotoxicity;"
Other
Comment:

202	Data from a randomized trial of  <e0>HEXALEN</e0>  and  cisplatin  plus or minus  pyridoxine  in ovarian cancer indicated that  <e1>pyridoxine</e1>  significantly reduced neurotoxicity;"
Other
Comment:

203	Data from a randomized trial of  HEXALEN  and  <e0>cisplatin</e0>  plus or minus  <e1>pyridoxine</e1>  in ovarian cancer indicated that  pyridoxine  significantly reduced neurotoxicity;"
Other
Comment:

204	Data from a randomized trial of  HEXALEN  and  <e0>cisplatin</e0>  plus or minus  pyridoxine  in ovarian cancer indicated that  <e1>pyridoxine</e1>  significantly reduced neurotoxicity;"
Other
Comment:

205	Data from a randomized trial of  HEXALEN  and  cisplatin  plus or minus  <e0>pyridoxine</e0>  in ovarian cancer indicated that  <e1>pyridoxine</e1>  significantly reduced neurotoxicity;"
Other
Comment:

300	however, it adversely affected response duration suggesting that  <e0>pyridoxine</e0>  should not be administered with  <e1>HEXALEN</e1>  and/or  cisplatin .1"
advise(e0,e1)Comment:

301	however, it adversely affected response duration suggesting that  <e0>pyridoxine</e0>  should not be administered with  HEXALEN  and/or  <e1>cisplatin</e1> .1"
advise(e0,e1)Comment:

302	however, it adversely affected response duration suggesting that  pyridoxine  should not be administered with  <e0>HEXALEN</e0>  and/or  <e1>cisplatin</e1> .1"
Other
Comment:


100	Careful observation is required when  <e0>amantadine</e0>  is administered concurrently with  <e1>central nervous system stimulants</e1> ."
advise(e0,e1)Comment:


100	Special consideration should be given to the administration of  <e0>ETHYOL</e0>  in patients receiving  <e1>antihypertensive medications</e1>  or other drugs that could cause or potentiate hypotension."
advise(e0,e1)Comment:


100	When  <e0>amiloride</e0>  HCl is administered concomitantly with an  <e1>angiotensin-converting enzyme inhibitor</e1> , the risk of hyperkalemia may be increased."
effect(e0,e1)Comment:

300	 <e0>Lithium</e0>  generally should not be given with  <e1>diuretics</e1>  because they reduce its renal clearance and add a high risk of lithium toxicity."
advise(e0,e1)Comment:

500	In some patients, the administration of a  <e0>non-steroidal anti-inflammatory agent</e0>  can reduce the diuretic, natriuretic, and antihypertensive effects of  <e1>loop diuretics</e1> ,  potassium-sparing diuretics  and  thiazide diuretics ."
effect(e0,e1)Comment:

501	In some patients, the administration of a  <e0>non-steroidal anti-inflammatory agent</e0>  can reduce the diuretic, natriuretic, and antihypertensive effects of  loop diuretics ,  <e1>potassium-sparing diuretics</e1>  and  thiazide diuretics ."
effect(e0,e1)Comment:

502	In some patients, the administration of a  <e0>non-steroidal anti-inflammatory agent</e0>  can reduce the diuretic, natriuretic, and antihypertensive effects of  loop diuretics ,  potassium-sparing diuretics  and  <e1>thiazide diuretics</e1> ."
effect(e0,e1)Comment:

503	In some patients, the administration of a  non-steroidal anti-inflammatory agent  can reduce the diuretic, natriuretic, and antihypertensive effects of  <e0>loop diuretics</e0> ,  <e1>potassium-sparing diuretics</e1>  and  thiazide diuretics ."
Other
Comment:

504	In some patients, the administration of a  non-steroidal anti-inflammatory agent  can reduce the diuretic, natriuretic, and antihypertensive effects of  <e0>loop diuretics</e0> ,  potassium-sparing diuretics  and  <e1>thiazide diuretics</e1> ."
Other
Comment:

505	In some patients, the administration of a  non-steroidal anti-inflammatory agent  can reduce the diuretic, natriuretic, and antihypertensive effects of  loop diuretics ,  <e0>potassium-sparing diuretics</e0>  and  <e1>thiazide diuretics</e1> ."
Other
Comment:

600	Therefore, when  <e0>MIDAMOR</e0>  and  <e1>non-steroidal anti-inflammatory agents</e1>  are used concomitantly, the patient should be observed closely to determine if the desired effect of the  diuretic  is obtained."
advise(e0,e1)Comment:

601	Therefore, when  <e0>MIDAMOR</e0>  and  non-steroidal anti-inflammatory agents  are used concomitantly, the patient should be observed closely to determine if the desired effect of the  <e1>diuretic</e1>  is obtained."
Other
Comment:

602	Therefore, when  MIDAMOR  and  <e0>non-steroidal anti-inflammatory agents</e0>  are used concomitantly, the patient should be observed closely to determine if the desired effect of the  <e1>diuretic</e1>  is obtained."
Other
Comment:

700	Since  <e0>indomethacin</e0>  and  <e1>potassium-sparing diuretics</e1> , including  MIDAMOR , may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently."
effect(e0,e1)Comment:

701	Since  <e0>indomethacin</e0>  and  potassium-sparing diuretics , including  <e1>MIDAMOR</e1> , may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently."
effect(e0,e1)Comment:

702	Since  indomethacin  and  <e0>potassium-sparing diuretics</e0> , including  <e1>MIDAMOR</e1> , may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently."
Other
Comment:



100	 <e0>Cytadren</e0>  accelerates the metabolism of  <e1>dexamethasone</e1> ;"
mechanism(e0,e1)Comment:

200	therefore, if  <e0>glucocorticoid</e0>  replacement is needed,  <e1>hydrocortisone</e1>  should be prescribed."
Other
Comment:

300	 <e0>Aminoglutethimide</e0>  diminishes the effect of  <e1>coumarin</e1>  and  warfarin ."
effect(e0,e1)Comment:

301	 <e0>Aminoglutethimide</e0>  diminishes the effect of  coumarin  and  <e1>warfarin</e1> ."
effect(e0,e1)Comment:

302	 Aminoglutethimide  diminishes the effect of  <e0>coumarin</e0>  and  <e1>warfarin</e1> ."
Other
Comment:


100	Renal clearance measurements of  <e0>PAH</e0>  cannot be made with any significant accuracy in patients receiving  <e1>sulfonamides</e1> ,  procaine , or  thiazolesulfone ."
effect(e0,e1)Comment:

101	Renal clearance measurements of  <e0>PAH</e0>  cannot be made with any significant accuracy in patients receiving  sulfonamides ,  <e1>procaine</e1> , or  thiazolesulfone ."
effect(e0,e1)Comment:

102	Renal clearance measurements of  <e0>PAH</e0>  cannot be made with any significant accuracy in patients receiving  sulfonamides ,  procaine , or  <e1>thiazolesulfone</e1> ."
effect(e0,e1)Comment:

103	Renal clearance measurements of  PAH  cannot be made with any significant accuracy in patients receiving  <e0>sulfonamides</e0> ,  <e1>procaine</e1> , or  thiazolesulfone ."
Other
Comment:

104	Renal clearance measurements of  PAH  cannot be made with any significant accuracy in patients receiving  <e0>sulfonamides</e0> ,  procaine , or  <e1>thiazolesulfone</e1> ."
Other
Comment:

105	Renal clearance measurements of  PAH  cannot be made with any significant accuracy in patients receiving  sulfonamides ,  <e0>procaine</e0> , or  <e1>thiazolesulfone</e1> ."
Other
Comment:

300	 <e0>Probenecid</e0>  depresses tubular secretion of certain weak acids such as  <e1>PAH</e1> ."
mechanism(e0,e1)Comment:

400	Therefore, patients receiving  <e0>probenecid</e0>  will have erroneously low ERPF and Tm  <e1>PAH</e1>  values."
effect(e0,e1)Comment:


200	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  <e1>griseofulvin</e1> ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

201	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  <e1>thiazide diuretics</e1> ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

202	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  thiazide diuretics ,  <e1>sulfonylureas</e1> ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

203	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  <e1>phenothiazines</e1> ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

204	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  <e1>sulfonamides</e1>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

205	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

206	It is, however, possible that concomitant use of other known  <e0>photosensitizing agents</e0>  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

207	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  <e1>thiazide diuretics</e1> ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

208	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  thiazide diuretics ,  <e1>sulfonylureas</e1> ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

209	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  thiazide diuretics ,  sulfonylureas ,  <e1>phenothiazines</e1> ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

210	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  <e1>sulfonamides</e1>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

211	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

212	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  <e0>griseofulvin</e0> ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

213	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  <e0>thiazide diuretics</e0> ,  <e1>sulfonylureas</e1> ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

214	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  <e0>thiazide diuretics</e0> ,  sulfonylureas ,  <e1>phenothiazines</e1> ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

215	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  <e0>thiazide diuretics</e0> ,  sulfonylureas ,  phenothiazines ,  <e1>sulfonamides</e1>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

216	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  <e0>thiazide diuretics</e0> ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

217	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  <e0>thiazide diuretics</e0> ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

218	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  <e0>sulfonylureas</e0> ,  <e1>phenothiazines</e1> ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

219	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  <e0>sulfonylureas</e0> ,  phenothiazines ,  <e1>sulfonamides</e1>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

220	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  <e0>sulfonylureas</e0> ,  phenothiazines ,  sulfonamides  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

221	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  <e0>sulfonylureas</e0> ,  phenothiazines ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

222	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  <e0>phenothiazines</e0> ,  <e1>sulfonamides</e1>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

223	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  <e0>phenothiazines</e0> ,  sulfonamides  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

224	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  <e0>phenothiazines</e0> ,  sulfonamides  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

225	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  <e0>sulfonamides</e0>  and  <e1>tetracyclines</e1>  might increase the photosensitivity reaction of actinic keratoses treated with the  LEVULAN KERASTICK  for Topical Solution."
Other
Comment:

226	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  <e0>sulfonamides</e0>  and  tetracyclines  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:

227	It is, however, possible that concomitant use of other known  photosensitizing agents  such as  griseofulvin ,  thiazide diuretics ,  sulfonylureas ,  phenothiazines ,  sulfonamides  and  <e0>tetracyclines</e0>  might increase the photosensitivity reaction of actinic keratoses treated with the  <e1>LEVULAN KERASTICK</e1>  for Topical Solution."
effect(e0,e1)Comment:


100	 <e0>Aminosalicylic acid</e0>  may decrease the amount of  <e1>digoxin</e1>  ( Lanoxin ,  Lanoxicaps ) that gets absorbed into your body."
mechanism(e0,e1)Comment:

101	 <e0>Aminosalicylic acid</e0>  may decrease the amount of  digoxin  ( <e1>Lanoxin</e1> ,  Lanoxicaps ) that gets absorbed into your body."
mechanism(e0,e1)Comment:

102	 <e0>Aminosalicylic acid</e0>  may decrease the amount of  digoxin  ( Lanoxin ,  <e1>Lanoxicaps</e1> ) that gets absorbed into your body."
Other
Comment:

103	 Aminosalicylic acid  may decrease the amount of  <e0>digoxin</e0>  ( <e1>Lanoxin</e1> ,  Lanoxicaps ) that gets absorbed into your body."
Other
Comment:

104	 Aminosalicylic acid  may decrease the amount of  <e0>digoxin</e0>  ( Lanoxin ,  <e1>Lanoxicaps</e1> ) that gets absorbed into your body."
Other
Comment:

105	 Aminosalicylic acid  may decrease the amount of  digoxin  ( <e0>Lanoxin</e0> ,  <e1>Lanoxicaps</e1> ) that gets absorbed into your body."
Other
Comment:

200	In the case that you are taking  <e0>digoxin</e0>  while taking  <e1>aminosalicylic acid</e1> , higher doses of  digoxin  may be needed."
advise(e0,e1)Comment:

201	In the case that you are taking  <e0>digoxin</e0>  while taking  aminosalicylic acid , higher doses of  <e1>digoxin</e1>  may be needed."
Other
Comment:

202	In the case that you are taking  digoxin  while taking  <e0>aminosalicylic acid</e0> , higher doses of  <e1>digoxin</e1>  may be needed."
Other
Comment:

300	 <e0>Aminosalicylic acid</e0>  may also decrease the absorption of  <e1>vitamin B12</e1> , which can lead to a deficiency."
mechanism(e0,e1)Comment:

400	Therefore you may need to take a  <e0>vitamin B12</e0>  supplement while taking  <e1>aminosalicylic acid</e1> ."
advise(e0,e1)Comment:


100	 <e0>Amiodarone</e0>  is metabolized to  <e1>desethylamiodarone</e1>  by the cytochrome P450 (CYP450) enzyme group, specifically cytochromes P450 3A4 (CYP3A4) and CYP2C8."
Other
Comment:

800	In view of the long and variable half-life of  <e0>amiodarone</e0> , potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of  <e1>amiodarone</e1> ."
Other
Comment:

900	Since  <e0>amiodarone</e0>  is a substrate for CYP3A4 and CYP2C8, drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of  <e1>amiodarone</e1> ."
Other
Comment:

1000	Reported examples include the following:  <e0>Protease Inhibitors</e0> :  <e1>Protease inhibitors</e1>  are known to inhibit CYP3A4 to varying degrees."
Other
Comment:

1100	A case report of one patient taking  <e0>amiodarone</e0>  200 mg and  <e1>indinavir</e1>  800 mg three times a day resulted in increases in  amiodarone  concentrations from 0.9 mg/L to 1.3 mg/L."
mechanism(e0,e1)Comment:

1101	A case report of one patient taking  <e0>amiodarone</e0>  200 mg and  indinavir  800 mg three times a day resulted in increases in  <e1>amiodarone</e1>  concentrations from 0.9 mg/L to 1.3 mg/L."
Other
Comment:

1102	A case report of one patient taking  amiodarone  200 mg and  <e0>indinavir</e0>  800 mg three times a day resulted in increases in  <e1>amiodarone</e1>  concentrations from 0.9 mg/L to 1.3 mg/L."
Other
Comment:

1400	Monitoring for  <e0>amiodarone</e0>  toxicity and serial measurement of  <e1>amiodarone</e1>  serum concentration during concomitant  protease inhibitor  therapy should be considered."
Other
Comment:

1401	Monitoring for  <e0>amiodarone</e0>  toxicity and serial measurement of  amiodarone  serum concentration during concomitant  <e1>protease inhibitor</e1>  therapy should be considered."
Other
Comment:

1402	Monitoring for  amiodarone  toxicity and serial measurement of  <e0>amiodarone</e0>  serum concentration during concomitant  <e1>protease inhibitor</e1>  therapy should be considered."
advise(e0,e1)Comment:

1500	 <e0>Histamine H2 antagonists</e0> :  <e1>Cimetidine</e1>  inhibits CYP3A4 and can increase serum  amiodarone  levels."
mechanism(e0,e1)Comment:

1501	 <e0>Histamine H2 antagonists</e0> :  Cimetidine  inhibits CYP3A4 and can increase serum  <e1>amiodarone</e1>  levels."
Other
Comment:

1502	 Histamine H2 antagonists :  <e0>Cimetidine</e0>  inhibits CYP3A4 and can increase serum  <e1>amiodarone</e1>  levels."
Other
Comment:

1600	Other substances: Grapefruit juice given to healthy volunteers increased  <e0>amiodarone</e0>  AUC by 50% and Cmax by 84%, resulting in increased plasma levels of  <e1>amiodarone</e1> ."
Other
Comment:

1800	This information should be considered when changing from intravenous  <e0>amiodarone</e0>  to oral  <e1>amiodarone</e1>  ."
Other
Comment:

1900	 <e0>Amiodarone</e0>  may suppress certain CYP450 enzymes, including  <e1>CYP1A2</e1> ,  CYP2C9 ,  CYP2D6 , and  CYP3A4 ."
Other
Comment:

1901	 <e0>Amiodarone</e0>  may suppress certain CYP450 enzymes, including  CYP1A2 ,  <e1>CYP2C9</e1> ,  CYP2D6 , and  CYP3A4 ."
Other
Comment:

1902	 <e0>Amiodarone</e0>  may suppress certain CYP450 enzymes, including  CYP1A2 ,  CYP2C9 ,  <e1>CYP2D6</e1> , and  CYP3A4 ."
Other
Comment:

1903	 <e0>Amiodarone</e0>  may suppress certain CYP450 enzymes, including  CYP1A2 ,  CYP2C9 ,  CYP2D6 , and  <e1>CYP3A4</e1> ."
Other
Comment:

1904	 Amiodarone  may suppress certain CYP450 enzymes, including  <e0>CYP1A2</e0> ,  <e1>CYP2C9</e1> ,  CYP2D6 , and  CYP3A4 ."
Other
Comment:

1905	 Amiodarone  may suppress certain CYP450 enzymes, including  <e0>CYP1A2</e0> ,  CYP2C9 ,  <e1>CYP2D6</e1> , and  CYP3A4 ."
Other
Comment:

1906	 Amiodarone  may suppress certain CYP450 enzymes, including  <e0>CYP1A2</e0> ,  CYP2C9 ,  CYP2D6 , and  <e1>CYP3A4</e1> ."
Other
Comment:

1907	 Amiodarone  may suppress certain CYP450 enzymes, including  CYP1A2 ,  <e0>CYP2C9</e0> ,  <e1>CYP2D6</e1> , and  CYP3A4 ."
Other
Comment:

1908	 Amiodarone  may suppress certain CYP450 enzymes, including  CYP1A2 ,  <e0>CYP2C9</e0> ,  CYP2D6 , and  <e1>CYP3A4</e1> ."
Other
Comment:

1909	 Amiodarone  may suppress certain CYP450 enzymes, including  CYP1A2 ,  CYP2C9 ,  <e0>CYP2D6</e0> , and  <e1>CYP3A4</e1> ."
Other
Comment:

2100	Reported examples of this interaction include the following:  <e0>Immunosuppressive</e0> s:  <e1>Cyclosporine</e1>  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2101	Reported examples of this interaction include the following:  <e0>Immunosuppressive</e0> s:  Cyclosporine  ( <e1>CYP3A4</e1>  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2102	Reported examples of this interaction include the following:  <e0>Immunosuppressive</e0> s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  <e1>amiodarone</e1>  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2103	Reported examples of this interaction include the following:  <e0>Immunosuppressive</e0> s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  <e1>cyclosporine</e1>  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2104	Reported examples of this interaction include the following:  <e0>Immunosuppressive</e0> s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  <e1>cyclosporine</e1> ."
Other
Comment:

2105	Reported examples of this interaction include the following:  Immunosuppressive s:  <e0>Cyclosporine</e0>  ( <e1>CYP3A4</e1>  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2106	Reported examples of this interaction include the following:  Immunosuppressive s:  <e0>Cyclosporine</e0>  ( CYP3A4  substrate) administered in combination with oral  <e1>amiodarone</e1>  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2107	Reported examples of this interaction include the following:  Immunosuppressive s:  <e0>Cyclosporine</e0>  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  <e1>cyclosporine</e1>  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2108	Reported examples of this interaction include the following:  Immunosuppressive s:  <e0>Cyclosporine</e0>  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  <e1>cyclosporine</e1> ."
Other
Comment:

2109	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( <e0>CYP3A4</e0>  substrate) administered in combination with oral  <e1>amiodarone</e1>  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2110	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( <e0>CYP3A4</e0>  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  <e1>cyclosporine</e1>  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2111	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( <e0>CYP3A4</e0>  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  <e1>cyclosporine</e1> ."
Other
Comment:

2112	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  <e0>amiodarone</e0>  has been reported to produce persistently elevated plasma concentrations of  <e1>cyclosporine</e1>  resulting in elevated creatinine, despite reduction in dose of  cyclosporine ."
Other
Comment:

2113	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  <e0>amiodarone</e0>  has been reported to produce persistently elevated plasma concentrations of  cyclosporine  resulting in elevated creatinine, despite reduction in dose of  <e1>cyclosporine</e1> ."
Other
Comment:

2114	Reported examples of this interaction include the following:  Immunosuppressive s:  Cyclosporine  ( CYP3A4  substrate) administered in combination with oral  amiodarone  has been reported to produce persistently elevated plasma concentrations of  <e0>cyclosporine</e0>  resulting in elevated creatinine, despite reduction in dose of  <e1>cyclosporine</e1> ."
Other
Comment:

2200	 <e0>HMG-CoA Reductase Inhibitors</e0> :  <e1>Simvastatin</e1>  ( CYP3A4  substrate) in combination with  amiodarone  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2201	 <e0>HMG-CoA Reductase Inhibitors</e0> :  Simvastatin  ( <e1>CYP3A4</e1>  substrate) in combination with  amiodarone  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2202	 <e0>HMG-CoA Reductase Inhibitors</e0> :  Simvastatin  ( CYP3A4  substrate) in combination with  <e1>amiodarone</e1>  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2203	 HMG-CoA Reductase Inhibitors :  <e0>Simvastatin</e0>  ( <e1>CYP3A4</e1>  substrate) in combination with  amiodarone  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2204	 HMG-CoA Reductase Inhibitors :  <e0>Simvastatin</e0>  ( CYP3A4  substrate) in combination with  <e1>amiodarone</e1>  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2205	 HMG-CoA Reductase Inhibitors :  Simvastatin  ( <e0>CYP3A4</e0>  substrate) in combination with  <e1>amiodarone</e1>  has been associated with reports of myopathy/rhabdomyolysis."
Other
Comment:

2300	Cardiovasculars:  <e0>Cardiac glycosides</e0> : In patients receiving  <e1>digoxin</e1>  therapy, administration of oral  amiodarone  regularly results in an increase in serum  digoxin  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2301	Cardiovasculars:  <e0>Cardiac glycosides</e0> : In patients receiving  digoxin  therapy, administration of oral  <e1>amiodarone</e1>  regularly results in an increase in serum  digoxin  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2302	Cardiovasculars:  <e0>Cardiac glycosides</e0> : In patients receiving  digoxin  therapy, administration of oral  amiodarone  regularly results in an increase in serum  <e1>digoxin</e1>  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2303	Cardiovasculars:  Cardiac glycosides : In patients receiving  <e0>digoxin</e0>  therapy, administration of oral  <e1>amiodarone</e1>  regularly results in an increase in serum  digoxin  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2304	Cardiovasculars:  Cardiac glycosides : In patients receiving  <e0>digoxin</e0>  therapy, administration of oral  amiodarone  regularly results in an increase in serum  <e1>digoxin</e1>  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2305	Cardiovasculars:  Cardiac glycosides : In patients receiving  digoxin  therapy, administration of oral  <e0>amiodarone</e0>  regularly results in an increase in serum  <e1>digoxin</e1>  concentration that may reach toxic levels with resultant clinical toxicity."
Other
Comment:

2400	 <e0>Amiodarone</e0>  taken concomitantly with  <e1>digoxin</e1>  increases the serum  digoxin  concentration by 70% after one day."
Other
Comment:

2401	 <e0>Amiodarone</e0>  taken concomitantly with  digoxin  increases the serum  <e1>digoxin</e1>  concentration by 70% after one day."
Other
Comment:

2402	 Amiodarone  taken concomitantly with  <e0>digoxin</e0>  increases the serum  <e1>digoxin</e1>  concentration by 70% after one day."
Other
Comment:

2500	On administration of oral  <e0>amiodarone</e0> , the need for  <e1>digitalis</e1>  therapy should be reviewed and the dose reduced by approximately 50% or discontinued."
advise(e0,e1)Comment:

2800	 <e0>Antiarrhythmics</e0> : Other  <e1>antiarrhythmic</e1>  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2801	 <e0>Antiarrhythmics</e0> : Other  antiarrhythmic  drugs, such as  <e1>quinidine</e1> ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2802	 <e0>Antiarrhythmics</e0> : Other  antiarrhythmic  drugs, such as  quinidine ,  <e1>procainamide</e1> ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2803	 <e0>Antiarrhythmics</e0> : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  <e1>disopyramide</e1> , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2804	 <e0>Antiarrhythmics</e0> : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  <e1>phenytoin</e1> , have been used concurrently with  amiodarone ."
Other
Comment:

2805	 <e0>Antiarrhythmics</e0> : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2806	 Antiarrhythmics : Other  <e0>antiarrhythmic</e0>  drugs, such as  <e1>quinidine</e1> ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2807	 Antiarrhythmics : Other  <e0>antiarrhythmic</e0>  drugs, such as  quinidine ,  <e1>procainamide</e1> ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2808	 Antiarrhythmics : Other  <e0>antiarrhythmic</e0>  drugs, such as  quinidine ,  procainamide ,  <e1>disopyramide</e1> , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2809	 Antiarrhythmics : Other  <e0>antiarrhythmic</e0>  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  <e1>phenytoin</e1> , have been used concurrently with  amiodarone ."
Other
Comment:

2810	 Antiarrhythmics : Other  <e0>antiarrhythmic</e0>  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2811	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  <e0>quinidine</e0> ,  <e1>procainamide</e1> ,  disopyramide , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2812	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  <e0>quinidine</e0> ,  procainamide ,  <e1>disopyramide</e1> , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2813	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  <e0>quinidine</e0> ,  procainamide ,  disopyramide , and  <e1>phenytoin</e1> , have been used concurrently with  amiodarone ."
Other
Comment:

2814	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  <e0>quinidine</e0> ,  procainamide ,  disopyramide , and  phenytoin , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2815	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  <e0>procainamide</e0> ,  <e1>disopyramide</e1> , and  phenytoin , have been used concurrently with  amiodarone ."
Other
Comment:

2816	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  <e0>procainamide</e0> ,  disopyramide , and  <e1>phenytoin</e1> , have been used concurrently with  amiodarone ."
Other
Comment:

2817	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  <e0>procainamide</e0> ,  disopyramide , and  phenytoin , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2818	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  <e0>disopyramide</e0> , and  <e1>phenytoin</e1> , have been used concurrently with  amiodarone ."
Other
Comment:

2819	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  <e0>disopyramide</e0> , and  phenytoin , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2820	 Antiarrhythmics : Other  antiarrhythmic  drugs, such as  quinidine ,  procainamide ,  disopyramide , and  <e0>phenytoin</e0> , have been used concurrently with  <e1>amiodarone</e1> ."
Other
Comment:

2900	There have been case reports of increased steady-state levels of  <e0>quinidine</e0> ,  <e1>procainamide</e1> , and  phenytoin  during concomitant therapy with  amiodarone ."
Other
Comment:

2901	There have been case reports of increased steady-state levels of  <e0>quinidine</e0> ,  procainamide , and  <e1>phenytoin</e1>  during concomitant therapy with  amiodarone ."
Other
Comment:

2902	There have been case reports of increased steady-state levels of  <e0>quinidine</e0> ,  procainamide , and  phenytoin  during concomitant therapy with  <e1>amiodarone</e1> ."
Other
Comment:

2903	There have been case reports of increased steady-state levels of  quinidine ,  <e0>procainamide</e0> , and  <e1>phenytoin</e1>  during concomitant therapy with  amiodarone ."
Other
Comment:

2904	There have been case reports of increased steady-state levels of  quinidine ,  <e0>procainamide</e0> , and  phenytoin  during concomitant therapy with  <e1>amiodarone</e1> ."
Other
Comment:

2905	There have been case reports of increased steady-state levels of  quinidine ,  procainamide , and  <e0>phenytoin</e0>  during concomitant therapy with  <e1>amiodarone</e1> ."
Other
Comment:

3100	 <e0>Amiodarone</e0>  taken concomitantly with  <e1>quinidine</e1>  increases  quinidine  serum concentration by 33% after two days."
Other
Comment:

3101	 <e0>Amiodarone</e0>  taken concomitantly with  quinidine  increases  <e1>quinidine</e1>  serum concentration by 33% after two days."
Other
Comment:

3102	 Amiodarone  taken concomitantly with  <e0>quinidine</e0>  increases  <e1>quinidine</e1>  serum concentration by 33% after two days."
Other
Comment:

3200	 <e0>Amiodarone</e0>  taken concomitantly with  <e1>procainamide</e1>  for less than seven days increases plasma concentrations of  procainamide  and n-acetyl  procainamide  by 55% and 33%, respectively."
Other
Comment:

3201	 <e0>Amiodarone</e0>  taken concomitantly with  procainamide  for less than seven days increases plasma concentrations of  <e1>procainamide</e1>  and n-acetyl  procainamide  by 55% and 33%, respectively."
Other
Comment:

3202	 <e0>Amiodarone</e0>  taken concomitantly with  procainamide  for less than seven days increases plasma concentrations of  procainamide  and n-acetyl  <e1>procainamide</e1>  by 55% and 33%, respectively."
Other
Comment:

3203	 Amiodarone  taken concomitantly with  <e0>procainamide</e0>  for less than seven days increases plasma concentrations of  <e1>procainamide</e1>  and n-acetyl  procainamide  by 55% and 33%, respectively."
Other
Comment:

3204	 Amiodarone  taken concomitantly with  <e0>procainamide</e0>  for less than seven days increases plasma concentrations of  procainamide  and n-acetyl  <e1>procainamide</e1>  by 55% and 33%, respectively."
Other
Comment:

3205	 Amiodarone  taken concomitantly with  procainamide  for less than seven days increases plasma concentrations of  <e0>procainamide</e0>  and n-acetyl  <e1>procainamide</e1>  by 55% and 33%, respectively."
Other
Comment:

3300	 <e0>Quinidine</e0>  and procainamide doses should be reduced by one-third when either is administered with  <e1>amiodarone</e1> ."
Other
Comment:

3400	Plasma levels of  <e0>flecainide</e0>  have been reported to increase in the presence of oral  <e1>amiodarone</e1> ;"
Other
Comment:

3500	because of this, the dosage of  <e0>flecainide</e0>  should be adjusted when these  <e1>drugs</e1>  are administered concomitantly."
Other
Comment:

3700	Combination of  <e0>amiodarone</e0>  with other  <e1>antiarrhythmic</e1>  therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to  amiodarone ."
Other
Comment:

3701	Combination of  <e0>amiodarone</e0>  with other  antiarrhythmic  therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to  <e1>amiodarone</e1> ."
Other
Comment:

3702	Combination of  amiodarone  with other  <e0>antiarrhythmic</e0>  therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to  <e1>amiodarone</e1> ."
Other
Comment:

3800	During transfer to oral  <e0>amiodarone</e0> , the dose levels of previously administered agents should be reduced by 30 to 50% several days after the addition of oral  <e1>amiodarone</e1> ."
Other
Comment:

3900	The continued need for the other  <e0>antiarrhythmic</e0>  agent should be reviewed after the effects of  <e1>amiodarone</e1>  have been established, and discontinuation ordinarily should be attempted."
Other
Comment:

4100	In  <e0>amiodarone</e0> -treated patients who require additional  <e1>antiarrhythmic</e1>  therapy, the initial dose of such agents should be approximately half of the usual recommended dose."
Other
Comment:

4200	 <e0>Antihypertensives</e0> :  <e1>Amiodarone</e1>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4201	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - <e1>receptor</e1>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4202	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e1>propranolol</e1> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4203	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e1>CYP3A4</e1>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4204	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e1>calcium channel</e1>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4205	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4206	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4207	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4208	 <e0>Antihypertensives</e0> :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4209	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - <e1>receptor</e1>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4210	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e1>propranolol</e1> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4211	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e1>CYP3A4</e1>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4212	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e1>calcium channel</e1>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4213	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4214	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4215	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4216	 Antihypertensives :  <e0>Amiodarone</e0>  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4217	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  <e1>propranolol</e1> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4218	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  <e1>CYP3A4</e1>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4219	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e1>calcium channel</e1>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4220	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4221	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4222	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4223	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - <e0>receptor</e0>  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4224	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  <e1>CYP3A4</e1>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4225	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  CYP3A4  inhibitor) or  <e1>calcium channel</e1>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4226	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4227	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4228	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4229	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  <e0>propranolol</e0> , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4230	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e0>CYP3A4</e0>  inhibitor) or  <e1>calcium channel</e1>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4231	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e0>CYP3A4</e0>  inhibitor) or  calcium channel  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4232	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e0>CYP3A4</e0>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4233	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e0>CYP3A4</e0>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4234	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  <e0>CYP3A4</e0>  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4235	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e0>calcium channel</e0>  antagonists (e.g.,  <e1>verapamil</e1> , a  CYP3A4  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4236	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e0>calcium channel</e0>  antagonists (e.g.,  verapamil , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4237	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e0>calcium channel</e0>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4238	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  <e0>calcium channel</e0>  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4239	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e0>verapamil</e0> , a  <e1>CYP3A4</e1>  substrate, and  diltiazem , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4240	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e0>verapamil</e0> , a  CYP3A4  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4241	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  <e0>verapamil</e0> , a  CYP3A4  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4242	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e0>CYP3A4</e0>  substrate, and  <e1>diltiazem</e1> , a  CYP3A4  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4243	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  <e0>CYP3A4</e0>  substrate, and  diltiazem , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4244	 Antihypertensives :  Amiodarone  should be used with caution in patients receiving  - receptor  blocking agents (e.g.,  propranolol , a  CYP3A4  inhibitor) or  calcium channel  antagonists (e.g.,  verapamil , a  CYP3A4  substrate, and  <e0>diltiazem</e0> , a  <e1>CYP3A4</e1>  inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;"
Other
Comment:

4400	 <e0>Anticoagulants</e0> : Potentiation of  <e1>warfarin</e1> -type ( CYP2C9  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4401	 <e0>Anticoagulants</e0> : Potentiation of  warfarin -type ( <e1>CYP2C9</e1>  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4402	 <e0>Anticoagulants</e0> : Potentiation of  warfarin -type ( CYP2C9  and  <e1>CYP3A4</e1>  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4403	 <e0>Anticoagulants</e0> : Potentiation of  warfarin -type ( CYP2C9  and  CYP3A4  substrate)  <e1>anticoagulant</e1>  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4404	 <e0>Anticoagulants</e0> : Potentiation of  warfarin -type ( CYP2C9  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  <e1>amiodarone</e1>  and can result in serious or fatal bleeding."
Other
Comment:

4405	 Anticoagulants : Potentiation of  <e0>warfarin</e0> -type ( <e1>CYP2C9</e1>  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4406	 Anticoagulants : Potentiation of  <e0>warfarin</e0> -type ( CYP2C9  and  <e1>CYP3A4</e1>  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4407	 Anticoagulants : Potentiation of  <e0>warfarin</e0> -type ( CYP2C9  and  CYP3A4  substrate)  <e1>anticoagulant</e1>  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4408	 Anticoagulants : Potentiation of  <e0>warfarin</e0> -type ( CYP2C9  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  <e1>amiodarone</e1>  and can result in serious or fatal bleeding."
Other
Comment:

4409	 Anticoagulants : Potentiation of  warfarin -type ( <e0>CYP2C9</e0>  and  <e1>CYP3A4</e1>  substrate)  anticoagulant  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4410	 Anticoagulants : Potentiation of  warfarin -type ( <e0>CYP2C9</e0>  and  CYP3A4  substrate)  <e1>anticoagulant</e1>  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4411	 Anticoagulants : Potentiation of  warfarin -type ( <e0>CYP2C9</e0>  and  CYP3A4  substrate)  anticoagulant  response is almost always seen in patients receiving  <e1>amiodarone</e1>  and can result in serious or fatal bleeding."
Other
Comment:

4412	 Anticoagulants : Potentiation of  warfarin -type ( CYP2C9  and  <e0>CYP3A4</e0>  substrate)  <e1>anticoagulant</e1>  response is almost always seen in patients receiving  amiodarone  and can result in serious or fatal bleeding."
Other
Comment:

4413	 Anticoagulants : Potentiation of  warfarin -type ( CYP2C9  and  <e0>CYP3A4</e0>  substrate)  anticoagulant  response is almost always seen in patients receiving  <e1>amiodarone</e1>  and can result in serious or fatal bleeding."
Other
Comment:

4414	 Anticoagulants : Potentiation of  warfarin -type ( CYP2C9  and  CYP3A4  substrate)  <e0>anticoagulant</e0>  response is almost always seen in patients receiving  <e1>amiodarone</e1>  and can result in serious or fatal bleeding."
Other
Comment:

4500	Since the concomitant administration of  <e0>warfarin</e0>  with  <e1>amiodarone</e1>  increases the prothrombin time by 100% after 3 to 4 days, the dose of the  anticoagulant  should be reduced by one-third to one-half, and prothrombin times should be monitored closely."
Other
Comment:

4501	Since the concomitant administration of  <e0>warfarin</e0>  with  amiodarone  increases the prothrombin time by 100% after 3 to 4 days, the dose of the  <e1>anticoagulant</e1>  should be reduced by one-third to one-half, and prothrombin times should be monitored closely."
Other
Comment:

4502	Since the concomitant administration of  warfarin  with  <e0>amiodarone</e0>  increases the prothrombin time by 100% after 3 to 4 days, the dose of the  <e1>anticoagulant</e1>  should be reduced by one-third to one-half, and prothrombin times should be monitored closely."
Other
Comment:

4600	Some  <e0>drugs</e0> /substances are known to accelerate the metabolism of  <e1>amiodarone</e1>  by stimulating the synthesis of  CYP3A4  (enzyme induction)."
Other
Comment:

4601	Some  <e0>drugs</e0> /substances are known to accelerate the metabolism of  amiodarone  by stimulating the synthesis of  <e1>CYP3A4</e1>  (enzyme induction)."
Other
Comment:

4602	Some  drugs /substances are known to accelerate the metabolism of  <e0>amiodarone</e0>  by stimulating the synthesis of  <e1>CYP3A4</e1>  (enzyme induction)."
Other
Comment:

4800	Reported examples of this interaction include the following:  <e0>Antibiotics</e0> :  <e1>Rifampin</e1>  is a potent inducer of  CYP3A4 ."
Other
Comment:

4801	Reported examples of this interaction include the following:  <e0>Antibiotics</e0> :  Rifampin  is a potent inducer of  <e1>CYP3A4</e1> ."
Other
Comment:

4802	Reported examples of this interaction include the following:  Antibiotics :  <e0>Rifampin</e0>  is a potent inducer of  <e1>CYP3A4</e1> ."
Other
Comment:

4900	Administration of  <e0>rifampin</e0>  concomitantly with oral  <e1>amiodarone</e1>  has been shown to result in decreases in serum concentrations of  amiodarone  and  desethylamiodarone ."
Other
Comment:

4901	Administration of  <e0>rifampin</e0>  concomitantly with oral  amiodarone  has been shown to result in decreases in serum concentrations of  <e1>amiodarone</e1>  and  desethylamiodarone ."
Other
Comment:

4902	Administration of  <e0>rifampin</e0>  concomitantly with oral  amiodarone  has been shown to result in decreases in serum concentrations of  amiodarone  and  <e1>desethylamiodarone</e1> ."
Other
Comment:

4903	Administration of  rifampin  concomitantly with oral  <e0>amiodarone</e0>  has been shown to result in decreases in serum concentrations of  <e1>amiodarone</e1>  and  desethylamiodarone ."
Other
Comment:

4904	Administration of  rifampin  concomitantly with oral  <e0>amiodarone</e0>  has been shown to result in decreases in serum concentrations of  amiodarone  and  <e1>desethylamiodarone</e1> ."
Other
Comment:

4905	Administration of  rifampin  concomitantly with oral  amiodarone  has been shown to result in decreases in serum concentrations of  <e0>amiodarone</e0>  and  <e1>desethylamiodarone</e1> ."
Other
Comment:

5100	Since  <e0>amiodarone</e0>  is a substrate for  <e1>CYP3A4</e1> , there is the potential that the use of St. John s Wort in patients receiving  amiodarone  could result in reduced  amiodarone  levels."
Other
Comment:

5101	Since  <e0>amiodarone</e0>  is a substrate for  CYP3A4 , there is the potential that the use of St. John s Wort in patients receiving  <e1>amiodarone</e1>  could result in reduced  amiodarone  levels."
Other
Comment:

5102	Since  <e0>amiodarone</e0>  is a substrate for  CYP3A4 , there is the potential that the use of St. John s Wort in patients receiving  amiodarone  could result in reduced  <e1>amiodarone</e1>  levels."
Other
Comment:

5103	Since  amiodarone  is a substrate for  <e0>CYP3A4</e0> , there is the potential that the use of St. John s Wort in patients receiving  <e1>amiodarone</e1>  could result in reduced  amiodarone  levels."
Other
Comment:

5104	Since  amiodarone  is a substrate for  <e0>CYP3A4</e0> , there is the potential that the use of St. John s Wort in patients receiving  amiodarone  could result in reduced  <e1>amiodarone</e1>  levels."
Other
Comment:

5105	Since  amiodarone  is a substrate for  CYP3A4 , there is the potential that the use of St. John s Wort in patients receiving  <e0>amiodarone</e0>  could result in reduced  <e1>amiodarone</e1>  levels."
Other
Comment:

5200	Other reported interactions with  <e0>amiodarone</e0> :  <e1>Fentanyl</e1>  ( CYP3A4  substrate) in combination with  amiodarone  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5201	Other reported interactions with  <e0>amiodarone</e0> :  Fentanyl  ( <e1>CYP3A4</e1>  substrate) in combination with  amiodarone  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5202	Other reported interactions with  <e0>amiodarone</e0> :  Fentanyl  ( CYP3A4  substrate) in combination with  <e1>amiodarone</e1>  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5203	Other reported interactions with  amiodarone :  <e0>Fentanyl</e0>  ( <e1>CYP3A4</e1>  substrate) in combination with  amiodarone  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5204	Other reported interactions with  amiodarone :  <e0>Fentanyl</e0>  ( CYP3A4  substrate) in combination with  <e1>amiodarone</e1>  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5205	Other reported interactions with  amiodarone :  Fentanyl  ( <e0>CYP3A4</e0>  substrate) in combination with  <e1>amiodarone</e1>  may cause hypotension, bradycardia, and decreased cardiac output."
Other
Comment:

5300	Sinus bradycardia has been reported with oral  <e0>amiodarone</e0>  in combination with  <e1>lidocaine</e1>  ( CYP3A4  substrate) given for local  anesthesia ."
Other
Comment:

5301	Sinus bradycardia has been reported with oral  <e0>amiodarone</e0>  in combination with  lidocaine  ( <e1>CYP3A4</e1>  substrate) given for local  anesthesia ."
Other
Comment:

5302	Sinus bradycardia has been reported with oral  <e0>amiodarone</e0>  in combination with  lidocaine  ( CYP3A4  substrate) given for local  <e1>anesthesia</e1> ."
Other
Comment:

5303	Sinus bradycardia has been reported with oral  amiodarone  in combination with  <e0>lidocaine</e0>  ( <e1>CYP3A4</e1>  substrate) given for local  anesthesia ."
Other
Comment:

5304	Sinus bradycardia has been reported with oral  amiodarone  in combination with  <e0>lidocaine</e0>  ( CYP3A4  substrate) given for local  <e1>anesthesia</e1> ."
Other
Comment:

5305	Sinus bradycardia has been reported with oral  amiodarone  in combination with  lidocaine  ( <e0>CYP3A4</e0>  substrate) given for local  <e1>anesthesia</e1> ."
Other
Comment:

5400	Seizure, associated with increased  <e0>lidocaine</e0>  concentrations, has been reported with concomitant administration of intravenous  <e1>amiodarone</e1> ."
Other
Comment:

5500	 <e0>Dextromethorphan</e0>  is a substrate for both  <e1>CYP2D6</e1>  and  CYP3A4 ."
Other
Comment:

5501	 <e0>Dextromethorphan</e0>  is a substrate for both  CYP2D6  and  <e1>CYP3A4</e1> ."
Other
Comment:

5502	 Dextromethorphan  is a substrate for both  <e0>CYP2D6</e0>  and  <e1>CYP3A4</e1> ."
Other
Comment:

5600	 <e0>Amiodarone</e0>  inhibits  <e1>CYP2D6</e1> ."
Other
Comment:

5700	 <e0>Cholestyramine</e0>  increases enterohepatic elimination of  <e1>amiodarone</e1>  and may reduce its serum levels and  t1 /2."
Other
Comment:

5701	 <e0>Cholestyramine</e0>  increases enterohepatic elimination of  amiodarone  and may reduce its serum levels and  <e1>t1</e1> /2."
Other
Comment:

5702	 Cholestyramine  increases enterohepatic elimination of  <e0>amiodarone</e0>  and may reduce its serum levels and  <e1>t1</e1> /2."
Other
Comment:

5900	 <e0>Fluoroquinolones</e0> ,  <e1>macrolide antibiotics</e1> , and azoles are known to cause QTc prolongation."
Other
Comment:

6000	There have been reports of QTc prolongation, with or without TdP, in patients taking  <e0>amiodarone</e0>  when  <e1>fluoroquinolones</e1> ,  macrolide antibiotics , or azoles were administered concomitantly."
Other
Comment:

6001	There have been reports of QTc prolongation, with or without TdP, in patients taking  <e0>amiodarone</e0>  when  fluoroquinolones ,  <e1>macrolide antibiotics</e1> , or azoles were administered concomitantly."
Other
Comment:

6002	There have been reports of QTc prolongation, with or without TdP, in patients taking  amiodarone  when  <e0>fluoroquinolones</e0> ,  <e1>macrolide antibiotics</e1> , or azoles were administered concomitantly."
Other
Comment:

6100	Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with  <e0>propranolol</e0> ,  <e1>diltiazem</e1> , and  verapamil ."
Other
Comment:

6101	Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with  <e0>propranolol</e0> ,  diltiazem , and  <e1>verapamil</e1> ."
Other
Comment:

6102	Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with  propranolol ,  <e0>diltiazem</e0> , and  <e1>verapamil</e1> ."
Other
Comment:

6300	In addition to the interactions noted above, chronic (  2 weeks) oral  <e0>Cordarone</e0>  administration impairs metabolism of  <e1>phenytoin</e1> ,  dextromethorphan , and  methotrexate ."
Other
Comment:

6301	In addition to the interactions noted above, chronic (  2 weeks) oral  <e0>Cordarone</e0>  administration impairs metabolism of  phenytoin ,  <e1>dextromethorphan</e1> , and  methotrexate ."
Other
Comment:

6302	In addition to the interactions noted above, chronic (  2 weeks) oral  <e0>Cordarone</e0>  administration impairs metabolism of  phenytoin ,  dextromethorphan , and  <e1>methotrexate</e1> ."
Other
Comment:

6303	In addition to the interactions noted above, chronic (  2 weeks) oral  Cordarone  administration impairs metabolism of  <e0>phenytoin</e0> ,  <e1>dextromethorphan</e1> , and  methotrexate ."
Other
Comment:

6304	In addition to the interactions noted above, chronic (  2 weeks) oral  Cordarone  administration impairs metabolism of  <e0>phenytoin</e0> ,  dextromethorphan , and  <e1>methotrexate</e1> ."
Other
Comment:

6305	In addition to the interactions noted above, chronic (  2 weeks) oral  Cordarone  administration impairs metabolism of  phenytoin ,  <e0>dextromethorphan</e0> , and  <e1>methotrexate</e1> ."
Other
Comment:


300	Poor metabolizers have higher than expected plasma concentrations of  <e0>tricyclic antidepressants</e0>  ( <e1>TCAs</e1> ) when given usual doses."
Other
Comment:

800	 <e0>cimetidine</e0> ) and many that are substrates for P450 2D6 (many other  <e1>antidepressants</e1> ,  phenothiazines , and the  Type 1C antiarrhythmics   propafenone  and  flecainide )."
Other
Comment:

801	 <e0>cimetidine</e0> ) and many that are substrates for P450 2D6 (many other  antidepressants ,  <e1>phenothiazines</e1> , and the  Type 1C antiarrhythmics   propafenone  and  flecainide )."
Other
Comment:

802	 <e0>cimetidine</e0> ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  <e1>Type 1C antiarrhythmics</e1>   propafenone  and  flecainide )."
Other
Comment:

803	 <e0>cimetidine</e0> ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  Type 1C antiarrhythmics   <e1>propafenone</e1>  and  flecainide )."
Other
Comment:

804	 <e0>cimetidine</e0> ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  Type 1C antiarrhythmics   propafenone  and  <e1>flecainide</e1> )."
Other
Comment:

805	 cimetidine ) and many that are substrates for P450 2D6 (many other  <e0>antidepressants</e0> ,  <e1>phenothiazines</e1> , and the  Type 1C antiarrhythmics   propafenone  and  flecainide )."
Other
Comment:

806	 cimetidine ) and many that are substrates for P450 2D6 (many other  <e0>antidepressants</e0> ,  phenothiazines , and the  <e1>Type 1C antiarrhythmics</e1>   propafenone  and  flecainide )."
Other
Comment:

807	 cimetidine ) and many that are substrates for P450 2D6 (many other  <e0>antidepressants</e0> ,  phenothiazines , and the  Type 1C antiarrhythmics   <e1>propafenone</e1>  and  flecainide )."
Other
Comment:

808	 cimetidine ) and many that are substrates for P450 2D6 (many other  <e0>antidepressants</e0> ,  phenothiazines , and the  Type 1C antiarrhythmics   propafenone  and  <e1>flecainide</e1> )."
Other
Comment:

809	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  <e0>phenothiazines</e0> , and the  <e1>Type 1C antiarrhythmics</e1>   propafenone  and  flecainide )."
Other
Comment:

810	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  <e0>phenothiazines</e0> , and the  Type 1C antiarrhythmics   <e1>propafenone</e1>  and  flecainide )."
Other
Comment:

811	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  <e0>phenothiazines</e0> , and the  Type 1C antiarrhythmics   propafenone  and  <e1>flecainide</e1> )."
Other
Comment:

812	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  <e0>Type 1C antiarrhythmics</e0>   <e1>propafenone</e1>  and  flecainide )."
Other
Comment:

813	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  <e0>Type 1C antiarrhythmics</e0>   propafenone  and  <e1>flecainide</e1> )."
Other
Comment:

814	 cimetidine ) and many that are substrates for P450 2D6 (many other  antidepressants ,  phenothiazines , and the  Type 1C antiarrhythmics   <e0>propafenone</e0>  and  <e1>flecainide</e1> )."
Other
Comment:

900	While all the selective  <e0>serotonin reuptake inhibitors</e0>  ( <e1>SSRIs</e1> ), e.g.,  fluoxetine ,  sertraline , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

901	While all the selective  <e0>serotonin reuptake inhibitors</e0>  ( SSRIs ), e.g.,  <e1>fluoxetine</e1> ,  sertraline , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

902	While all the selective  <e0>serotonin reuptake inhibitors</e0>  ( SSRIs ), e.g.,  fluoxetine ,  <e1>sertraline</e1> , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

903	While all the selective  <e0>serotonin reuptake inhibitors</e0>  ( SSRIs ), e.g.,  fluoxetine ,  sertraline , and  <e1>paroxetine</e1> , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

904	While all the selective  serotonin reuptake inhibitors  ( <e0>SSRIs</e0> ), e.g.,  <e1>fluoxetine</e1> ,  sertraline , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

905	While all the selective  serotonin reuptake inhibitors  ( <e0>SSRIs</e0> ), e.g.,  fluoxetine ,  <e1>sertraline</e1> , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

906	While all the selective  serotonin reuptake inhibitors  ( <e0>SSRIs</e0> ), e.g.,  fluoxetine ,  sertraline , and  <e1>paroxetine</e1> , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

907	While all the selective  serotonin reuptake inhibitors  ( SSRIs ), e.g.,  <e0>fluoxetine</e0> ,  <e1>sertraline</e1> , and  paroxetine , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

908	While all the selective  serotonin reuptake inhibitors  ( SSRIs ), e.g.,  <e0>fluoxetine</e0> ,  sertraline , and  <e1>paroxetine</e1> , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

909	While all the selective  serotonin reuptake inhibitors  ( SSRIs ), e.g.,  fluoxetine ,  <e0>sertraline</e0> , and  <e1>paroxetine</e1> , inhibit P450 2D6, they may vary in the extent of inhibition."
Other
Comment:

1000	The extent to which  <e0>SSRI</e0> - <e1>TCA</e1>  interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the  SSRI  involved."
effect(e0,e1)Comment:

1001	The extent to which  <e0>SSRI</e0> - TCA  interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the  <e1>SSRI</e1>  involved."
Other
Comment:

1002	The extent to which  SSRI - <e0>TCA</e0>  interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the  <e1>SSRI</e1>  involved."
Other
Comment:

1100	Nevertheless, caution is indicated in the coadministration of  <e0>TCAs</e0>  with any of the  <e1>SSRIs</e1>  and also in switching from one class to the other."
advise(e0,e1)Comment:

1300	Concomitant use of  <e0>tricyclic antidepressants</e0>  with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the  <e1>tricyclic antidepressant</e1>  or the other drug."
Other
Comment:

1500	It is desirable to monitor  <e0>TCA</e0>  plasma levels whenever a  <e1>TCA</e1>  is going to be coadministered with another drug known to be an inhibitor of P450 2D6."
Other
Comment:

1600	 <e0>Monoamine Oxidase Inhibitors</e0> :  <e1>Guanethidine</e1>  or similarly acting compounds;"
Other
Comment:

1800	 <e0>alcohol</e0> ,  <e1>barbiturates</e1>  and other  CNS depressants ;"
Other
Comment:

1801	 <e0>alcohol</e0> ,  barbiturates  and other  <e1>CNS depressants</e1> ;"
Other
Comment:

1802	 alcohol ,  <e0>barbiturates</e0>  and other  <e1>CNS depressants</e1> ;"
Other
Comment:

1900	and  <e0>disulfiram</e0>  When  <e1>amitriptyline HCl</e1>  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1901	and  <e0>disulfiram</e0>  When  amitriptyline HCl  is given with  <e1>anticholinergic</e1>  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1902	and  <e0>disulfiram</e0>  When  amitriptyline HCl  is given with  anticholinergic  agents or  <e1>sympathomimetic</e1>  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1903	and  <e0>disulfiram</e0>  When  amitriptyline HCl  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  <e1>epinephrine</e1>  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1904	and  <e0>disulfiram</e0>  When  amitriptyline HCl  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  <e1>anesthetics</e1> , close supervision and careful adjustment of dosages are required."
Other
Comment:

1905	and  disulfiram  When  <e0>amitriptyline HCl</e0>  is given with  <e1>anticholinergic</e1>  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1906	and  disulfiram  When  <e0>amitriptyline HCl</e0>  is given with  anticholinergic  agents or  <e1>sympathomimetic</e1>  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1907	and  disulfiram  When  <e0>amitriptyline HCl</e0>  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  <e1>epinephrine</e1>  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1908	and  disulfiram  When  <e0>amitriptyline HCl</e0>  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  <e1>anesthetics</e1> , close supervision and careful adjustment of dosages are required."
Other
Comment:

1909	and  disulfiram  When  amitriptyline HCl  is given with  <e0>anticholinergic</e0>  agents or  <e1>sympathomimetic</e1>  drugs, including  epinephrine  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1910	and  disulfiram  When  amitriptyline HCl  is given with  <e0>anticholinergic</e0>  agents or  sympathomimetic  drugs, including  <e1>epinephrine</e1>  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1911	and  disulfiram  When  amitriptyline HCl  is given with  <e0>anticholinergic</e0>  agents or  sympathomimetic  drugs, including  epinephrine  combined with local  <e1>anesthetics</e1> , close supervision and careful adjustment of dosages are required."
Other
Comment:

1912	and  disulfiram  When  amitriptyline HCl  is given with  anticholinergic  agents or  <e0>sympathomimetic</e0>  drugs, including  <e1>epinephrine</e1>  combined with local  anesthetics , close supervision and careful adjustment of dosages are required."
Other
Comment:

1913	and  disulfiram  When  amitriptyline HCl  is given with  anticholinergic  agents or  <e0>sympathomimetic</e0>  drugs, including  epinephrine  combined with local  <e1>anesthetics</e1> , close supervision and careful adjustment of dosages are required."
Other
Comment:

1914	and  disulfiram  When  amitriptyline HCl  is given with  anticholinergic  agents or  sympathomimetic  drugs, including  <e0>epinephrine</e0>  combined with local  <e1>anesthetics</e1> , close supervision and careful adjustment of dosages are required."
Other
Comment:

2000	Hyperpyrexia has been reported when  <e0>amitriptyline HCl</e0>  is administered with  <e1>anticholinergic</e1>  agents or with  neuroleptic  drugs, particularly during hot weather."
effect(e0,e1)Comment:

2001	Hyperpyrexia has been reported when  <e0>amitriptyline HCl</e0>  is administered with  anticholinergic  agents or with  <e1>neuroleptic</e1>  drugs, particularly during hot weather."
Other
Comment:

2002	Hyperpyrexia has been reported when  amitriptyline HCl  is administered with  <e0>anticholinergic</e0>  agents or with  <e1>neuroleptic</e1>  drugs, particularly during hot weather."
Other
Comment:

2100	Paralytic ileus may occur in patients taking  <e0>tricyclic antidepressants</e0>  in combination with  <e1>anticholinergic</e1> -type drugs."
effect(e0,e1)Comment:

2200	 <e0>Cimetidine</e0>  is reported to reduce hepatic metabolism of certain  <e1>tricyclic antidepressants</e1> , thereby delaying elimination and increasing steady-state concentrations of these  drugs ."
mechanism(e0,e1)Comment:

2201	 <e0>Cimetidine</e0>  is reported to reduce hepatic metabolism of certain  tricyclic antidepressants , thereby delaying elimination and increasing steady-state concentrations of these  <e1>drugs</e1> ."
Other
Comment:

2202	 Cimetidine  is reported to reduce hepatic metabolism of certain  <e0>tricyclic antidepressants</e0> , thereby delaying elimination and increasing steady-state concentrations of these  <e1>drugs</e1> ."
Other
Comment:

2300	Clinically significant effects have been reported with the  <e0>tricyclic antidepressants</e0>  when used concomitantly with  <e1>cimetidine</e1> ."
effect(e0,e1)Comment:

2400	Increases in plasma levels of  <e0>tricyclic antidepressants</e0> , and in the frequency and severity of side effects, particularly  <e1>anticholinergic</e1> , have been reported when  cimetidine  was added to the  drug  regimen."
Other
Comment:

2401	Increases in plasma levels of  <e0>tricyclic antidepressants</e0> , and in the frequency and severity of side effects, particularly  anticholinergic , have been reported when  <e1>cimetidine</e1>  was added to the  drug  regimen."
mechanism(e0,e1)Comment:

2402	Increases in plasma levels of  <e0>tricyclic antidepressants</e0> , and in the frequency and severity of side effects, particularly  anticholinergic , have been reported when  cimetidine  was added to the  <e1>drug</e1>  regimen."
Other
Comment:

2403	Increases in plasma levels of  tricyclic antidepressants , and in the frequency and severity of side effects, particularly  <e0>anticholinergic</e0> , have been reported when  <e1>cimetidine</e1>  was added to the  drug  regimen."
Other
Comment:

2404	Increases in plasma levels of  tricyclic antidepressants , and in the frequency and severity of side effects, particularly  <e0>anticholinergic</e0> , have been reported when  cimetidine  was added to the  <e1>drug</e1>  regimen."
Other
Comment:

2405	Increases in plasma levels of  tricyclic antidepressants , and in the frequency and severity of side effects, particularly  anticholinergic , have been reported when  <e0>cimetidine</e0>  was added to the  <e1>drug</e1>  regimen."
Other
Comment:

2500	Discontinuation of  <e0>cimetidine</e0>  in well-controlled patients receiving  <e1>tricyclic antidepressants</e1>  and  cimetidine  may decrease the plasma levels and efficacy of the  antidepressants ."
Other
Comment:

2501	Discontinuation of  <e0>cimetidine</e0>  in well-controlled patients receiving  tricyclic antidepressants  and  <e1>cimetidine</e1>  may decrease the plasma levels and efficacy of the  antidepressants ."
Other
Comment:

2502	Discontinuation of  <e0>cimetidine</e0>  in well-controlled patients receiving  tricyclic antidepressants  and  cimetidine  may decrease the plasma levels and efficacy of the  <e1>antidepressants</e1> ."
Other
Comment:

2503	Discontinuation of  cimetidine  in well-controlled patients receiving  <e0>tricyclic antidepressants</e0>  and  <e1>cimetidine</e1>  may decrease the plasma levels and efficacy of the  antidepressants ."
mechanism(e0,e1)Comment:

2504	Discontinuation of  cimetidine  in well-controlled patients receiving  <e0>tricyclic antidepressants</e0>  and  cimetidine  may decrease the plasma levels and efficacy of the  <e1>antidepressants</e1> ."
Other
Comment:

2505	Discontinuation of  cimetidine  in well-controlled patients receiving  tricyclic antidepressants  and  <e0>cimetidine</e0>  may decrease the plasma levels and efficacy of the  <e1>antidepressants</e1> ."
Other
Comment:

2700	Transient delirium has been reported in patients who were treated with one gram of  <e0>ethchlorvynol</e0>  and 75 - 150 mg of  <e1>amitriptyline HCl</e1> ."
effect(e0,e1)Comment:


100	When administered concurrently, the following drugs may interact with  <e0>amphotericin B</e0> :  <e1>Antineoplastic agents</e1> : may enhance the potential for renal toxicity, bronchospasm and hypotension."
effect(e0,e1)Comment:

200	 <e0>Antineoplastic agents</e0>  (e. g.,  <e1>nitrogen mustard</e1> , etc.) should be given concomitantly only with great caution."
Other
Comment:

300	 <e0>Corticosteroids</e0>  and  <e1>Corticotropin</e1>  ( ACTH ): may potentiate  amphotericin B - induced hypokalemia which may predispose the patient to cardiac dysfunction."
Other
Comment:

301	 <e0>Corticosteroids</e0>  and  Corticotropin  ( <e1>ACTH</e1> ): may potentiate  amphotericin B - induced hypokalemia which may predispose the patient to cardiac dysfunction."
Other
Comment:

302	 <e0>Corticosteroids</e0>  and  Corticotropin  ( ACTH ): may potentiate  <e1>amphotericin B</e1> - induced hypokalemia which may predispose the patient to cardiac dysfunction."
effect(e0,e1)Comment:

303	 Corticosteroids  and  <e0>Corticotropin</e0>  ( <e1>ACTH</e1> ): may potentiate  amphotericin B - induced hypokalemia which may predispose the patient to cardiac dysfunction."
Other
Comment:

304	 Corticosteroids  and  <e0>Corticotropin</e0>  ( ACTH ): may potentiate  <e1>amphotericin B</e1> - induced hypokalemia which may predispose the patient to cardiac dysfunction."
effect(e0,e1)Comment:

305	 Corticosteroids  and  Corticotropin  ( <e0>ACTH</e0> ): may potentiate  <e1>amphotericin B</e1> - induced hypokalemia which may predispose the patient to cardiac dysfunction."
effect(e0,e1)Comment:

600	 <e0>Digitalis glycosides</e0> :  <e1>amphotericin B</e1> -induced hypokalemia may potentiate  digitalis  toxicity."
Other
Comment:

601	 <e0>Digitalis glycosides</e0> :  amphotericin B -induced hypokalemia may potentiate  <e1>digitalis</e1>  toxicity."
Other
Comment:

602	 Digitalis glycosides :  <e0>amphotericin B</e0> -induced hypokalemia may potentiate  <e1>digitalis</e1>  toxicity."
effect(e0,e1)Comment:

800	 <e0>Flucytosine</e0> : while a synergistic relationship with  <e1>amphotericin B</e1>  has been reported, concomitant use may increase the toxicity of  flucytosine  by possibly increasing its cellular uptake and/or impairing its renal excretion."
Other
Comment:

801	 <e0>Flucytosine</e0> : while a synergistic relationship with  amphotericin B  has been reported, concomitant use may increase the toxicity of  <e1>flucytosine</e1>  by possibly increasing its cellular uptake and/or impairing its renal excretion."
Other
Comment:

802	 Flucytosine : while a synergistic relationship with  <e0>amphotericin B</e0>  has been reported, concomitant use may increase the toxicity of  <e1>flucytosine</e1>  by possibly increasing its cellular uptake and/or impairing its renal excretion."
effect(e0,e1)Comment:

900	 <e0>Imidazoles</e0>  (e. g.,  <e1>ketoconazole</e1> ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

901	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  <e1>miconazole</e1> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

902	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  <e1>clotrimazole</e1> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

903	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  <e1>fluconazole</e1> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

904	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e1>amphotericin B</e1>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

905	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

906	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

907	 <e0>Imidazoles</e0>  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

908	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  <e1>miconazole</e1> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

909	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  <e1>clotrimazole</e1> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

910	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  clotrimazole ,  <e1>fluconazole</e1> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

911	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e1>amphotericin B</e1>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

912	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

913	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

914	 Imidazoles  (e. g.,  <e0>ketoconazole</e0> ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

915	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  <e1>clotrimazole</e1> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

916	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  clotrimazole ,  <e1>fluconazole</e1> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

917	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e1>amphotericin B</e1>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

918	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

919	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

920	 Imidazoles  (e. g.,  ketoconazole ,  <e0>miconazole</e0> ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

921	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  <e0>clotrimazole</e0> ,  <e1>fluconazole</e1> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

922	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  <e0>clotrimazole</e0> ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e1>amphotericin B</e1>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

923	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  <e0>clotrimazole</e0> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

924	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  <e0>clotrimazole</e0> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

925	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  <e0>clotrimazole</e0> ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

926	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  <e0>fluconazole</e0> , etc.): in vitro and animal studies with the combination of  <e1>amphotericin B</e1>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

927	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  <e0>fluconazole</e0> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

928	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  <e0>fluconazole</e0> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

929	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  <e0>fluconazole</e0> , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

930	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e0>amphotericin B</e0>  and  <e1>imidazoles</e1>  suggest that  imidazoles  may induce fungal resistance to  amphotericin B ."
Other
Comment:

931	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e0>amphotericin B</e0>  and  imidazoles  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

932	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  <e0>amphotericin B</e0>  and  imidazoles  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

933	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e0>imidazoles</e0>  suggest that  <e1>imidazoles</e1>  may induce fungal resistance to  amphotericin B ."
Other
Comment:

934	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  <e0>imidazoles</e0>  suggest that  imidazoles  may induce fungal resistance to  <e1>amphotericin B</e1> ."
Other
Comment:

935	 Imidazoles  (e. g.,  ketoconazole ,  miconazole ,  clotrimazole ,  fluconazole , etc.): in vitro and animal studies with the combination of  amphotericin B  and  imidazoles  suggest that  <e0>imidazoles</e0>  may induce fungal resistance to  <e1>amphotericin B</e1> ."
effect(e0,e1)Comment:

1100	Other nephrotoxic medications: agents such as  <e0>aminoglycosides</e0> ,  <e1>cyclosporine</e1> , and  pentamidine  may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution."
Other
Comment:

1101	Other nephrotoxic medications: agents such as  <e0>aminoglycosides</e0> ,  cyclosporine , and  <e1>pentamidine</e1>  may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution."
Other
Comment:

1102	Other nephrotoxic medications: agents such as  aminoglycosides ,  <e0>cyclosporine</e0> , and  <e1>pentamidine</e1>  may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution."
Other
Comment:

1300	 <e0>Skeletal muscle relaxants</e0> :  <e1>amphotericin B</e1> -induced hypokalemia may enhance the curariform effect of  skeletal muscle relaxants  (e.g.,  tubocurarine )."
Other
Comment:

1301	 <e0>Skeletal muscle relaxants</e0> :  amphotericin B -induced hypokalemia may enhance the curariform effect of  <e1>skeletal muscle relaxants</e1>  (e.g.,  tubocurarine )."
Other
Comment:

1302	 <e0>Skeletal muscle relaxants</e0> :  amphotericin B -induced hypokalemia may enhance the curariform effect of  skeletal muscle relaxants  (e.g.,  <e1>tubocurarine</e1> )."
Other
Comment:

1303	 Skeletal muscle relaxants :  <e0>amphotericin B</e0> -induced hypokalemia may enhance the curariform effect of  <e1>skeletal muscle relaxants</e1>  (e.g.,  tubocurarine )."
effect(e0,e1)Comment:

1304	 Skeletal muscle relaxants :  <e0>amphotericin B</e0> -induced hypokalemia may enhance the curariform effect of  skeletal muscle relaxants  (e.g.,  <e1>tubocurarine</e1> )."
effect(e0,e1)Comment:

1305	 Skeletal muscle relaxants :  amphotericin B -induced hypokalemia may enhance the curariform effect of  <e0>skeletal muscle relaxants</e0>  (e.g.,  <e1>tubocurarine</e1> )."
Other
Comment:

1500	 <e0>Leukocyte transfusions</e0> : acute pulmonary toxicity has been reported in patients receiving intravenous  <e1>amphotericin B</e1>  and  leukocyte transfusions ."
Other
Comment:

1501	 <e0>Leukocyte transfusions</e0> : acute pulmonary toxicity has been reported in patients receiving intravenous  amphotericin B  and  <e1>leukocyte transfusions</e1> ."
Other
Comment:

1502	 Leukocyte transfusions : acute pulmonary toxicity has been reported in patients receiving intravenous  <e0>amphotericin B</e0>  and  <e1>leukocyte transfusions</e1> ."
effect(e0,e1)Comment:


300	 <e0>Bacteriostatic Antibiotics</e0> :  <e1>Chloramphenicol</e1> ,  erythromycins ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

301	 <e0>Bacteriostatic Antibiotics</e0> :  Chloramphenicol ,  <e1>erythromycins</e1> ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

302	 <e0>Bacteriostatic Antibiotics</e0> :  Chloramphenicol ,  erythromycins ,  <e1>sulfonamides</e1> , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

303	 <e0>Bacteriostatic Antibiotics</e0> :  Chloramphenicol ,  erythromycins ,  sulfonamides , or  <e1>tetracyclines</e1>  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

304	 <e0>Bacteriostatic Antibiotics</e0> :  Chloramphenicol ,  erythromycins ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  <e1>penicillins</e1> ."
Other
Comment:

305	 Bacteriostatic Antibiotics :  <e0>Chloramphenicol</e0> ,  <e1>erythromycins</e1> ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

306	 Bacteriostatic Antibiotics :  <e0>Chloramphenicol</e0> ,  erythromycins ,  <e1>sulfonamides</e1> , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

307	 Bacteriostatic Antibiotics :  <e0>Chloramphenicol</e0> ,  erythromycins ,  sulfonamides , or  <e1>tetracyclines</e1>  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

308	 Bacteriostatic Antibiotics :  <e0>Chloramphenicol</e0> ,  erythromycins ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  <e1>penicillins</e1> ."
effect(e0,e1)Comment:

309	 Bacteriostatic Antibiotics :  Chloramphenicol ,  <e0>erythromycins</e0> ,  <e1>sulfonamides</e1> , or  tetracyclines  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

310	 Bacteriostatic Antibiotics :  Chloramphenicol ,  <e0>erythromycins</e0> ,  sulfonamides , or  <e1>tetracyclines</e1>  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

311	 Bacteriostatic Antibiotics :  Chloramphenicol ,  <e0>erythromycins</e0> ,  sulfonamides , or  tetracyclines  may interfere with the bactericidal effect of  <e1>penicillins</e1> ."
effect(e0,e1)Comment:

312	 Bacteriostatic Antibiotics :  Chloramphenicol ,  erythromycins ,  <e0>sulfonamides</e0> , or  <e1>tetracyclines</e1>  may interfere with the bactericidal effect of  penicillins ."
Other
Comment:

313	 Bacteriostatic Antibiotics :  Chloramphenicol ,  erythromycins ,  <e0>sulfonamides</e0> , or  tetracyclines  may interfere with the bactericidal effect of  <e1>penicillins</e1> ."
effect(e0,e1)Comment:

314	 Bacteriostatic Antibiotics :  Chloramphenicol ,  erythromycins ,  sulfonamides , or  <e0>tetracyclines</e0>  may interfere with the bactericidal effect of  <e1>penicillins</e1> ."
effect(e0,e1)Comment:

600	 <e0>Probenecid</e0> : May decrease renal tubular secretion of  <e1>ampicillin</e1>  resulting in increased blood levels and/or  ampicillin  toxicity."
mechanism(e0,e1)Comment:

601	 <e0>Probenecid</e0> : May decrease renal tubular secretion of  ampicillin  resulting in increased blood levels and/or  <e1>ampicillin</e1>  toxicity."
Other
Comment:

602	 Probenecid : May decrease renal tubular secretion of  <e0>ampicillin</e0>  resulting in increased blood levels and/or  <e1>ampicillin</e1>  toxicity."
Other
Comment:

700	Drug/Laboratory Test Interaction After treatment with  <e0>ampicillin</e0> , a false-positive reaction for glucose in the urine may occur with  <e1>copper sulfate</e1>  tests (Benedicts solution, Fehlings solution, or Clinitest tablets) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP."
Other
Comment:


500	 <e0>HIV Protease Inhibitors</e0> : The effect of  <e1>amprenavir</e1>  on total drug concentrations of other  HIV protease inhibitors  in subjects receiving both agents was evaluated using comparisons to historical data."
Other
Comment:

501	 <e0>HIV Protease Inhibitors</e0> : The effect of  amprenavir  on total drug concentrations of other  <e1>HIV protease inhibitors</e1>  in subjects receiving both agents was evaluated using comparisons to historical data."
Other
Comment:

502	 HIV Protease Inhibitors : The effect of  <e0>amprenavir</e0>  on total drug concentrations of other  <e1>HIV protease inhibitors</e1>  in subjects receiving both agents was evaluated using comparisons to historical data."
Other
Comment:

600	 <e0>Indinavir</e0>  steady-state Cmax, A.C. and Cmin were decreased by 22%, 38%, and 27%, respectively, by concomitant  <e1>amprenavir</e1> ."
mechanism(e0,e1)Comment:

800	 <e0>Saquinavir</e0>  steady-state Cmax, A.C. and Cmin were increased 21%, decreased 19%, and decreased 48%, respectively, by concomitant  <e1>amprenavir</e1> ."
mechanism(e0,e1)Comment:

900	 <e0>Nelfinavir</e0>  steady-state Cmax, A.C. and Cmin were increased by 12%, 15%, and 14%, respectively, by concomitant  <e1>amprenavir</e1> ."
mechanism(e0,e1)Comment:

1000	 <e0>Methadone</e0> : Coadministration of  <e1>amprenavir</e1>  and  methadone  can decrease plasma levels of  methadone ."
Other
Comment:

1001	 <e0>Methadone</e0> : Coadministration of  amprenavir  and  <e1>methadone</e1>  can decrease plasma levels of  methadone ."
Other
Comment:

1002	 <e0>Methadone</e0> : Coadministration of  amprenavir  and  methadone  can decrease plasma levels of  <e1>methadone</e1> ."
Other
Comment:

1003	 Methadone : Coadministration of  <e0>amprenavir</e0>  and  <e1>methadone</e1>  can decrease plasma levels of  methadone ."
effect(e0,e1)Comment:

1004	 Methadone : Coadministration of  <e0>amprenavir</e0>  and  methadone  can decrease plasma levels of  <e1>methadone</e1> ."
Other
Comment:

1005	 Methadone : Coadministration of  amprenavir  and  <e0>methadone</e0>  can decrease plasma levels of  <e1>methadone</e1> ."
Other
Comment:

1100	Coadministration of  <e0>amprenavir</e0>  and  <e1>methadone</e1>  as compared to a non-matched historicalcontrol group resulted in a 30%, 27%, and 25% decrease in serum  amprenavir  AUC, Cmax, andCmin, respectively."
mechanism(e0,e1)Comment:

1101	Coadministration of  <e0>amprenavir</e0>  and  methadone  as compared to a non-matched historicalcontrol group resulted in a 30%, 27%, and 25% decrease in serum  <e1>amprenavir</e1>  AUC, Cmax, andCmin, respectively."
Other
Comment:

1102	Coadministration of  amprenavir  and  <e0>methadone</e0>  as compared to a non-matched historicalcontrol group resulted in a 30%, 27%, and 25% decrease in serum  <e1>amprenavir</e1>  AUC, Cmax, andCmin, respectively."
Other
Comment:

1400	Laboratory Tests: The combination of  <e0>Amprenavir</e0>  and low-dose  <e1>ritonavir</e1>  has been associated with elevations of cholesterol and triglycerides, SGOT (AST), and SGPT (ALT) in some patients."
effect(e0,e1)Comment:

1500	Appropriate laboratory testing should be considered prior to initiating combination therapy with  <e0>Amprenavir</e0>  and  <e1>ritonavir</e1>  and at periodic intervals or if any clinical signs or symptoms of hyperlipidemia or elevated liver function tests occur during therapy."
advise(e0,e1)Comment:

1600	For comprehensive information concerning laboratory test alterations associated with  <e0>ritonavir</e0> , physicians should refer to the complete prescribing information for  <e1>NORVIR</e1>  ( ritonavir )."
Other
Comment:

1601	For comprehensive information concerning laboratory test alterations associated with  <e0>ritonavir</e0> , physicians should refer to the complete prescribing information for  NORVIR  ( <e1>ritonavir</e1> )."
Other
Comment:

1602	For comprehensive information concerning laboratory test alterations associated with  ritonavir , physicians should refer to the complete prescribing information for  <e0>NORVIR</e0>  ( <e1>ritonavir</e1> )."
Other
Comment:


100	Taking  <e0>amyl nitrite</e0>  after drinking  <e1>alcohol</e1>  may worsen side effects and may cause severe hypotension and cardiovascular collapse."
effect(e0,e1)Comment:


200	In vivo interaction studies in humans have demonstrated that  <e0>digoxin</e0>  and  <e1>warfarin</e1>  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

201	In vivo interaction studies in humans have demonstrated that  <e0>digoxin</e0>  and  warfarin  do not affect the PK properties of  <e1>anagrelide</e1> , nor does  anagrelide  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

202	In vivo interaction studies in humans have demonstrated that  <e0>digoxin</e0>  and  warfarin  do not affect the PK properties of  anagrelide , nor does  <e1>anagrelide</e1>  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

203	In vivo interaction studies in humans have demonstrated that  <e0>digoxin</e0>  and  warfarin  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  <e1>digoxin</e1>  or  warfarin ."
Other
Comment:

204	In vivo interaction studies in humans have demonstrated that  <e0>digoxin</e0>  and  warfarin  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  digoxin  or  <e1>warfarin</e1> ."
Other
Comment:

205	In vivo interaction studies in humans have demonstrated that  digoxin  and  <e0>warfarin</e0>  do not affect the PK properties of  <e1>anagrelide</e1> , nor does  anagrelide  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

206	In vivo interaction studies in humans have demonstrated that  digoxin  and  <e0>warfarin</e0>  do not affect the PK properties of  anagrelide , nor does  <e1>anagrelide</e1>  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

207	In vivo interaction studies in humans have demonstrated that  digoxin  and  <e0>warfarin</e0>  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  <e1>digoxin</e1>  or  warfarin ."
Other
Comment:

208	In vivo interaction studies in humans have demonstrated that  digoxin  and  <e0>warfarin</e0>  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  digoxin  or  <e1>warfarin</e1> ."
Other
Comment:

209	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  <e0>anagrelide</e0> , nor does  <e1>anagrelide</e1>  affect the PK properties of  digoxin  or  warfarin ."
Other
Comment:

210	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  <e0>anagrelide</e0> , nor does  anagrelide  affect the PK properties of  <e1>digoxin</e1>  or  warfarin ."
Other
Comment:

211	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  <e0>anagrelide</e0> , nor does  anagrelide  affect the PK properties of  digoxin  or  <e1>warfarin</e1> ."
Other
Comment:

212	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  anagrelide , nor does  <e0>anagrelide</e0>  affect the PK properties of  <e1>digoxin</e1>  or  warfarin ."
Other
Comment:

213	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  anagrelide , nor does  <e0>anagrelide</e0>  affect the PK properties of  digoxin  or  <e1>warfarin</e1> ."
Other
Comment:

214	In vivo interaction studies in humans have demonstrated that  digoxin  and  warfarin  do not affect the PK properties of  anagrelide , nor does  anagrelide  affect the PK properties of  <e0>digoxin</e0>  or  <e1>warfarin</e1> ."
Other
Comment:

300	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  <e1>aspirin</e1> ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

301	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  <e1>acetaminophen</e1> ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

302	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  acetaminophen ,  <e1>furosemide</e1> ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

303	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  <e1>iron</e1> ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

304	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  <e1>ranitidine</e1> ,  hydroxyurea , and  allopurinol ."
Other
Comment:

305	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

306	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  <e0>anagrelide</e0>  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

307	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  <e1>acetaminophen</e1> ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

308	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  acetaminophen ,  <e1>furosemide</e1> ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

309	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  acetaminophen ,  furosemide ,  <e1>iron</e1> ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

310	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  acetaminophen ,  furosemide ,  iron ,  <e1>ranitidine</e1> ,  hydroxyurea , and  allopurinol ."
Other
Comment:

311	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

312	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  <e0>aspirin</e0> ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

313	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  <e0>acetaminophen</e0> ,  <e1>furosemide</e1> ,  iron ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

314	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  <e0>acetaminophen</e0> ,  furosemide ,  <e1>iron</e1> ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

315	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  <e0>acetaminophen</e0> ,  furosemide ,  iron ,  <e1>ranitidine</e1> ,  hydroxyurea , and  allopurinol ."
Other
Comment:

316	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  <e0>acetaminophen</e0> ,  furosemide ,  iron ,  ranitidine ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

317	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  <e0>acetaminophen</e0> ,  furosemide ,  iron ,  ranitidine ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

318	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  <e0>furosemide</e0> ,  <e1>iron</e1> ,  ranitidine ,  hydroxyurea , and  allopurinol ."
Other
Comment:

319	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  <e0>furosemide</e0> ,  iron ,  <e1>ranitidine</e1> ,  hydroxyurea , and  allopurinol ."
Other
Comment:

320	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  <e0>furosemide</e0> ,  iron ,  ranitidine ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

321	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  <e0>furosemide</e0> ,  iron ,  ranitidine ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

322	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  <e0>iron</e0> ,  <e1>ranitidine</e1> ,  hydroxyurea , and  allopurinol ."
Other
Comment:

323	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  <e0>iron</e0> ,  ranitidine ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

324	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  <e0>iron</e0> ,  ranitidine ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

325	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  <e0>ranitidine</e0> ,  <e1>hydroxyurea</e1> , and  allopurinol ."
Other
Comment:

326	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  <e0>ranitidine</e0> ,  hydroxyurea , and  <e1>allopurinol</e1> ."
Other
Comment:

327	Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with  anagrelide  in clinical trials were  aspirin ,  acetaminophen ,  furosemide ,  iron ,  ranitidine ,  <e0>hydroxyurea</e0> , and  <e1>allopurinol</e1> ."
Other
Comment:

500	An in vivo interaction study in humans demonstrated that a single 1mg dose of  <e0>anagrelide</e0>  administered concomitantly with a single 900 mg dose of  <e1>aspirin</e1>  was generally well tolerated."
Other
Comment:

700	No clinically relevant pharmacokinetic interactions between  <e0>anagrelide</e0>  and  <e1>acetylsalicylic acid</e1>  were observed."
Other
Comment:

900	 <e0>Anagrelide</e0>  alone had no effect on platelet aggregation, but did slightly enhance the inhibition of platelet aggregation by  <e1>aspirin</e1> ."
effect(e0,e1)Comment:

1100	It is known that CYP1A2 is inhibited by several medicinal products, including  <e0>fluvoxamine</e0> , and such medicinal products could theoretically adversely influence the clearance of  <e1>anagrelide</e1> ."
mechanism(e0,e1)Comment:

1300	 <e0>Anagrelide</e0>  demonstrates some limited inhibitory activity towards CYP1A2 which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g.  <e1>theophylline</e1> ."
mechanism(e0,e1)Comment:

1500	The effects of medicinal products with similar properties such as inotropes  <e0>milrinone</e0> ,  <e1>enoximone</e1> ,  amrinone ,  olprinone  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1501	The effects of medicinal products with similar properties such as inotropes  <e0>milrinone</e0> ,  enoximone ,  <e1>amrinone</e1> ,  olprinone  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1502	The effects of medicinal products with similar properties such as inotropes  <e0>milrinone</e0> ,  enoximone ,  amrinone ,  <e1>olprinone</e1>  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1503	The effects of medicinal products with similar properties such as inotropes  <e0>milrinone</e0> ,  enoximone ,  amrinone ,  olprinone  and  <e1>cilostazol</e1>  may be exacerbated by  anagrelide ."
Other
Comment:

1504	The effects of medicinal products with similar properties such as inotropes  <e0>milrinone</e0> ,  enoximone ,  amrinone ,  olprinone  and  cilostazol  may be exacerbated by  <e1>anagrelide</e1> ."
effect(e0,e1)Comment:

1505	The effects of medicinal products with similar properties such as inotropes  milrinone ,  <e0>enoximone</e0> ,  <e1>amrinone</e1> ,  olprinone  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1506	The effects of medicinal products with similar properties such as inotropes  milrinone ,  <e0>enoximone</e0> ,  amrinone ,  <e1>olprinone</e1>  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1507	The effects of medicinal products with similar properties such as inotropes  milrinone ,  <e0>enoximone</e0> ,  amrinone ,  olprinone  and  <e1>cilostazol</e1>  may be exacerbated by  anagrelide ."
Other
Comment:

1508	The effects of medicinal products with similar properties such as inotropes  milrinone ,  <e0>enoximone</e0> ,  amrinone ,  olprinone  and  cilostazol  may be exacerbated by  <e1>anagrelide</e1> ."
effect(e0,e1)Comment:

1509	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  <e0>amrinone</e0> ,  <e1>olprinone</e1>  and  cilostazol  may be exacerbated by  anagrelide ."
Other
Comment:

1510	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  <e0>amrinone</e0> ,  olprinone  and  <e1>cilostazol</e1>  may be exacerbated by  anagrelide ."
Other
Comment:

1511	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  <e0>amrinone</e0> ,  olprinone  and  cilostazol  may be exacerbated by  <e1>anagrelide</e1> ."
effect(e0,e1)Comment:

1512	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  amrinone ,  <e0>olprinone</e0>  and  <e1>cilostazol</e1>  may be exacerbated by  anagrelide ."
Other
Comment:

1513	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  amrinone ,  <e0>olprinone</e0>  and  cilostazol  may be exacerbated by  <e1>anagrelide</e1> ."
effect(e0,e1)Comment:

1514	The effects of medicinal products with similar properties such as inotropes  milrinone ,  enoximone ,  amrinone ,  olprinone  and  <e0>cilostazol</e0>  may be exacerbated by  <e1>anagrelide</e1> ."
effect(e0,e1)Comment:

1600	There is a single case report, which suggests that  <e0>sucralfate</e0>  may interfere with  <e1>anagrelide</e1>  absorption."
mechanism(e0,e1)Comment:


200	Toxicologic and toxicokinetic studies in rats did not demonstrate any alterations in the clearance or toxicologic profile of either  <e0>methotrexate</e0>  or  <e1>Kineret</e1>  when the two agents were administered together."
Other
Comment:

300	In a study in which patients with active RA were treated for up to 24 weeks with concurrent  <e0>Kineret</e0>  and  <e1>etanercept</e1>  therapy, a 7% rate of serious infections was observed, which was higher than that observed with  etanercept  alone (0%)."
effect(e0,e1)Comment:

301	In a study in which patients with active RA were treated for up to 24 weeks with concurrent  <e0>Kineret</e0>  and  etanercept  therapy, a 7% rate of serious infections was observed, which was higher than that observed with  <e1>etanercept</e1>  alone (0%)."
Other
Comment:

302	In a study in which patients with active RA were treated for up to 24 weeks with concurrent  Kineret  and  <e0>etanercept</e0>  therapy, a 7% rate of serious infections was observed, which was higher than that observed with  <e1>etanercept</e1>  alone (0%)."
Other
Comment:

400	Two percent of patients treated concurrently with  <e0>Kineret</e0>  and  <e1>etanercept</e1>  developed neutropenia (ANC  1 x 109/L)."
effect(e0,e1)Comment:


300	 <e0>Anastrozole</e0>  did not alter the pharmacokinetics of  <e1>antipyrine</e1> ."
Other
Comment:

400	Although there have been no formal interaction studies other than with  <e0>antipyrine</e0> , based on these in vivo and in vitro studies, it is unlikely that co-administration of a 1 mg dose of  <e1>ARIMIDEX</e1>  with other drugs will result in clinically significant drug inhibition of cytochrome P450-mediated metabolism of the other drugs."
Other
Comment:

500	An interaction study with  <e0>warfarin</e0>  showed no clinically significant effect of  <e1>anastrozole</e1>  on  warfarin  pharmacokinetics or anticoagulant activity."
Other
Comment:

501	An interaction study with  <e0>warfarin</e0>  showed no clinically significant effect of  anastrozole  on  <e1>warfarin</e1>  pharmacokinetics or anticoagulant activity."
Other
Comment:

502	An interaction study with  warfarin  showed no clinically significant effect of  <e0>anastrozole</e0>  on  <e1>warfarin</e1>  pharmacokinetics or anticoagulant activity."
Other
Comment:

600	At a median follow-up of 33 months, the combination of  <e0>ARIMIDEX</e0>  and  <e1>tamoxifen</e1>  did not demonstrate any efficacy benefit when compared with  tamoxifen  in all patients as well as in the hormone receptor-positive subpopulation."
Other
Comment:

601	At a median follow-up of 33 months, the combination of  <e0>ARIMIDEX</e0>  and  tamoxifen  did not demonstrate any efficacy benefit when compared with  <e1>tamoxifen</e1>  in all patients as well as in the hormone receptor-positive subpopulation."
Other
Comment:

602	At a median follow-up of 33 months, the combination of  ARIMIDEX  and  <e0>tamoxifen</e0>  did not demonstrate any efficacy benefit when compared with  <e1>tamoxifen</e1>  in all patients as well as in the hormone receptor-positive subpopulation."
Other
Comment:

800	Based on clinical and pharmacokinetic results from the ATAC trial,  <e0>tamoxifen</e0>  should not be administered with  <e1>anastrozole</e1>  (see CLINICAL PHARMACOLOGY   Drug Interactions and CLINICAL PHARMACOLOGY - Clinical Studies - Adjuvant Treatment of Breast Cancer in Postmenopausal Women subsections)."
advise(e0,e1)Comment:

900	Co-administration of  <e0>anastrozole</e0>  and  <e1>tamoxifen</e1>  resulted in a reduction of  anastrozole  plasma levels by 27% compared with those achieved with  anastrozole  alone."
mechanism(e0,e1)Comment:

901	Co-administration of  <e0>anastrozole</e0>  and  tamoxifen  resulted in a reduction of  <e1>anastrozole</e1>  plasma levels by 27% compared with those achieved with  anastrozole  alone."
Other
Comment:

902	Co-administration of  <e0>anastrozole</e0>  and  tamoxifen  resulted in a reduction of  anastrozole  plasma levels by 27% compared with those achieved with  <e1>anastrozole</e1>  alone."
Other
Comment:

903	Co-administration of  anastrozole  and  <e0>tamoxifen</e0>  resulted in a reduction of  <e1>anastrozole</e1>  plasma levels by 27% compared with those achieved with  anastrozole  alone."
Other
Comment:

904	Co-administration of  anastrozole  and  <e0>tamoxifen</e0>  resulted in a reduction of  anastrozole  plasma levels by 27% compared with those achieved with  <e1>anastrozole</e1>  alone."
Other
Comment:

905	Co-administration of  anastrozole  and  tamoxifen  resulted in a reduction of  <e0>anastrozole</e0>  plasma levels by 27% compared with those achieved with  <e1>anastrozole</e1>  alone."
Other
Comment:

1000	 <e0>Estrogen</e0> -containing therapies should not be used with  <e1>ARIMIDEX</e1>  as they may diminish its pharmacologic action."
advise(e0,e1)Comment:



100	Caution should be observed when  <e0>anileridine</e0>  is coadministered with other  <e1>opioids</e1> ,  sedatives ,  phenothiazines , or  anesthetics , as these agents may increase respiratory and circulatory depression."
advise(e0,e1)Comment:

101	Caution should be observed when  <e0>anileridine</e0>  is coadministered with other  opioids ,  <e1>sedatives</e1> ,  phenothiazines , or  anesthetics , as these agents may increase respiratory and circulatory depression."
advise(e0,e1)Comment:

102	Caution should be observed when  <e0>anileridine</e0>  is coadministered with other  opioids ,  sedatives ,  <e1>phenothiazines</e1> , or  anesthetics , as these agents may increase respiratory and circulatory depression."
advise(e0,e1)Comment:

103	Caution should be observed when  <e0>anileridine</e0>  is coadministered with other  opioids ,  sedatives ,  phenothiazines , or  <e1>anesthetics</e1> , as these agents may increase respiratory and circulatory depression."
advise(e0,e1)Comment:

104	Caution should be observed when  anileridine  is coadministered with other  <e0>opioids</e0> ,  <e1>sedatives</e1> ,  phenothiazines , or  anesthetics , as these agents may increase respiratory and circulatory depression."
Other
Comment:

105	Caution should be observed when  anileridine  is coadministered with other  <e0>opioids</e0> ,  sedatives ,  <e1>phenothiazines</e1> , or  anesthetics , as these agents may increase respiratory and circulatory depression."
Other
Comment:

106	Caution should be observed when  anileridine  is coadministered with other  <e0>opioids</e0> ,  sedatives ,  phenothiazines , or  <e1>anesthetics</e1> , as these agents may increase respiratory and circulatory depression."
Other
Comment:

107	Caution should be observed when  anileridine  is coadministered with other  opioids ,  <e0>sedatives</e0> ,  <e1>phenothiazines</e1> , or  anesthetics , as these agents may increase respiratory and circulatory depression."
Other
Comment:

108	Caution should be observed when  anileridine  is coadministered with other  opioids ,  <e0>sedatives</e0> ,  phenothiazines , or  <e1>anesthetics</e1> , as these agents may increase respiratory and circulatory depression."
Other
Comment:

109	Caution should be observed when  anileridine  is coadministered with other  opioids ,  sedatives ,  <e0>phenothiazines</e0> , or  <e1>anesthetics</e1> , as these agents may increase respiratory and circulatory depression."
Other
Comment:


100	Addition or deletion of any drug from the therapeutic regimen of patients receiving oral  <e0>anticoagulants</e0>  may affect patient response to the  <e1>anticoagulant</e1> ."
Other
Comment:

400	For example, since  <e0>cholestyramine</e0>  may reduce the gastrointestinal absorption of both the oral  <e1>anticoagulants</e1>  and  vitamin K , the net effects are unpredictable."
mechanism(e0,e1)Comment:

401	For example, since  <e0>cholestyramine</e0>  may reduce the gastrointestinal absorption of both the oral  anticoagulants  and  <e1>vitamin K</e1> , the net effects are unpredictable."
mechanism(e0,e1)Comment:

402	For example, since  cholestyramine  may reduce the gastrointestinal absorption of both the oral  <e0>anticoagulants</e0>  and  <e1>vitamin K</e1> , the net effects are unpredictable."
Other
Comment:

500	 <e0>Chloral hydrate</e0>  may cause an increased prothrombin response by displacing the  <e1>anticoagulant</e1>  from protein binding sites or a diminished prothrombin response through increased metabolism of the unbound drug by hepatic enzyme induction, thus leading to inter-patient variation in ultimate prothrombin effect."
mechanism(e0,e1)Comment:

700	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  <e1>adrenocortical steroids</e1> ;"
effect(e0,e1)Comment:

3000	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  <e1>adrenocortical steroids</e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3001	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e1>alcohol</e1> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3002	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e1>antacids</e1> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3003	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e1>antihistamines</e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3004	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1>barbiturates</e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3005	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3006	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3007	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3008	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3009	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3010	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3011	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3012	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3013	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3014	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3015	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3016	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3017	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3018	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3019	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3020	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3021	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
effect(e0,e1)Comment:

3022	Drugs that have been reported to diminish oral  <e0>anticoagulant</e0>  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
effect(e0,e1)Comment:

3023	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; <e1>alcohol</e1> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3024	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; <e1>antacids</e1> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3025	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; <e1>antihistamines</e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3026	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; <e1>barbiturates</e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3027	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3028	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3029	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3030	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3031	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3032	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3033	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3034	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3035	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3036	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3037	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3038	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3039	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3040	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3041	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3042	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3043	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3044	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  <e0>adrenocortical steroids</e0> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3045	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; <e1>antacids</e1> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3046	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; <e1>antihistamines</e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3047	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; <e1>barbiturates</e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3048	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3049	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3050	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3051	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3052	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3053	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3054	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3055	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3056	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3057	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3058	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3059	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3060	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3061	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3062	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3063	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3064	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3065	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; <e0>alcohol</e0> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3066	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; <e1>antihistamines</e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3067	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; <e1>barbiturates</e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3068	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3069	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3070	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3071	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3072	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3073	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3074	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3075	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3076	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3077	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3078	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3079	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3080	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3081	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3082	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3083	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3084	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3085	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; <e0>antacids</e0> ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3086	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; <e1>barbiturates</e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3087	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3088	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3089	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3090	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3091	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3092	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3093	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3094	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3095	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3096	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3097	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3098	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3099	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3100	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3101	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3102	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3103	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3104	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; <e0>antihistamines</e0> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3105	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; <e1>carbamazepine</e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3106	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3107	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3108	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3109	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3110	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3111	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3112	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3113	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3114	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3115	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3116	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3117	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3118	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3119	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3120	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3121	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3122	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e0>barbiturates</e0> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3123	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; <e1>chloral hydrate</e1> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3124	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3125	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3126	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3127	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3128	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3129	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3130	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3131	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3132	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3133	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3134	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3135	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3136	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3137	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3138	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3139	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e0>carbamazepine</e0> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3140	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; <e1>chlordiazepoxide</e1> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3141	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3142	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3143	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3144	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3145	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3146	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3147	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3148	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3149	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3150	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3151	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3152	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3153	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3154	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3155	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e0>chloral hydrate</e0> *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3156	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; <e1>cholestyramine</e1> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3157	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3158	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3159	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3160	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3161	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3162	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3163	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3164	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3165	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3166	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3167	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3168	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3169	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3170	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e0>chlordiazepoxide</e0> ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3171	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  <e1>vitamin K</e1> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3172	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3173	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3174	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3175	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3176	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3177	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3178	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3179	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3180	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3181	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3182	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3183	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3184	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e0>cholestyramine</e0> ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3185	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; <e1>diuretics</e1> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3186	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3187	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3188	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3189	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3190	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3191	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3192	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3193	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3194	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3195	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3196	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3197	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  <e0>vitamin K</e0> ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3198	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; <e1>ethchlorvynol</e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3199	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3200	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3201	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3202	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3203	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3204	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3205	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3206	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3207	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3208	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3209	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; <e0>diuretics</e0> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3210	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; <e1>glutethimide</e1> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3211	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3212	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3213	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3214	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3215	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3216	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3217	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3218	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3219	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3220	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; <e0>ethchlorvynol</e0> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3221	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; <e1>griseofulvin</e1> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3222	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3223	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3224	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3225	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3226	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3227	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3228	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3229	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3230	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; <e0>glutethimide</e0> ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3231	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; <e1>haloperidol</e1> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3232	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3233	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3234	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3235	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3236	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3237	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3238	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3239	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e0>griseofulvin</e0> ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3240	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; <e1>meprobamate</e1> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3241	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3242	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3243	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3244	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3245	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3246	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3247	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e0>haloperidol</e0> ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3248	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  <e1>contraceptives</e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3249	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3250	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3251	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3252	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3253	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3254	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e0>meprobamate</e0> ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3255	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; <e1>paraldehyde</e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3256	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; paraldehyde ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3257	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; paraldehyde ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3258	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; paraldehyde ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3259	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3260	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  <e0>contraceptives</e0> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3261	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e0>paraldehyde</e0> ; <e1>primidone</e1> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3262	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e0>paraldehyde</e0> ; primidone ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3263	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e0>paraldehyde</e0> ; primidone ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3264	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e0>paraldehyde</e0> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3265	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; <e0>paraldehyde</e0> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3266	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e0>primidone</e0> ; <e1>ranitidine</e1> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3267	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e0>primidone</e0> ; ranitidine *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3268	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e0>primidone</e0> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3269	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; <e0>primidone</e0> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3270	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e0>ranitidine</e0> *; <e1>rifampin</e1> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium  under-dosage."
Other
Comment:

3271	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e0>ranitidine</e0> *; rifampin ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3272	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; <e0>ranitidine</e0> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3273	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e0>rifampin</e0> ;unreliable prothrombin time determinations; <e1>vitamin C</e1> ; warfarin sodium  under-dosage."
Other
Comment:

3274	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; <e0>rifampin</e0> ;unreliable prothrombin time determinations; vitamin C ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3275	Drugs that have been reported to diminish oral  anticoagulant  response, ie, decreased prothrom-bin time response, in man significantly include:  adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in  vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral  contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e0>vitamin C</e0> ; <e1>warfarin sodium</e1>  under-dosage."
Other
Comment:

3100	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: <e1>alcohol</e1> *;"
effect(e0,e1)Comment:

8000	 <e0>salicylates</e0> ; <e1>sulfinpyrazone</e1> ;"
Other
Comment:

8600	 <e0>trimethoprim</e0> / <e1>sulfamethoxazole</e1> ;"
Other
Comment:

8800	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: <e1>alcohol</e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8801	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; <e1>allopurinol</e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8802	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e1>aminosalicylic acid</e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8803	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e1>amiodarone</e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8804	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1>anabolic steroids</e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8805	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8806	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8807	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8808	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8809	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8810	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8811	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8812	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8813	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8814	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8815	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8816	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8817	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8818	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8819	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8820	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8821	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8822	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8823	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8824	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8825	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8826	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8827	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8828	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8829	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8830	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8831	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8832	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8833	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8834	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8835	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8836	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8837	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8838	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8839	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8840	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8841	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8842	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8843	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8844	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8845	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8846	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8847	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8848	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8849	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8850	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8851	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8852	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
effect(e0,e1)Comment:

8853	Drugs that reportedly may increase oral  <e0>anticoagulant</e0>  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
effect(e0,e1)Comment:

8854	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; <e1>allopurinol</e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8855	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; <e1>aminosalicylic acid</e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8856	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; <e1>amiodarone</e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8857	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1>anabolic steroids</e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8858	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8859	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8860	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8861	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8862	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8863	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8864	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8865	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8866	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8867	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8868	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8869	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8870	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8871	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8872	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8873	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8874	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8875	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8876	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8877	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8878	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8879	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8880	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8881	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8882	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8883	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8884	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8885	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8886	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8887	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8888	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8889	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8890	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8891	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8892	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8893	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8894	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8895	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8896	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8897	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8898	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8899	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8900	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8901	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8902	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8903	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8904	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8905	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8906	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: <e0>alcohol</e0> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

8907	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; <e1>aminosalicylic acid</e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8908	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; <e1>amiodarone</e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8909	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; <e1>anabolic steroids</e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8910	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8911	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8912	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8913	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8914	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8915	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8916	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8917	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8918	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8919	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8920	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8921	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8922	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8923	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8924	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8925	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8926	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8927	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8928	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8929	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8930	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8931	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8932	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8933	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8934	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8935	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8936	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8937	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8938	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8939	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8940	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8941	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8942	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8943	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8944	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8945	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8946	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8947	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8948	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8949	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8950	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8951	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8952	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8953	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8954	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8955	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8956	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8957	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8958	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; <e0>allopurinol</e0> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

8959	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; <e1>amiodarone</e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8960	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; <e1>anabolic steroids</e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8961	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8962	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8963	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8964	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8965	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8966	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8967	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8968	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8969	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8970	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8971	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8972	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8973	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8974	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8975	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8976	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8977	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8978	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8979	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8980	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8981	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8982	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8983	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8984	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8985	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8986	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8987	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8988	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8989	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8990	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8991	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8992	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8993	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8994	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8995	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8996	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8997	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8998	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

8999	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9000	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9001	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9002	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9003	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9004	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9005	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9006	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9007	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9008	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9009	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; <e0>aminosalicylic acid</e0> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9010	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; <e1>anabolic steroids</e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9011	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9012	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9013	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9014	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9015	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9016	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9017	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9018	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9019	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9020	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9021	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9022	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9023	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9024	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9025	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9026	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9027	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9028	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9029	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9030	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9031	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9032	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9033	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9034	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9035	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9036	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9037	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9038	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9039	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9040	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9041	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9042	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9043	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9044	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9045	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9046	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9047	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9048	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9049	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9050	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9051	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9052	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9053	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9054	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9055	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9056	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9057	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9058	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9059	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; <e0>amiodarone</e0> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9060	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; <e1>antibiotics</e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9061	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9062	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9063	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9064	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9065	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9066	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9067	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9068	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9069	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9070	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9071	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9072	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9073	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9074	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9075	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9076	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9077	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9078	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9079	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9080	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9081	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9082	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9083	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9084	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9085	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9086	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9087	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9088	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9089	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9090	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9091	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9092	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9093	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9094	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9095	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9096	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9097	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9098	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9099	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9100	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9101	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9102	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9103	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9104	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9105	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9106	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9107	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9108	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e0>anabolic steroids</e0> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9109	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; <e1>bromelains</e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9110	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9111	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9112	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9113	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9114	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9115	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9116	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9117	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9118	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9119	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9120	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9121	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9122	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9123	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9124	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9125	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9126	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9127	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9128	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9129	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9130	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9131	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9132	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9133	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9134	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9135	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9136	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9137	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9138	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9139	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9140	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9141	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9142	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9143	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9144	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9145	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9146	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9147	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9148	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9149	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9150	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9151	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9152	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9153	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9154	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9155	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9156	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e0>antibiotics</e0> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9157	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; <e1>chloral hydrate</e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9158	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9159	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9160	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9161	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9162	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9163	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9164	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9165	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9166	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9167	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9168	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9169	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9170	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9171	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9172	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9173	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9174	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9175	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9176	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9177	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9178	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9179	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9180	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9181	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9182	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9183	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9184	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9185	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9186	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9187	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9188	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9189	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9190	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9191	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9192	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9193	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9194	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9195	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9196	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9197	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9198	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9199	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9200	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9201	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9202	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9203	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e0>bromelains</e0> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9204	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; <e1>chlorpropamide</e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9205	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9206	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9207	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9208	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9209	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9210	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9211	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9212	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9213	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9214	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9215	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9216	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9217	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9218	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9219	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9220	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9221	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9222	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9223	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9224	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9225	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9226	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9227	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9228	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9229	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9230	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9231	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9232	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9233	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9234	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9235	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9236	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9237	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9238	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9239	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9240	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9241	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9242	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9243	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9244	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9245	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9246	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9247	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9248	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9249	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e0>chloral hydrate</e0> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9250	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; <e1>chymotrypsin</e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9251	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9252	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9253	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9254	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9255	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9256	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9257	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9258	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9259	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9260	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9261	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9262	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9263	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9264	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9265	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9266	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9267	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9268	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9269	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9270	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9271	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9272	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9273	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9274	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9275	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9276	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9277	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9278	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9279	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9280	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9281	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9282	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9283	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9284	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9285	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9286	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9287	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9288	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9289	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9290	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9291	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9292	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9293	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9294	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e0>chlorpropamide</e0> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9295	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; <e1>cimetidine</e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9296	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9297	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9298	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9299	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9300	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9301	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9302	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9303	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9304	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9305	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9306	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9307	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9308	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9309	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9310	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9311	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9312	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9313	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9314	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9315	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9316	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9317	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9318	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9319	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9320	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9321	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9322	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9323	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9324	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9325	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9326	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9327	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9328	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9329	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9330	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9331	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9332	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9333	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9334	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9335	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9336	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9337	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9338	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e0>chymotrypsin</e0> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9339	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; <e1>cinchophen</e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9340	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9341	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9342	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9343	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9344	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9345	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9346	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9347	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9348	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9349	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9350	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9351	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9352	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9353	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9354	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9355	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9356	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9357	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9358	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9359	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9360	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9361	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9362	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9363	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9364	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9365	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9366	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9367	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9368	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9369	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9370	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9371	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9372	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9373	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9374	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9375	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9376	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9377	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9378	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9379	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9380	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9381	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e0>cimetidine</e0> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9382	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; <e1>clofibrate</e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9383	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9384	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9385	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9386	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9387	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9388	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9389	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9390	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9391	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9392	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9393	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9394	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9395	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9396	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9397	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9398	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9399	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9400	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9401	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9402	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9403	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9404	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9405	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9406	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9407	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9408	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9409	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9410	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9411	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9412	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9413	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9414	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9415	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9416	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9417	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9418	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9419	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9420	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9421	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9422	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9423	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e0>cinchophen</e0> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9424	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; <e1>dextran</e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9425	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9426	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9427	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9428	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9429	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9430	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9431	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9432	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9433	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9434	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9435	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9436	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9437	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9438	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9439	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9440	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9441	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9442	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9443	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9444	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9445	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9446	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9447	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9448	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9449	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9450	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9451	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9452	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9453	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9454	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9455	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9456	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9457	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9458	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9459	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9460	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9461	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9462	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9463	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9464	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e0>clofibrate</e0> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9465	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; <e1>dextrothyroxine</e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9466	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9467	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9468	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9469	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9470	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9471	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9472	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9473	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9474	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9475	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9476	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9477	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9478	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9479	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9480	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9481	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9482	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9483	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9484	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9485	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9486	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9487	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9488	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9489	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9490	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9491	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9492	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9493	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9494	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9495	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9496	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9497	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9498	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9499	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9500	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9501	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9502	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9503	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9504	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e0>dextran</e0> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9505	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; <e1>diazoxide</e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9506	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9507	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9508	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9509	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9510	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9511	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9512	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9513	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9514	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9515	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9516	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9517	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9518	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9519	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9520	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9521	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9522	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9523	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9524	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9525	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9526	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9527	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9528	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9529	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9530	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9531	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9532	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9533	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9534	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9535	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9536	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9537	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9538	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9539	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9540	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9541	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9542	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9543	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e0>dextrothyroxine</e0> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9544	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; <e1>diflunisal</e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9545	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9546	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9547	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9548	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9549	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9550	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9551	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9552	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9553	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9554	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9555	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9556	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9557	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9558	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9559	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9560	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9561	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9562	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9563	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9564	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9565	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9566	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9567	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9568	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9569	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9570	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9571	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9572	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9573	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9574	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9575	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9576	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9577	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9578	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9579	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9580	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9581	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e0>diazoxide</e0> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9582	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; <e1>disulfiram</e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9583	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9584	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9585	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9586	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9587	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9588	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9589	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9590	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9591	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9592	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9593	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9594	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9595	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9596	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9597	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9598	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9599	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9600	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9601	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9602	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9603	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9604	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9605	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9606	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9607	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9608	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9609	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9610	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9611	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9612	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9613	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9614	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9615	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9616	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9617	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9618	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e0>diflunisal</e0> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9619	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; <e1>ethacrynic acid</e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9620	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9621	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9622	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9623	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9624	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9625	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9626	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9627	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9628	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9629	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9630	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9631	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9632	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9633	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9634	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9635	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9636	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9637	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9638	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9639	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9640	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9641	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9642	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9643	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9644	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9645	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9646	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9647	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9648	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9649	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9650	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9651	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9652	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9653	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9654	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e0>disulfiram</e0> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9655	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; <e1>fenoprofen</e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9656	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9657	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9658	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9659	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9660	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9661	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9662	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9663	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9664	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9665	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9666	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9667	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9668	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9669	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9670	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9671	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9672	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9673	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9674	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9675	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9676	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9677	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9678	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9679	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9680	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9681	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9682	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9683	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9684	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9685	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9686	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9687	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9688	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9689	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e0>ethacrynic acid</e0> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9690	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; <e1>glucagon</e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9691	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9692	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9693	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9694	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9695	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9696	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9697	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9698	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9699	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9700	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9701	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9702	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9703	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9704	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9705	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9706	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9707	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9708	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9709	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9710	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9711	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9712	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9713	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9714	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9715	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9716	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9717	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9718	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9719	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9720	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9721	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9722	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9723	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e0>fenoprofen</e0> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9724	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; <e1>ibuprofen</e1> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9725	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9726	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9727	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9728	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9729	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9730	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9731	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9732	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9733	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9734	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9735	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9736	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9737	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9738	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9739	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9740	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9741	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9742	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9743	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9744	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9745	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9746	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9747	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9748	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9749	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9750	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9751	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9752	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9753	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9754	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9755	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9756	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e0>glucagon</e0> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9757	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; <e1>indomethacin</e1> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9758	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9759	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9760	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9761	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9762	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9763	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9764	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9765	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9766	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9767	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9768	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9769	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9770	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9771	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9772	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9773	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9774	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9775	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9776	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9777	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9778	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9779	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9780	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9781	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9782	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9783	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9784	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9785	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9786	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9787	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9788	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e0>ibuprofen</e0> ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9789	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; <e1>influenza virus vaccine</e1> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9790	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9791	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9792	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9793	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9794	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9795	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9796	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9797	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9798	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9799	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9800	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9801	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9802	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9803	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9804	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9805	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9806	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9807	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9808	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9809	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9810	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9811	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9812	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9813	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9814	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9815	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9816	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9817	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9818	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9819	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e0>indomethacin</e0> ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9820	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  <e1>anesthetics</e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9821	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9822	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9823	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9824	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9825	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9826	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9827	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9828	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9829	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9830	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9831	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9832	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9833	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9834	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9835	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9836	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9837	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9838	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9839	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9840	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9841	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9842	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9843	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9844	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9845	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9846	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9847	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9848	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9849	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e0>influenza virus vaccine</e0> ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9850	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; <e1>mefenamic acid</e1> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9851	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9852	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9853	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9854	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9855	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9856	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9857	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9858	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9859	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9860	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9861	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9862	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9863	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9864	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9865	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9866	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9867	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9868	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9869	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9870	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9871	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9872	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9873	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9874	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9875	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9876	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9877	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9878	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  <e0>anesthetics</e0> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9879	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; <e1>methyldopa</e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9880	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9881	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9882	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9883	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9884	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9885	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9886	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9887	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9888	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9889	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9890	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9891	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9892	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9893	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9894	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9895	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9896	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9897	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9898	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9899	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9900	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9901	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9902	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9903	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9904	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9905	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9906	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; <e0>mefenamic acid</e0> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9907	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; <e1>methylphenidate</e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9908	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9909	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9910	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9911	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9912	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9913	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9914	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9915	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9916	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9917	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9918	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9919	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9920	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9921	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9922	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9923	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9924	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9925	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9926	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9927	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9928	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9929	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9930	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9931	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9932	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9933	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; <e0>methyldopa</e0> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9934	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; <e1>metronidazole</e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9935	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9936	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9937	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9938	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9939	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9940	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9941	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9942	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9943	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9944	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9945	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9946	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9947	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9948	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9949	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9950	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9951	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9952	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9953	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9954	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9955	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9956	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9957	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9958	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9959	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; <e0>methylphenidate</e0> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9960	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; <e1>miconazole</e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9961	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9962	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9963	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9964	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9965	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9966	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9967	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9968	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9969	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9970	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9971	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9972	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9973	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9974	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9975	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9976	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9977	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9978	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9979	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9980	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9981	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9982	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9983	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9984	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e0>metronidazole</e0> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

9985	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; <e1>monoamine oxidase inhibitors</e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9986	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9987	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9988	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9989	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9990	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9991	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9992	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9993	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9994	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9995	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9996	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9997	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9998	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

9999	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10000	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10001	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10002	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10003	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10004	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10005	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10006	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10007	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10008	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e0>miconazole</e0> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10009	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; <e1>nalidixic acid</e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10010	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10011	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10012	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10013	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10014	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10015	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10016	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10017	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10018	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10019	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10020	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10021	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10022	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10023	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10024	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10025	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10026	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10027	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10028	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10029	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10030	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10031	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e0>monoamine oxidase inhibitors</e0> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10032	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; <e1>naproxen</e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10033	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10034	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10035	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10036	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10037	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10038	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10039	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10040	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10041	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10042	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10043	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10044	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10045	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10046	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10047	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10048	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10049	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10050	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10051	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10052	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10053	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e0>nalidixic acid</e0> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10054	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; <e1>oxolinic acid</e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10055	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10056	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10057	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10058	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10059	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10060	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10061	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10062	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10063	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10064	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10065	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10066	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10067	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10068	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10069	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10070	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10071	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10072	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10073	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10074	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e0>naproxen</e0> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10075	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; <e1>oxyphenbutazone</e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10076	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10077	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10078	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10079	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10080	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10081	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10082	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10083	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10084	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10085	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10086	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10087	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10088	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10089	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10090	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10091	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10092	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10093	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10094	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e0>oxolinic acid</e0> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10095	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; <e1>pentoxifylline</e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10096	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10097	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10098	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10099	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10100	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10101	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10102	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10103	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10104	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10105	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10106	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10107	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10108	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10109	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10110	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10111	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10112	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10113	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e0>oxyphenbutazone</e0> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10114	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; <e1>phenylbutazone</e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10115	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10116	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10117	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10118	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10119	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10120	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10121	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10122	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10123	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10124	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10125	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10126	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10127	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10128	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10129	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10130	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10131	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e0>pentoxifylline</e0> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10132	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; <e1>phenyramidol</e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10133	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10134	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10135	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10136	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10137	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10138	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10139	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10140	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10141	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10142	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10143	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10144	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10145	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10146	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10147	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10148	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e0>phenylbutazone</e0> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10149	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; <e1>phenytoin</e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10150	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10151	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10152	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10153	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10154	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10155	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10156	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10157	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10158	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10159	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10160	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10161	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10162	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10163	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10164	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e0>phenyramidol</e0> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10165	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; <e1>prolonged narcotics</e1> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10166	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10167	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10168	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10169	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10170	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10171	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10172	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10173	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10174	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10175	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10176	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10177	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10178	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10179	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e0>phenytoin</e0> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10180	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; <e1>pyrazolones</e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10181	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10182	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10183	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10184	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10185	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10186	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10187	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10188	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10189	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10190	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10191	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10192	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10193	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e0>prolonged narcotics</e0> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10194	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; <e1>quinidine</e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10195	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10196	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10197	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10198	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10199	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10200	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10201	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10202	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10203	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10204	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10205	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10206	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e0>pyrazolones</e0> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10207	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; <e1>quinine</e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10208	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10209	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10210	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10211	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10212	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10213	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10214	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10215	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10216	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10217	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10218	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e0>quinidine</e0> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10219	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; <e1>ranitidine</e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10220	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10221	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10222	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10223	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10224	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10225	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10226	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10227	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10228	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10229	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e0>quinine</e0> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10230	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; <e1>salicylates</e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10231	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10232	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10233	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10234	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10235	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10236	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10237	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10238	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10239	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e0>ranitidine</e0> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10240	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; <e1>sulfinpyrazone</e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10241	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10242	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10243	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10244	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10245	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10246	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10247	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10248	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e0>salicylates</e0> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10249	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; <e1>sulfonamides</e1> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10250	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10251	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10252	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10253	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10254	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10255	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10256	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e0>sulfinpyrazone</e0> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10257	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; <e1>sulindac</e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10258	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10259	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10260	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10261	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10262	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10263	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e0>sulfonamides</e0> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10264	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; <e1>thyroid drugs</e1> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10265	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; thyroid drugs ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10266	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; thyroid drugs ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10267	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10268	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10269	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e0>sulindac</e0> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10270	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e0>thyroid drugs</e0> ; <e1>tolbutamide</e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10271	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e0>thyroid drugs</e0> ; tolbutamide ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10272	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e0>thyroid drugs</e0> ; tolbutamide ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10273	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e0>thyroid drugs</e0> ; tolbutamide ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10274	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e0>thyroid drugs</e0> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10275	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e0>tolbutamide</e0> ; <e1>triclofos sodium</e1> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10276	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e0>tolbutamide</e0> ; triclofos sodium ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10277	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e0>tolbutamide</e0> ; triclofos sodium ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10278	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e0>tolbutamide</e0> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10279	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e0>triclofos sodium</e0> ; <e1>trimethoprim</e1> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10280	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e0>triclofos sodium</e0> ; trimethoprim / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10281	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e0>triclofos sodium</e0> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10282	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e0>trimethoprim</e0> / <e1>sulfamethoxazole</e1> ;unreliable prothrombin time determinations; warfarin sodium  overdosage."
Other
Comment:

10283	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e0>trimethoprim</e0> / sulfamethoxazole ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

10284	Drugs that reportedly may increase oral  anticoagulant  response, ie, increased prothrombin response, in man include: alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation  anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e0>sulfamethoxazole</e0> ;unreliable prothrombin time determinations; <e1>warfarin sodium</e1>  overdosage."
Other
Comment:

8900	Oral  <e0>anticoagulants</e0>  may potentiate the hypoglycemic action of  <e1>hypoglycemic agents</e1> , eg,  tolbutamide  and  chlorpropamide , by inhibiting their metabolism in the liver."
mechanism(e0,e1)Comment:

8901	Oral  <e0>anticoagulants</e0>  may potentiate the hypoglycemic action of  hypoglycemic agents , eg,  <e1>tolbutamide</e1>  and  chlorpropamide , by inhibiting their metabolism in the liver."
mechanism(e0,e1)Comment:

8902	Oral  <e0>anticoagulants</e0>  may potentiate the hypoglycemic action of  hypoglycemic agents , eg,  tolbutamide  and  <e1>chlorpropamide</e1> , by inhibiting their metabolism in the liver."
mechanism(e0,e1)Comment:

8903	Oral  anticoagulants  may potentiate the hypoglycemic action of  <e0>hypoglycemic agents</e0> , eg,  <e1>tolbutamide</e1>  and  chlorpropamide , by inhibiting their metabolism in the liver."
Other
Comment:

8904	Oral  anticoagulants  may potentiate the hypoglycemic action of  <e0>hypoglycemic agents</e0> , eg,  tolbutamide  and  <e1>chlorpropamide</e1> , by inhibiting their metabolism in the liver."
Other
Comment:

8905	Oral  anticoagulants  may potentiate the hypoglycemic action of  hypoglycemic agents , eg,  <e0>tolbutamide</e0>  and  <e1>chlorpropamide</e1> , by inhibiting their metabolism in the liver."
Other
Comment:

9000	Because oral  <e0>anticoagulants</e0>  may interfere with the hepatic metabolism of  <e1>phenytoin</e1> , toxic levels of the  anticonvulsant  may occur when an oral  anticoagulant  and  phenytoin  are administered concurrently."
mechanism(e0,e1)Comment:

9001	Because oral  <e0>anticoagulants</e0>  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  <e1>anticonvulsant</e1>  may occur when an oral  anticoagulant  and  phenytoin  are administered concurrently."
Other
Comment:

9002	Because oral  <e0>anticoagulants</e0>  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  anticonvulsant  may occur when an oral  <e1>anticoagulant</e1>  and  phenytoin  are administered concurrently."
Other
Comment:

9003	Because oral  <e0>anticoagulants</e0>  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  anticonvulsant  may occur when an oral  anticoagulant  and  <e1>phenytoin</e1>  are administered concurrently."
Other
Comment:

9004	Because oral  anticoagulants  may interfere with the hepatic metabolism of  <e0>phenytoin</e0> , toxic levels of the  <e1>anticonvulsant</e1>  may occur when an oral  anticoagulant  and  phenytoin  are administered concurrently."
Other
Comment:

9005	Because oral  anticoagulants  may interfere with the hepatic metabolism of  <e0>phenytoin</e0> , toxic levels of the  anticonvulsant  may occur when an oral  <e1>anticoagulant</e1>  and  phenytoin  are administered concurrently."
Other
Comment:

9006	Because oral  anticoagulants  may interfere with the hepatic metabolism of  <e0>phenytoin</e0> , toxic levels of the  anticonvulsant  may occur when an oral  anticoagulant  and  <e1>phenytoin</e1>  are administered concurrently."
Other
Comment:

9007	Because oral  anticoagulants  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  <e0>anticonvulsant</e0>  may occur when an oral  <e1>anticoagulant</e1>  and  phenytoin  are administered concurrently."
Other
Comment:

9008	Because oral  anticoagulants  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  <e0>anticonvulsant</e0>  may occur when an oral  anticoagulant  and  <e1>phenytoin</e1>  are administered concurrently."
Other
Comment:

9009	Because oral  anticoagulants  may interfere with the hepatic metabolism of  phenytoin , toxic levels of the  anticonvulsant  may occur when an oral  <e0>anticoagulant</e0>  and  <e1>phenytoin</e1>  are administered concurrently."
mechanism(e0,e1)Comment:

9100	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  <e1>aspirin</e1>  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9101	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e1>non-steroidal anti-inflammatory drugs</e1> ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9102	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  <e1>dipyridamole</e1> ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9103	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  <e1>hydrochloroquine</e1> ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9104	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  <e1>clofibrate</e1> ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9105	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9106	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  <e0>antineoplastic agents</e0> ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9107	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  <e1>non-steroidal anti-inflammatory drugs</e1> ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9108	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  non-steroidal anti-inflammatory drugs ,  <e1>dipyridamole</e1> ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9109	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  <e1>hydrochloroquine</e1> ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9110	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  <e1>clofibrate</e1> ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9111	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9112	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  <e0>aspirin</e0>  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9113	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e0>non-steroidal anti-inflammatory drugs</e0> ,  <e1>dipyridamole</e1> ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9114	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e0>non-steroidal anti-inflammatory drugs</e0> ,  dipyridamole ,  <e1>hydrochloroquine</e1> ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9115	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e0>non-steroidal anti-inflammatory drugs</e0> ,  dipyridamole ,  hydrochloroquine ,  <e1>clofibrate</e1> ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9116	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e0>non-steroidal anti-inflammatory drugs</e0> ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9117	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  <e0>non-steroidal anti-inflammatory drugs</e0> ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9118	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  <e0>dipyridamole</e0> ,  <e1>hydrochloroquine</e1> ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9119	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  <e0>dipyridamole</e0> ,  hydrochloroquine ,  <e1>clofibrate</e1> ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9120	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  <e0>dipyridamole</e0> ,  hydrochloroquine ,  clofibrate ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9121	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  <e0>dipyridamole</e0> ,  hydrochloroquine ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9122	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  <e0>hydrochloroquine</e0> ,  <e1>clofibrate</e1> ,  dextran ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9123	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  <e0>hydrochloroquine</e0> ,  clofibrate ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9124	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  <e0>hydrochloroquine</e0> ,  clofibrate ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9125	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  <e0>clofibrate</e0> ,  <e1>dextran</e1> ) may increase the bleeding tendency produced by  anticoagulants  without altering prothrombin time determinations."
Other
Comment:

9126	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  <e0>clofibrate</e0> ,  dextran ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9127	Drugs that reduce the number of blood platelets by causing bone marrow depression (such as  antineoplastic agents ) or drugs which inhibit platelet function (eg,  aspirin  and other  non-steroidal anti-inflammatory drugs ,  dipyridamole ,  hydrochloroquine ,  clofibrate ,  <e0>dextran</e0> ) may increase the bleeding tendency produced by  <e1>anticoagulants</e1>  without altering prothrombin time determinations."
effect(e0,e1)Comment:

9200	The beneficial effects on arterial thrombus formation from combined therapy with  <e0>antiplatelet medication</e0>  and  <e1>anticoagulant medication</e1>  must be weighed against an increased risk of inducing hemorrhage."
advise(e0,e1)Comment:

9400	Drug/Laboratory Test Interferences:  <e0>Dicumarol</e0>  and  <e1>indanedione anticoagulants</e1> , including  anisindione , or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests."
Other
Comment:

9401	Drug/Laboratory Test Interferences:  <e0>Dicumarol</e0>  and  indanedione anticoagulants , including  <e1>anisindione</e1> , or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests."
Other
Comment:

9402	Drug/Laboratory Test Interferences:  Dicumarol  and  <e0>indanedione anticoagulants</e0> , including  <e1>anisindione</e1> , or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests."
Other
Comment:


100	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  <e1>apomorphine</e1>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

101	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e1>ondansetron</e1> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

102	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e1>apomorphine</e1>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

103	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e1>5HT3 antagonist class</e1>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

104	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e1>ondansetron</e1> ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

105	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

106	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

107	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

108	 <e0>5HT3 Antagonists</e0> : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

109	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  <e1>ondansetron</e1> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
effect(e0,e1)Comment:

110	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  <e1>apomorphine</e1>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

111	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e1>5HT3 antagonist class</e1>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

112	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e1>ondansetron</e1> ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

113	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

114	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

115	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

116	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  <e0>apomorphine</e0>  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

117	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  <e1>apomorphine</e1>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

118	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  <e1>5HT3 antagonist class</e1>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

119	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e1>ondansetron</e1> ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

120	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

121	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

122	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

123	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  <e0>ondansetron</e0> , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

124	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  <e1>5HT3 antagonist class</e1>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
advise(e0,e1)Comment:

125	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  5HT3 antagonist class  (including, for example,  <e1>ondansetron</e1> ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
advise(e0,e1)Comment:

126	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
advise(e0,e1)Comment:

127	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
advise(e0,e1)Comment:

128	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
advise(e0,e1)Comment:

129	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  <e0>apomorphine</e0>  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
advise(e0,e1)Comment:

130	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e0>5HT3 antagonist class</e0>  (including, for example,  <e1>ondansetron</e1> ,  granisetron ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

131	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e0>5HT3 antagonist class</e0>  (including, for example,  ondansetron ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

132	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e0>5HT3 antagonist class</e0>  (including, for example,  ondansetron ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

133	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e0>5HT3 antagonist class</e0>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

134	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  <e0>5HT3 antagonist class</e0>  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

135	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e0>ondansetron</e0> ,  <e1>granisetron</e1> ,  dolasetron ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

136	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e0>ondansetron</e0> ,  granisetron ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

137	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e0>ondansetron</e0> ,  granisetron ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

138	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  <e0>ondansetron</e0> ,  granisetron ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

139	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e0>granisetron</e0> ,  <e1>dolasetron</e1> ,  palonosetron , and  alosetron ) is contraindicated ."
Other
Comment:

140	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e0>granisetron</e0> ,  dolasetron ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

141	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  <e0>granisetron</e0> ,  dolasetron ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

142	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e0>dolasetron</e0> ,  <e1>palonosetron</e1> , and  alosetron ) is contraindicated ."
Other
Comment:

143	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  <e0>dolasetron</e0> ,  palonosetron , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

144	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when  apomorphine  was administered with  ondansetron , the concomitant use of  apomorphine  with drugs of the  5HT3 antagonist class  (including, for example,  ondansetron ,  granisetron ,  dolasetron ,  <e0>palonosetron</e0> , and  <e1>alosetron</e1> ) is contraindicated ."
Other
Comment:

200	 <e0>Antihypertensive Medication</e0> s and  <e1>Vasodilators</e1> : The following adverse events were experienced more commonly in patients receiving concomitant  antihypertensive medications  or  vasodilators  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
Other
Comment:

201	 <e0>Antihypertensive Medication</e0> s and  Vasodilators : The following adverse events were experienced more commonly in patients receiving concomitant  <e1>antihypertensive medications</e1>  or  vasodilators  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
Other
Comment:

202	 <e0>Antihypertensive Medication</e0> s and  Vasodilators : The following adverse events were experienced more commonly in patients receiving concomitant  antihypertensive medications  or  <e1>vasodilators</e1>  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
Other
Comment:

203	 Antihypertensive Medication s and  <e0>Vasodilators</e0> : The following adverse events were experienced more commonly in patients receiving concomitant  <e1>antihypertensive medications</e1>  or  vasodilators  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
Other
Comment:

204	 Antihypertensive Medication s and  <e0>Vasodilators</e0> : The following adverse events were experienced more commonly in patients receiving concomitant  antihypertensive medications  or  <e1>vasodilators</e1>  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
Other
Comment:

205	 Antihypertensive Medication s and  Vasodilators : The following adverse events were experienced more commonly in patients receiving concomitant  <e0>antihypertensive medications</e0>  or  <e1>vasodilators</e1>  (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%."
effect(e0,e1)Comment:

400	 <e0>Dopamine Antagonists</e0> : Since  <e1>apomorphine</e1>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

401	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  <e1>dopamine agonist</e1> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

402	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  <e1>dopamine antagonists</e1> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

403	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e1>neuroleptics</e1>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

404	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e1>phenothiazines</e1> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

405	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

406	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

407	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

408	 <e0>Dopamine Antagonists</e0> : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
Other
Comment:

409	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  <e1>dopamine agonist</e1> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

410	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  <e1>dopamine antagonists</e1> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

411	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e1>neuroleptics</e1>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

412	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e1>phenothiazines</e1> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

413	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

414	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

415	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

416	 Dopamine Antagonists : Since  <e0>apomorphine</e0>  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
Other
Comment:

417	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  <e1>dopamine antagonists</e1> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

418	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  <e1>neuroleptics</e1>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

419	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e1>phenothiazines</e1> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

420	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

421	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

422	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

423	 Dopamine Antagonists : Since  apomorphine  is a  <e0>dopamine agonist</e0> , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
Other
Comment:

424	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  <e1>neuroleptics</e1>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

425	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  neuroleptics  ( <e1>phenothiazines</e1> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

426	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  neuroleptics  ( phenothiazines ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

427	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

428	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
effect(e0,e1)Comment:

429	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  <e0>dopamine antagonists</e0> , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
Other
Comment:

430	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e0>neuroleptics</e0>  ( <e1>phenothiazines</e1> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

431	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e0>neuroleptics</e0>  ( phenothiazines ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

432	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e0>neuroleptics</e0>  ( phenothiazines ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

433	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e0>neuroleptics</e0>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

434	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  <e0>neuroleptics</e0>  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
Other
Comment:

435	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e0>phenothiazines</e0> ,  <e1>butyrophenones</e1> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

436	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e0>phenothiazines</e0> ,  butyrophenones ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

437	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e0>phenothiazines</e0> ,  butyrophenones ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

438	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( <e0>phenothiazines</e0> ,  butyrophenones ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
effect(e0,e1)Comment:

439	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e0>butyrophenones</e0> ,  <e1>thioxanthenes</e1> ) or  metoclopramide , may diminish the effectiveness of  APOKYN ."
Other
Comment:

440	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e0>butyrophenones</e0> ,  thioxanthenes ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

441	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  <e0>butyrophenones</e0> ,  thioxanthenes ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
effect(e0,e1)Comment:

442	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e0>thioxanthenes</e0> ) or  <e1>metoclopramide</e1> , may diminish the effectiveness of  APOKYN ."
Other
Comment:

443	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  <e0>thioxanthenes</e0> ) or  metoclopramide , may diminish the effectiveness of  <e1>APOKYN</e1> ."
effect(e0,e1)Comment:

444	 Dopamine Antagonists : Since  apomorphine  is a  dopamine agonist , it is possible that  dopamine antagonists , such as the  neuroleptics  ( phenothiazines ,  butyrophenones ,  thioxanthenes ) or  <e0>metoclopramide</e0> , may diminish the effectiveness of  <e1>APOKYN</e1> ."
effect(e0,e1)Comment:

500	Patients with major psychotic disorders, treated with  <e0>neuroleptics</e0> , should be treated with  <e1>dopamine agonists</e1>  only if the potential benefits outweigh the risks."
advise(e0,e1)Comment:


100	 <e0>Apraclonidine</e0>  should not be used in patients receiving  <e1>MAO inhibitors</e1> .."
advise(e0,e1)Comment:

200	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e1>CNS depressants</e1>  ( alcohol ,  barbiturates ,  opiates ,  sedatives ,  anesthetics ) should be considered."
advise(e0,e1)Comment:

201	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( <e1>alcohol</e1> ,  barbiturates ,  opiates ,  sedatives ,  anesthetics ) should be considered."
advise(e0,e1)Comment:

202	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e1>barbiturates</e1> ,  opiates ,  sedatives ,  anesthetics ) should be considered."
advise(e0,e1)Comment:

203	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e1>opiates</e1> ,  sedatives ,  anesthetics ) should be considered."
advise(e0,e1)Comment:

204	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  <e1>sedatives</e1> ,  anesthetics ) should be considered."
advise(e0,e1)Comment:

205	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  <e0>IOPIDINE</e0>  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  sedatives ,  <e1>anesthetics</e1> ) should be considered."
advise(e0,e1)Comment:

206	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( <e1>alcohol</e1> ,  barbiturates ,  opiates ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

207	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  <e1>barbiturates</e1> ,  opiates ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

208	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  <e1>opiates</e1> ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

209	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  opiates ,  <e1>sedatives</e1> ,  anesthetics ) should be considered."
Other
Comment:

210	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  opiates ,  sedatives ,  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

211	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  <e1>barbiturates</e1> ,  opiates ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

212	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  <e1>opiates</e1> ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

213	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  opiates ,  <e1>sedatives</e1> ,  anesthetics ) should be considered."
Other
Comment:

214	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  opiates ,  sedatives ,  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

215	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  <e1>opiates</e1> ,  sedatives ,  anesthetics ) should be considered."
Other
Comment:

216	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  opiates ,  <e1>sedatives</e1> ,  anesthetics ) should be considered."
Other
Comment:

217	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  opiates ,  sedatives ,  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

218	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e0>opiates</e0> ,  <e1>sedatives</e1> ,  anesthetics ) should be considered."
Other
Comment:

219	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e0>opiates</e0> ,  sedatives ,  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

220	Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of  IOPIDINE  0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  <e0>sedatives</e0> ,  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

300	 <e0>Tricyclic antidepressants</e0>  have been reported to blunt the hypotensive effect of systemic  <e1>clonidine</e1> ."
effect(e0,e1)Comment:

700	An additive hypotensive effect has been reported with the combination of systemic  <e0>clonidine</e0>  and  <e1>neuroleptic</e1>  therapy."
effect(e0,e1)Comment:

900	Since  <e0>apraclonidine</e0>  may reduce pulse and blood pressure, caution in using drugs such as  <e1>beta-blockers</e1>  (ophthalmic and systemic),  antihypertensives , and  cardiac glycosides  is advised."
advise(e0,e1)Comment:

901	Since  <e0>apraclonidine</e0>  may reduce pulse and blood pressure, caution in using drugs such as  beta-blockers  (ophthalmic and systemic),  <e1>antihypertensives</e1> , and  cardiac glycosides  is advised."
advise(e0,e1)Comment:

902	Since  <e0>apraclonidine</e0>  may reduce pulse and blood pressure, caution in using drugs such as  beta-blockers  (ophthalmic and systemic),  antihypertensives , and  <e1>cardiac glycosides</e1>  is advised."
advise(e0,e1)Comment:

903	Since  apraclonidine  may reduce pulse and blood pressure, caution in using drugs such as  <e0>beta-blockers</e0>  (ophthalmic and systemic),  <e1>antihypertensives</e1> , and  cardiac glycosides  is advised."
Other
Comment:

904	Since  apraclonidine  may reduce pulse and blood pressure, caution in using drugs such as  <e0>beta-blockers</e0>  (ophthalmic and systemic),  antihypertensives , and  <e1>cardiac glycosides</e1>  is advised."
Other
Comment:

905	Since  apraclonidine  may reduce pulse and blood pressure, caution in using drugs such as  beta-blockers  (ophthalmic and systemic),  <e0>antihypertensives</e0> , and  <e1>cardiac glycosides</e1>  is advised."
Other
Comment:


500	 <e0>Aprepitant</e0>  has been shown to induce the metabolism of  <e1>S(-) warfarin</e1>  and  tolbutamide , which are metabolized through CYP2C9."
mechanism(e0,e1)Comment:

501	 <e0>Aprepitant</e0>  has been shown to induce the metabolism of  S(-) warfarin  and  <e1>tolbutamide</e1> , which are metabolized through CYP2C9."
mechanism(e0,e1)Comment:

502	 Aprepitant  has been shown to induce the metabolism of  <e0>S(-) warfarin</e0>  and  <e1>tolbutamide</e1> , which are metabolized through CYP2C9."
Other
Comment:

600	Coadministration of  <e0>Aprepitant</e0>  with these drugs or other drugs that are known to be metabolized by CYP2C9, such as  <e1>phenytoin</e1> , may result in lower plasma concentrations of these drugs."
mechanism(e0,e1)Comment:

700	 <e0>Aprepitant</e0>  is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of  <e1>Aprepitant</e1>  with  digoxin  in a clinical drug interaction study."
Other
Comment:

701	 <e0>Aprepitant</e0>  is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of  Aprepitant  with  <e1>digoxin</e1>  in a clinical drug interaction study."
Other
Comment:

702	 Aprepitant  is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of  <e0>Aprepitant</e0>  with  <e1>digoxin</e1>  in a clinical drug interaction study."
Other
Comment:

800	 <e0>5-HT3 antagonists</e0> : In clinical drug interaction studies,  <e1>aprepitant</e1>  did not have clinically important effects on the pharmacokinetics of  ondansetron  or  granisetron ."
Other
Comment:

801	 <e0>5-HT3 antagonists</e0> : In clinical drug interaction studies,  aprepitant  did not have clinically important effects on the pharmacokinetics of  <e1>ondansetron</e1>  or  granisetron ."
Other
Comment:

802	 <e0>5-HT3 antagonists</e0> : In clinical drug interaction studies,  aprepitant  did not have clinically important effects on the pharmacokinetics of  ondansetron  or  <e1>granisetron</e1> ."
Other
Comment:

803	 5-HT3 antagonists : In clinical drug interaction studies,  <e0>aprepitant</e0>  did not have clinically important effects on the pharmacokinetics of  <e1>ondansetron</e1>  or  granisetron ."
Other
Comment:

804	 5-HT3 antagonists : In clinical drug interaction studies,  <e0>aprepitant</e0>  did not have clinically important effects on the pharmacokinetics of  ondansetron  or  <e1>granisetron</e1> ."
Other
Comment:

805	 5-HT3 antagonists : In clinical drug interaction studies,  aprepitant  did not have clinically important effects on the pharmacokinetics of  <e0>ondansetron</e0>  or  <e1>granisetron</e1> ."
Other
Comment:

1000	 <e0>Corticosteroids</e0> :  <e1>Dexamethasone</e1> :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1001	 <e0>Corticosteroids</e0> :  Dexamethasone :  <e1>Aprepitant</e1> , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1002	 <e0>Corticosteroids</e0> :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  <e1>dexamethasone</e1>  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1003	 <e0>Corticosteroids</e0> :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  <e1>Aprepitant</e1>  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1004	 <e0>Corticosteroids</e0> :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  <e1>dexamethasone</e1>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1005	 <e0>Corticosteroids</e0> :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1006	 Corticosteroids :  <e0>Dexamethasone</e0> :  <e1>Aprepitant</e1> , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1007	 Corticosteroids :  <e0>Dexamethasone</e0> :  Aprepitant , when given as a regimen of 125mg with  <e1>dexamethasone</e1>  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1008	 Corticosteroids :  <e0>Dexamethasone</e0> :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  <e1>Aprepitant</e1>  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1009	 Corticosteroids :  <e0>Dexamethasone</e0> :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  <e1>dexamethasone</e1>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1010	 Corticosteroids :  <e0>Dexamethasone</e0> :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1011	 Corticosteroids :  Dexamethasone :  <e0>Aprepitant</e0> , when given as a regimen of 125mg with  <e1>dexamethasone</e1>  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
mechanism(e0,e1)Comment:

1012	 Corticosteroids :  Dexamethasone :  <e0>Aprepitant</e0> , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  <e1>Aprepitant</e1>  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1013	 Corticosteroids :  Dexamethasone :  <e0>Aprepitant</e0> , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  <e1>dexamethasone</e1>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1014	 Corticosteroids :  Dexamethasone :  <e0>Aprepitant</e0> , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1015	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  <e0>dexamethasone</e0>  coadministered orally as 20 mg on Day 1, and  <e1>Aprepitant</e1>  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1016	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  <e0>dexamethasone</e0>  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  <e1>dexamethasone</e1>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1017	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  <e0>dexamethasone</e0>  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1018	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  <e0>Aprepitant</e0>  when given as 80 mg/day with  <e1>dexamethasone</e1>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  dexamethasone , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
mechanism(e0,e1)Comment:

1019	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  <e0>Aprepitant</e0>  when given as 80 mg/day with  dexamethasone  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1020	 Corticosteroids :  Dexamethasone :  Aprepitant , when given as a regimen of 125mg with  dexamethasone  coadministered orally as 20 mg on Day 1, and  Aprepitant  when given as 80 mg/day with  <e0>dexamethasone</e0>  coadministered orally as 8 mg on Days 2 through 5, increased the AUC of  <e1>dexamethasone</e1> , a CYP3A4 substrate by 2.2-fold, on Days 1 and 5."
Other
Comment:

1100	The oral  <e0>dexamethasone</e0>  doses should be reduced by approximately 50% when coadministered with  <e1>Aprepitant</e1> , to achieve exposures of  dexamethasone  similar to those obtained when it is given without  Aprepitant ."
advise(e0,e1)Comment:

1101	The oral  <e0>dexamethasone</e0>  doses should be reduced by approximately 50% when coadministered with  Aprepitant , to achieve exposures of  <e1>dexamethasone</e1>  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1102	The oral  <e0>dexamethasone</e0>  doses should be reduced by approximately 50% when coadministered with  Aprepitant , to achieve exposures of  dexamethasone  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1103	The oral  dexamethasone  doses should be reduced by approximately 50% when coadministered with  <e0>Aprepitant</e0> , to achieve exposures of  <e1>dexamethasone</e1>  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1104	The oral  dexamethasone  doses should be reduced by approximately 50% when coadministered with  <e0>Aprepitant</e0> , to achieve exposures of  dexamethasone  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1105	The oral  dexamethasone  doses should be reduced by approximately 50% when coadministered with  Aprepitant , to achieve exposures of  <e0>dexamethasone</e0>  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1200	The daily dose of  <e0>dexamethasone</e0>  administered in clinical studies with  <e1>Aprepitant</e1>  reflects an approximate 50% reduction of the dose of  dexamethasone ."
mechanism(e0,e1)Comment:

1201	The daily dose of  <e0>dexamethasone</e0>  administered in clinical studies with  Aprepitant  reflects an approximate 50% reduction of the dose of  <e1>dexamethasone</e1> ."
Other
Comment:

1202	The daily dose of  dexamethasone  administered in clinical studies with  <e0>Aprepitant</e0>  reflects an approximate 50% reduction of the dose of  <e1>dexamethasone</e1> ."
Other
Comment:

1400	 <e0>Aprepitant</e0> , when given as a regimen of 125 mg on Day 1 and 80 mg/day on Days 2 and 3, increased the AUC of  <e1>methylprednisolone</e1> , a CYP3A4 substrate, by 1.34-fold on Day 1 and by 2.5-fold on Day 3, when  methylprednisolone  was coadministered intravenously as 125 mg on Day 1 and orally as 40 mg on Days 2 and 3."
mechanism(e0,e1)Comment:

1401	 <e0>Aprepitant</e0> , when given as a regimen of 125 mg on Day 1 and 80 mg/day on Days 2 and 3, increased the AUC of  methylprednisolone , a CYP3A4 substrate, by 1.34-fold on Day 1 and by 2.5-fold on Day 3, when  <e1>methylprednisolone</e1>  was coadministered intravenously as 125 mg on Day 1 and orally as 40 mg on Days 2 and 3."
Other
Comment:

1402	 Aprepitant , when given as a regimen of 125 mg on Day 1 and 80 mg/day on Days 2 and 3, increased the AUC of  <e0>methylprednisolone</e0> , a CYP3A4 substrate, by 1.34-fold on Day 1 and by 2.5-fold on Day 3, when  <e1>methylprednisolone</e1>  was coadministered intravenously as 125 mg on Day 1 and orally as 40 mg on Days 2 and 3."
Other
Comment:

1500	The IV  <e0>methylprednisolone</e0>  dose should be reduced by approximately 25%, and the oral  <e1>methylprednisolone</e1>  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1501	The IV  <e0>methylprednisolone</e0>  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  <e1>Aprepitant</e1>  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  Aprepitant ."
advise(e0,e1)Comment:

1502	The IV  <e0>methylprednisolone</e0>  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  <e1>methylprednisolone</e1>  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1503	The IV  <e0>methylprednisolone</e0>  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1504	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  <e0>methylprednisolone</e0>  dose should be reduced by approximately 50% when coadministered with  <e1>Aprepitant</e1>  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  Aprepitant ."
advise(e0,e1)Comment:

1505	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  <e0>methylprednisolone</e0>  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  <e1>methylprednisolone</e1>  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1506	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  <e0>methylprednisolone</e0>  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1507	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  <e0>Aprepitant</e0>  to achieve exposures of  <e1>methylprednisolone</e1>  similar to those obtained when it is given without  Aprepitant ."
Other
Comment:

1508	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  <e0>Aprepitant</e0>  to achieve exposures of  methylprednisolone  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1509	The IV  methylprednisolone  dose should be reduced by approximately 25%, and the oral  methylprednisolone  dose should be reduced by approximately 50% when coadministered with  Aprepitant  to achieve exposures of  <e0>methylprednisolone</e0>  similar to those obtained when it is given without  <e1>Aprepitant</e1> ."
Other
Comment:

1600	 <e0>Warfarin</e0> : A single 125-mg dose of  <e1>Aprepitant</e1>  was administered on Day 1 and 80 mg/day on Days 2 and 3 to healthy subjects who were stabilized on chronic  warfarin  therapy."
Other
Comment:

1601	 <e0>Warfarin</e0> : A single 125-mg dose of  Aprepitant  was administered on Day 1 and 80 mg/day on Days 2 and 3 to healthy subjects who were stabilized on chronic  <e1>warfarin</e1>  therapy."
Other
Comment:

1602	 Warfarin : A single 125-mg dose of  <e0>Aprepitant</e0>  was administered on Day 1 and 80 mg/day on Days 2 and 3 to healthy subjects who were stabilized on chronic  <e1>warfarin</e1>  therapy."
Other
Comment:

1700	Although there was no effect of  <e0>Aprepitant</e0>  on the plasma AUC of  <e1>R(+) warfarin</e1>  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1701	Although there was no effect of  <e0>Aprepitant</e0>  on the plasma AUC of  R(+) warfarin  or  <e1>S(-) warfarin</e1>  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1702	Although there was no effect of  <e0>Aprepitant</e0>  on the plasma AUC of  R(+) warfarin  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  <e1>S(-)warfarin</e1>  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1703	Although there was no effect of  <e0>Aprepitant</e0>  on the plasma AUC of  R(+) warfarin  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  <e1>Aprepitant</e1> ."
Other
Comment:

1704	Although there was no effect of  Aprepitant  on the plasma AUC of  <e0>R(+) warfarin</e0>  or  <e1>S(-) warfarin</e1>  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1705	Although there was no effect of  Aprepitant  on the plasma AUC of  <e0>R(+) warfarin</e0>  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  <e1>S(-)warfarin</e1>  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1706	Although there was no effect of  Aprepitant  on the plasma AUC of  <e0>R(+) warfarin</e0>  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  <e1>Aprepitant</e1> ."
Other
Comment:

1707	Although there was no effect of  Aprepitant  on the plasma AUC of  R(+) warfarin  or  <e0>S(-) warfarin</e0>  determined on Day 3, there was a 34% decrease in  <e1>S(-)warfarin</e1>  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  Aprepitant ."
Other
Comment:

1708	Although there was no effect of  Aprepitant  on the plasma AUC of  R(+) warfarin  or  <e0>S(-) warfarin</e0>  determined on Day 3, there was a 34% decrease in  S(-)warfarin  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  <e1>Aprepitant</e1> ."
Other
Comment:

1709	Although there was no effect of  Aprepitant  on the plasma AUC of  R(+) warfarin  or  S(-) warfarin  determined on Day 3, there was a 34% decrease in  <e0>S(-)warfarin</e0>  (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with  <e1>Aprepitant</e1> ."
mechanism(e0,e1)Comment:

1800	In patients on chronic  <e0>warfarin</e0>  therapy, the prothrombin time (INR) should be closely monitored in the 2-week period, particularly at 7 to 10 days, following initiation of the 3-day regimen of  <e1>Aprepitant</e1>  with each chemotherapy cycle."
advise(e0,e1)Comment:

1900	 <e0>Tolbutamide</e0> :  <e1>Aprepitant</e1> , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1901	 <e0>Tolbutamide</e0> :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  <e1>tolbutamide</e1>  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1902	 <e0>Tolbutamide</e0> :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  <e1>tolbutamide</e1>  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1903	 <e0>Tolbutamide</e0> :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4,8, and 15."
Other
Comment:

1904	 Tolbutamide :  <e0>Aprepitant</e0> , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  <e1>tolbutamide</e1>  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1905	 Tolbutamide :  <e0>Aprepitant</e0> , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  <e1>tolbutamide</e1>  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1906	 Tolbutamide :  <e0>Aprepitant</e0> , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4,8, and 15."
Other
Comment:

1907	 Tolbutamide :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  <e0>tolbutamide</e0>  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  <e1>tolbutamide</e1>  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4,8, and 15."
Other
Comment:

1908	 Tolbutamide :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  <e0>tolbutamide</e0>  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  tolbutamide  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4,8, and 15."
Other
Comment:

1909	 Tolbutamide :  Aprepitant , when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of  tolbutamide  (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of  <e0>tolbutamide</e0>  500 mg was admini,stered orally prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4,8, and 15."
mechanism(e0,e1)Comment:

2000	Oral  <e0>contraceptives</e0> :  <e1>Aprepitant</e1> , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2001	Oral  <e0>contraceptives</e0> :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  <e1>contraceptive</e1>  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2002	Oral  <e0>contraceptives</e0> :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  <e1>ethinyl estradiol</e1>  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2003	Oral  <e0>contraceptives</e0> :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  <e1>norethindrone</e1> , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2004	Oral  <e0>contraceptives</e0> :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  <e1>ethinyl estradiol</e1>  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2005	Oral  <e0>contraceptives</e0> :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2006	Oral  contraceptives :  <e0>Aprepitant</e0> , when given once daily for 14 days as a 100-mg capsule with an oral  <e1>contraceptive</e1>  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2007	Oral  contraceptives :  <e0>Aprepitant</e0> , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  <e1>ethinyl estradiol</e1>  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
mechanism(e0,e1)Comment:

2008	Oral  contraceptives :  <e0>Aprepitant</e0> , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  <e1>norethindrone</e1> , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
mechanism(e0,e1)Comment:

2009	Oral  contraceptives :  <e0>Aprepitant</e0> , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  <e1>ethinyl estradiol</e1>  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2010	Oral  contraceptives :  <e0>Aprepitant</e0> , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2011	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  <e0>contraceptive</e0>  containing 35 mcg of  <e1>ethinyl estradiol</e1>  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2012	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  <e0>contraceptive</e0>  containing 35 mcg of  ethinyl estradiol  and 1 mg of  <e1>norethindrone</e1> , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2013	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  <e0>contraceptive</e0>  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  <e1>ethinyl estradiol</e1>  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2014	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  <e0>contraceptive</e0>  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2015	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  <e0>ethinyl estradiol</e0>  and 1 mg of  <e1>norethindrone</e1> , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2016	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  <e0>ethinyl estradiol</e0>  and 1 mg of  norethindrone , decreased the AUC of  <e1>ethinyl estradiol</e1>  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2017	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  <e0>ethinyl estradiol</e0>  and 1 mg of  norethindrone , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2018	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  <e0>norethindrone</e0> , decreased the AUC of  <e1>ethinyl estradiol</e1>  by 43%, and decreased the AUC of  norethindrone  by 8%;"
Other
Comment:

2019	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  <e0>norethindrone</e0> , decreased the AUC of  ethinyl estradiol  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2020	Oral  contraceptives :  Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral  contraceptive  containing 35 mcg of  ethinyl estradiol  and 1 mg of  norethindrone , decreased the AUC of  <e0>ethinyl estradiol</e0>  by 43%, and decreased the AUC of  <e1>norethindrone</e1>  by 8%;"
Other
Comment:

2100	therefore, the efficacy of oral  <e0>contraceptives</e0>  during administration of  <e1>Aprepitant</e1>  may be reduced."
effect(e0,e1)Comment:

2200	Although a 3-day regimen of  <e0>Aprepitant</e0>  given concomitantly with oral  <e1>contraceptives</e1>  has not been studied, alternative or back-up methods of contraception should be used."
advise(e0,e1)Comment:

2300	 <e0>Midazolam</e0> :  <e1>Aprepitant</e1>  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2301	 <e0>Midazolam</e0> :  Aprepitant  increased the AUC of  <e1>midazolam</e1> , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2302	 <e0>Midazolam</e0> :  Aprepitant  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  <e1>midazolam</e1>  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2303	 <e0>Midazolam</e0> :  Aprepitant  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  <e1>Aprepitant</e1>  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2304	 Midazolam :  <e0>Aprepitant</e0>  increased the AUC of  <e1>midazolam</e1> , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
mechanism(e0,e1)Comment:

2305	 Midazolam :  <e0>Aprepitant</e0>  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  <e1>midazolam</e1>  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2306	 Midazolam :  <e0>Aprepitant</e0>  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  <e1>Aprepitant</e1>  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2307	 Midazolam :  Aprepitant  increased the AUC of  <e0>midazolam</e0> , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  <e1>midazolam</e1>  2 mg was coadministered on Day 1 and Day 5 of a regimen of  Aprepitant  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2308	 Midazolam :  Aprepitant  increased the AUC of  <e0>midazolam</e0> , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  midazolam  2 mg was coadministered on Day 1 and Day 5 of a regimen of  <e1>Aprepitant</e1>  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2309	 Midazolam :  Aprepitant  increased the AUC of  midazolam , a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of  <e0>midazolam</e0>  2 mg was coadministered on Day 1 and Day 5 of a regimen of  <e1>Aprepitant</e1>  125 mg on Day 1 and 80 mg/day on Days 2 through 5."
Other
Comment:

2400	The potential effects of increased plasma concentrations of  <e0>midazolam</e0>  or other  <e1>benzodiazepines</e1>  metabolized via CYP3A4 ( alprazolam ,  triazolam ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2401	The potential effects of increased plasma concentrations of  <e0>midazolam</e0>  or other  benzodiazepines  metabolized via CYP3A4 ( <e1>alprazolam</e1> ,  triazolam ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2402	The potential effects of increased plasma concentrations of  <e0>midazolam</e0>  or other  benzodiazepines  metabolized via CYP3A4 ( alprazolam ,  <e1>triazolam</e1> ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2403	The potential effects of increased plasma concentrations of  <e0>midazolam</e0>  or other  benzodiazepines  metabolized via CYP3A4 ( alprazolam ,  triazolam ) should be considered when coadministering these agents with  <e1>Aprepitant</e1> ."
advise(e0,e1)Comment:

2404	The potential effects of increased plasma concentrations of  midazolam  or other  <e0>benzodiazepines</e0>  metabolized via CYP3A4 ( <e1>alprazolam</e1> ,  triazolam ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2405	The potential effects of increased plasma concentrations of  midazolam  or other  <e0>benzodiazepines</e0>  metabolized via CYP3A4 ( alprazolam ,  <e1>triazolam</e1> ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2406	The potential effects of increased plasma concentrations of  midazolam  or other  <e0>benzodiazepines</e0>  metabolized via CYP3A4 ( alprazolam ,  triazolam ) should be considered when coadministering these agents with  <e1>Aprepitant</e1> ."
advise(e0,e1)Comment:

2407	The potential effects of increased plasma concentrations of  midazolam  or other  benzodiazepines  metabolized via CYP3A4 ( <e0>alprazolam</e0> ,  <e1>triazolam</e1> ) should be considered when coadministering these agents with  Aprepitant ."
Other
Comment:

2408	The potential effects of increased plasma concentrations of  midazolam  or other  benzodiazepines  metabolized via CYP3A4 ( <e0>alprazolam</e0> ,  triazolam ) should be considered when coadministering these agents with  <e1>Aprepitant</e1> ."
advise(e0,e1)Comment:

2409	The potential effects of increased plasma concentrations of  midazolam  or other  benzodiazepines  metabolized via CYP3A4 ( alprazolam ,  <e0>triazolam</e0> ) should be considered when coadministering these agents with  <e1>Aprepitant</e1> ."
advise(e0,e1)Comment:

2500	In another study with intravenous administration of  <e0>midazolam</e0> ,  <e1>Aprepitant</e1>  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  midazolam  2 mg IV was given prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4, 8, and 15."
Other
Comment:

2501	In another study with intravenous administration of  <e0>midazolam</e0> ,  Aprepitant  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  <e1>midazolam</e1>  2 mg IV was given prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4, 8, and 15."
Other
Comment:

2502	In another study with intravenous administration of  <e0>midazolam</e0> ,  Aprepitant  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  midazolam  2 mg IV was given prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4, 8, and 15."
Other
Comment:

2503	In another study with intravenous administration of  midazolam ,  <e0>Aprepitant</e0>  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  <e1>midazolam</e1>  2 mg IV was given prior to the administration of the 3-day regimen of  Aprepitant  and on Days 4, 8, and 15."
Other
Comment:

2504	In another study with intravenous administration of  midazolam ,  <e0>Aprepitant</e0>  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  midazolam  2 mg IV was given prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4, 8, and 15."
Other
Comment:

2505	In another study with intravenous administration of  midazolam ,  Aprepitant  was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and  <e0>midazolam</e0>  2 mg IV was given prior to the administration of the 3-day regimen of  <e1>Aprepitant</e1>  and on Days 4, 8, and 15."
Other
Comment:

2600	 <e0>Aprepitant</e0>  increased the AUC of  <e1>midazolam</e1>  by 25% on Day 4 and decreased the AUC of  midazolam  by 19% on Day 8 relative to the dosing of  Aprepitant  on Days 1 through 3."
mechanism(e0,e1)Comment:

2601	 <e0>Aprepitant</e0>  increased the AUC of  midazolam  by 25% on Day 4 and decreased the AUC of  <e1>midazolam</e1>  by 19% on Day 8 relative to the dosing of  Aprepitant  on Days 1 through 3."
mechanism(e0,e1)Comment:

2602	 <e0>Aprepitant</e0>  increased the AUC of  midazolam  by 25% on Day 4 and decreased the AUC of  midazolam  by 19% on Day 8 relative to the dosing of  <e1>Aprepitant</e1>  on Days 1 through 3."
Other
Comment:

2603	 Aprepitant  increased the AUC of  <e0>midazolam</e0>  by 25% on Day 4 and decreased the AUC of  <e1>midazolam</e1>  by 19% on Day 8 relative to the dosing of  Aprepitant  on Days 1 through 3."
Other
Comment:

2604	 Aprepitant  increased the AUC of  <e0>midazolam</e0>  by 25% on Day 4 and decreased the AUC of  midazolam  by 19% on Day 8 relative to the dosing of  <e1>Aprepitant</e1>  on Days 1 through 3."
Other
Comment:

2605	 Aprepitant  increased the AUC of  midazolam  by 25% on Day 4 and decreased the AUC of  <e0>midazolam</e0>  by 19% on Day 8 relative to the dosing of  <e1>Aprepitant</e1>  on Days 1 through 3."
Other
Comment:

3100	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that inhibit CYP3A4 activity may result in increased plasma concentrations of  <e1>aprepitant</e1> ."
Other
Comment:

3200	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  <e1>ketoconazole</e1> ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3201	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e1>itraconazole</e1> ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3202	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  <e1>nefazodone</e1> ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3203	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  <e1>troleandomycin</e1> ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3204	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  <e1>clarithromycin</e1> ,  ritonavir ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3205	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
advise(e0,e1)Comment:

3206	Consequently, concomitant administration of  <e0>Aprepitant</e0>  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
advise(e0,e1)Comment:

3207	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  <e1>itraconazole</e1> ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3208	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  itraconazole ,  <e1>nefazodone</e1> ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3209	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  itraconazole ,  nefazodone ,  <e1>troleandomycin</e1> ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3210	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  itraconazole ,  nefazodone ,  troleandomycin ,  <e1>clarithromycin</e1> ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3211	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
Other
Comment:

3212	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  <e0>ketoconazole</e0> ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3213	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e0>itraconazole</e0> ,  <e1>nefazodone</e1> ,  troleandomycin ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3214	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e0>itraconazole</e0> ,  nefazodone ,  <e1>troleandomycin</e1> ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3215	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e0>itraconazole</e0> ,  nefazodone ,  troleandomycin ,  <e1>clarithromycin</e1> ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3216	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e0>itraconazole</e0> ,  nefazodone ,  troleandomycin ,  clarithromycin ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
Other
Comment:

3217	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  <e0>itraconazole</e0> ,  nefazodone ,  troleandomycin ,  clarithromycin ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3218	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  <e0>nefazodone</e0> ,  <e1>troleandomycin</e1> ,  clarithromycin ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3219	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  <e0>nefazodone</e0> ,  troleandomycin ,  <e1>clarithromycin</e1> ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3220	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  <e0>nefazodone</e0> ,  troleandomycin ,  clarithromycin ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
Other
Comment:

3221	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  <e0>nefazodone</e0> ,  troleandomycin ,  clarithromycin ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3222	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  <e0>troleandomycin</e0> ,  <e1>clarithromycin</e1> ,  ritonavir ,  nelfinavir ) should be approached with caution."
Other
Comment:

3223	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  <e0>troleandomycin</e0> ,  clarithromycin ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
Other
Comment:

3224	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  <e0>troleandomycin</e0> ,  clarithromycin ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3225	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  <e0>clarithromycin</e0> ,  <e1>ritonavir</e1> ,  nelfinavir ) should be approached with caution."
Other
Comment:

3226	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  <e0>clarithromycin</e0> ,  ritonavir ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3227	Consequently, concomitant administration of  Aprepitant  with strong CYP3A4 inhibitors (e.g.,  ketoconazole ,  itraconazole ,  nefazodone ,  troleandomycin ,  clarithromycin ,  <e0>ritonavir</e0> ,  <e1>nelfinavir</e1> ) should be approached with caution."
Other
Comment:

3300	Because moderate CYP3A4 inhibitors (e.g.,  <e0>diltiazem</e0> ) result in 2-fold increase in plasma concentrations of  <e1>aprepitant</e1> , concomitant administration should also be approached with caution."
advise(e0,e1)Comment:

3500	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that strongly induce CYP3A4 activity (e.g.,  <e1>rifampin</e1> ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
mechanism(e0,e1)Comment:

3501	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  <e1>carbamazepine</e1> ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3502	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  <e1>phenytoin</e1> ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
mechanism(e0,e1)Comment:

3503	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  <e1>aprepitant</e1>  that may result in decreased efficacy of  Aprepitant ."
mechanism(e0,e1)Comment:

3504	therefore, coadministration of  <e0>Aprepitant</e0>  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

3505	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  <e0>rifampin</e0> ,  <e1>carbamazepine</e1> ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3506	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  <e0>rifampin</e0> ,  carbamazepine ,  <e1>phenytoin</e1> ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3507	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  <e0>rifampin</e0> ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  <e1>aprepitant</e1>  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3508	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  <e0>rifampin</e0> ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

3509	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  <e0>carbamazepine</e0> ,  <e1>phenytoin</e1> ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3510	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  <e0>carbamazepine</e0> ,  phenytoin ) may result in reduced plasma concentrations of  <e1>aprepitant</e1>  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3511	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  <e0>carbamazepine</e0> ,  phenytoin ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

3512	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  <e0>phenytoin</e0> ) may result in reduced plasma concentrations of  <e1>aprepitant</e1>  that may result in decreased efficacy of  Aprepitant ."
Other
Comment:

3513	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  <e0>phenytoin</e0> ) may result in reduced plasma concentrations of  aprepitant  that may result in decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

3514	therefore, coadministration of  Aprepitant  with drugs that strongly induce CYP3A4 activity (e.g.,  rifampin ,  carbamazepine ,  phenytoin ) may result in reduced plasma concentrations of  <e0>aprepitant</e0>  that may result in decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

3600	 <e0>Ketoconazole</e0> : When a single 125-mg dose of  <e1>Aprepitant</e1>  was administered on Day5 of a"
Other
Comment:

3700	 <e0>Ketoconazole</e0> : When a single 125-mg dose of  <e1>Aprepitant</e1>  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
Other
Comment:

3701	 <e0>Ketoconazole</e0> : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  <e1>ketoconazole</e1> , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
Other
Comment:

3702	 <e0>Ketoconazole</e0> : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  <e1>aprepitant</e1>  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
Other
Comment:

3703	 <e0>Ketoconazole</e0> : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  <e1>aprepitant</e1>  increased approximately 3-fold."
Other
Comment:

3704	 Ketoconazole : When a single 125-mg dose of  <e0>Aprepitant</e0>  was administered on Day5 of a 10-day regimen of 400 mg/day of  <e1>ketoconazole</e1> , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
mechanism(e0,e1)Comment:

3705	 Ketoconazole : When a single 125-mg dose of  <e0>Aprepitant</e0>  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  <e1>aprepitant</e1>  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
Other
Comment:

3706	 Ketoconazole : When a single 125-mg dose of  <e0>Aprepitant</e0>  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  <e1>aprepitant</e1>  increased approximately 3-fold."
Other
Comment:

3707	 Ketoconazole : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  <e0>ketoconazole</e0> , a strong CYP3A4 inhibitor, the AUC of  <e1>aprepitant</e1>  increased approximately 5-fold and the mean terminal half-life of  aprepitant  increased approximately 3-fold."
Other
Comment:

3708	 Ketoconazole : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  <e0>ketoconazole</e0> , a strong CYP3A4 inhibitor, the AUC of  aprepitant  increased approximately 5-fold and the mean terminal half-life of  <e1>aprepitant</e1>  increased approximately 3-fold."
Other
Comment:

3709	 Ketoconazole : When a single 125-mg dose of  Aprepitant  was administered on Day5 of a 10-day regimen of 400 mg/day of  ketoconazole , a strong CYP3A4 inhibitor, the AUC of  <e0>aprepitant</e0>  increased approximately 5-fold and the mean terminal half-life of  <e1>aprepitant</e1>  increased approximately 3-fold."
Other
Comment:

3900	 <e0>Rifampin</e0> : When a single 375-mg dose of  <e1>Aprepitant</e1>  was administered on Day9 of a 14-day regimen of 600 mg/day of  rifampin , a strong CYP3A4 inducer, the AUC of  aprepitant  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
Other
Comment:

3901	 <e0>Rifampin</e0> : When a single 375-mg dose of  Aprepitant  was administered on Day9 of a 14-day regimen of 600 mg/day of  <e1>rifampin</e1> , a strong CYP3A4 inducer, the AUC of  aprepitant  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
Other
Comment:

3902	 <e0>Rifampin</e0> : When a single 375-mg dose of  Aprepitant  was administered on Day9 of a 14-day regimen of 600 mg/day of  rifampin , a strong CYP3A4 inducer, the AUC of  <e1>aprepitant</e1>  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
Other
Comment:

3903	 Rifampin : When a single 375-mg dose of  <e0>Aprepitant</e0>  was administered on Day9 of a 14-day regimen of 600 mg/day of  <e1>rifampin</e1> , a strong CYP3A4 inducer, the AUC of  aprepitant  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
mechanism(e0,e1)Comment:

3904	 Rifampin : When a single 375-mg dose of  <e0>Aprepitant</e0>  was administered on Day9 of a 14-day regimen of 600 mg/day of  rifampin , a strong CYP3A4 inducer, the AUC of  <e1>aprepitant</e1>  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
Other
Comment:

3905	 Rifampin : When a single 375-mg dose of  Aprepitant  was administered on Day9 of a 14-day regimen of 600 mg/day of  <e0>rifampin</e0> , a strong CYP3A4 inducer, the AUC of  <e1>aprepitant</e1>  decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold."
Other
Comment:

4000	Coadministration of  <e0>Aprepitant</e0>  with drugs that induce CYP3A4 activity may result in reduced plasma concentrations and decreased efficacy of  <e1>Aprepitant</e1> ."
Other
Comment:

4200	 <e0>Diltiazem</e0> : In patients with mild to moderate hypertension, administration of  <e1>aprepitant</e1>  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
Other
Comment:

4201	 <e0>Diltiazem</e0> : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  <e1>diltiazem</e1>  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
Other
Comment:

4202	 <e0>Diltiazem</e0> : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  <e1>aprepitant</e1>  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
Other
Comment:

4203	 <e0>Diltiazem</e0> : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  <e1>diltiazem</e1>  AUC."
Other
Comment:

4204	 Diltiazem : In patients with mild to moderate hypertension, administration of  <e0>aprepitant</e0>  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  <e1>diltiazem</e1>  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
mechanism(e0,e1)Comment:

4205	 Diltiazem : In patients with mild to moderate hypertension, administration of  <e0>aprepitant</e0>  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  <e1>aprepitant</e1>  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
Other
Comment:

4206	 Diltiazem : In patients with mild to moderate hypertension, administration of  <e0>aprepitant</e0>  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  <e1>diltiazem</e1>  AUC."
Other
Comment:

4207	 Diltiazem : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  <e0>diltiazem</e0>  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  <e1>aprepitant</e1>  AUC and a simultaneous 1.7-fold increase of  diltiazem  AUC."
Other
Comment:

4208	 Diltiazem : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  <e0>diltiazem</e0>  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  aprepitant  AUC and a simultaneous 1.7-fold increase of  <e1>diltiazem</e1>  AUC."
Other
Comment:

4209	 Diltiazem : In patients with mild to moderate hypertension, administration of  aprepitant  once daily, as a tablet formulation comparable to 230 mg of the capsule formulation, with  diltiazem  120 mg 3 times daily for 5 days, resulted in a 2-fold increase of  <e0>aprepitant</e0>  AUC and a simultaneous 1.7-fold increase of  <e1>diltiazem</e1>  AUC."
Other
Comment:

4400	 <e0>Paroxetine</e0> : Coadministration of once daily doses of  <e1>aprepitant</e1> , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  paroxetine ."
Other
Comment:

4401	 <e0>Paroxetine</e0> : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  <e1>paroxetine</e1>  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  paroxetine ."
Other
Comment:

4402	 <e0>Paroxetine</e0> : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  <e1>aprepitant</e1>  and  paroxetine ."
Other
Comment:

4403	 <e0>Paroxetine</e0> : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  <e1>paroxetine</e1> ."
Other
Comment:

4404	 Paroxetine : Coadministration of once daily doses of  <e0>aprepitant</e0> , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  <e1>paroxetine</e1>  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  paroxetine ."
mechanism(e0,e1)Comment:

4405	 Paroxetine : Coadministration of once daily doses of  <e0>aprepitant</e0> , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  <e1>aprepitant</e1>  and  paroxetine ."
Other
Comment:

4406	 Paroxetine : Coadministration of once daily doses of  <e0>aprepitant</e0> , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  <e1>paroxetine</e1> ."
Other
Comment:

4407	 Paroxetine : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  <e0>paroxetine</e0>  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  <e1>aprepitant</e1>  and  paroxetine ."
Other
Comment:

4408	 Paroxetine : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  <e0>paroxetine</e0>  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  aprepitant  and  <e1>paroxetine</e1> ."
Other
Comment:

4409	 Paroxetine : Coadministration of once daily doses of  aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with  paroxetine  20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both  <e0>aprepitant</e0>  and  <e1>paroxetine</e1> ."
Other
Comment:


100	 <e0>Beta-adrenergic blocking agents</e0> : concurrent use may blunt the response to  <e1>arbutamine</e1> ."
Other
Comment:

200	 <e0>Beta-adrenergic blocking agents</e0>  should be withdrawn at least 48 hours before conducting an  <e1>arbutamine</e1> -mediated stress test."
advise(e0,e1)Comment:

300	 <e0>Antiarrhythmic agents, class I</e0>  (such as  <e1>flecainide</e1> ,  lidocaine , or  quinidine ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

301	 <e0>Antiarrhythmic agents, class I</e0>  (such as  flecainide ,  <e1>lidocaine</e1> , or  quinidine ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

302	 <e0>Antiarrhythmic agents, class I</e0>  (such as  flecainide ,  lidocaine , or  <e1>quinidine</e1> ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

303	 <e0>Antiarrhythmic agents, class I</e0>  (such as  flecainide ,  lidocaine , or  quinidine ): concurrent use with  <e1>arbutamine</e1>  may have a proarrhythmic effect."
Other
Comment:

304	 Antiarrhythmic agents, class I  (such as  <e0>flecainide</e0> ,  <e1>lidocaine</e1> , or  quinidine ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

305	 Antiarrhythmic agents, class I  (such as  <e0>flecainide</e0> ,  lidocaine , or  <e1>quinidine</e1> ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

306	 Antiarrhythmic agents, class I  (such as  <e0>flecainide</e0> ,  lidocaine , or  quinidine ): concurrent use with  <e1>arbutamine</e1>  may have a proarrhythmic effect."
Other
Comment:

307	 Antiarrhythmic agents, class I  (such as  flecainide ,  <e0>lidocaine</e0> , or  <e1>quinidine</e1> ): concurrent use with  arbutamine  may have a proarrhythmic effect."
Other
Comment:

308	 Antiarrhythmic agents, class I  (such as  flecainide ,  <e0>lidocaine</e0> , or  quinidine ): concurrent use with  <e1>arbutamine</e1>  may have a proarrhythmic effect."
Other
Comment:

309	 Antiarrhythmic agents, class I  (such as  flecainide ,  lidocaine , or  <e0>quinidine</e0> ): concurrent use with  <e1>arbutamine</e1>  may have a proarrhythmic effect."
Other
Comment:

400	 <e0>Antidepressants</e0>  ( <e1>tricyclic</e1> ),  atropine  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

401	 <e0>Antidepressants</e0>  ( tricyclic ),  <e1>atropine</e1>  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

402	 <e0>Antidepressants</e0>  ( tricyclic ),  atropine  or other  <e1>anticholinergic agents</e1> , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

403	 <e0>Antidepressants</e0>  ( tricyclic ),  atropine  or other  anticholinergic agents , or  <e1>digitalis glycosides</e1> : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

404	 <e0>Antidepressants</e0>  ( tricyclic ),  atropine  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  <e1>arbutamine</e1>  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

405	 Antidepressants  ( <e0>tricyclic</e0> ),  <e1>atropine</e1>  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

406	 Antidepressants  ( <e0>tricyclic</e0> ),  atropine  or other  <e1>anticholinergic agents</e1> , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

407	 Antidepressants  ( <e0>tricyclic</e0> ),  atropine  or other  anticholinergic agents , or  <e1>digitalis glycosides</e1> : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

408	 Antidepressants  ( <e0>tricyclic</e0> ),  atropine  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  <e1>arbutamine</e1>  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

409	 Antidepressants  ( tricyclic ),  <e0>atropine</e0>  or other  <e1>anticholinergic agents</e1> , or  digitalis glycosides : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

410	 Antidepressants  ( tricyclic ),  <e0>atropine</e0>  or other  anticholinergic agents , or  <e1>digitalis glycosides</e1> : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

411	 Antidepressants  ( tricyclic ),  <e0>atropine</e0>  or other  anticholinergic agents , or  digitalis glycosides : concurrent use with  <e1>arbutamine</e1>  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

412	 Antidepressants  ( tricyclic ),  atropine  or other  <e0>anticholinergic agents</e0> , or  <e1>digitalis glycosides</e1> : concurrent use with  arbutamine  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

413	 Antidepressants  ( tricyclic ),  atropine  or other  <e0>anticholinergic agents</e0> , or  digitalis glycosides : concurrent use with  <e1>arbutamine</e1>  may produce additive inotropic and/or chronotropic effects."
Other
Comment:

414	 Antidepressants  ( tricyclic ),  atropine  or other  anticholinergic agents , or  <e0>digitalis glycosides</e0> : concurrent use with  <e1>arbutamine</e1>  may produce additive inotropic and/or chronotropic effects."
Other
Comment:


100	 <e0>Anticoagulants</e0>  including coumarin derivatives, indandione derivatives, and  <e1>platelet aggregation inhibitors</e1>  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

101	 <e0>Anticoagulants</e0>  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  <e1>nonsteroidal anti-inflammatory drugs</e1>  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

102	 <e0>Anticoagulants</e0>  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( <e1>NSAIDs</e1> ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

103	 <e0>Anticoagulants</e0>  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  <e1>aspirin</e1>  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

104	 <e0>Anticoagulants</e0>  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  <e1>ardeparin</e1> ."
effect(e0,e1)Comment:

105	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  <e0>platelet aggregation inhibitors</e0>  such as  <e1>nonsteroidal anti-inflammatory drugs</e1>  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

106	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  <e0>platelet aggregation inhibitors</e0>  such as  nonsteroidal anti-inflammatory drugs  ( <e1>NSAIDs</e1> ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

107	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  <e0>platelet aggregation inhibitors</e0>  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  <e1>aspirin</e1>  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

108	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  <e0>platelet aggregation inhibitors</e0>  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  <e1>ardeparin</e1> ."
effect(e0,e1)Comment:

109	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  <e0>nonsteroidal anti-inflammatory drugs</e0>  ( <e1>NSAIDs</e1> ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

110	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  <e0>nonsteroidal anti-inflammatory drugs</e0>  ( NSAIDs ), and  <e1>aspirin</e1>  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

111	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  <e0>nonsteroidal anti-inflammatory drugs</e0>  ( NSAIDs ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  <e1>ardeparin</e1> ."
effect(e0,e1)Comment:

112	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( <e0>NSAIDs</e0> ), and  <e1>aspirin</e1>  may increase the risk of bleeding when administered concomitantly with  ardeparin ."
Other
Comment:

113	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( <e0>NSAIDs</e0> ), and  aspirin  may increase the risk of bleeding when administered concomitantly with  <e1>ardeparin</e1> ."
effect(e0,e1)Comment:

114	 Anticoagulants  including coumarin derivatives, indandione derivatives, and  platelet aggregation inhibitors  such as  nonsteroidal anti-inflammatory drugs  ( NSAIDs ), and  <e0>aspirin</e0>  may increase the risk of bleeding when administered concomitantly with  <e1>ardeparin</e1> ."
effect(e0,e1)Comment:


100	If additional  <e0>adrenergic drugs</e0>  are to be administered by any route, they should be used with caution because the pharmacologically predictable sympathetic effects of  <e1>BROVANA</e1>  may be potentiated."
advise(e0,e1)Comment:

200	When  <e0>paroxetine</e0> , a potent inhibitor of CYP2D6, was co-administered with  <e1>BROVANA</e1>  at steady-state, exposure to either drug was not altered."
Other
Comment:

400	Concomitant treatment with  <e0>methylxanthines</e0>  ( <e1>aminophylline</e1> ,  theophylline ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

401	Concomitant treatment with  <e0>methylxanthines</e0>  ( aminophylline ,  <e1>theophylline</e1> ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

402	Concomitant treatment with  <e0>methylxanthines</e0>  ( aminophylline ,  theophylline ),  <e1>steroids</e1> , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

403	Concomitant treatment with  <e0>methylxanthines</e0>  ( aminophylline ,  theophylline ),  steroids , or  <e1>diuretics</e1>  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

404	Concomitant treatment with  <e0>methylxanthines</e0>  ( aminophylline ,  theophylline ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  <e1>adrenergic agonists</e1> ."
effect(e0,e1)Comment:

405	Concomitant treatment with  methylxanthines  ( <e0>aminophylline</e0> ,  <e1>theophylline</e1> ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

406	Concomitant treatment with  methylxanthines  ( <e0>aminophylline</e0> ,  theophylline ),  <e1>steroids</e1> , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

407	Concomitant treatment with  methylxanthines  ( <e0>aminophylline</e0> ,  theophylline ),  steroids , or  <e1>diuretics</e1>  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

408	Concomitant treatment with  methylxanthines  ( <e0>aminophylline</e0> ,  theophylline ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  <e1>adrenergic agonists</e1> ."
effect(e0,e1)Comment:

409	Concomitant treatment with  methylxanthines  ( aminophylline ,  <e0>theophylline</e0> ),  <e1>steroids</e1> , or  diuretics  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

410	Concomitant treatment with  methylxanthines  ( aminophylline ,  <e0>theophylline</e0> ),  steroids , or  <e1>diuretics</e1>  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

411	Concomitant treatment with  methylxanthines  ( aminophylline ,  <e0>theophylline</e0> ),  steroids , or  diuretics  may potentiate any hypokalemic effect of  <e1>adrenergic agonists</e1> ."
effect(e0,e1)Comment:

412	Concomitant treatment with  methylxanthines  ( aminophylline ,  theophylline ),  <e0>steroids</e0> , or  <e1>diuretics</e1>  may potentiate any hypokalemic effect of  adrenergic agonists ."
Other
Comment:

413	Concomitant treatment with  methylxanthines  ( aminophylline ,  theophylline ),  <e0>steroids</e0> , or  diuretics  may potentiate any hypokalemic effect of  <e1>adrenergic agonists</e1> ."
effect(e0,e1)Comment:

414	Concomitant treatment with  methylxanthines  ( aminophylline ,  theophylline ),  steroids , or  <e0>diuretics</e0>  may potentiate any hypokalemic effect of  <e1>adrenergic agonists</e1> ."
effect(e0,e1)Comment:

500	The ECG changes and/or hypokalemia that may result from the administration of  <e0>non-potassium sparing diuretics</e0>  (such as  <e1>loop diuretics</e1>  or  thiazide diuretics ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  beta-agonist  is exceeded."
Other
Comment:

501	The ECG changes and/or hypokalemia that may result from the administration of  <e0>non-potassium sparing diuretics</e0>  (such as  loop diuretics  or  <e1>thiazide diuretics</e1> ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  beta-agonist  is exceeded."
Other
Comment:

502	The ECG changes and/or hypokalemia that may result from the administration of  <e0>non-potassium sparing diuretics</e0>  (such as  loop diuretics  or  thiazide diuretics ) can be acutely worsened by  <e1>beta-agonists</e1> , especially when the recommended dose of the  beta-agonist  is exceeded."
effect(e0,e1)Comment:

503	The ECG changes and/or hypokalemia that may result from the administration of  <e0>non-potassium sparing diuretics</e0>  (such as  loop diuretics  or  thiazide diuretics ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  <e1>beta-agonist</e1>  is exceeded."
Other
Comment:

504	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  <e0>loop diuretics</e0>  or  <e1>thiazide diuretics</e1> ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  beta-agonist  is exceeded."
Other
Comment:

505	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  <e0>loop diuretics</e0>  or  thiazide diuretics ) can be acutely worsened by  <e1>beta-agonists</e1> , especially when the recommended dose of the  beta-agonist  is exceeded."
effect(e0,e1)Comment:

506	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  <e0>loop diuretics</e0>  or  thiazide diuretics ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  <e1>beta-agonist</e1>  is exceeded."
Other
Comment:

507	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  loop diuretics  or  <e0>thiazide diuretics</e0> ) can be acutely worsened by  <e1>beta-agonists</e1> , especially when the recommended dose of the  beta-agonist  is exceeded."
effect(e0,e1)Comment:

508	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  loop diuretics  or  <e0>thiazide diuretics</e0> ) can be acutely worsened by  beta-agonists , especially when the recommended dose of the  <e1>beta-agonist</e1>  is exceeded."
Other
Comment:

509	The ECG changes and/or hypokalemia that may result from the administration of  non-potassium sparing diuretics  (such as  loop diuretics  or  thiazide diuretics ) can be acutely worsened by  <e0>beta-agonists</e0> , especially when the recommended dose of the  <e1>beta-agonist</e1>  is exceeded."
Other
Comment:

600	Although the clinical significance of these effects is not known, caution is advised in the co-administration of  <e0>beta-agonists</e0>  with  <e1>non-potassium sparing diuretics</e1> ."
advise(e0,e1)Comment:

700	 <e0>BROVANA</e0> , as with other  <e1>beta2-agonists</e1> , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
Other
Comment:

701	 <e0>BROVANA</e0> , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  <e1>monoamine oxidase inhibitors</e1> ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
advise(e0,e1)Comment:

702	 <e0>BROVANA</e0> , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  <e1>tricyclic antidepressants</e1> , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
advise(e0,e1)Comment:

703	 <e0>BROVANA</e0> , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  <e1>adrenergic agonists</e1>  on the cardiovascular system may be potentiated by these agents."
Other
Comment:

704	 BROVANA , as with other  <e0>beta2-agonists</e0> , should be administered with extreme caution to patients being treated with  <e1>monoamine oxidase inhibitors</e1> ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
advise(e0,e1)Comment:

705	 BROVANA , as with other  <e0>beta2-agonists</e0> , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  <e1>tricyclic antidepressants</e1> , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
advise(e0,e1)Comment:

706	 BROVANA , as with other  <e0>beta2-agonists</e0> , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  <e1>adrenergic agonists</e1>  on the cardiovascular system may be potentiated by these agents."
Other
Comment:

707	 BROVANA , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  <e0>monoamine oxidase inhibitors</e0> ,  <e1>tricyclic antidepressants</e1> , or drugs known to prolong the QTc interval because the action of  adrenergic agonists  on the cardiovascular system may be potentiated by these agents."
Other
Comment:

708	 BROVANA , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  <e0>monoamine oxidase inhibitors</e0> ,  tricyclic antidepressants , or drugs known to prolong the QTc interval because the action of  <e1>adrenergic agonists</e1>  on the cardiovascular system may be potentiated by these agents."
effect(e0,e1)Comment:

709	 BROVANA , as with other  beta2-agonists , should be administered with extreme caution to patients being treated with  monoamine oxidase inhibitors ,  <e0>tricyclic antidepressants</e0> , or drugs known to prolong the QTc interval because the action of  <e1>adrenergic agonists</e1>  on the cardiovascular system may be potentiated by these agents."
effect(e0,e1)Comment:

900	The concurrent use of intravenously or orally administered  <e0>methylxanthines</e0>  (e.g.,  <e1>aminophylline</e1> ,  theophylline ) by patients receiving  BROVANA  has not been completely evaluated."
Other
Comment:

901	The concurrent use of intravenously or orally administered  <e0>methylxanthines</e0>  (e.g.,  aminophylline ,  <e1>theophylline</e1> ) by patients receiving  BROVANA  has not been completely evaluated."
Other
Comment:

902	The concurrent use of intravenously or orally administered  <e0>methylxanthines</e0>  (e.g.,  aminophylline ,  theophylline ) by patients receiving  <e1>BROVANA</e1>  has not been completely evaluated."
Other
Comment:

903	The concurrent use of intravenously or orally administered  methylxanthines  (e.g.,  <e0>aminophylline</e0> ,  <e1>theophylline</e1> ) by patients receiving  BROVANA  has not been completely evaluated."
Other
Comment:

904	The concurrent use of intravenously or orally administered  methylxanthines  (e.g.,  <e0>aminophylline</e0> ,  theophylline ) by patients receiving  <e1>BROVANA</e1>  has not been completely evaluated."
Other
Comment:

905	The concurrent use of intravenously or orally administered  methylxanthines  (e.g.,  aminophylline ,  <e0>theophylline</e0> ) by patients receiving  <e1>BROVANA</e1>  has not been completely evaluated."
Other
Comment:

1000	In two combined 12-week placebo controlled trials that included  <e0>BROVANA</e0>  doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873  <e1>BROVANA</e1>  -treated subjects received concomitant  theophylline  at study entry."
Other
Comment:

1001	In two combined 12-week placebo controlled trials that included  <e0>BROVANA</e0>  doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873  BROVANA  -treated subjects received concomitant  <e1>theophylline</e1>  at study entry."
Other
Comment:

1002	In two combined 12-week placebo controlled trials that included  BROVANA  doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873  <e0>BROVANA</e0>  -treated subjects received concomitant  <e1>theophylline</e1>  at study entry."
Other
Comment:

1100	In a 12-month controlled trial that included a 50 mcg once daily  <e0>BROVANA</e0>  dose, 30 of the 528  <e1>BROVANA</e1>  -treated subjects received concomitant  theophylline  at study entry."
Other
Comment:

1101	In a 12-month controlled trial that included a 50 mcg once daily  <e0>BROVANA</e0>  dose, 30 of the 528  BROVANA  -treated subjects received concomitant  <e1>theophylline</e1>  at study entry."
Other
Comment:

1102	In a 12-month controlled trial that included a 50 mcg once daily  BROVANA  dose, 30 of the 528  <e0>BROVANA</e0>  -treated subjects received concomitant  <e1>theophylline</e1>  at study entry."
Other
Comment:

1300	 <e0>Beta-adrenergic receptor antagonists</e0>  ( <e1>beta-blockers</e1> ) and  BROVANA  may interfere with the effect of each other when administered concurrently."
Other
Comment:

1301	 <e0>Beta-adrenergic receptor antagonists</e0>  ( beta-blockers ) and  <e1>BROVANA</e1>  may interfere with the effect of each other when administered concurrently."
effect(e0,e1)Comment:

1302	 Beta-adrenergic receptor antagonists  ( <e0>beta-blockers</e0> ) and  <e1>BROVANA</e1>  may interfere with the effect of each other when administered concurrently."
effect(e0,e1)Comment:

1400	 <e0>Beta-blockers</e0>  not only block the therapeutic effects of  <e1>beta-agonists</e1> , but may produce severe bronchospasm in COPD patients."
effect(e0,e1)Comment:


100	 <e0>Heparin</e0> : Since  <e1>heparin</e1>  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  Argatroban  and  heparin  is unlikely for this indication."
Other
Comment:

101	 <e0>Heparin</e0> : Since  heparin  is contraindicated in patients with  <e1>heparin</e1> -induced thrombocytopenia, the co-administration of  Argatroban  and  heparin  is unlikely for this indication."
Other
Comment:

102	 <e0>Heparin</e0> : Since  heparin  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  <e1>Argatroban</e1>  and  heparin  is unlikely for this indication."
Other
Comment:

103	 <e0>Heparin</e0> : Since  heparin  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  Argatroban  and  <e1>heparin</e1>  is unlikely for this indication."
Other
Comment:

104	 Heparin : Since  <e0>heparin</e0>  is contraindicated in patients with  <e1>heparin</e1> -induced thrombocytopenia, the co-administration of  Argatroban  and  heparin  is unlikely for this indication."
Other
Comment:

105	 Heparin : Since  <e0>heparin</e0>  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  <e1>Argatroban</e1>  and  heparin  is unlikely for this indication."
Other
Comment:

106	 Heparin : Since  <e0>heparin</e0>  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  Argatroban  and  <e1>heparin</e1>  is unlikely for this indication."
Other
Comment:

107	 Heparin : Since  heparin  is contraindicated in patients with  <e0>heparin</e0> -induced thrombocytopenia, the co-administration of  <e1>Argatroban</e1>  and  heparin  is unlikely for this indication."
Other
Comment:

108	 Heparin : Since  heparin  is contraindicated in patients with  <e0>heparin</e0> -induced thrombocytopenia, the co-administration of  Argatroban  and  <e1>heparin</e1>  is unlikely for this indication."
Other
Comment:

109	 Heparin : Since  heparin  is contraindicated in patients with  heparin -induced thrombocytopenia, the co-administration of  <e0>Argatroban</e0>  and  <e1>heparin</e1>  is unlikely for this indication."
Other
Comment:

200	However, if  <e0>Argatroban</e0>  is to be initiated after cessation of  <e1>heparin</e1>  therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of  Argatroban  therapy."
Other
Comment:

201	However, if  <e0>Argatroban</e0>  is to be initiated after cessation of  heparin  therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of  <e1>Argatroban</e1>  therapy."
Other
Comment:

202	However, if  Argatroban  is to be initiated after cessation of  <e0>heparin</e0>  therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of  <e1>Argatroban</e1>  therapy."
Other
Comment:

300	 <e0>Aspirin</e0> / <e1>Acetaminophen</e1> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

301	 <e0>Aspirin</e0> / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e1>Argatroban</e1>  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

302	 <e0>Aspirin</e0> / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  <e1>aspirin</e1>  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

303	 <e0>Aspirin</e0> / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e1>Argatroban</e1>  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

304	 <e0>Aspirin</e0> / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  <e1>acetaminophen</e1>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

305	 <e0>Aspirin</e0> / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

306	 Aspirin / <e0>Acetaminophen</e0> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e1>Argatroban</e1>  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

307	 Aspirin / <e0>Acetaminophen</e0> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  <e1>aspirin</e1>  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

308	 Aspirin / <e0>Acetaminophen</e0> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e1>Argatroban</e1>  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

309	 Aspirin / <e0>Acetaminophen</e0> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  <e1>acetaminophen</e1>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

310	 Aspirin / <e0>Acetaminophen</e0> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

311	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e0>Argatroban</e0>  and concomitantly administered  <e1>aspirin</e1>  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

312	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e0>Argatroban</e0>  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e1>Argatroban</e1>  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

313	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e0>Argatroban</e0>  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  <e1>acetaminophen</e1>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

314	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  <e0>Argatroban</e0>  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

315	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  <e0>aspirin</e0>  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e1>Argatroban</e1>  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

316	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  <e0>aspirin</e0>  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  <e1>acetaminophen</e1>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

317	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  <e0>aspirin</e0>  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

318	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e0>Argatroban</e0>  1  g/kg/min. over 4 hours) or  <e1>acetaminophen</e1>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  Argatroban  1.5  g/kg/min. over 18 hours)."
Other
Comment:

319	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  <e0>Argatroban</e0>  1  g/kg/min. over 4 hours) or  acetaminophen  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

320	 Aspirin / Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between  Argatroban  and concomitantly administered  aspirin  (162.5 mg orally given 26 and 2 hours prior to initiation of  Argatroban  1  g/kg/min. over 4 hours) or  <e0>acetaminophen</e0>  (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of  <e1>Argatroban</e1>  1.5  g/kg/min. over 18 hours)."
Other
Comment:

400	Oral  <e0>anticoagulant agents</e0> : Pharmacokinetic drug-drug interactions between  <e1>Argatroban</e1>  and  warfarin  (7.5 mg single oral dose) have not been demonstrated."
Other
Comment:

401	Oral  <e0>anticoagulant agents</e0> : Pharmacokinetic drug-drug interactions between  Argatroban  and  <e1>warfarin</e1>  (7.5 mg single oral dose) have not been demonstrated."
Other
Comment:

402	Oral  anticoagulant agents : Pharmacokinetic drug-drug interactions between  <e0>Argatroban</e0>  and  <e1>warfarin</e1>  (7.5 mg single oral dose) have not been demonstrated."
Other
Comment:

500	However, the concomitant use of  <e0>Argatroban</e0>  and  <e1>warfarin</e1>  (5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days) results in prolongation of the prothrombin time (PT) and International Normalized Ratio (INR)."
effect(e0,e1)Comment:

600	 <e0>Thrombolytic agents</e0> : The safety and effectiveness of  <e1>Argatroban</e1>  with  thrombolytic agents  have not been established."
Other
Comment:

601	 <e0>Thrombolytic agents</e0> : The safety and effectiveness of  Argatroban  with  <e1>thrombolytic agents</e1>  have not been established."
Other
Comment:

602	 Thrombolytic agents : The safety and effectiveness of  <e0>Argatroban</e0>  with  <e1>thrombolytic agents</e1>  have not been established."
Other
Comment:

700	Co-administration: Concomitant use of  <e0>Argatroban</e0>  with  <e1>antiplatelet agents</e1> ,  thrombolytics , and other  anticoagulants  may increase the risk of bleeding."
effect(e0,e1)Comment:

701	Co-administration: Concomitant use of  <e0>Argatroban</e0>  with  antiplatelet agents ,  <e1>thrombolytics</e1> , and other  anticoagulants  may increase the risk of bleeding."
effect(e0,e1)Comment:

702	Co-administration: Concomitant use of  <e0>Argatroban</e0>  with  antiplatelet agents ,  thrombolytics , and other  <e1>anticoagulants</e1>  may increase the risk of bleeding."
effect(e0,e1)Comment:

703	Co-administration: Concomitant use of  Argatroban  with  <e0>antiplatelet agents</e0> ,  <e1>thrombolytics</e1> , and other  anticoagulants  may increase the risk of bleeding."
Other
Comment:

704	Co-administration: Concomitant use of  Argatroban  with  <e0>antiplatelet agents</e0> ,  thrombolytics , and other  <e1>anticoagulants</e1>  may increase the risk of bleeding."
Other
Comment:

705	Co-administration: Concomitant use of  Argatroban  with  antiplatelet agents ,  <e0>thrombolytics</e0> , and other  <e1>anticoagulants</e1>  may increase the risk of bleeding."
Other
Comment:

800	Drug-drug interactions have not been observed between  <e0>Argatroban</e0>  and  <e1>digoxin</e1>  or  erythromycin ."
Other
Comment:

801	Drug-drug interactions have not been observed between  <e0>Argatroban</e0>  and  digoxin  or  <e1>erythromycin</e1> ."
Other
Comment:

802	Drug-drug interactions have not been observed between  Argatroban  and  <e0>digoxin</e0>  or  <e1>erythromycin</e1> ."
Other
Comment:


100	Drug-Drug Interactions Given the primary CNS effects of  <e0>aripiprazole</e0> , caution should be used when  <e1>ABILIFY</e1>  is taken in combination with other  centrally acting drugs  and  alcohol ."
Other
Comment:

101	Drug-Drug Interactions Given the primary CNS effects of  <e0>aripiprazole</e0> , caution should be used when  ABILIFY  is taken in combination with other  <e1>centrally acting drugs</e1>  and  alcohol ."
Other
Comment:

102	Drug-Drug Interactions Given the primary CNS effects of  <e0>aripiprazole</e0> , caution should be used when  ABILIFY  is taken in combination with other  centrally acting drugs  and  <e1>alcohol</e1> ."
Other
Comment:

103	Drug-Drug Interactions Given the primary CNS effects of  aripiprazole , caution should be used when  <e0>ABILIFY</e0>  is taken in combination with other  <e1>centrally acting drugs</e1>  and  alcohol ."
advise(e0,e1)Comment:

104	Drug-Drug Interactions Given the primary CNS effects of  aripiprazole , caution should be used when  <e0>ABILIFY</e0>  is taken in combination with other  centrally acting drugs  and  <e1>alcohol</e1> ."
advise(e0,e1)Comment:

105	Drug-Drug Interactions Given the primary CNS effects of  aripiprazole , caution should be used when  ABILIFY  is taken in combination with other  <e0>centrally acting drugs</e0>  and  <e1>alcohol</e1> ."
Other
Comment:

300	1- adrenergic receptor antagonism,  <e0>aripiprazole</e0>  has the potential to enhance the effect of certain  <e1>antihypertensive agents</e1> ."
effect(e0,e1)Comment:

400	Potential for Other Drugs to Affect  <e0>ABILIFY</e0>   <e1>Aripiprazole</e1>  is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes."
Other
Comment:

800	Agents that induce CYP3A4 (eg,  <e0>carbamazepine</e0> ) could cause an increase in  <e1>aripiprazole</e1>  clearance and lower blood levels."
mechanism(e0,e1)Comment:

900	Inhibitors of CYP3A4 (eg,  <e0>ketoconazole</e0> ) or CYP2D6 (eg,  <e1>quinidine</e1> ,  fluoxetine , or  paroxetine ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

901	Inhibitors of CYP3A4 (eg,  <e0>ketoconazole</e0> ) or CYP2D6 (eg,  quinidine ,  <e1>fluoxetine</e1> , or  paroxetine ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

902	Inhibitors of CYP3A4 (eg,  <e0>ketoconazole</e0> ) or CYP2D6 (eg,  quinidine ,  fluoxetine , or  <e1>paroxetine</e1> ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

903	Inhibitors of CYP3A4 (eg,  <e0>ketoconazole</e0> ) or CYP2D6 (eg,  quinidine ,  fluoxetine , or  paroxetine ) can inhibit  <e1>aripiprazole</e1>  elimination and cause increased blood levels."
mechanism(e0,e1)Comment:

904	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  <e0>quinidine</e0> ,  <e1>fluoxetine</e1> , or  paroxetine ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

905	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  <e0>quinidine</e0> ,  fluoxetine , or  <e1>paroxetine</e1> ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

906	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  <e0>quinidine</e0> ,  fluoxetine , or  paroxetine ) can inhibit  <e1>aripiprazole</e1>  elimination and cause increased blood levels."
mechanism(e0,e1)Comment:

907	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  quinidine ,  <e0>fluoxetine</e0> , or  <e1>paroxetine</e1> ) can inhibit  aripiprazole  elimination and cause increased blood levels."
Other
Comment:

908	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  quinidine ,  <e0>fluoxetine</e0> , or  paroxetine ) can inhibit  <e1>aripiprazole</e1>  elimination and cause increased blood levels."
mechanism(e0,e1)Comment:

909	Inhibitors of CYP3A4 (eg,  ketoconazole ) or CYP2D6 (eg,  quinidine ,  fluoxetine , or  <e0>paroxetine</e0> ) can inhibit  <e1>aripiprazole</e1>  elimination and cause increased blood levels."
mechanism(e0,e1)Comment:

1000	 <e0>Ketoconazole</e0> : Coadministration of  <e1>ketoconazole</e1>  (200 mg/day for 14 days) with a 15-mg single dose of  aripiprazole  increased the AUC of  aripiprazole  and its active metabolite by 63% and 77%, respectively."
Other
Comment:

1001	 <e0>Ketoconazole</e0> : Coadministration of  ketoconazole  (200 mg/day for 14 days) with a 15-mg single dose of  <e1>aripiprazole</e1>  increased the AUC of  aripiprazole  and its active metabolite by 63% and 77%, respectively."
Other
Comment:

1002	 <e0>Ketoconazole</e0> : Coadministration of  ketoconazole  (200 mg/day for 14 days) with a 15-mg single dose of  aripiprazole  increased the AUC of  <e1>aripiprazole</e1>  and its active metabolite by 63% and 77%, respectively."
Other
Comment:

1003	 Ketoconazole : Coadministration of  <e0>ketoconazole</e0>  (200 mg/day for 14 days) with a 15-mg single dose of  <e1>aripiprazole</e1>  increased the AUC of  aripiprazole  and its active metabolite by 63% and 77%, respectively."
mechanism(e0,e1)Comment:

1004	 Ketoconazole : Coadministration of  <e0>ketoconazole</e0>  (200 mg/day for 14 days) with a 15-mg single dose of  aripiprazole  increased the AUC of  <e1>aripiprazole</e1>  and its active metabolite by 63% and 77%, respectively."
Other
Comment:

1005	 Ketoconazole : Coadministration of  ketoconazole  (200 mg/day for 14 days) with a 15-mg single dose of  <e0>aripiprazole</e0>  increased the AUC of  <e1>aripiprazole</e1>  and its active metabolite by 63% and 77%, respectively."
Other
Comment:

1200	When concomitant administration of  <e0>ketoconazole</e0>  with  <e1>aripiprazole</e1>  occurs,  aripiprazole  dose should be reduced to one-half of its normal dose."
advise(e0,e1)Comment:

1201	When concomitant administration of  <e0>ketoconazole</e0>  with  aripiprazole  occurs,  <e1>aripiprazole</e1>  dose should be reduced to one-half of its normal dose."
Other
Comment:

1202	When concomitant administration of  ketoconazole  with  <e0>aripiprazole</e0>  occurs,  <e1>aripiprazole</e1>  dose should be reduced to one-half of its normal dose."
Other
Comment:

1600	 <e0>Quinidine</e0> : Coadministration of a 10-mg single dose of  <e1>aripiprazole</e1>  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
Other
Comment:

1601	 <e0>Quinidine</e0> : Coadministration of a 10-mg single dose of  aripiprazole  with  <e1>quinidine</e1>  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
Other
Comment:

1602	 <e0>Quinidine</e0> : Coadministration of a 10-mg single dose of  aripiprazole  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  <e1>aripiprazole</e1>  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
Other
Comment:

1603	 <e0>Quinidine</e0> : Coadministration of a 10-mg single dose of  aripiprazole  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  <e1>dehydroaripiprazole</e1> , by 35%."
Other
Comment:

1604	 Quinidine : Coadministration of a 10-mg single dose of  <e0>aripiprazole</e0>  with  <e1>quinidine</e1>  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
mechanism(e0,e1)Comment:

1605	 Quinidine : Coadministration of a 10-mg single dose of  <e0>aripiprazole</e0>  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  <e1>aripiprazole</e1>  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
Other
Comment:

1606	 Quinidine : Coadministration of a 10-mg single dose of  <e0>aripiprazole</e0>  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  <e1>dehydroaripiprazole</e1> , by 35%."
Other
Comment:

1607	 Quinidine : Coadministration of a 10-mg single dose of  aripiprazole  with  <e0>quinidine</e0>  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  <e1>aripiprazole</e1>  by 112% but decreased the AUC of its active metabolite,  dehydroaripiprazole , by 35%."
Other
Comment:

1608	 Quinidine : Coadministration of a 10-mg single dose of  aripiprazole  with  <e0>quinidine</e0>  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  aripiprazole  by 112% but decreased the AUC of its active metabolite,  <e1>dehydroaripiprazole</e1> , by 35%."
Other
Comment:

1609	 Quinidine : Coadministration of a 10-mg single dose of  aripiprazole  with  quinidine  (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of  <e0>aripiprazole</e0>  by 112% but decreased the AUC of its active metabolite,  <e1>dehydroaripiprazole</e1> , by 35%."
Other
Comment:

1700	 <e0>Aripiprazole</e0>  dose should be reduced to one-half of its normal dose when concomitant administration of  <e1>quinidine</e1>  with  aripiprazole  occurs."
Other
Comment:

1701	 <e0>Aripiprazole</e0>  dose should be reduced to one-half of its normal dose when concomitant administration of  quinidine  with  <e1>aripiprazole</e1>  occurs."
Other
Comment:

1702	 Aripiprazole  dose should be reduced to one-half of its normal dose when concomitant administration of  <e0>quinidine</e0>  with  <e1>aripiprazole</e1>  occurs."
advise(e0,e1)Comment:

1800	Other significant inhibitors of CYP2D6, such as  <e0>fluoxetine</e0>  or  <e1>paroxetine</e1> , would be expected to have similar effects and, therefore, should be accompanied by similar dose reductions."
Other
Comment:

2000	 <e0>Carbamazepine</e0> : Coadministration of  <e1>carbamazepine</e1>  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  dehydro-aripiprazole ."
Other
Comment:

2001	 <e0>Carbamazepine</e0> : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  <e1>aripiprazole</e1>  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  dehydro-aripiprazole ."
Other
Comment:

2002	 <e0>Carbamazepine</e0> : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  <e1>aripiprazole</e1>  and its active metabolite,  dehydro-aripiprazole ."
Other
Comment:

2003	 <e0>Carbamazepine</e0> : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  <e1>dehydro-aripiprazole</e1> ."
Other
Comment:

2004	 Carbamazepine : Coadministration of  <e0>carbamazepine</e0>  (200 mg BID), a potent CYP3A4 inducer, with  <e1>aripiprazole</e1>  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  dehydro-aripiprazole ."
mechanism(e0,e1)Comment:

2005	 Carbamazepine : Coadministration of  <e0>carbamazepine</e0>  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  <e1>aripiprazole</e1>  and its active metabolite,  dehydro-aripiprazole ."
Other
Comment:

2006	 Carbamazepine : Coadministration of  <e0>carbamazepine</e0>  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  <e1>dehydro-aripiprazole</e1> ."
Other
Comment:

2007	 Carbamazepine : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  <e0>aripiprazole</e0>  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  <e1>aripiprazole</e1>  and its active metabolite,  dehydro-aripiprazole ."
Other
Comment:

2008	 Carbamazepine : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  <e0>aripiprazole</e0>  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  aripiprazole  and its active metabolite,  <e1>dehydro-aripiprazole</e1> ."
Other
Comment:

2009	 Carbamazepine : Coadministration of  carbamazepine  (200 mg BID), a potent CYP3A4 inducer, with  aripiprazole  (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both  <e0>aripiprazole</e0>  and its active metabolite,  <e1>dehydro-aripiprazole</e1> ."
Other
Comment:

2100	When  <e0>carbamazepine</e0>  is added to  <e1>aripiprazole</e1>  therapy,  aripiprazole  dose should be doubled."
advise(e0,e1)Comment:

2101	When  <e0>carbamazepine</e0>  is added to  aripiprazole  therapy,  <e1>aripiprazole</e1>  dose should be doubled."
Other
Comment:

2102	When  carbamazepine  is added to  <e0>aripiprazole</e0>  therapy,  <e1>aripiprazole</e1>  dose should be doubled."
Other
Comment:

2300	When  <e0>carbamazepine</e0>  is withdrawn from the combination therapy,  <e1>aripiprazole</e1>  dose should then be reduced."
advise(e0,e1)Comment:

2400	No clinically significant effect of  <e0>famotidine</e0> ,  <e1>valproate</e1> , or  lithium  was seen on the pharmacokinetics of  aripiprazole  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2401	No clinically significant effect of  <e0>famotidine</e0> ,  valproate , or  <e1>lithium</e1>  was seen on the pharmacokinetics of  aripiprazole  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2402	No clinically significant effect of  <e0>famotidine</e0> ,  valproate , or  lithium  was seen on the pharmacokinetics of  <e1>aripiprazole</e1>  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2403	No clinically significant effect of  famotidine ,  <e0>valproate</e0> , or  <e1>lithium</e1>  was seen on the pharmacokinetics of  aripiprazole  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2404	No clinically significant effect of  famotidine ,  <e0>valproate</e0> , or  lithium  was seen on the pharmacokinetics of  <e1>aripiprazole</e1>  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2405	No clinically significant effect of  famotidine ,  valproate , or  <e0>lithium</e0>  was seen on the pharmacokinetics of  <e1>aripiprazole</e1>  (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions)."
Other
Comment:

2500	Potential for  <e0>ABILIFY</e0>  to Affect Other Drugs  <e1>Aripiprazole</e1>  is unlikely to cause clinically important pharmacokinetic interactions with drugs metabolized by cytochrome P450 enzymes."
Other
Comment:

2600	In in vivo studies, 10- to 30-mg/day doses of  <e0>aripiprazole</e0>  had no significant effect on metabolism by CYP2D6 ( <e1>dextromethorphan</e1> ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2601	In in vivo studies, 10- to 30-mg/day doses of  <e0>aripiprazole</e0>  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( <e1>warfarin</e1> ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2602	In in vivo studies, 10- to 30-mg/day doses of  <e0>aripiprazole</e0>  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( <e1>omeprazole</e1> ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2603	In in vivo studies, 10- to 30-mg/day doses of  <e0>aripiprazole</e0>  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  <e1>warfarin</e1> ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2604	In in vivo studies, 10- to 30-mg/day doses of  <e0>aripiprazole</e0>  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( <e1>dextromethorphan</e1> ) substrates."
Other
Comment:

2605	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( <e0>dextromethorphan</e0> ), CYP2C9 ( <e1>warfarin</e1> ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2606	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( <e0>dextromethorphan</e0> ), CYP2C9 ( warfarin ), CYP2C19 ( <e1>omeprazole</e1> ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2607	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( <e0>dextromethorphan</e0> ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  <e1>warfarin</e1> ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2608	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( <e0>dextromethorphan</e0> ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( <e1>dextromethorphan</e1> ) substrates."
Other
Comment:

2609	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( <e0>warfarin</e0> ), CYP2C19 ( <e1>omeprazole</e1> ,  warfarin ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2610	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( <e0>warfarin</e0> ), CYP2C19 ( omeprazole ,  <e1>warfarin</e1> ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2611	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( <e0>warfarin</e0> ), CYP2C19 ( omeprazole ,  warfarin ), and CYP3A4 ( <e1>dextromethorphan</e1> ) substrates."
Other
Comment:

2612	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( <e0>omeprazole</e0> ,  <e1>warfarin</e1> ), and CYP3A4 ( dextromethorphan ) substrates."
Other
Comment:

2613	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( <e0>omeprazole</e0> ,  warfarin ), and CYP3A4 ( <e1>dextromethorphan</e1> ) substrates."
Other
Comment:

2614	In in vivo studies, 10- to 30-mg/day doses of  aripiprazole  had no significant effect on metabolism by CYP2D6 ( dextromethorphan ), CYP2C9 ( warfarin ), CYP2C19 ( omeprazole ,  <e0>warfarin</e0> ), and CYP3A4 ( <e1>dextromethorphan</e1> ) substrates."
Other
Comment:

2700	Additionally,  <e0>aripiprazole</e0>  and  <e1>dehydroaripiprazole</e1>  did not show potential for altering CYP1A2-mediated metabolism in vitro."
Other
Comment:

2800	 <e0>Alcohol</e0> : There was no significant difference between  <e1>aripiprazole</e1>  coadministered with  ethanol  and placebo coadministered with  ethanol  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2801	 <e0>Alcohol</e0> : There was no significant difference between  aripiprazole  coadministered with  <e1>ethanol</e1>  and placebo coadministered with  ethanol  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2802	 <e0>Alcohol</e0> : There was no significant difference between  aripiprazole  coadministered with  ethanol  and placebo coadministered with  <e1>ethanol</e1>  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2803	 Alcohol : There was no significant difference between  <e0>aripiprazole</e0>  coadministered with  <e1>ethanol</e1>  and placebo coadministered with  ethanol  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2804	 Alcohol : There was no significant difference between  <e0>aripiprazole</e0>  coadministered with  ethanol  and placebo coadministered with  <e1>ethanol</e1>  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2805	 Alcohol : There was no significant difference between  aripiprazole  coadministered with  <e0>ethanol</e0>  and placebo coadministered with  <e1>ethanol</e1>  on performance of gross motor skills or stimulus response in healthy subjects."
Other
Comment:

2900	As with most psychoactive medications, patients should be advised to avoid  <e0>alcohol</e0>  while taking  <e1>ABILIFY</e1> "
advise(e0,e1)Comment:


200	Caution is advised when  <e0>TRISENOX</e0>  is coadministered with other medications that can prolong the QT interval (e.g. certain  <e1>antiarrhythmics</e1>  or  thioridazine ) or lead to electrolyte abnormalities (such as  diuretics  or  amphotericin B )."
advise(e0,e1)Comment:

201	Caution is advised when  <e0>TRISENOX</e0>  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  <e1>thioridazine</e1> ) or lead to electrolyte abnormalities (such as  diuretics  or  amphotericin B )."
advise(e0,e1)Comment:

202	Caution is advised when  <e0>TRISENOX</e0>  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  thioridazine ) or lead to electrolyte abnormalities (such as  <e1>diuretics</e1>  or  amphotericin B )."
advise(e0,e1)Comment:

203	Caution is advised when  <e0>TRISENOX</e0>  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  thioridazine ) or lead to electrolyte abnormalities (such as  diuretics  or  <e1>amphotericin B</e1> )."
advise(e0,e1)Comment:

204	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  <e0>antiarrhythmics</e0>  or  <e1>thioridazine</e1> ) or lead to electrolyte abnormalities (such as  diuretics  or  amphotericin B )."
Other
Comment:

205	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  <e0>antiarrhythmics</e0>  or  thioridazine ) or lead to electrolyte abnormalities (such as  <e1>diuretics</e1>  or  amphotericin B )."
Other
Comment:

206	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  <e0>antiarrhythmics</e0>  or  thioridazine ) or lead to electrolyte abnormalities (such as  diuretics  or  <e1>amphotericin B</e1> )."
Other
Comment:

207	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  <e0>thioridazine</e0> ) or lead to electrolyte abnormalities (such as  <e1>diuretics</e1>  or  amphotericin B )."
Other
Comment:

208	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  <e0>thioridazine</e0> ) or lead to electrolyte abnormalities (such as  diuretics  or  <e1>amphotericin B</e1> )."
Other
Comment:

209	Caution is advised when  TRISENOX  is coadministered with other medications that can prolong the QT interval (e.g. certain  antiarrhythmics  or  thioridazine ) or lead to electrolyte abnormalities (such as  <e0>diuretics</e0>  or  <e1>amphotericin B</e1> )."
Other
Comment:


100	Tissue culture and animal studies indicate that  <e0>ELSPAR</e0>  can diminish or abolish the effect of  <e1>methotrexate</e1>  on malignant cells.14 This effect on  methotrexate  activity persists as long as plasma asparagine levels are suppressed."
effect(e0,e1)Comment:

101	Tissue culture and animal studies indicate that  <e0>ELSPAR</e0>  can diminish or abolish the effect of  methotrexate  on malignant cells.14 This effect on  <e1>methotrexate</e1>  activity persists as long as plasma asparagine levels are suppressed."
Other
Comment:

102	Tissue culture and animal studies indicate that  ELSPAR  can diminish or abolish the effect of  <e0>methotrexate</e0>  on malignant cells.14 This effect on  <e1>methotrexate</e1>  activity persists as long as plasma asparagine levels are suppressed."
Other
Comment:

200	These results would seem to dictate against the clinical use of  <e0>methotrexate</e0>  with  <e1>ELSPAR</e1> , or during the period following  ELSPAR  therapy when plasma asparagine levels are below normal."
advise(e0,e1)Comment:

201	These results would seem to dictate against the clinical use of  <e0>methotrexate</e0>  with  ELSPAR , or during the period following  <e1>ELSPAR</e1>  therapy when plasma asparagine levels are below normal."
Other
Comment:

202	These results would seem to dictate against the clinical use of  methotrexate  with  <e0>ELSPAR</e0> , or during the period following  <e1>ELSPAR</e1>  therapy when plasma asparagine levels are below normal."
Other
Comment:


100	 <e0>Uricosuric Agents</e0> :  <e1>Aspirin</e1>  may decrease the effects of  probenecid ,  sulfinpyrazone , and  phenylbutazone ."
Other
Comment:

101	 <e0>Uricosuric Agents</e0> :  Aspirin  may decrease the effects of  <e1>probenecid</e1> ,  sulfinpyrazone , and  phenylbutazone ."
Other
Comment:

102	 <e0>Uricosuric Agents</e0> :  Aspirin  may decrease the effects of  probenecid ,  <e1>sulfinpyrazone</e1> , and  phenylbutazone ."
Other
Comment:

103	 <e0>Uricosuric Agents</e0> :  Aspirin  may decrease the effects of  probenecid ,  sulfinpyrazone , and  <e1>phenylbutazone</e1> ."
Other
Comment:

104	 Uricosuric Agents :  <e0>Aspirin</e0>  may decrease the effects of  <e1>probenecid</e1> ,  sulfinpyrazone , and  phenylbutazone ."
effect(e0,e1)Comment:

105	 Uricosuric Agents :  <e0>Aspirin</e0>  may decrease the effects of  probenecid ,  <e1>sulfinpyrazone</e1> , and  phenylbutazone ."
effect(e0,e1)Comment:

106	 Uricosuric Agents :  <e0>Aspirin</e0>  may decrease the effects of  probenecid ,  sulfinpyrazone , and  <e1>phenylbutazone</e1> ."
effect(e0,e1)Comment:

107	 Uricosuric Agents :  Aspirin  may decrease the effects of  <e0>probenecid</e0> ,  <e1>sulfinpyrazone</e1> , and  phenylbutazone ."
Other
Comment:

108	 Uricosuric Agents :  Aspirin  may decrease the effects of  <e0>probenecid</e0> ,  sulfinpyrazone , and  <e1>phenylbutazone</e1> ."
Other
Comment:

109	 Uricosuric Agents :  Aspirin  may decrease the effects of  probenecid ,  <e0>sulfinpyrazone</e0> , and  <e1>phenylbutazone</e1> ."
Other
Comment:

200	 <e0>Alcohol</e0> : Has a synergistic effect with  <e1>aspirin</e1>  in causing gastrointestinal bleeding."
effect(e0,e1)Comment:

300	 <e0>Corticosteroids</e0> : Concomitant administration with  <e1>aspirin</e1>  may increase the risk of gastrointestinal ulceration and may reduce serum salicylate levels."
effect(e0,e1)Comment:

400	 <e0>Pyrazolone Derivatives</e0>  ( <e1>phenylbutazone</e1> ,  oxyphenbutazone , and possibly  dipyrone ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

401	 <e0>Pyrazolone Derivatives</e0>  ( phenylbutazone ,  <e1>oxyphenbutazone</e1> , and possibly  dipyrone ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

402	 <e0>Pyrazolone Derivatives</e0>  ( phenylbutazone ,  oxyphenbutazone , and possibly  <e1>dipyrone</e1> ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

403	 <e0>Pyrazolone Derivatives</e0>  ( phenylbutazone ,  oxyphenbutazone , and possibly  dipyrone ): Concomitant administration with  <e1>aspirin</e1>  may increase the risk of gastrointestinal ulceration."
effect(e0,e1)Comment:

404	 Pyrazolone Derivatives  ( <e0>phenylbutazone</e0> ,  <e1>oxyphenbutazone</e1> , and possibly  dipyrone ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

405	 Pyrazolone Derivatives  ( <e0>phenylbutazone</e0> ,  oxyphenbutazone , and possibly  <e1>dipyrone</e1> ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

406	 Pyrazolone Derivatives  ( <e0>phenylbutazone</e0> ,  oxyphenbutazone , and possibly  dipyrone ): Concomitant administration with  <e1>aspirin</e1>  may increase the risk of gastrointestinal ulceration."
effect(e0,e1)Comment:

407	 Pyrazolone Derivatives  ( phenylbutazone ,  <e0>oxyphenbutazone</e0> , and possibly  <e1>dipyrone</e1> ): Concomitant administration with  aspirin  may increase the risk of gastrointestinal ulceration."
Other
Comment:

408	 Pyrazolone Derivatives  ( phenylbutazone ,  <e0>oxyphenbutazone</e0> , and possibly  dipyrone ): Concomitant administration with  <e1>aspirin</e1>  may increase the risk of gastrointestinal ulceration."
effect(e0,e1)Comment:

409	 Pyrazolone Derivatives  ( phenylbutazone ,  oxyphenbutazone , and possibly  <e0>dipyrone</e0> ): Concomitant administration with  <e1>aspirin</e1>  may increase the risk of gastrointestinal ulceration."
effect(e0,e1)Comment:

500	 <e0>Nonsteroidal Antiinflammatory</e0>  Agents:  <e1>Aspirin</e1>  is contraindicated in patients who are hypersensitive to  nonsteroidal anti-inflammatory  agents."
Other
Comment:

501	 <e0>Nonsteroidal Antiinflammatory</e0>  Agents:  Aspirin  is contraindicated in patients who are hypersensitive to  <e1>nonsteroidal anti-inflammatory</e1>  agents."
Other
Comment:

502	 Nonsteroidal Antiinflammatory  Agents:  <e0>Aspirin</e0>  is contraindicated in patients who are hypersensitive to  <e1>nonsteroidal anti-inflammatory</e1>  agents."
advise(e0,e1)Comment:

600	Urinary Alkalinizers: Decrease  <e0>aspirin</e0>  effectiveness by increasing the rate of  <e1>salicylate</e1>  renal excretion."
Other
Comment:

700	 <e0>Phenobarbital</e0> : Decreases  <e1>aspirin</e1>  effectiveness by enzyme induction."
mechanism(e0,e1)Comment:

800	 <e0>Phenytoin</e0> : Serum  <e1>phenytoin</e1>  levels may be increased by  aspirin ."
Other
Comment:

801	 <e0>Phenytoin</e0> : Serum  phenytoin  levels may be increased by  <e1>aspirin</e1> ."
Other
Comment:

802	 Phenytoin : Serum  <e0>phenytoin</e0>  levels may be increased by  <e1>aspirin</e1> ."
effect(e0,e1)Comment:

900	 <e0>Propranolol</e0> : May decrease  <e1>aspirins</e1>  anti-inflammatory action by competing for the same receptors."
effect(e0,e1)Comment:

1000	 <e0>Antacids</e0> : Enteric Coated  <e1>Aspirin</e1>  should not be given concurrently with  antacids , since an increase in the pH of the stomach may effect the enteric coating of the tablets."
Other
Comment:

1001	 <e0>Antacids</e0> : Enteric Coated  Aspirin  should not be given concurrently with  <e1>antacids</e1> , since an increase in the pH of the stomach may effect the enteric coating of the tablets."
Other
Comment:

1002	 Antacids : Enteric Coated  <e0>Aspirin</e0>  should not be given concurrently with  <e1>antacids</e1> , since an increase in the pH of the stomach may effect the enteric coating of the tablets."
advise(e0,e1)Comment:


100	 <e0>Ketoconazole</e0> / <e1>Itraconazole</e1> ,  Macrolides , Including  Erythromycin "
Other
Comment:

101	 <e0>Ketoconazole</e0> / Itraconazole ,  <e1>Macrolides</e1> , Including  Erythromycin "
Other
Comment:

102	 <e0>Ketoconazole</e0> / Itraconazole ,  Macrolides , Including  <e1>Erythromycin</e1> "
Other
Comment:

103	 Ketoconazole / <e0>Itraconazole</e0> ,  <e1>Macrolides</e1> , Including  Erythromycin "
Other
Comment:

104	 Ketoconazole / <e0>Itraconazole</e0> ,  Macrolides , Including  <e1>Erythromycin</e1> "
Other
Comment:

105	 Ketoconazole / Itraconazole ,  <e0>Macrolides</e0> , Including  <e1>Erythromycin</e1> "
Other
Comment:


100	Catecholamine-depleting drugs (eg,  <e0>reserpine</e0> ) may have an additive effect when given with  <e1>beta-blocking agent</e1> s."
effect(e0,e1)Comment:

300	 <e0>Calcium channel blockers</e0>  may also have an additive effect when given with  <e1>TENORMIN</e1>  ."
effect(e0,e1)Comment:

400	 <e0>Beta blockers</e0>  may exacerbate the rebound hypertension which can follow the withdrawal of  <e1>clonidine</e1> ."
effect(e0,e1)Comment:

500	If the two drugs are coadministered, the  <e0>beta blocker</e0>  should be withdrawn several days before the gradual withdrawal of  <e1>clonidine</e1> ."
advise(e0,e1)Comment:

600	If replacing  <e0>clonidine</e0>  by  <e1>beta-blocker</e1>  therapy, the introduction of  beta blockers  should be delayed for several days after  clonidine  administration has stopped."
Other
Comment:

601	If replacing  <e0>clonidine</e0>  by  beta-blocker  therapy, the introduction of  <e1>beta blockers</e1>  should be delayed for several days after  clonidine  administration has stopped."
Other
Comment:

602	If replacing  <e0>clonidine</e0>  by  beta-blocker  therapy, the introduction of  beta blockers  should be delayed for several days after  <e1>clonidine</e1>  administration has stopped."
Other
Comment:

603	If replacing  clonidine  by  <e0>beta-blocker</e0>  therapy, the introduction of  <e1>beta blockers</e1>  should be delayed for several days after  clonidine  administration has stopped."
Other
Comment:

604	If replacing  clonidine  by  <e0>beta-blocker</e0>  therapy, the introduction of  beta blockers  should be delayed for several days after  <e1>clonidine</e1>  administration has stopped."
Other
Comment:

605	If replacing  clonidine  by  beta-blocker  therapy, the introduction of  <e0>beta blockers</e0>  should be delayed for several days after  <e1>clonidine</e1>  administration has stopped."
advise(e0,e1)Comment:

700	Concomitant use of prostaglandin synthase inhibiting drugs, eg,  <e0>indomethacin</e0> , may decrease the hypotensive effects of  <e1>beta blockers</e1> ."
effect(e0,e1)Comment:

800	Information on concurrent usage of  <e0>atenolol</e0>  and  <e1>aspirin</e1>  is limited."
Other
Comment:

900	Data from several studies, ie, TIMI-II, ISIS-2, currently do not suggest any clinical interaction between  <e0>aspirin</e0>  and  <e1>beta blockers</e1>  in the acute myocardial infarction setting."
Other
Comment:


100	Drug-Drug Interactions  <e0>Albuterol</e0>  -  <e1>STRATTERA</e1>  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  beta2 agonists ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

101	Drug-Drug Interactions  <e0>Albuterol</e0>  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  <e1>albuterol</e1>  (or other  beta2 agonists ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

102	Drug-Drug Interactions  <e0>Albuterol</e0>  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  <e1>beta2 agonists</e1> ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

103	Drug-Drug Interactions  <e0>Albuterol</e0>  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  beta2 agonists ) because the action of  <e1>albuterol</e1>  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

104	Drug-Drug Interactions  Albuterol  -  <e0>STRATTERA</e0>  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  <e1>albuterol</e1>  (or other  beta2 agonists ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
advise(e0,e1)Comment:

105	Drug-Drug Interactions  Albuterol  -  <e0>STRATTERA</e0>  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  <e1>beta2 agonists</e1> ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

106	Drug-Drug Interactions  Albuterol  -  <e0>STRATTERA</e0>  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  beta2 agonists ) because the action of  <e1>albuterol</e1>  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

107	Drug-Drug Interactions  Albuterol  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  <e0>albuterol</e0>  (or other  <e1>beta2 agonists</e1> ) because the action of  albuterol  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

108	Drug-Drug Interactions  Albuterol  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  <e0>albuterol</e0>  (or other  beta2 agonists ) because the action of  <e1>albuterol</e1>  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

109	Drug-Drug Interactions  Albuterol  -  STRATTERA  should be administered with caution to patients being treated with systemically-administered (oral or intravenous)  albuterol  (or other  <e0>beta2 agonists</e0> ) because the action of  <e1>albuterol</e1>  on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure."
Other
Comment:

200	CYP2D6 inhibitors -  <e0>Atomoxetine</e0>  is primarily metabolized by the CYP2D6 pathway to  <e1>4-hydroxyatomoxetine</e1> ."
Other
Comment:

400	Dosage adjustment of  <e0>STRATTERA</e0>  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  <e1>paroxetine</e1> ,  fluoxetine , and  quinidine ."
advise(e0,e1)Comment:

401	Dosage adjustment of  <e0>STRATTERA</e0>  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  paroxetine ,  <e1>fluoxetine</e1> , and  quinidine ."
advise(e0,e1)Comment:

402	Dosage adjustment of  <e0>STRATTERA</e0>  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  paroxetine ,  fluoxetine , and  <e1>quinidine</e1> ."
advise(e0,e1)Comment:

403	Dosage adjustment of  STRATTERA  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  <e0>paroxetine</e0> ,  <e1>fluoxetine</e1> , and  quinidine ."
Other
Comment:

404	Dosage adjustment of  STRATTERA  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  <e0>paroxetine</e0> ,  fluoxetine , and  <e1>quinidine</e1> ."
Other
Comment:

405	Dosage adjustment of  STRATTERA  may be necessary when coadministered with CYP2D6 inhibitors, e.g.,  paroxetine ,  <e0>fluoxetine</e0> , and  <e1>quinidine</e1> ."
Other
Comment:

500	In EM individuals treated with  <e0>paroxetine</e0>  or  <e1>fluoxetine</e1> , the AUC of  atomoxetine  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  atomoxetine  alone."
Other
Comment:

501	In EM individuals treated with  <e0>paroxetine</e0>  or  fluoxetine , the AUC of  <e1>atomoxetine</e1>  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  atomoxetine  alone."
mechanism(e0,e1)Comment:

502	In EM individuals treated with  <e0>paroxetine</e0>  or  fluoxetine , the AUC of  atomoxetine  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  <e1>atomoxetine</e1>  alone."
Other
Comment:

503	In EM individuals treated with  paroxetine  or  <e0>fluoxetine</e0> , the AUC of  <e1>atomoxetine</e1>  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  atomoxetine  alone."
mechanism(e0,e1)Comment:

504	In EM individuals treated with  paroxetine  or  <e0>fluoxetine</e0> , the AUC of  atomoxetine  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  <e1>atomoxetine</e1>  alone."
Other
Comment:

505	In EM individuals treated with  paroxetine  or  fluoxetine , the AUC of  <e0>atomoxetine</e0>  is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than  <e1>atomoxetine</e1>  alone."
Other
Comment:


100	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  <e0>cyclosporine</e0> ,  <e1>fibric acid derivatives</e1> ,  niacin  ( nicotinic acid ),  erythromycin ,  azole antifungals ."
Other
Comment:

101	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  <e0>cyclosporine</e0> ,  fibric acid derivatives ,  <e1>niacin</e1>  ( nicotinic acid ),  erythromycin ,  azole antifungals ."
Other
Comment:

102	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  <e0>cyclosporine</e0> ,  fibric acid derivatives ,  niacin  ( <e1>nicotinic acid</e1> ),  erythromycin ,  azole antifungals ."
Other
Comment:

103	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  <e0>cyclosporine</e0> ,  fibric acid derivatives ,  niacin  ( nicotinic acid ),  <e1>erythromycin</e1> ,  azole antifungals ."
Other
Comment:

104	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  <e0>cyclosporine</e0> ,  fibric acid derivatives ,  niacin  ( nicotinic acid ),  erythromycin ,  <e1>azole antifungals</e1> ."
Other
Comment:

105	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  <e0>fibric acid derivatives</e0> ,  <e1>niacin</e1>  ( nicotinic acid ),  erythromycin ,  azole antifungals ."
Other
Comment:

106	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  <e0>fibric acid derivatives</e0> ,  niacin  ( <e1>nicotinic acid</e1> ),  erythromycin ,  azole antifungals ."
Other
Comment:

107	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  <e0>fibric acid derivatives</e0> ,  niacin  ( nicotinic acid ),  <e1>erythromycin</e1> ,  azole antifungals ."
Other
Comment:

108	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  <e0>fibric acid derivatives</e0> ,  niacin  ( nicotinic acid ),  erythromycin ,  <e1>azole antifungals</e1> ."
Other
Comment:

109	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  <e0>niacin</e0>  ( <e1>nicotinic acid</e1> ),  erythromycin ,  azole antifungals ."
Other
Comment:

110	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  <e0>niacin</e0>  ( nicotinic acid ),  <e1>erythromycin</e1> ,  azole antifungals ."
Other
Comment:

111	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  <e0>niacin</e0>  ( nicotinic acid ),  erythromycin ,  <e1>azole antifungals</e1> ."
Other
Comment:

112	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  niacin  ( <e0>nicotinic acid</e0> ),  <e1>erythromycin</e1> ,  azole antifungals ."
Other
Comment:

113	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  niacin  ( <e0>nicotinic acid</e0> ),  erythromycin ,  <e1>azole antifungals</e1> ."
Other
Comment:

114	The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of  cyclosporine ,  fibric acid derivatives ,  niacin  ( nicotinic acid ),  <e0>erythromycin</e0> ,  <e1>azole antifungals</e1> ."
Other
Comment:

200	 <e0>Antacid</e0> : When  <e1>atorvastatin</e1>  and  Maalox TC  suspension were coadministered, plasma concentrations of  atorvastatin  decreased approximately 35%."
Other
Comment:

201	 <e0>Antacid</e0> : When  atorvastatin  and  <e1>Maalox TC</e1>  suspension were coadministered, plasma concentrations of  atorvastatin  decreased approximately 35%."
Other
Comment:

202	 <e0>Antacid</e0> : When  atorvastatin  and  Maalox TC  suspension were coadministered, plasma concentrations of  <e1>atorvastatin</e1>  decreased approximately 35%."
Other
Comment:

203	 Antacid : When  <e0>atorvastatin</e0>  and  <e1>Maalox TC</e1>  suspension were coadministered, plasma concentrations of  atorvastatin  decreased approximately 35%."
mechanism(e0,e1)Comment:

204	 Antacid : When  <e0>atorvastatin</e0>  and  Maalox TC  suspension were coadministered, plasma concentrations of  <e1>atorvastatin</e1>  decreased approximately 35%."
Other
Comment:

205	 Antacid : When  atorvastatin  and  <e0>Maalox TC</e0>  suspension were coadministered, plasma concentrations of  <e1>atorvastatin</e1>  decreased approximately 35%."
Other
Comment:

400	 <e0>Antipyrine</e0> : Because  <e1>atorvastatin</e1>  does not affect the pharmacokinetics of  antipyrine , interactions with other  drugs  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

401	 <e0>Antipyrine</e0> : Because  atorvastatin  does not affect the pharmacokinetics of  <e1>antipyrine</e1> , interactions with other  drugs  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

402	 <e0>Antipyrine</e0> : Because  atorvastatin  does not affect the pharmacokinetics of  antipyrine , interactions with other  <e1>drugs</e1>  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

403	 Antipyrine : Because  <e0>atorvastatin</e0>  does not affect the pharmacokinetics of  <e1>antipyrine</e1> , interactions with other  drugs  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

404	 Antipyrine : Because  <e0>atorvastatin</e0>  does not affect the pharmacokinetics of  antipyrine , interactions with other  <e1>drugs</e1>  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

405	 Antipyrine : Because  atorvastatin  does not affect the pharmacokinetics of  <e0>antipyrine</e0> , interactions with other  <e1>drugs</e1>  metabolized via the same cytochrome isozymes are not expected."
Other
Comment:

500	 <e0>Colestipol</e0> : Plasma concentrations of  <e1>atorvastatin</e1>  decreased approximately 25% when  colestipol  and  atorvastatin  were coadministered."
Other
Comment:

501	 <e0>Colestipol</e0> : Plasma concentrations of  atorvastatin  decreased approximately 25% when  <e1>colestipol</e1>  and  atorvastatin  were coadministered."
Other
Comment:

502	 <e0>Colestipol</e0> : Plasma concentrations of  atorvastatin  decreased approximately 25% when  colestipol  and  <e1>atorvastatin</e1>  were coadministered."
Other
Comment:

503	 Colestipol : Plasma concentrations of  <e0>atorvastatin</e0>  decreased approximately 25% when  <e1>colestipol</e1>  and  atorvastatin  were coadministered."
Other
Comment:

504	 Colestipol : Plasma concentrations of  <e0>atorvastatin</e0>  decreased approximately 25% when  colestipol  and  <e1>atorvastatin</e1>  were coadministered."
Other
Comment:

505	 Colestipol : Plasma concentrations of  atorvastatin  decreased approximately 25% when  <e0>colestipol</e0>  and  <e1>atorvastatin</e1>  were coadministered."
mechanism(e0,e1)Comment:

600	However, LDL-C reduction was greater when  <e0>atorvastatin</e0>  and  <e1>colestipol</e1>  were coadministered than when either drug was given alone."
effect(e0,e1)Comment:

700	 <e0>Cimetidine</e0> :  <e1>Atorvastatin</e1>  plasma concentrations and LDL-C reduction were not altered by coadministration of  cimetidine ."
Other
Comment:

701	 <e0>Cimetidine</e0> :  Atorvastatin  plasma concentrations and LDL-C reduction were not altered by coadministration of  <e1>cimetidine</e1> ."
Other
Comment:

702	 Cimetidine :  <e0>Atorvastatin</e0>  plasma concentrations and LDL-C reduction were not altered by coadministration of  <e1>cimetidine</e1> ."
Other
Comment:

800	 <e0>Digoxin</e0> : When multiple doses of  <e1>atorvastatin</e1>  and  digoxin  were coadministered, steady-state plasma  digoxin  concentrations increased by approximately 20%."
Other
Comment:

801	 <e0>Digoxin</e0> : When multiple doses of  atorvastatin  and  <e1>digoxin</e1>  were coadministered, steady-state plasma  digoxin  concentrations increased by approximately 20%."
Other
Comment:

802	 <e0>Digoxin</e0> : When multiple doses of  atorvastatin  and  digoxin  were coadministered, steady-state plasma  <e1>digoxin</e1>  concentrations increased by approximately 20%."
Other
Comment:

803	 Digoxin : When multiple doses of  <e0>atorvastatin</e0>  and  <e1>digoxin</e1>  were coadministered, steady-state plasma  digoxin  concentrations increased by approximately 20%."
mechanism(e0,e1)Comment:

804	 Digoxin : When multiple doses of  <e0>atorvastatin</e0>  and  digoxin  were coadministered, steady-state plasma  <e1>digoxin</e1>  concentrations increased by approximately 20%."
Other
Comment:

805	 Digoxin : When multiple doses of  atorvastatin  and  <e0>digoxin</e0>  were coadministered, steady-state plasma  <e1>digoxin</e1>  concentrations increased by approximately 20%."
Other
Comment:

1000	 <e0>Erythromycin</e0> : In healthy individuals, plasma concentrations of  <e1>atorvastatin</e1>  increased approximately 40% with coadministration of  atorvastatin  and  erythromycin , a known inhibitor of cytochrome P450 3A4."
Other
Comment:

1001	 <e0>Erythromycin</e0> : In healthy individuals, plasma concentrations of  atorvastatin  increased approximately 40% with coadministration of  <e1>atorvastatin</e1>  and  erythromycin , a known inhibitor of cytochrome P450 3A4."
Other
Comment:

1002	 <e0>Erythromycin</e0> : In healthy individuals, plasma concentrations of  atorvastatin  increased approximately 40% with coadministration of  atorvastatin  and  <e1>erythromycin</e1> , a known inhibitor of cytochrome P450 3A4."
Other
Comment:

1003	 Erythromycin : In healthy individuals, plasma concentrations of  <e0>atorvastatin</e0>  increased approximately 40% with coadministration of  <e1>atorvastatin</e1>  and  erythromycin , a known inhibitor of cytochrome P450 3A4."
Other
Comment:

1004	 Erythromycin : In healthy individuals, plasma concentrations of  <e0>atorvastatin</e0>  increased approximately 40% with coadministration of  atorvastatin  and  <e1>erythromycin</e1> , a known inhibitor of cytochrome P450 3A4."
Other
Comment:

1005	 Erythromycin : In healthy individuals, plasma concentrations of  atorvastatin  increased approximately 40% with coadministration of  <e0>atorvastatin</e0>  and  <e1>erythromycin</e1> , a known inhibitor of cytochrome P450 3A4."
mechanism(e0,e1)Comment:

1100	Oral  <e0>Contraceptives</e0> : Coadministration of  <e1>atorvastatin</e1>  and an oral  contraceptive  increased AUC values for  norethindrone  and  ethinyl estradiol  by approximately 30% and 20%."
Other
Comment:

1101	Oral  <e0>Contraceptives</e0> : Coadministration of  atorvastatin  and an oral  <e1>contraceptive</e1>  increased AUC values for  norethindrone  and  ethinyl estradiol  by approximately 30% and 20%."
Other
Comment:

1102	Oral  <e0>Contraceptives</e0> : Coadministration of  atorvastatin  and an oral  contraceptive  increased AUC values for  <e1>norethindrone</e1>  and  ethinyl estradiol  by approximately 30% and 20%."
Other
Comment:

1103	Oral  <e0>Contraceptives</e0> : Coadministration of  atorvastatin  and an oral  contraceptive  increased AUC values for  norethindrone  and  <e1>ethinyl estradiol</e1>  by approximately 30% and 20%."
Other
Comment:

1104	Oral  Contraceptives : Coadministration of  <e0>atorvastatin</e0>  and an oral  <e1>contraceptive</e1>  increased AUC values for  norethindrone  and  ethinyl estradiol  by approximately 30% and 20%."
mechanism(e0,e1)Comment:

1105	Oral  Contraceptives : Coadministration of  <e0>atorvastatin</e0>  and an oral  contraceptive  increased AUC values for  <e1>norethindrone</e1>  and  ethinyl estradiol  by approximately 30% and 20%."
mechanism(e0,e1)Comment:

1106	Oral  Contraceptives : Coadministration of  <e0>atorvastatin</e0>  and an oral  contraceptive  increased AUC values for  norethindrone  and  <e1>ethinyl estradiol</e1>  by approximately 30% and 20%."
mechanism(e0,e1)Comment:

1107	Oral  Contraceptives : Coadministration of  atorvastatin  and an oral  <e0>contraceptive</e0>  increased AUC values for  <e1>norethindrone</e1>  and  ethinyl estradiol  by approximately 30% and 20%."
Other
Comment:

1108	Oral  Contraceptives : Coadministration of  atorvastatin  and an oral  <e0>contraceptive</e0>  increased AUC values for  norethindrone  and  <e1>ethinyl estradiol</e1>  by approximately 30% and 20%."
Other
Comment:

1109	Oral  Contraceptives : Coadministration of  atorvastatin  and an oral  contraceptive  increased AUC values for  <e0>norethindrone</e0>  and  <e1>ethinyl estradiol</e1>  by approximately 30% and 20%."
Other
Comment:

1200	These increases should be considered when selecting an oral  <e0>contraceptive</e0>  for a woman taking  <e1>atorvastatin</e1> ."
advise(e0,e1)Comment:

1300	 <e0>Warfarin</e0> :  <e1>Atorvastatin</e1>  had no clinically significant effect on prothrombin time when administered to patients receiving chronic  warfarin  treatment."
Other
Comment:

1301	 <e0>Warfarin</e0> :  Atorvastatin  had no clinically significant effect on prothrombin time when administered to patients receiving chronic  <e1>warfarin</e1>  treatment."
Other
Comment:

1302	 Warfarin :  <e0>Atorvastatin</e0>  had no clinically significant effect on prothrombin time when administered to patients receiving chronic  <e1>warfarin</e1>  treatment."
Other
Comment:

1800	Caution should be exercised if an  <e0>HMG-CoA reductase inhibitor</e0>  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  <e1>ketoconazole</e1> ,  spironolactone , and  cimetidine ."
advise(e0,e1)Comment:

1801	Caution should be exercised if an  <e0>HMG-CoA reductase inhibitor</e0>  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  ketoconazole ,  <e1>spironolactone</e1> , and  cimetidine ."
advise(e0,e1)Comment:

1802	Caution should be exercised if an  <e0>HMG-CoA reductase inhibitor</e0>  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  ketoconazole ,  spironolactone , and  <e1>cimetidine</e1> ."
advise(e0,e1)Comment:

1803	Caution should be exercised if an  HMG-CoA reductase inhibitor  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  <e0>ketoconazole</e0> ,  <e1>spironolactone</e1> , and  cimetidine ."
Other
Comment:

1804	Caution should be exercised if an  HMG-CoA reductase inhibitor  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  <e0>ketoconazole</e0> ,  spironolactone , and  <e1>cimetidine</e1> ."
Other
Comment:

1805	Caution should be exercised if an  HMG-CoA reductase inhibitor  is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as  ketoconazole ,  <e0>spironolactone</e0> , and  <e1>cimetidine</e1> ."
Other
Comment:


300	The extent of plasma protein binding of  <e0>atovaquone</e0>  in human plasma is not affected by the presence of therapeutic concentrations of  <e1>phenytoin</e1>  (15 mcg/ mL), nor is the binding of  phenytoin  affected by the presence of  atovaquone ."
Other
Comment:

301	The extent of plasma protein binding of  <e0>atovaquone</e0>  in human plasma is not affected by the presence of therapeutic concentrations of  phenytoin  (15 mcg/ mL), nor is the binding of  <e1>phenytoin</e1>  affected by the presence of  atovaquone ."
Other
Comment:

302	The extent of plasma protein binding of  <e0>atovaquone</e0>  in human plasma is not affected by the presence of therapeutic concentrations of  phenytoin  (15 mcg/ mL), nor is the binding of  phenytoin  affected by the presence of  <e1>atovaquone</e1> ."
Other
Comment:

303	The extent of plasma protein binding of  atovaquone  in human plasma is not affected by the presence of therapeutic concentrations of  <e0>phenytoin</e0>  (15 mcg/ mL), nor is the binding of  <e1>phenytoin</e1>  affected by the presence of  atovaquone ."
Other
Comment:

304	The extent of plasma protein binding of  atovaquone  in human plasma is not affected by the presence of therapeutic concentrations of  <e0>phenytoin</e0>  (15 mcg/ mL), nor is the binding of  phenytoin  affected by the presence of  <e1>atovaquone</e1> ."
Other
Comment:

305	The extent of plasma protein binding of  atovaquone  in human plasma is not affected by the presence of therapeutic concentrations of  phenytoin  (15 mcg/ mL), nor is the binding of  <e0>phenytoin</e0>  affected by the presence of  <e1>atovaquone</e1> ."
Other
Comment:

400	 <e0>Rifampin</e0> : Coadministration of  <e1>rifampin</e1>  and  MEPRON  Suspension results in a significant decrease in average steady- state plasma  atovaquone  concentrations."
Other
Comment:

401	 <e0>Rifampin</e0> : Coadministration of  rifampin  and  <e1>MEPRON</e1>  Suspension results in a significant decrease in average steady- state plasma  atovaquone  concentrations."
Other
Comment:

402	 <e0>Rifampin</e0> : Coadministration of  rifampin  and  MEPRON  Suspension results in a significant decrease in average steady- state plasma  <e1>atovaquone</e1>  concentrations."
Other
Comment:

403	 Rifampin : Coadministration of  <e0>rifampin</e0>  and  <e1>MEPRON</e1>  Suspension results in a significant decrease in average steady- state plasma  atovaquone  concentrations."
mechanism(e0,e1)Comment:

404	 Rifampin : Coadministration of  <e0>rifampin</e0>  and  MEPRON  Suspension results in a significant decrease in average steady- state plasma  <e1>atovaquone</e1>  concentrations."
Other
Comment:

405	 Rifampin : Coadministration of  rifampin  and  <e0>MEPRON</e0>  Suspension results in a significant decrease in average steady- state plasma  <e1>atovaquone</e1>  concentrations."
Other
Comment:

500	Alternatives to  <e0>rifampin</e0>  should be considered during the course of PCP treatment with  <e1>MEPRON</e1> ."
advise(e0,e1)Comment:

600	 <e0>Rifabutin</e0> , another  <e1>rifamycin</e1> , is structurally similar to  rifampin  and may possibly have some of the same drug interactions as  rifampin ."
Other
Comment:

601	 <e0>Rifabutin</e0> , another  rifamycin , is structurally similar to  <e1>rifampin</e1>  and may possibly have some of the same drug interactions as  rifampin ."
Other
Comment:

602	 <e0>Rifabutin</e0> , another  rifamycin , is structurally similar to  rifampin  and may possibly have some of the same drug interactions as  <e1>rifampin</e1> ."
Other
Comment:

603	 Rifabutin , another  <e0>rifamycin</e0> , is structurally similar to  <e1>rifampin</e1>  and may possibly have some of the same drug interactions as  rifampin ."
Other
Comment:

604	 Rifabutin , another  <e0>rifamycin</e0> , is structurally similar to  rifampin  and may possibly have some of the same drug interactions as  <e1>rifampin</e1> ."
Other
Comment:

605	 Rifabutin , another  rifamycin , is structurally similar to  <e0>rifampin</e0>  and may possibly have some of the same drug interactions as  <e1>rifampin</e1> ."
Other
Comment:

700	No interaction trials have been conducted with  <e0>MEPRON</e0>  and  <e1>rifabutin</e1> ."
Other
Comment:


100	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  <e1>enflurane</e1> ;"
effect(e0,e1)Comment:

400	certain  <e0>antibiotics</e0> , especially the  <e1>aminoglycosides</e1>  and  polymyxins ;"
Other
Comment:

401	certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  <e1>polymyxins</e1> ;"
Other
Comment:

402	certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  <e1>polymyxins</e1> ;"
Other
Comment:

800	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  <e1>enflurane</e1> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

801	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; <e1>isoflurane</e1> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

802	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; <e1>halothane</e1> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

803	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  <e1>antibiotics</e1> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

804	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e1>aminoglycosides</e1>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

805	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

806	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

807	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
effect(e0,e1)Comment:

808	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
effect(e0,e1)Comment:

809	Drugs which may enhance the neuromuscular blocking action of  <e0>TRACRIUM</e0>  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
effect(e0,e1)Comment:

810	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; <e1>isoflurane</e1> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

811	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; <e1>halothane</e1> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

812	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  <e1>antibiotics</e1> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

813	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  <e1>aminoglycosides</e1>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

814	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

815	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

816	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

817	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

818	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  <e0>enflurane</e0> ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

819	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; <e1>halothane</e1> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

820	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  <e1>antibiotics</e1> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

821	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  <e1>aminoglycosides</e1>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

822	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

823	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

824	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

825	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

826	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; <e0>isoflurane</e0> ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

827	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  <e1>antibiotics</e1> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

828	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  <e1>aminoglycosides</e1>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

829	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  aminoglycosides  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

830	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

831	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

832	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

833	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; <e0>halothane</e0> ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

834	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  <e1>aminoglycosides</e1>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

835	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

836	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

837	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

838	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

839	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  <e0>antibiotics</e0> , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

840	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  <e1>polymyxins</e1> ; lithium ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

841	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  polymyxins ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

842	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  polymyxins ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

843	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  polymyxins ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

844	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  <e0>aminoglycosides</e0>  and  polymyxins ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

845	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e0>polymyxins</e0> ; <e1>lithium</e1> ; magnesium  salts; procainamide ;and  quinidine ."
Other
Comment:

846	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e0>polymyxins</e0> ; lithium ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

847	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e0>polymyxins</e0> ; lithium ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

848	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  <e0>polymyxins</e0> ; lithium ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

849	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e0>lithium</e0> ; <e1>magnesium</e1>  salts; procainamide ;and  quinidine ."
Other
Comment:

850	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e0>lithium</e0> ; magnesium  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

851	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; <e0>lithium</e0> ; magnesium  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

852	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e0>magnesium</e0>  salts; <e1>procainamide</e1> ;and  quinidine ."
Other
Comment:

853	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; <e0>magnesium</e0>  salts; procainamide ;and  <e1>quinidine</e1> ."
Other
Comment:

854	Drugs which may enhance the neuromuscular blocking action of  TRACRIUM  include:  enflurane ; isoflurane ; halothane ;certain  antibiotics , especially the  aminoglycosides  and  polymyxins ; lithium ; magnesium  salts; <e0>procainamide</e0> ;and  <e1>quinidine</e1> ."
Other
Comment:

1000	The prior administration of  <e0>succinylcholine</e0>  does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by  <e1>TRACRIUM</e1> ."
effect(e0,e1)Comment:

1100	 <e0>TRACRIUM</e0>  should not be administered until a patient has recovered from  <e1>succinylcholine</e1> -induced neuromuscular block."
advise(e0,e1)Comment:


100	When  <e0>atropine</e0>  and  <e1>pralidoxime</e1>  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  pralidoxime  may potentiate the effect of  atropine ."
effect(e0,e1)Comment:

101	When  <e0>atropine</e0>  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  <e1>atropine</e1>  is used alone because  pralidoxime  may potentiate the effect of  atropine ."
Other
Comment:

102	When  <e0>atropine</e0>  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  <e1>pralidoxime</e1>  may potentiate the effect of  atropine ."
Other
Comment:

103	When  <e0>atropine</e0>  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  pralidoxime  may potentiate the effect of  <e1>atropine</e1> ."
Other
Comment:

104	When  atropine  and  <e0>pralidoxime</e0>  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  <e1>atropine</e1>  is used alone because  pralidoxime  may potentiate the effect of  atropine ."
Other
Comment:

105	When  atropine  and  <e0>pralidoxime</e0>  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  <e1>pralidoxime</e1>  may potentiate the effect of  atropine ."
Other
Comment:

106	When  atropine  and  <e0>pralidoxime</e0>  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  pralidoxime  may potentiate the effect of  <e1>atropine</e1> ."
Other
Comment:

107	When  atropine  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  <e0>atropine</e0>  is used alone because  <e1>pralidoxime</e1>  may potentiate the effect of  atropine ."
Other
Comment:

108	When  atropine  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  <e0>atropine</e0>  is used alone because  pralidoxime  may potentiate the effect of  <e1>atropine</e1> ."
Other
Comment:

109	When  atropine  and  pralidoxime  are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when  atropine  is used alone because  <e0>pralidoxime</e0>  may potentiate the effect of  <e1>atropine</e1> ."
effect(e0,e1)Comment:

200	The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of  <e0>atropine</e0>  and  <e1>pralidoxime</e1> ."
advise(e0,e1)Comment:

300	Since  <e0>barbiturates</e0>  are potentiated by the  <e1>anticholinesterases</e1> , they should be used cautiously in the treatment of convulsions."
advise(e0,e1)Comment:


100	 <e0>Auranofin</e0>  should be avoided by patients with a history of serious reaction to any  <e1>gold medication</e1> , including  Solganal  and  Myochrysine ."
advise(e0,e1)Comment:

101	 <e0>Auranofin</e0>  should be avoided by patients with a history of serious reaction to any  gold medication , including  <e1>Solganal</e1>  and  Myochrysine ."
advise(e0,e1)Comment:

102	 <e0>Auranofin</e0>  should be avoided by patients with a history of serious reaction to any  gold medication , including  Solganal  and  <e1>Myochrysine</e1> ."
advise(e0,e1)Comment:

103	 Auranofin  should be avoided by patients with a history of serious reaction to any  <e0>gold medication</e0> , including  <e1>Solganal</e1>  and  Myochrysine ."
Other
Comment:

104	 Auranofin  should be avoided by patients with a history of serious reaction to any  <e0>gold medication</e0> , including  Solganal  and  <e1>Myochrysine</e1> ."
Other
Comment:

105	 Auranofin  should be avoided by patients with a history of serious reaction to any  gold medication , including  <e0>Solganal</e0>  and  <e1>Myochrysine</e1> ."
Other
Comment:

200	 <e0>Auranofin</e0>  should not be used together with  <e1>penicillamine</e1>  ( Depen ,  Cuprimine ), another arthritis medication."
advise(e0,e1)Comment:

201	 <e0>Auranofin</e0>  should not be used together with  penicillamine  ( <e1>Depen</e1> ,  Cuprimine ), another arthritis medication."
advise(e0,e1)Comment:

202	 <e0>Auranofin</e0>  should not be used together with  penicillamine  ( Depen ,  <e1>Cuprimine</e1> ), another arthritis medication."
advise(e0,e1)Comment:

203	 Auranofin  should not be used together with  <e0>penicillamine</e0>  ( <e1>Depen</e1> ,  Cuprimine ), another arthritis medication."
Other
Comment:

204	 Auranofin  should not be used together with  <e0>penicillamine</e0>  ( Depen ,  <e1>Cuprimine</e1> ), another arthritis medication."
Other
Comment:

205	 Auranofin  should not be used together with  penicillamine  ( <e0>Depen</e0> ,  <e1>Cuprimine</e1> ), another arthritis medication."
Other
Comment:



100	 <e0>MAO inhibitors</e0>  prolong and intensify the effects of  <e1>antihistamines</e1> ."
effect(e0,e1)Comment:

200	Concomitant use of  <e0>antihistamines</e0>  with  <e1>alcohol</e1> ,  tricyclic antidepressants ,  barbiturates , or other  central nervous system depressants  may have an additive effect."
effect(e0,e1)Comment:

201	Concomitant use of  <e0>antihistamines</e0>  with  alcohol ,  <e1>tricyclic antidepressants</e1> ,  barbiturates , or other  central nervous system depressants  may have an additive effect."
effect(e0,e1)Comment:

202	Concomitant use of  <e0>antihistamines</e0>  with  alcohol ,  tricyclic antidepressants ,  <e1>barbiturates</e1> , or other  central nervous system depressants  may have an additive effect."
effect(e0,e1)Comment:

203	Concomitant use of  <e0>antihistamines</e0>  with  alcohol ,  tricyclic antidepressants ,  barbiturates , or other  <e1>central nervous system depressants</e1>  may have an additive effect."
effect(e0,e1)Comment:

204	Concomitant use of  antihistamines  with  <e0>alcohol</e0> ,  <e1>tricyclic antidepressants</e1> ,  barbiturates , or other  central nervous system depressants  may have an additive effect."
Other
Comment:

205	Concomitant use of  antihistamines  with  <e0>alcohol</e0> ,  tricyclic antidepressants ,  <e1>barbiturates</e1> , or other  central nervous system depressants  may have an additive effect."
Other
Comment:

206	Concomitant use of  antihistamines  with  <e0>alcohol</e0> ,  tricyclic antidepressants ,  barbiturates , or other  <e1>central nervous system depressants</e1>  may have an additive effect."
Other
Comment:

207	Concomitant use of  antihistamines  with  alcohol ,  <e0>tricyclic antidepressants</e0> ,  <e1>barbiturates</e1> , or other  central nervous system depressants  may have an additive effect."
Other
Comment:

208	Concomitant use of  antihistamines  with  alcohol ,  <e0>tricyclic antidepressants</e0> ,  barbiturates , or other  <e1>central nervous system depressants</e1>  may have an additive effect."
Other
Comment:

209	Concomitant use of  antihistamines  with  alcohol ,  tricyclic antidepressants ,  <e0>barbiturates</e0> , or other  <e1>central nervous system depressants</e1>  may have an additive effect."
Other
Comment:

300	When  <e0>sympathomimetic drugs</e0>  are given to patients receiving  <e1>monoamine oxidase inhibitors</e1> , hypertensive reactions, including hypertensive crises, may occur."
effect(e0,e1)Comment:

400	The antihypertensive effects of  <e0>methyldopa</e0> ,  <e1>mecamylamine</e1> ,  reserpine , and  veratrum alkaloids  may be reduced by  sympathomimetics ."
Other
Comment:

401	The antihypertensive effects of  <e0>methyldopa</e0> ,  mecamylamine ,  <e1>reserpine</e1> , and  veratrum alkaloids  may be reduced by  sympathomimetics ."
Other
Comment:

402	The antihypertensive effects of  <e0>methyldopa</e0> ,  mecamylamine ,  reserpine , and  <e1>veratrum alkaloids</e1>  may be reduced by  sympathomimetics ."
Other
Comment:

403	The antihypertensive effects of  <e0>methyldopa</e0> ,  mecamylamine ,  reserpine , and  veratrum alkaloids  may be reduced by  <e1>sympathomimetics</e1> ."
effect(e0,e1)Comment:

404	The antihypertensive effects of  methyldopa ,  <e0>mecamylamine</e0> ,  <e1>reserpine</e1> , and  veratrum alkaloids  may be reduced by  sympathomimetics ."
Other
Comment:

405	The antihypertensive effects of  methyldopa ,  <e0>mecamylamine</e0> ,  reserpine , and  <e1>veratrum alkaloids</e1>  may be reduced by  sympathomimetics ."
Other
Comment:

406	The antihypertensive effects of  methyldopa ,  <e0>mecamylamine</e0> ,  reserpine , and  veratrum alkaloids  may be reduced by  <e1>sympathomimetics</e1> ."
effect(e0,e1)Comment:

407	The antihypertensive effects of  methyldopa ,  mecamylamine ,  <e0>reserpine</e0> , and  <e1>veratrum alkaloids</e1>  may be reduced by  sympathomimetics ."
Other
Comment:

408	The antihypertensive effects of  methyldopa ,  mecamylamine ,  <e0>reserpine</e0> , and  veratrum alkaloids  may be reduced by  <e1>sympathomimetics</e1> ."
effect(e0,e1)Comment:

409	The antihypertensive effects of  methyldopa ,  mecamylamine ,  reserpine , and  <e0>veratrum alkaloids</e0>  may be reduced by  <e1>sympathomimetics</e1> ."
effect(e0,e1)Comment:

500	 <e0>Beta-adrenergic blocking agents</e0>  may also interact with  <e1>sympathomimetics</e1> ."
int(e0,e1)Comment:

600	Increased ectopic pacemaker activity can occur when  <e0>pseudoephedrine</e0>  is used concomitantly with  <e1>digitalis</e1> ."
effect(e0,e1)Comment:

700	 <e0>Antacids</e0>  increase the rate of absorption of  <e1>pseudoephedrine</e1> , while  kaolin  decreases it."
mechanism(e0,e1)Comment:

701	 <e0>Antacids</e0>  increase the rate of absorption of  pseudoephedrine , while  <e1>kaolin</e1>  decreases it."
Other
Comment:

702	 Antacids  increase the rate of absorption of  <e0>pseudoephedrine</e0> , while  <e1>kaolin</e1>  decreases it."
mechanism(e0,e1)Comment:


100	Use with  <e0>Allopurinol</e0> : The principal pathway for detoxification of  <e1>azathioprine</e1>  is inhibited by  allopurinol ."
Other
Comment:

101	Use with  <e0>Allopurinol</e0> : The principal pathway for detoxification of  azathioprine  is inhibited by  <e1>allopurinol</e1> ."
Other
Comment:

102	Use with  Allopurinol : The principal pathway for detoxification of  <e0>azathioprine</e0>  is inhibited by  <e1>allopurinol</e1> ."
mechanism(e0,e1)Comment:

200	Patients receiving  <e0>azathioprine</e0>  and  <e1>allopurinol</e1>  concomitantly should have a dose reduction of  azathioprine , to approximately 1/3 to 1/4 the usual dose."
advise(e0,e1)Comment:

201	Patients receiving  <e0>azathioprine</e0>  and  allopurinol  concomitantly should have a dose reduction of  <e1>azathioprine</e1> , to approximately 1/3 to 1/4 the usual dose."
Other
Comment:

202	Patients receiving  azathioprine  and  <e0>allopurinol</e0>  concomitantly should have a dose reduction of  <e1>azathioprine</e1> , to approximately 1/3 to 1/4 the usual dose."
Other
Comment:

400	Use with  <e0>Angiotensln Converting Enzyme Inhibitors</e0> : The use of  <e1>angiotensin converting enzyme inhibitors</e1>  to control hypertension in patients on  azathioprine  has been reported to induce severe leukopenia."
Other
Comment:

401	Use with  <e0>Angiotensln Converting Enzyme Inhibitors</e0> : The use of  angiotensin converting enzyme inhibitors  to control hypertension in patients on  <e1>azathioprine</e1>  has been reported to induce severe leukopenia."
Other
Comment:

402	Use with  Angiotensln Converting Enzyme Inhibitors : The use of  <e0>angiotensin converting enzyme inhibitors</e0>  to control hypertension in patients on  <e1>azathioprine</e1>  has been reported to induce severe leukopenia."
effect(e0,e1)Comment:



100	Co-administration of  <e0>nelfinavir</e0>  at steady-state with a single dose of  <e1>azithromycin</e1> ."
Other
Comment:

200	Co-administration of  <e0>nelfinavir</e0>  at steady-state with a single dose of  <e1>azithromycin</e1>  (2 x 600 mg tablets) results in increased  azithromycin  serum concentrations."
effect(e0,e1)Comment:

201	Co-administration of  <e0>nelfinavir</e0>  at steady-state with a single dose of  azithromycin  (2 x 600 mg tablets) results in increased  <e1>azithromycin</e1>  serum concentrations."
Other
Comment:

202	Co-administration of  nelfinavir  at steady-state with a single dose of  <e0>azithromycin</e0>  (2 x 600 mg tablets) results in increased  <e1>azithromycin</e1>  serum concentrations."
Other
Comment:

300	Although a dose adjustment of  <e0>azithromycin</e0>  is not recommended when administered in combination with  <e1>nelfinavir</e1> , close monitoring for known side effects of  azithromycin , such as liver enzyme abnormalities and hearing impairment, is warranted."
advise(e0,e1)Comment:

301	Although a dose adjustment of  <e0>azithromycin</e0>  is not recommended when administered in combination with  nelfinavir , close monitoring for known side effects of  <e1>azithromycin</e1> , such as liver enzyme abnormalities and hearing impairment, is warranted."
Other
Comment:

302	Although a dose adjustment of  azithromycin  is not recommended when administered in combination with  <e0>nelfinavir</e0> , close monitoring for known side effects of  <e1>azithromycin</e1> , such as liver enzyme abnormalities and hearing impairment, is warranted."
Other
Comment:

400	 <e0>Azithromycin</e0>  did not affect the prothrombin time response to a single dose of  <e1>warfarin</e1> ."
Other
Comment:

500	However, prudent medical practice dictates careful monitoring of prothrombin time in all patients treated with  <e0>azithromycin</e0>  and  <e1>warfarin</e1>  concomitantly."
advise(e0,e1)Comment:

600	Concurrent use of  <e0>macrolides</e0>  and  <e1>warfarin</e1>  in clinical practice has been associated with increased anticoagulant effects."
effect(e0,e1)Comment:

800	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  <e1>atorvastatin</e1> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

801	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e1>carbamazepine</e1> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

802	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e1>cetirizine</e1> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

803	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e1>didanosine</e1> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

804	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e1>efavirenz</e1> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

805	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

806	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

807	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

808	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

809	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

810	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

811	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

812	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
mechanism(e0,e1)Comment:

813	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
mechanism(e0,e1)Comment:

814	When used in therapeutic doses,  <e0>azithromycin</e0>  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
mechanism(e0,e1)Comment:

815	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  <e1>carbamazepine</e1> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

816	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  <e1>cetirizine</e1> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

817	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  <e1>didanosine</e1> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

818	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  <e1>efavirenz</e1> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

819	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

820	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

821	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

822	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

823	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

824	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

825	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

826	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

827	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

828	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  <e0>atorvastatin</e0> ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

829	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  <e1>cetirizine</e1> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

830	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  <e1>didanosine</e1> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

831	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  <e1>efavirenz</e1> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

832	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

833	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

834	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

835	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

836	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

837	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

838	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

839	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

840	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

841	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  <e0>carbamazepine</e0> ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

842	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  <e1>didanosine</e1> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

843	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  <e1>efavirenz</e1> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

844	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

845	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

846	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

847	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

848	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

849	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

850	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

851	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

852	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

853	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  <e0>cetirizine</e0> ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

854	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  <e1>efavirenz</e1> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

855	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

856	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

857	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

858	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

859	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

860	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

861	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

862	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

863	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

864	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  <e0>didanosine</e0> ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

865	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  <e1>fluconazole</e1> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

866	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

867	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

868	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

869	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

870	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

871	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

872	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

873	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

874	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  <e0>efavirenz</e0> ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

875	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  <e1>indinavir</e1> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

876	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

877	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

878	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

879	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

880	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

881	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

882	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

883	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  <e0>fluconazole</e0> ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

884	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  <e1>midazolam</e1> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

885	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

886	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

887	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

888	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

889	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

890	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

891	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  <e0>indinavir</e0> ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

892	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  <e1>rifabutin</e1> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

893	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

894	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

895	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

896	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

897	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

898	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  <e0>midazolam</e0> ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

899	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  <e1>sildenafil</e1> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

900	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  sildenafil ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

901	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  sildenafil ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

902	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

903	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

904	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  <e0>rifabutin</e0> ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

905	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e0>sildenafil</e0> ,  <e1>theophylline</e1>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

906	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e0>sildenafil</e0> ,  theophylline  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

907	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e0>sildenafil</e0> ,  theophylline  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

908	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e0>sildenafil</e0> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

909	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  <e0>sildenafil</e0> ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

910	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e0>theophylline</e0>  (intravenous and oral),  <e1>triazolam</e1> ,  trimethoprim / sulfamethoxazole  or  zidovudine ."
Other
Comment:

911	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e0>theophylline</e0>  (intravenous and oral),  triazolam ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

912	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e0>theophylline</e0>  (intravenous and oral),  triazolam ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

913	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  <e0>theophylline</e0>  (intravenous and oral),  triazolam ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

914	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e0>triazolam</e0> ,  <e1>trimethoprim</e1> / sulfamethoxazole  or  zidovudine ."
Other
Comment:

915	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e0>triazolam</e0> ,  trimethoprim / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

916	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  <e0>triazolam</e0> ,  trimethoprim / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

917	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e0>trimethoprim</e0> / <e1>sulfamethoxazole</e1>  or  zidovudine ."
Other
Comment:

918	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  <e0>trimethoprim</e0> / sulfamethoxazole  or  <e1>zidovudine</e1> ."
Other
Comment:

919	When used in therapeutic doses,  azithromycin  had a modest effect on the pharmacokinetics of  atorvastatin ,  carbamazepine ,  cetirizine ,  didanosine ,  efavirenz ,  fluconazole ,  indinavir ,  midazolam ,  rifabutin ,  sildenafil ,  theophylline  (intravenous and oral),  triazolam ,  trimethoprim / <e0>sulfamethoxazole</e0>  or  <e1>zidovudine</e1> ."
Other
Comment:

900	Co-administration with  <e0>efavirenz</e0>  or  <e1>fluconazole</e1>  had a modest effect on the pharmacokinetics of  azithromycin ."
Other
Comment:

901	Co-administration with  <e0>efavirenz</e0>  or  fluconazole  had a modest effect on the pharmacokinetics of  <e1>azithromycin</e1> ."
mechanism(e0,e1)Comment:

902	Co-administration with  efavirenz  or  <e0>fluconazole</e0>  had a modest effect on the pharmacokinetics of  <e1>azithromycin</e1> ."
mechanism(e0,e1)Comment:

1400	Until further data are developed regarding drug interactions when  <e0>azithromycin</e0>  and these drugs are used concomitantly, careful monitoring of patients is advised:  <e1>Digoxin</e1>  elevated  digoxin  concentrations."
Other
Comment:

1401	Until further data are developed regarding drug interactions when  <e0>azithromycin</e0>  and these drugs are used concomitantly, careful monitoring of patients is advised:  Digoxin  elevated  <e1>digoxin</e1>  concentrations."
Other
Comment:

1402	Until further data are developed regarding drug interactions when  azithromycin  and these drugs are used concomitantly, careful monitoring of patients is advised:  <e0>Digoxin</e0>  elevated  <e1>digoxin</e1>  concentrations."
Other
Comment:

1500	 <e0>Ergotamine</e0>  or  <e1>dihydroergotamine</e1>  acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia."
Other
Comment:

1600	 <e0>Cyclosporine</e0> ,  <e1>hexobarbital</e1>  and  phenytoin  concentrations."
Other
Comment:

1601	 <e0>Cyclosporine</e0> ,  hexobarbital  and  <e1>phenytoin</e1>  concentrations."
Other
Comment:

1602	 Cyclosporine ,  <e0>hexobarbital</e0>  and  <e1>phenytoin</e1>  concentrations."
Other
Comment:


100	 <e0>Azlocillin</e0>  should not be administered concomitantly with  <e1>amikacin</e1> ,  ciprofloxacin ,  gentamicin ,  netilmicin , or  tobramycin ."
advise(e0,e1)Comment:

101	 <e0>Azlocillin</e0>  should not be administered concomitantly with  amikacin ,  <e1>ciprofloxacin</e1> ,  gentamicin ,  netilmicin , or  tobramycin ."
advise(e0,e1)Comment:

102	 <e0>Azlocillin</e0>  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  <e1>gentamicin</e1> ,  netilmicin , or  tobramycin ."
advise(e0,e1)Comment:

103	 <e0>Azlocillin</e0>  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  gentamicin ,  <e1>netilmicin</e1> , or  tobramycin ."
advise(e0,e1)Comment:

104	 <e0>Azlocillin</e0>  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  gentamicin ,  netilmicin , or  <e1>tobramycin</e1> ."
advise(e0,e1)Comment:

105	 Azlocillin  should not be administered concomitantly with  <e0>amikacin</e0> ,  <e1>ciprofloxacin</e1> ,  gentamicin ,  netilmicin , or  tobramycin ."
Other
Comment:

106	 Azlocillin  should not be administered concomitantly with  <e0>amikacin</e0> ,  ciprofloxacin ,  <e1>gentamicin</e1> ,  netilmicin , or  tobramycin ."
Other
Comment:

107	 Azlocillin  should not be administered concomitantly with  <e0>amikacin</e0> ,  ciprofloxacin ,  gentamicin ,  <e1>netilmicin</e1> , or  tobramycin ."
Other
Comment:

108	 Azlocillin  should not be administered concomitantly with  <e0>amikacin</e0> ,  ciprofloxacin ,  gentamicin ,  netilmicin , or  <e1>tobramycin</e1> ."
Other
Comment:

109	 Azlocillin  should not be administered concomitantly with  amikacin ,  <e0>ciprofloxacin</e0> ,  <e1>gentamicin</e1> ,  netilmicin , or  tobramycin ."
Other
Comment:

110	 Azlocillin  should not be administered concomitantly with  amikacin ,  <e0>ciprofloxacin</e0> ,  gentamicin ,  <e1>netilmicin</e1> , or  tobramycin ."
Other
Comment:

111	 Azlocillin  should not be administered concomitantly with  amikacin ,  <e0>ciprofloxacin</e0> ,  gentamicin ,  netilmicin , or  <e1>tobramycin</e1> ."
Other
Comment:

112	 Azlocillin  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  <e0>gentamicin</e0> ,  <e1>netilmicin</e1> , or  tobramycin ."
Other
Comment:

113	 Azlocillin  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  <e0>gentamicin</e0> ,  netilmicin , or  <e1>tobramycin</e1> ."
Other
Comment:

114	 Azlocillin  should not be administered concomitantly with  amikacin ,  ciprofloxacin ,  gentamicin ,  <e0>netilmicin</e0> , or  <e1>tobramycin</e1> ."
Other
Comment:


200	Interactions attributed to the combined use of  <e0>baclofen</e0>  injection and epidural  <e1>morphine</e1>  include hypotension and dyspnea."
effect(e0,e1)Comment:

300	SIDE EFFECTS ( <e0>KEMSTRO</e0> ) The most common adverse reaction during treatment with  <e1>baclofen</e1>  is transient drowsiness (10-63%)."
Other
Comment:

1700	The adverse experience profile seen with  <e0>KEMSTROTM</e0>  was similar to that seen with  <e1>baclofen</e1>  tablets."
Other
Comment:


100	No drug interaction studies have been conducted for  <e0>COLAZAL</e0> , however the use of orally administered  <e1>antibiotics</e1>  could, theoretically, interfere with the release of  mesalamine  in the colon."
Other
Comment:

101	No drug interaction studies have been conducted for  <e0>COLAZAL</e0> , however the use of orally administered  antibiotics  could, theoretically, interfere with the release of  <e1>mesalamine</e1>  in the colon."
Other
Comment:

102	No drug interaction studies have been conducted for  COLAZAL , however the use of orally administered  <e0>antibiotics</e0>  could, theoretically, interfere with the release of  <e1>mesalamine</e1>  in the colon."
Other
Comment:


100	No dose adjustment is necessary when  <e0>Simulect</e0>  is added to triple-immunosuppression regimens including  <e1>cyclosporine</e1> ,  corticosteroids , and either  azathioprine  or  mycophenolate mofetil ."
Other
Comment:

101	No dose adjustment is necessary when  <e0>Simulect</e0>  is added to triple-immunosuppression regimens including  cyclosporine ,  <e1>corticosteroids</e1> , and either  azathioprine  or  mycophenolate mofetil ."
Other
Comment:

102	No dose adjustment is necessary when  <e0>Simulect</e0>  is added to triple-immunosuppression regimens including  cyclosporine ,  corticosteroids , and either  <e1>azathioprine</e1>  or  mycophenolate mofetil ."
Other
Comment:

103	No dose adjustment is necessary when  <e0>Simulect</e0>  is added to triple-immunosuppression regimens including  cyclosporine ,  corticosteroids , and either  azathioprine  or  <e1>mycophenolate mofetil</e1> ."
Other
Comment:

104	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  <e0>cyclosporine</e0> ,  <e1>corticosteroids</e1> , and either  azathioprine  or  mycophenolate mofetil ."
Other
Comment:

105	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  <e0>cyclosporine</e0> ,  corticosteroids , and either  <e1>azathioprine</e1>  or  mycophenolate mofetil ."
Other
Comment:

106	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  <e0>cyclosporine</e0> ,  corticosteroids , and either  azathioprine  or  <e1>mycophenolate mofetil</e1> ."
Other
Comment:

107	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  cyclosporine ,  <e0>corticosteroids</e0> , and either  <e1>azathioprine</e1>  or  mycophenolate mofetil ."
Other
Comment:

108	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  cyclosporine ,  <e0>corticosteroids</e0> , and either  azathioprine  or  <e1>mycophenolate mofetil</e1> ."
Other
Comment:

109	No dose adjustment is necessary when  Simulect  is added to triple-immunosuppression regimens including  cyclosporine ,  corticosteroids , and either  <e0>azathioprine</e0>  or  <e1>mycophenolate mofetil</e1> ."
Other
Comment:

400	Total body clearance of  <e0>Simulect</e0>  was reduced by an average 22% and 51% when  <e1>azathioprine</e1>  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  corticosteroids ."
mechanism(e0,e1)Comment:

401	Total body clearance of  <e0>Simulect</e0>  was reduced by an average 22% and 51% when  azathioprine  and  <e1>mycophenolate mofetil</e1> , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  corticosteroids ."
mechanism(e0,e1)Comment:

402	Total body clearance of  <e0>Simulect</e0>  was reduced by an average 22% and 51% when  azathioprine  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  <e1>cyclosporine</e1> , USP (MODIFIED) and  corticosteroids ."
Other
Comment:

403	Total body clearance of  <e0>Simulect</e0>  was reduced by an average 22% and 51% when  azathioprine  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  <e1>corticosteroids</e1> ."
Other
Comment:

404	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  <e0>azathioprine</e0>  and  <e1>mycophenolate mofetil</e1> , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  corticosteroids ."
Other
Comment:

405	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  <e0>azathioprine</e0>  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  <e1>cyclosporine</e1> , USP (MODIFIED) and  corticosteroids ."
Other
Comment:

406	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  <e0>azathioprine</e0>  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  <e1>corticosteroids</e1> ."
Other
Comment:

407	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  azathioprine  and  <e0>mycophenolate mofetil</e0> , respectively, were added to a regimen consisting of  <e1>cyclosporine</e1> , USP (MODIFIED) and  corticosteroids ."
Other
Comment:

408	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  azathioprine  and  <e0>mycophenolate mofetil</e0> , respectively, were added to a regimen consisting of  cyclosporine , USP (MODIFIED) and  <e1>corticosteroids</e1> ."
Other
Comment:

409	Total body clearance of  Simulect  was reduced by an average 22% and 51% when  azathioprine  and  mycophenolate mofetil , respectively, were added to a regimen consisting of  <e0>cyclosporine</e0> , USP (MODIFIED) and  <e1>corticosteroids</e1> ."
Other
Comment:

500	Nonetheless, the range of individual  <e0>Simulect</e0>  clearance values in the presence of  <e1>azathioprine</e1>  (12-57 mL/h) or  mycophenolate mofetil  (7-54 mL/h) did not extend outside the range observed with dual therapy (10-78 mL/h)."
Other
Comment:

501	Nonetheless, the range of individual  <e0>Simulect</e0>  clearance values in the presence of  azathioprine  (12-57 mL/h) or  <e1>mycophenolate mofetil</e1>  (7-54 mL/h) did not extend outside the range observed with dual therapy (10-78 mL/h)."
Other
Comment:

502	Nonetheless, the range of individual  Simulect  clearance values in the presence of  <e0>azathioprine</e0>  (12-57 mL/h) or  <e1>mycophenolate mofetil</e1>  (7-54 mL/h) did not extend outside the range observed with dual therapy (10-78 mL/h)."
Other
Comment:

600	The following medications have been administered in clinical trials with  <e0>Simulect</e0>  with no increase in adverse reactions: ATG/ALG,  <e1>azathioprine</e1> ,  corticosteroids ,  cyclosporine ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

601	The following medications have been administered in clinical trials with  <e0>Simulect</e0>  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  <e1>corticosteroids</e1> ,  cyclosporine ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

602	The following medications have been administered in clinical trials with  <e0>Simulect</e0>  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  <e1>cyclosporine</e1> ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

603	The following medications have been administered in clinical trials with  <e0>Simulect</e0>  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  cyclosporine ,  <e1>mycophenolate mofetil</e1> , and  muromonab-CD3 ."
Other
Comment:

604	The following medications have been administered in clinical trials with  <e0>Simulect</e0>  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  cyclosporine ,  mycophenolate mofetil , and  <e1>muromonab-CD3</e1> ."
Other
Comment:

605	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  <e0>azathioprine</e0> ,  <e1>corticosteroids</e1> ,  cyclosporine ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

606	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  <e0>azathioprine</e0> ,  corticosteroids ,  <e1>cyclosporine</e1> ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

607	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  <e0>azathioprine</e0> ,  corticosteroids ,  cyclosporine ,  <e1>mycophenolate mofetil</e1> , and  muromonab-CD3 ."
Other
Comment:

608	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  <e0>azathioprine</e0> ,  corticosteroids ,  cyclosporine ,  mycophenolate mofetil , and  <e1>muromonab-CD3</e1> ."
Other
Comment:

609	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  <e0>corticosteroids</e0> ,  <e1>cyclosporine</e1> ,  mycophenolate mofetil , and  muromonab-CD3 ."
Other
Comment:

610	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  <e0>corticosteroids</e0> ,  cyclosporine ,  <e1>mycophenolate mofetil</e1> , and  muromonab-CD3 ."
Other
Comment:

611	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  <e0>corticosteroids</e0> ,  cyclosporine ,  mycophenolate mofetil , and  <e1>muromonab-CD3</e1> ."
Other
Comment:

612	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  <e0>cyclosporine</e0> ,  <e1>mycophenolate mofetil</e1> , and  muromonab-CD3 ."
Other
Comment:

613	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  <e0>cyclosporine</e0> ,  mycophenolate mofetil , and  <e1>muromonab-CD3</e1> ."
Other
Comment:

614	The following medications have been administered in clinical trials with  Simulect  with no increase in adverse reactions: ATG/ALG,  azathioprine ,  corticosteroids ,  cyclosporine ,  <e0>mycophenolate mofetil</e0> , and  <e1>muromonab-CD3</e1> ."
Other
Comment:



100	 <e0>Albuterol</e0> ,  <e1>Antihistamines</e1> ,  antidiabetic drugs ,  diuretics ,  digitalis ."
Other
Comment:

101	 <e0>Albuterol</e0> ,  Antihistamines ,  <e1>antidiabetic drugs</e1> ,  diuretics ,  digitalis ."
Other
Comment:

102	 <e0>Albuterol</e0> ,  Antihistamines ,  antidiabetic drugs ,  <e1>diuretics</e1> ,  digitalis ."
Other
Comment:

103	 <e0>Albuterol</e0> ,  Antihistamines ,  antidiabetic drugs ,  diuretics ,  <e1>digitalis</e1> ."
Other
Comment:

104	 Albuterol ,  <e0>Antihistamines</e0> ,  <e1>antidiabetic drugs</e1> ,  diuretics ,  digitalis ."
Other
Comment:

105	 Albuterol ,  <e0>Antihistamines</e0> ,  antidiabetic drugs ,  <e1>diuretics</e1> ,  digitalis ."
Other
Comment:

106	 Albuterol ,  <e0>Antihistamines</e0> ,  antidiabetic drugs ,  diuretics ,  <e1>digitalis</e1> ."
Other
Comment:

107	 Albuterol ,  Antihistamines ,  <e0>antidiabetic drugs</e0> ,  <e1>diuretics</e1> ,  digitalis ."
Other
Comment:

108	 Albuterol ,  Antihistamines ,  <e0>antidiabetic drugs</e0> ,  diuretics ,  <e1>digitalis</e1> ."
Other
Comment:

109	 Albuterol ,  Antihistamines ,  antidiabetic drugs ,  <e0>diuretics</e0> ,  <e1>digitalis</e1> ."
Other
Comment:


100	 <e0>Diuretics</e0> : Patients on  <e1>diuretics</e1> , especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with  Lotensin ."
Other
Comment:

101	 <e0>Diuretics</e0> : Patients on  diuretics , especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with  <e1>Lotensin</e1> ."
Other
Comment:

102	 Diuretics : Patients on  <e0>diuretics</e0> , especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with  <e1>Lotensin</e1> ."
effect(e0,e1)Comment:

200	The possibility of hypotensive effects with  <e0>Lotensin</e0>  can be minimized by either discontinuing the  <e1>diuretic</e1>  or increasing the salt intake prior to initiation of treatment with  Lotensin ."
Other
Comment:

201	The possibility of hypotensive effects with  <e0>Lotensin</e0>  can be minimized by either discontinuing the  diuretic  or increasing the salt intake prior to initiation of treatment with  <e1>Lotensin</e1> ."
Other
Comment:

202	The possibility of hypotensive effects with  Lotensin  can be minimized by either discontinuing the  <e0>diuretic</e0>  or increasing the salt intake prior to initiation of treatment with  <e1>Lotensin</e1> ."
advise(e0,e1)Comment:

400	 <e0>Potassium</e0>  Supplements and  <e1>Potassium-Sparing Diuretics</e1>  Lotensin can attenuate potassium loss caused by  thiazide diuretics ."
Other
Comment:

401	 <e0>Potassium</e0>  Supplements and  Potassium-Sparing Diuretics  Lotensin can attenuate potassium loss caused by  <e1>thiazide diuretics</e1> ."
Other
Comment:

402	 Potassium  Supplements and  <e0>Potassium-Sparing Diuretics</e0>  Lotensin can attenuate potassium loss caused by  <e1>thiazide diuretics</e1> ."
effect(e0,e1)Comment:

500	 <e0>Potassium-sparing diuretics</e0>  ( <e1>spironolactone</e1> ,  amiloride ,  triamterene , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

501	 <e0>Potassium-sparing diuretics</e0>  ( spironolactone ,  <e1>amiloride</e1> ,  triamterene , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

502	 <e0>Potassium-sparing diuretics</e0>  ( spironolactone ,  amiloride ,  <e1>triamterene</e1> , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

503	 <e0>Potassium-sparing diuretics</e0>  ( spironolactone ,  amiloride ,  triamterene , and others) or  <e1>potassium</e1>  supplements can increase the risk of hyperkalemia."
Other
Comment:

504	 Potassium-sparing diuretics  ( <e0>spironolactone</e0> ,  <e1>amiloride</e1> ,  triamterene , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

505	 Potassium-sparing diuretics  ( <e0>spironolactone</e0> ,  amiloride ,  <e1>triamterene</e1> , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

506	 Potassium-sparing diuretics  ( <e0>spironolactone</e0> ,  amiloride ,  triamterene , and others) or  <e1>potassium</e1>  supplements can increase the risk of hyperkalemia."
Other
Comment:

507	 Potassium-sparing diuretics  ( spironolactone ,  <e0>amiloride</e0> ,  <e1>triamterene</e1> , and others) or  potassium  supplements can increase the risk of hyperkalemia."
Other
Comment:

508	 Potassium-sparing diuretics  ( spironolactone ,  <e0>amiloride</e0> ,  triamterene , and others) or  <e1>potassium</e1>  supplements can increase the risk of hyperkalemia."
Other
Comment:

509	 Potassium-sparing diuretics  ( spironolactone ,  amiloride ,  <e0>triamterene</e0> , and others) or  <e1>potassium</e1>  supplements can increase the risk of hyperkalemia."
Other
Comment:

700	Oral  <e0>Anticoagulants</e0>  Interaction studies with  <e1>warfarin</e1>  and  acenocoumarol  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  anticoagulants ."
Other
Comment:

701	Oral  <e0>Anticoagulants</e0>  Interaction studies with  warfarin  and  <e1>acenocoumarol</e1>  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  anticoagulants ."
Other
Comment:

702	Oral  <e0>Anticoagulants</e0>  Interaction studies with  warfarin  and  acenocoumarol  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  <e1>anticoagulants</e1> ."
Other
Comment:

703	Oral  Anticoagulants  Interaction studies with  <e0>warfarin</e0>  and  <e1>acenocoumarol</e1>  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  anticoagulants ."
Other
Comment:

704	Oral  Anticoagulants  Interaction studies with  <e0>warfarin</e0>  and  acenocoumarol  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  <e1>anticoagulants</e1> ."
Other
Comment:

705	Oral  Anticoagulants  Interaction studies with  warfarin  and  <e0>acenocoumarol</e0>  failed to identify any clinically important effects on the serum concentrations or clinical effects of these  <e1>anticoagulants</e1> ."
Other
Comment:

800	 <e0>Lithium</e0> : Increased serum  <e1>lithium</e1>  levels and symptoms of  lithium  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  lithium ."
Other
Comment:

801	 <e0>Lithium</e0> : Increased serum  lithium  levels and symptoms of  <e1>lithium</e1>  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  lithium ."
Other
Comment:

802	 <e0>Lithium</e0> : Increased serum  lithium  levels and symptoms of  lithium  toxicity have been reported in patients receiving  <e1>ACE inhibitors</e1>  during therapy with  lithium ."
Other
Comment:

803	 <e0>Lithium</e0> : Increased serum  lithium  levels and symptoms of  lithium  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  <e1>lithium</e1> ."
Other
Comment:

804	 Lithium : Increased serum  <e0>lithium</e0>  levels and symptoms of  <e1>lithium</e1>  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  lithium ."
Other
Comment:

805	 Lithium : Increased serum  <e0>lithium</e0>  levels and symptoms of  lithium  toxicity have been reported in patients receiving  <e1>ACE inhibitors</e1>  during therapy with  lithium ."
Other
Comment:

806	 Lithium : Increased serum  <e0>lithium</e0>  levels and symptoms of  lithium  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  <e1>lithium</e1> ."
Other
Comment:

807	 Lithium : Increased serum  lithium  levels and symptoms of  <e0>lithium</e0>  toxicity have been reported in patients receiving  <e1>ACE inhibitors</e1>  during therapy with  lithium ."
Other
Comment:

808	 Lithium : Increased serum  lithium  levels and symptoms of  <e0>lithium</e0>  toxicity have been reported in patients receiving  ACE inhibitors  during therapy with  <e1>lithium</e1> ."
Other
Comment:

809	 Lithium : Increased serum  lithium  levels and symptoms of  lithium  toxicity have been reported in patients receiving  <e0>ACE inhibitors</e0>  during therapy with  <e1>lithium</e1> ."
mechanism(e0,e1)Comment:

1000	If a  <e0>diuretic</e0>  is also used, the risk of  <e1>lithium</e1>  toxicity may be increased."
effect(e0,e1)Comment:

1100	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  <e1>hydrochlorothiazide</e1> ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1101	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  <e1>chlorthalidone</e1> ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1102	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e1>furosemide</e1> ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1103	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  <e1>digoxin</e1> ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1104	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  <e1>propranolol</e1> ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1105	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1106	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1107	Other No clinically important pharmacokinetic interactions occurred when  <e0>Lotensin</e0>  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1108	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  <e1>chlorthalidone</e1> ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1109	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  <e1>furosemide</e1> ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1110	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  furosemide ,  <e1>digoxin</e1> ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1111	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  furosemide ,  digoxin ,  <e1>propranolol</e1> ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1112	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1113	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1114	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  <e0>hydrochlorothiazide</e0> ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1115	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  <e1>furosemide</e1> ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1116	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  furosemide ,  <e1>digoxin</e1> ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1117	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  furosemide ,  digoxin ,  <e1>propranolol</e1> ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1118	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  furosemide ,  digoxin ,  propranolol ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1119	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1120	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  <e0>chlorthalidone</e0> ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1121	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e0>furosemide</e0> ,  <e1>digoxin</e1> ,  propranolol ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1122	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e0>furosemide</e0> ,  digoxin ,  <e1>propranolol</e1> ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1123	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e0>furosemide</e0> ,  digoxin ,  propranolol ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1124	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e0>furosemide</e0> ,  digoxin ,  propranolol ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1125	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  <e0>furosemide</e0> ,  digoxin ,  propranolol ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1126	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  <e0>digoxin</e0> ,  <e1>propranolol</e1> ,  atenolol ,  naproxen , or  cimetidine ."
Other
Comment:

1127	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  <e0>digoxin</e0> ,  propranolol ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1128	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  <e0>digoxin</e0> ,  propranolol ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1129	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  <e0>digoxin</e0> ,  propranolol ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1130	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  <e0>propranolol</e0> ,  <e1>atenolol</e1> ,  naproxen , or  cimetidine ."
Other
Comment:

1131	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  <e0>propranolol</e0> ,  atenolol ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1132	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  <e0>propranolol</e0> ,  atenolol ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1133	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  <e0>atenolol</e0> ,  <e1>naproxen</e1> , or  cimetidine ."
Other
Comment:

1134	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  <e0>atenolol</e0> ,  naproxen , or  <e1>cimetidine</e1> ."
Other
Comment:

1135	Other No clinically important pharmacokinetic interactions occurred when  Lotensin  was administered concomitantly with  hydrochlorothiazide ,  chlorthalidone ,  furosemide ,  digoxin ,  propranolol ,  atenolol ,  <e0>naproxen</e0> , or  <e1>cimetidine</e1> ."
Other
Comment:

1200	 <e0>Lotensin</e0>  has been used concomitantly with  <e1>beta-adrenergic-blocking agents</e1> ,  calcium-channel-blocking agents ,  diuretics ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1201	 <e0>Lotensin</e0>  has been used concomitantly with  beta-adrenergic-blocking agents ,  <e1>calcium-channel-blocking agents</e1> ,  diuretics ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1202	 <e0>Lotensin</e0>  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  <e1>diuretics</e1> ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1203	 <e0>Lotensin</e0>  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  diuretics ,  <e1>digoxin</e1> , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1204	 <e0>Lotensin</e0>  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  diuretics ,  digoxin , and  <e1>hydralazine</e1> , without evidence of clinically important adverse interactions."
Other
Comment:

1205	 Lotensin  has been used concomitantly with  <e0>beta-adrenergic-blocking agents</e0> ,  <e1>calcium-channel-blocking agents</e1> ,  diuretics ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1206	 Lotensin  has been used concomitantly with  <e0>beta-adrenergic-blocking agents</e0> ,  calcium-channel-blocking agents ,  <e1>diuretics</e1> ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1207	 Lotensin  has been used concomitantly with  <e0>beta-adrenergic-blocking agents</e0> ,  calcium-channel-blocking agents ,  diuretics ,  <e1>digoxin</e1> , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1208	 Lotensin  has been used concomitantly with  <e0>beta-adrenergic-blocking agents</e0> ,  calcium-channel-blocking agents ,  diuretics ,  digoxin , and  <e1>hydralazine</e1> , without evidence of clinically important adverse interactions."
Other
Comment:

1209	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  <e0>calcium-channel-blocking agents</e0> ,  <e1>diuretics</e1> ,  digoxin , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1210	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  <e0>calcium-channel-blocking agents</e0> ,  diuretics ,  <e1>digoxin</e1> , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1211	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  <e0>calcium-channel-blocking agents</e0> ,  diuretics ,  digoxin , and  <e1>hydralazine</e1> , without evidence of clinically important adverse interactions."
Other
Comment:

1212	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  <e0>diuretics</e0> ,  <e1>digoxin</e1> , and  hydralazine , without evidence of clinically important adverse interactions."
Other
Comment:

1213	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  <e0>diuretics</e0> ,  digoxin , and  <e1>hydralazine</e1> , without evidence of clinically important adverse interactions."
Other
Comment:

1214	 Lotensin  has been used concomitantly with  beta-adrenergic-blocking agents ,  calcium-channel-blocking agents ,  diuretics ,  <e0>digoxin</e0> , and  <e1>hydralazine</e1> , without evidence of clinically important adverse interactions."
Other
Comment:

1300	 <e0>Benazepril</e0> , like other  <e1>ACE inhibitors</e1> , has had less than additive effects with  beta-adrenergic blockers , presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system"
Other
Comment:

1301	 <e0>Benazepril</e0> , like other  ACE inhibitors , has had less than additive effects with  <e1>beta-adrenergic blockers</e1> , presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system"
effect(e0,e1)Comment:

1302	 Benazepril , like other  <e0>ACE inhibitors</e0> , has had less than additive effects with  <e1>beta-adrenergic blockers</e1> , presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system"
effect(e0,e1)Comment:


100	May interact with the following:  <e0>cholestyramine</e0> ,  <e1>colestipol</e1>  (use with  thiazide diuretics  may prevent the  diuretic  from working properly;"
Other
Comment:

101	May interact with the following:  <e0>cholestyramine</e0> ,  colestipol  (use with  <e1>thiazide diuretics</e1>  may prevent the  diuretic  from working properly;"
effect(e0,e1)Comment:

102	May interact with the following:  <e0>cholestyramine</e0> ,  colestipol  (use with  thiazide diuretics  may prevent the  <e1>diuretic</e1>  from working properly;"
Other
Comment:

103	May interact with the following:  cholestyramine ,  <e0>colestipol</e0>  (use with  <e1>thiazide diuretics</e1>  may prevent the  diuretic  from working properly;"
effect(e0,e1)Comment:

104	May interact with the following:  cholestyramine ,  <e0>colestipol</e0>  (use with  thiazide diuretics  may prevent the  <e1>diuretic</e1>  from working properly;"
Other
Comment:

105	May interact with the following:  cholestyramine ,  colestipol  (use with  <e0>thiazide diuretics</e0>  may prevent the  <e1>diuretic</e1>  from working properly;"
Other
Comment:


100	 <e0>Bentiromide</e0>  may interact with  <e1>acetaminophen</e1>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

101	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  <e1>Tylenol</e1> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

102	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e1>chloramphenicol</e1>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

103	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e1>Chloromycetin</e1> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

104	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e1>anesthetics</e1>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

105	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

106	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

107	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

108	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

109	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

110	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

111	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

112	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

113	 <e0>Bentiromide</e0>  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
int(e0,e1)Comment:

114	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  <e1>Tylenol</e1> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

115	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  <e1>chloramphenicol</e1>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

116	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e1>Chloromycetin</e1> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

117	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e1>anesthetics</e1>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

118	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

119	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

120	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

121	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

122	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

123	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

124	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

125	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

126	 Bentiromide  may interact with  <e0>acetaminophen</e0>  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

127	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  <e1>chloramphenicol</e1>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

128	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  <e1>Chloromycetin</e1> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

129	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e1>anesthetics</e1>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

130	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

131	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

132	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

133	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

134	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

135	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

136	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

137	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

138	 Bentiromide  may interact with  acetaminophen  (e.g.,  <e0>Tylenol</e0> ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

139	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  <e1>Chloromycetin</e1> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

140	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  <e1>anesthetics</e1>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

141	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

142	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

143	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

144	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

145	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

146	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

147	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

148	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

149	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  <e0>chloramphenicol</e0>  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

150	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  <e1>anesthetics</e1>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

151	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

152	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

153	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

154	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

155	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

156	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

157	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

158	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

159	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  <e0>Chloromycetin</e0> ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

160	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  <e1>benzocaine</e1>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

161	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

162	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

163	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

164	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

165	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

166	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

167	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

168	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  <e0>anesthetics</e0>  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

169	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  <e1>lidocaine</e1> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

170	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

171	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

172	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

173	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

174	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

175	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

176	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  <e0>benzocaine</e0>  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

177	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  <e1>para-aminobenzoic acid</e1>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

178	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

179	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

180	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

181	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

182	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

183	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  <e0>lidocaine</e0> ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

184	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( <e1>PABA</e1> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

185	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( PABA )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

186	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

187	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

188	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

189	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  <e0>para-aminobenzoic acid</e0>  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

190	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e0>PABA</e0> )-containing preparations (e.g., sunscreens and some  <e1>multivitamins</e1> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

191	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e0>PABA</e0> )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

192	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e0>PABA</e0> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

193	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e0>PABA</e0> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

194	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( <e0>PABA</e0> )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

195	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e0>multivitamins</e0> ),  <e1>procainamide</e1>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

196	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e0>multivitamins</e0> ),  procainamide  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

197	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e0>multivitamins</e0> ),  procainamide  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

198	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  <e0>multivitamins</e0> ),  procainamide  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

199	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e0>procainamide</e0>  (e.g.,  <e1>Pronestyl</e1> ),  sulfonamides  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

200	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e0>procainamide</e0>  (e.g.,  Pronestyl ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

201	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  <e0>procainamide</e0>  (e.g.,  Pronestyl ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

202	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e0>Pronestyl</e0> ),  <e1>sulfonamides</e1>  (sulfa medicines),  thiazide diuretics  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

203	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  <e0>Pronestyl</e0> ),  sulfonamides  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:

204	 Bentiromide  may interact with  acetaminophen  (e.g.,  Tylenol ),  chloramphenicol  (e.g.,  Chloromycetin ), local  anesthetics  (e.g.,  benzocaine  and  lidocaine ),  para-aminobenzoic acid  ( PABA )-containing preparations (e.g., sunscreens and some  multivitamins ),  procainamide  (e.g.,  Pronestyl ),  <e0>sulfonamides</e0>  (sulfa medicines),  <e1>thiazide diuretics</e1>  (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results)."
Other
Comment:




100	Hypertensive crises have resulted when  <e0>sympathomimetic amines</e0>  have been used concomitantly within14 days following use of  <e1>monoamine oxidase inhibitors</e1> ."
effect(e0,e1)Comment:

200	 <e0>DIDREX</e0>  should not be used concomitantly with other  <e1>CNS stimulants</e1> ."
advise(e0,e1)Comment:

300	 <e0>Amphetamines</e0>  may decrease the hypotensive effect of  <e1>antihypertensives</e1> ."
effect(e0,e1)Comment:

400	 <e0>Amphetamines</e0>  may enhance the effects of  <e1>tricyclic antidepressants</e1> ."
effect(e0,e1)Comment:

600	 <e0>Urinary acidifying</e0>  agents decrease blood levels and increase excretion of  <e1>amphetamines</e1> ."
mechanism(e0,e1)Comment:


100	 <e0>Benzthiazide</e0>  may interact with  <e1>alcohol</e1> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

101	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  <e1>blood thinner</e1> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

102	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  <e1>decongestant drugs</e1>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

103	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e1>lithium</e1> ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

104	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e1>norepinephrine</e1> ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

105	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

106	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
int(e0,e1)Comment:

107	 <e0>Benzthiazide</e0>  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
int(e0,e1)Comment:

108	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  <e1>blood thinner</e1> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

109	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  <e1>decongestant drugs</e1>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

110	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e1>lithium</e1> ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

111	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e1>norepinephrine</e1> ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

112	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

113	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

114	 Benzthiazide  may interact with  <e0>alcohol</e0> ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

115	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  <e1>decongestant drugs</e1>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

116	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e1>lithium</e1> ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

117	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e1>norepinephrine</e1> ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

118	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

119	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

120	 Benzthiazide  may interact with  alcohol ,  <e0>blood thinner</e0> s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

121	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  <e0>decongestant drugs</e0>  (allergy, cold, and sinus medicines), diabetic drugs,  <e1>lithium</e1> ,  norepinephrine ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

122	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  <e0>decongestant drugs</e0>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e1>norepinephrine</e1> ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

123	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  <e0>decongestant drugs</e0>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

124	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  <e0>decongestant drugs</e0>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

125	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  <e0>decongestant drugs</e0>  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

126	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e0>lithium</e0> ,  <e1>norepinephrine</e1> ,  NSAIDs  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

127	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e0>lithium</e0> ,  norepinephrine ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

128	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e0>lithium</e0> ,  norepinephrine ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

129	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  <e0>lithium</e0> ,  norepinephrine ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

130	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e0>norepinephrine</e0> ,  <e1>NSAIDs</e1>  like  Aleve  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

131	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e0>norepinephrine</e0> ,  NSAIDs  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

132	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  <e0>norepinephrine</e0> ,  NSAIDs  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

133	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e0>NSAIDs</e0>  like  <e1>Aleve</e1>  or  Ibuprofen , and high blood pressure medications."
Other
Comment:

134	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  <e0>NSAIDs</e0>  like  Aleve  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:

135	 Benzthiazide  may interact with  alcohol ,  blood thinner s,  decongestant drugs  (allergy, cold, and sinus medicines), diabetic drugs,  lithium ,  norepinephrine ,  NSAIDs  like  <e0>Aleve</e0>  or  <e1>Ibuprofen</e1> , and high blood pressure medications."
Other
Comment:


100	 <e0>Antipsychotic drugs</e0>  such as  <e1>phenothiazines</e1>  or  haloperidol ;"
Other
Comment:

101	 <e0>Antipsychotic drugs</e0>  such as  phenothiazines  or  <e1>haloperidol</e1> ;"
Other
Comment:

102	 Antipsychotic drugs  such as  <e0>phenothiazines</e0>  or  <e1>haloperidol</e1> ;"
Other
Comment:


100	 <e0>Nitrates</e0> : The concomitant use of  <e1>Bepridil</e1>  with long- and short-acting  nitrates  has been safely tolerated in patients with stable angina pectoris."
Other
Comment:

101	 <e0>Nitrates</e0> : The concomitant use of  Bepridil  with long- and short-acting  <e1>nitrates</e1>  has been safely tolerated in patients with stable angina pectoris."
Other
Comment:

102	 Nitrates : The concomitant use of  <e0>Bepridil</e0>  with long- and short-acting  <e1>nitrates</e1>  has been safely tolerated in patients with stable angina pectoris."
Other
Comment:

200	Sublingual  <e0>nitroglycerin</e0>  may be taken if necessary for the control of acute angina attacks during  <e1>Bepridil</e1>  therapy."
Other
Comment:

300	 <e0>Beta-blocking Agents</e0> : The concomitant use of  <e1>Bepridil</e1>  and  beta-blocking agents  has been well tolerated in patients with stable angina."
Other
Comment:

301	 <e0>Beta-blocking Agents</e0> : The concomitant use of  Bepridil  and  <e1>beta-blocking agents</e1>  has been well tolerated in patients with stable angina."
Other
Comment:

302	 Beta-blocking Agents : The concomitant use of  <e0>Bepridil</e0>  and  <e1>beta-blocking agents</e1>  has been well tolerated in patients with stable angina."
Other
Comment:

500	 <e0>Digoxin</e0> : In controlled studies in healthy volunteers,  <e1>bepridil hydrochloride</e1>  either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum  digoxin  concentrations."
Other
Comment:

501	 <e0>Digoxin</e0> : In controlled studies in healthy volunteers,  bepridil hydrochloride  either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum  <e1>digoxin</e1>  concentrations."
Other
Comment:

502	 Digoxin : In controlled studies in healthy volunteers,  <e0>bepridil hydrochloride</e0>  either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum  <e1>digoxin</e1>  concentrations."
mechanism(e0,e1)Comment:

600	Limited clinical data in angina patients receiving concomitant  <e0>bepridil hydrochloride</e0>  and  <e1>digoxin</e1>  therapy indicate no discernible changes in serum digoxin levels."
Other
Comment:

800	Oral  <e0>Hypoglycemics</e0> :  <e1>Bepridil</e1>  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  insulin  or oral  hypoglycemic agents ."
Other
Comment:

801	Oral  <e0>Hypoglycemics</e0> :  Bepridil  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  <e1>insulin</e1>  or oral  hypoglycemic agents ."
Other
Comment:

802	Oral  <e0>Hypoglycemics</e0> :  Bepridil  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  insulin  or oral  <e1>hypoglycemic agents</e1> ."
Other
Comment:

803	Oral  Hypoglycemics :  <e0>Bepridil</e0>  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  <e1>insulin</e1>  or oral  hypoglycemic agents ."
Other
Comment:

804	Oral  Hypoglycemics :  <e0>Bepridil</e0>  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  insulin  or oral  <e1>hypoglycemic agents</e1> ."
Other
Comment:

805	Oral  Hypoglycemics :  Bepridil  has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for  <e0>insulin</e0>  or oral  <e1>hypoglycemic agents</e1> ."
Other
Comment:

1000	In general, these are drugs that have one or more pharmacologic activities similar to  <e0>bepridil hydrochloride</e0> , including  <e1>anti-arrhythmic agents</e1>  such as  quinidine  and  procainamide ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1001	In general, these are drugs that have one or more pharmacologic activities similar to  <e0>bepridil hydrochloride</e0> , including  anti-arrhythmic agents  such as  <e1>quinidine</e1>  and  procainamide ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1002	In general, these are drugs that have one or more pharmacologic activities similar to  <e0>bepridil hydrochloride</e0> , including  anti-arrhythmic agents  such as  quinidine  and  <e1>procainamide</e1> ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1003	In general, these are drugs that have one or more pharmacologic activities similar to  <e0>bepridil hydrochloride</e0> , including  anti-arrhythmic agents  such as  quinidine  and  procainamide ,  <e1>cardiac glycosides</e1>  and  tricyclic anti-depressants ."
Other
Comment:

1004	In general, these are drugs that have one or more pharmacologic activities similar to  <e0>bepridil hydrochloride</e0> , including  anti-arrhythmic agents  such as  quinidine  and  procainamide ,  cardiac glycosides  and  <e1>tricyclic anti-depressants</e1> ."
Other
Comment:

1005	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  <e0>anti-arrhythmic agents</e0>  such as  <e1>quinidine</e1>  and  procainamide ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1006	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  <e0>anti-arrhythmic agents</e0>  such as  quinidine  and  <e1>procainamide</e1> ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1007	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  <e0>anti-arrhythmic agents</e0>  such as  quinidine  and  procainamide ,  <e1>cardiac glycosides</e1>  and  tricyclic anti-depressants ."
Other
Comment:

1008	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  <e0>anti-arrhythmic agents</e0>  such as  quinidine  and  procainamide ,  cardiac glycosides  and  <e1>tricyclic anti-depressants</e1> ."
Other
Comment:

1009	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  <e0>quinidine</e0>  and  <e1>procainamide</e1> ,  cardiac glycosides  and  tricyclic anti-depressants ."
Other
Comment:

1010	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  <e0>quinidine</e0>  and  procainamide ,  <e1>cardiac glycosides</e1>  and  tricyclic anti-depressants ."
Other
Comment:

1011	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  <e0>quinidine</e0>  and  procainamide ,  cardiac glycosides  and  <e1>tricyclic anti-depressants</e1> ."
Other
Comment:

1012	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  quinidine  and  <e0>procainamide</e0> ,  <e1>cardiac glycosides</e1>  and  tricyclic anti-depressants ."
Other
Comment:

1013	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  quinidine  and  <e0>procainamide</e0> ,  cardiac glycosides  and  <e1>tricyclic anti-depressants</e1> ."
Other
Comment:

1014	In general, these are drugs that have one or more pharmacologic activities similar to  bepridil hydrochloride , including  anti-arrhythmic agents  such as  quinidine  and  procainamide ,  <e0>cardiac glycosides</e0>  and  <e1>tricyclic anti-depressants</e1> ."
Other
Comment:

1100	 <e0>Anti-arrhythmics</e0>  and  <e1>tricyclic anti-depressants</e1>  could exaggerate the prolongation of the QT interval observed with  bepridil hydrochloride ."
Other
Comment:

1101	 <e0>Anti-arrhythmics</e0>  and  tricyclic anti-depressants  could exaggerate the prolongation of the QT interval observed with  <e1>bepridil hydrochloride</e1> ."
effect(e0,e1)Comment:

1102	 Anti-arrhythmics  and  <e0>tricyclic anti-depressants</e0>  could exaggerate the prolongation of the QT interval observed with  <e1>bepridil hydrochloride</e1> ."
effect(e0,e1)Comment:

1200	 <e0>Cardiac glycosides</e0>  could exaggerate the depression of AV nodal conduction observed with  <e1>bepridil hydrochloride</e1> ."
effect(e0,e1)Comment:



100	The following drugs have been coadministered with  <e0>Kerlone</e0>  and have not altered its pharmacokinetics:  <e1>cimetidine</e1> ,  nifedipine ,  chlorthalidone , and  hydrochlorothiazide ."
Other
Comment:

101	The following drugs have been coadministered with  <e0>Kerlone</e0>  and have not altered its pharmacokinetics:  cimetidine ,  <e1>nifedipine</e1> ,  chlorthalidone , and  hydrochlorothiazide ."
Other
Comment:

102	The following drugs have been coadministered with  <e0>Kerlone</e0>  and have not altered its pharmacokinetics:  cimetidine ,  nifedipine ,  <e1>chlorthalidone</e1> , and  hydrochlorothiazide ."
Other
Comment:

103	The following drugs have been coadministered with  <e0>Kerlone</e0>  and have not altered its pharmacokinetics:  cimetidine ,  nifedipine ,  chlorthalidone , and  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

104	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  <e0>cimetidine</e0> ,  <e1>nifedipine</e1> ,  chlorthalidone , and  hydrochlorothiazide ."
Other
Comment:

105	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  <e0>cimetidine</e0> ,  nifedipine ,  <e1>chlorthalidone</e1> , and  hydrochlorothiazide ."
Other
Comment:

106	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  <e0>cimetidine</e0> ,  nifedipine ,  chlorthalidone , and  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

107	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  cimetidine ,  <e0>nifedipine</e0> ,  <e1>chlorthalidone</e1> , and  hydrochlorothiazide ."
Other
Comment:

108	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  cimetidine ,  <e0>nifedipine</e0> ,  chlorthalidone , and  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

109	The following drugs have been coadministered with  Kerlone  and have not altered its pharmacokinetics:  cimetidine ,  nifedipine ,  <e0>chlorthalidone</e0> , and  <e1>hydrochlorothiazide</e1> ."
Other
Comment:

200	Concomitant administration of  <e0>Kerlone</e0>  with the oral  <e1>anticoagulant</e1>   warfarin  has been shown not to potentiate the anticoagulant effect of  warfarin ."
Other
Comment:

201	Concomitant administration of  <e0>Kerlone</e0>  with the oral  anticoagulant   <e1>warfarin</e1>  has been shown not to potentiate the anticoagulant effect of  warfarin ."
Other
Comment:

202	Concomitant administration of  <e0>Kerlone</e0>  with the oral  anticoagulant   warfarin  has been shown not to potentiate the anticoagulant effect of  <e1>warfarin</e1> ."
Other
Comment:

203	Concomitant administration of  Kerlone  with the oral  <e0>anticoagulant</e0>   <e1>warfarin</e1>  has been shown not to potentiate the anticoagulant effect of  warfarin ."
Other
Comment:

204	Concomitant administration of  Kerlone  with the oral  <e0>anticoagulant</e0>   warfarin  has been shown not to potentiate the anticoagulant effect of  <e1>warfarin</e1> ."
Other
Comment:

205	Concomitant administration of  Kerlone  with the oral  anticoagulant   <e0>warfarin</e0>  has been shown not to potentiate the anticoagulant effect of  <e1>warfarin</e1> ."
Other
Comment:

300	Catecholamine-depleting drugs (e.g.,  <e0>reserpine</e0> ) may have an additive effect when given with  <e1>beta-blocking</e1>  agents."
effect(e0,e1)Comment:

500	Should it be decided to discontinue therapy in patients receiving  <e0>beta-blockers</e0>  and  <e1>clonidine</e1>  concurrently, the  beta-blocker  should be discontinued slowly over several days before the gradual withdrawal of  clonidine ."
advise(e0,e1)Comment:

501	Should it be decided to discontinue therapy in patients receiving  <e0>beta-blockers</e0>  and  clonidine  concurrently, the  <e1>beta-blocker</e1>  should be discontinued slowly over several days before the gradual withdrawal of  clonidine ."
Other
Comment:

502	Should it be decided to discontinue therapy in patients receiving  <e0>beta-blockers</e0>  and  clonidine  concurrently, the  beta-blocker  should be discontinued slowly over several days before the gradual withdrawal of  <e1>clonidine</e1> ."
Other
Comment:

503	Should it be decided to discontinue therapy in patients receiving  beta-blockers  and  <e0>clonidine</e0>  concurrently, the  <e1>beta-blocker</e1>  should be discontinued slowly over several days before the gradual withdrawal of  clonidine ."
Other
Comment:

504	Should it be decided to discontinue therapy in patients receiving  beta-blockers  and  <e0>clonidine</e0>  concurrently, the  beta-blocker  should be discontinued slowly over several days before the gradual withdrawal of  <e1>clonidine</e1> ."
Other
Comment:

505	Should it be decided to discontinue therapy in patients receiving  beta-blockers  and  clonidine  concurrently, the  <e0>beta-blocker</e0>  should be discontinued slowly over several days before the gradual withdrawal of  <e1>clonidine</e1> ."
advise(e0,e1)Comment:

600	Literature reports suggest that oral  <e0>calcium antagonists</e0>  may be used in combination with  <e1>beta-adrenergic blocking agents</e1>  when heart function is normal, but should be avoided in patients with impaired cardiac function."
advise(e0,e1)Comment:

700	Hypotension, AV conduction disturbances, and left ventricular failure have been reported in some patients receiving  <e0>beta-adrenergic blocking agents</e0>  when an oral  <e1>calcium antagonist</e1>  was added to the treatment regimen."
effect(e0,e1)Comment:

800	Hypotension was more likely to occur if the  <e0>calcium antagonist</e0>  were a  <e1>dihydropyridine derivative</e1> , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  diltiazem ."
Other
Comment:

801	Hypotension was more likely to occur if the  <e0>calcium antagonist</e0>  were a  dihydropyridine derivative , e.g.,  <e1>nifedipine</e1> , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  diltiazem ."
Other
Comment:

802	Hypotension was more likely to occur if the  <e0>calcium antagonist</e0>  were a  dihydropyridine derivative , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  <e1>verapamil</e1>  or  diltiazem ."
Other
Comment:

803	Hypotension was more likely to occur if the  <e0>calcium antagonist</e0>  were a  dihydropyridine derivative , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  <e1>diltiazem</e1> ."
Other
Comment:

804	Hypotension was more likely to occur if the  calcium antagonist  were a  <e0>dihydropyridine derivative</e0> , e.g.,  <e1>nifedipine</e1> , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  diltiazem ."
Other
Comment:

805	Hypotension was more likely to occur if the  calcium antagonist  were a  <e0>dihydropyridine derivative</e0> , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  <e1>verapamil</e1>  or  diltiazem ."
Other
Comment:

806	Hypotension was more likely to occur if the  calcium antagonist  were a  <e0>dihydropyridine derivative</e0> , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  <e1>diltiazem</e1> ."
Other
Comment:

807	Hypotension was more likely to occur if the  calcium antagonist  were a  dihydropyridine derivative , e.g.,  <e0>nifedipine</e0> , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  <e1>verapamil</e1>  or  diltiazem ."
Other
Comment:

808	Hypotension was more likely to occur if the  calcium antagonist  were a  dihydropyridine derivative , e.g.,  <e0>nifedipine</e0> , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  verapamil  or  <e1>diltiazem</e1> ."
Other
Comment:

809	Hypotension was more likely to occur if the  calcium antagonist  were a  dihydropyridine derivative , e.g.,  nifedipine , while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either  <e0>verapamil</e0>  or  <e1>diltiazem</e1> ."
Other
Comment:

900	Risk of Anaphylactic Reaction: Although it is known that patients on  <e0>beta-blockers</e0>  may be refractory to  <e1>epinephrine</e1>  in the treatment of anaphylactic shock,  beta-blockers  can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks."
effect(e0,e1)Comment:

901	Risk of Anaphylactic Reaction: Although it is known that patients on  <e0>beta-blockers</e0>  may be refractory to  epinephrine  in the treatment of anaphylactic shock,  <e1>beta-blockers</e1>  can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks."
Other
Comment:

902	Risk of Anaphylactic Reaction: Although it is known that patients on  beta-blockers  may be refractory to  <e0>epinephrine</e0>  in the treatment of anaphylactic shock,  <e1>beta-blockers</e1>  can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks."
Other
Comment:



200	In Study 1, patients with colorectal cancer were given  <e0>irinotecan</e0> / <e1>5-FU</e1> / leucovorin  (bolus-IFL) with or without  AVASTIN ."
Other
Comment:

201	In Study 1, patients with colorectal cancer were given  <e0>irinotecan</e0> / 5-FU / <e1>leucovorin</e1>  (bolus-IFL) with or without  AVASTIN ."
Other
Comment:

202	In Study 1, patients with colorectal cancer were given  <e0>irinotecan</e0> / 5-FU / leucovorin  (bolus-IFL) with or without  <e1>AVASTIN</e1> ."
Other
Comment:

203	In Study 1, patients with colorectal cancer were given  irinotecan / <e0>5-FU</e0> / <e1>leucovorin</e1>  (bolus-IFL) with or without  AVASTIN ."
Other
Comment:

204	In Study 1, patients with colorectal cancer were given  irinotecan / <e0>5-FU</e0> / leucovorin  (bolus-IFL) with or without  <e1>AVASTIN</e1> ."
Other
Comment:

205	In Study 1, patients with colorectal cancer were given  irinotecan / 5-FU / <e0>leucovorin</e0>  (bolus-IFL) with or without  <e1>AVASTIN</e1> ."
Other
Comment:

300	 <e0>Irinotecan</e0>  concentrations were similar in patients receiving bolus-IFL alone and in combination with  <e1>AVASTIN</e1> ."
Other
Comment:

400	The concentrations of  <e0>SN38</e0> , the active metabolite of  <e1>irinotecan</e1> , were on average 33% higher in patients receiving bolus-IFL in combination with  AVASTIN  when compared with bolus-IFL alone."
Other
Comment:

401	The concentrations of  <e0>SN38</e0> , the active metabolite of  irinotecan , were on average 33% higher in patients receiving bolus-IFL in combination with  <e1>AVASTIN</e1>  when compared with bolus-IFL alone."
Other
Comment:

402	The concentrations of  SN38 , the active metabolite of  <e0>irinotecan</e0> , were on average 33% higher in patients receiving bolus-IFL in combination with  <e1>AVASTIN</e1>  when compared with bolus-IFL alone."
Other
Comment:

600	Due to high inter-patient variability and limited sampling, the extent of the increase in  <e0>SN38</e0>  levels in patients receiving concurrent  <e1>irinotecan</e1>  and  AVASTIN  is uncertain."
Other
Comment:

601	Due to high inter-patient variability and limited sampling, the extent of the increase in  <e0>SN38</e0>  levels in patients receiving concurrent  irinotecan  and  <e1>AVASTIN</e1>  is uncertain."
Other
Comment:

602	Due to high inter-patient variability and limited sampling, the extent of the increase in  SN38  levels in patients receiving concurrent  <e0>irinotecan</e0>  and  <e1>AVASTIN</e1>  is uncertain."
Other
Comment:


300	On the basis of the metabolism of  <e0>bexarotene</e0>  by cytochrome P450 3A4,  <e1>ketoconazole</e1> ,  itraconazole ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

301	On the basis of the metabolism of  <e0>bexarotene</e0>  by cytochrome P450 3A4,  ketoconazole ,  <e1>itraconazole</e1> ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

302	On the basis of the metabolism of  <e0>bexarotene</e0>  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  <e1>erythromycin</e1> ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

303	On the basis of the metabolism of  <e0>bexarotene</e0>  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  erythromycin ,  <e1>gemfibrozil</e1> , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

304	On the basis of the metabolism of  <e0>bexarotene</e0>  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  <e1>bexarotene</e1>  concentrations."
Other
Comment:

305	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  <e0>ketoconazole</e0> ,  <e1>itraconazole</e1> ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

306	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  <e0>ketoconazole</e0> ,  itraconazole ,  <e1>erythromycin</e1> ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

307	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  <e0>ketoconazole</e0> ,  itraconazole ,  erythromycin ,  <e1>gemfibrozil</e1> , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

308	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  <e0>ketoconazole</e0> ,  itraconazole ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

309	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  <e0>itraconazole</e0> ,  <e1>erythromycin</e1> ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

310	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  <e0>itraconazole</e0> ,  erythromycin ,  <e1>gemfibrozil</e1> , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

311	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  <e0>itraconazole</e0> ,  erythromycin ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

312	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  <e0>erythromycin</e0> ,  <e1>gemfibrozil</e1> , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  bexarotene  concentrations."
Other
Comment:

313	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  <e0>erythromycin</e0> ,  gemfibrozil , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

314	On the basis of the metabolism of  bexarotene  by cytochrome P450 3A4,  ketoconazole ,  itraconazole ,  erythromycin ,  <e0>gemfibrozil</e0> , grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

400	Furthermore,  <e0>rifampin</e0> ,  <e1>phenytoin</e1> ,  phenobarbital , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  bexarotene  concentrations."
Other
Comment:

401	Furthermore,  <e0>rifampin</e0> ,  phenytoin ,  <e1>phenobarbital</e1> , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  bexarotene  concentrations."
Other
Comment:

402	Furthermore,  <e0>rifampin</e0> ,  phenytoin ,  phenobarbital , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

403	Furthermore,  rifampin ,  <e0>phenytoin</e0> ,  <e1>phenobarbital</e1> , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  bexarotene  concentrations."
Other
Comment:

404	Furthermore,  rifampin ,  <e0>phenytoin</e0> ,  phenobarbital , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

405	Furthermore,  rifampin ,  phenytoin ,  <e0>phenobarbital</e0> , and other inducers of cytochrome P450 3A4 may cause a reduction in plasma  <e1>bexarotene</e1>  concentrations."
mechanism(e0,e1)Comment:

500	Concomitant administration of  <e0>Targretin</e0>  capsules and  <e1>gemfibrozil</e1>  resulted in substantial increases in plasma concentrations of  bexarotene , probably at least partially related to cytochrome P450 3A4 inhibition by  gemfibrozil ."
mechanism(e0,e1)Comment:

501	Concomitant administration of  <e0>Targretin</e0>  capsules and  gemfibrozil  resulted in substantial increases in plasma concentrations of  <e1>bexarotene</e1> , probably at least partially related to cytochrome P450 3A4 inhibition by  gemfibrozil ."
Other
Comment:

502	Concomitant administration of  <e0>Targretin</e0>  capsules and  gemfibrozil  resulted in substantial increases in plasma concentrations of  bexarotene , probably at least partially related to cytochrome P450 3A4 inhibition by  <e1>gemfibrozil</e1> ."
Other
Comment:

503	Concomitant administration of  Targretin  capsules and  <e0>gemfibrozil</e0>  resulted in substantial increases in plasma concentrations of  <e1>bexarotene</e1> , probably at least partially related to cytochrome P450 3A4 inhibition by  gemfibrozil ."
Other
Comment:

504	Concomitant administration of  Targretin  capsules and  <e0>gemfibrozil</e0>  resulted in substantial increases in plasma concentrations of  bexarotene , probably at least partially related to cytochrome P450 3A4 inhibition by  <e1>gemfibrozil</e1> ."
Other
Comment:

505	Concomitant administration of  Targretin  capsules and  gemfibrozil  resulted in substantial increases in plasma concentrations of  <e0>bexarotene</e0> , probably at least partially related to cytochrome P450 3A4 inhibition by  <e1>gemfibrozil</e1> ."
Other
Comment:

600	Under similar conditions,  <e0>bexarotene</e0>  concentrations were not affected by concomitant  <e1>atorvastatin</e1>  administration."
Other
Comment:

700	Concomitant administration of  <e0>gemfibrozil</e0>  with  <e1>Targretin</e1>  capsules is not recommended."
advise(e0,e1)Comment:


100	When  <e0>Bezalip</e0>  or  <e1>Bezalip retard</e1>  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  Bezalip retard  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

101	When  <e0>Bezalip</e0>  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  <e1>Bezalip</e1>  and  Bezalip retard  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

102	When  <e0>Bezalip</e0>  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  <e1>Bezalip retard</e1>  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

103	When  <e0>Bezalip</e0>  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  Bezalip retard  may enhance the action of  <e1>anticoagulants of the coumarin type</e1> ."
Other
Comment:

104	When  Bezalip  or  <e0>Bezalip retard</e0>  is used at the same time as other medicines or substances the following interactions must be taken into account: -  <e1>Bezalip</e1>  and  Bezalip retard  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

105	When  Bezalip  or  <e0>Bezalip retard</e0>  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  <e1>Bezalip retard</e1>  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

106	When  Bezalip  or  <e0>Bezalip retard</e0>  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  Bezalip retard  may enhance the action of  <e1>anticoagulants of the coumarin type</e1> ."
Other
Comment:

107	When  Bezalip  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  <e0>Bezalip</e0>  and  <e1>Bezalip retard</e1>  may enhance the action of  anticoagulants of the coumarin type ."
Other
Comment:

108	When  Bezalip  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  <e0>Bezalip</e0>  and  Bezalip retard  may enhance the action of  <e1>anticoagulants of the coumarin type</e1> ."
effect(e0,e1)Comment:

109	When  Bezalip  or  Bezalip retard  is used at the same time as other medicines or substances the following interactions must be taken into account: -  Bezalip  and  <e0>Bezalip retard</e0>  may enhance the action of  <e1>anticoagulants of the coumarin type</e1> ."
effect(e0,e1)Comment:

200	For this reason, the dose of the  <e0>anticoagulant</e0>  should be reduced by 30 - 50% at the start of treatment with  <e1>Bezalip</e1>  or  Bezalip  retard and then titrated according to the blood clotting parameters"
advise(e0,e1)Comment:

201	For this reason, the dose of the  <e0>anticoagulant</e0>  should be reduced by 30 - 50% at the start of treatment with  Bezalip  or  <e1>Bezalip</e1>  retard and then titrated according to the blood clotting parameters"
advise(e0,e1)Comment:

202	For this reason, the dose of the  anticoagulant  should be reduced by 30 - 50% at the start of treatment with  <e0>Bezalip</e0>  or  <e1>Bezalip</e1>  retard and then titrated according to the blood clotting parameters"
Other
Comment:

400	- The action of  <e0>sulphonylureas</e0>  and  <e1>insulin</e1>  may be enhanced by  Bezalip  or  Bezalip retard ."
Other
Comment:

401	- The action of  <e0>sulphonylureas</e0>  and  insulin  may be enhanced by  <e1>Bezalip</e1>  or  Bezalip retard ."
effect(e0,e1)Comment:

402	- The action of  <e0>sulphonylureas</e0>  and  insulin  may be enhanced by  Bezalip  or  <e1>Bezalip retard</e1> ."
effect(e0,e1)Comment:

403	- The action of  sulphonylureas  and  <e0>insulin</e0>  may be enhanced by  <e1>Bezalip</e1>  or  Bezalip retard ."
effect(e0,e1)Comment:

404	- The action of  sulphonylureas  and  <e0>insulin</e0>  may be enhanced by  Bezalip  or  <e1>Bezalip retard</e1> ."
effect(e0,e1)Comment:

405	- The action of  sulphonylureas  and  insulin  may be enhanced by  <e0>Bezalip</e0>  or  <e1>Bezalip retard</e1> ."
Other
Comment:

700	- In isolated cases, a pronounced though reversible, impairment of renal function (accompanied by a corresponding increase in the serum creatinine level) has been reported in organ transplant patients receiving  <e0>immuno-suppressant</e0>  therapy and concomitant  <e1>bezafibrate</e1> ."
effect(e0,e1)Comment:

1000	- When  <e0>Bezalip</e0>  or  <e1>Bezalip retard</e1>  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
Other
Comment:

1001	- When  <e0>Bezalip</e0>  or  Bezalip retard  is used concurrently with  <e1>anion-exchange resins</e1>  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
advise(e0,e1)Comment:

1002	- When  <e0>Bezalip</e0>  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  <e1>cholestryramine</e1> ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
advise(e0,e1)Comment:

1003	- When  <e0>Bezalip</e0>  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  <e1>Bezalip</e1>  or  Bezalip retard  is impaired"
Other
Comment:

1004	- When  <e0>Bezalip</e0>  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  <e1>Bezalip retard</e1>  is impaired"
Other
Comment:

1005	- When  Bezalip  or  <e0>Bezalip retard</e0>  is used concurrently with  <e1>anion-exchange resins</e1>  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
advise(e0,e1)Comment:

1006	- When  Bezalip  or  <e0>Bezalip retard</e0>  is used concurrently with  anion-exchange resins  (e.g.  <e1>cholestryramine</e1> ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
advise(e0,e1)Comment:

1007	- When  Bezalip  or  <e0>Bezalip retard</e0>  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  <e1>Bezalip</e1>  or  Bezalip retard  is impaired"
Other
Comment:

1008	- When  Bezalip  or  <e0>Bezalip retard</e0>  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  <e1>Bezalip retard</e1>  is impaired"
Other
Comment:

1009	- When  Bezalip  or  Bezalip retard  is used concurrently with  <e0>anion-exchange resins</e0>  (e.g.  <e1>cholestryramine</e1> ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  Bezalip retard  is impaired"
Other
Comment:

1010	- When  Bezalip  or  Bezalip retard  is used concurrently with  <e0>anion-exchange resins</e0>  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  <e1>Bezalip</e1>  or  Bezalip retard  is impaired"
Other
Comment:

1011	- When  Bezalip  or  Bezalip retard  is used concurrently with  <e0>anion-exchange resins</e0>  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  <e1>Bezalip retard</e1>  is impaired"
Other
Comment:

1012	- When  Bezalip  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  <e0>cholestryramine</e0> ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  <e1>Bezalip</e1>  or  Bezalip retard  is impaired"
Other
Comment:

1013	- When  Bezalip  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  <e0>cholestryramine</e0> ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  Bezalip  or  <e1>Bezalip retard</e1>  is impaired"
Other
Comment:

1014	- When  Bezalip  or  Bezalip retard  is used concurrently with  anion-exchange resins  (e.g.  cholestryramine ), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of  <e0>Bezalip</e0>  or  <e1>Bezalip retard</e1>  is impaired"
Other
Comment:

1200	-  <e0>Perhexiline hydrogen maleate</e0>  or  <e1>MAO-inhibitors</e1>  (with hepatotoxic potential) must not be administered together with  Bezalip  or  Bezalip retard ."
Other
Comment:

1201	-  <e0>Perhexiline hydrogen maleate</e0>  or  MAO-inhibitors  (with hepatotoxic potential) must not be administered together with  <e1>Bezalip</e1>  or  Bezalip retard ."
advise(e0,e1)Comment:

1202	-  <e0>Perhexiline hydrogen maleate</e0>  or  MAO-inhibitors  (with hepatotoxic potential) must not be administered together with  Bezalip  or  <e1>Bezalip retard</e1> ."
advise(e0,e1)Comment:

1203	-  Perhexiline hydrogen maleate  or  <e0>MAO-inhibitors</e0>  (with hepatotoxic potential) must not be administered together with  <e1>Bezalip</e1>  or  Bezalip retard ."
advise(e0,e1)Comment:

1204	-  Perhexiline hydrogen maleate  or  <e0>MAO-inhibitors</e0>  (with hepatotoxic potential) must not be administered together with  Bezalip  or  <e1>Bezalip retard</e1> ."
advise(e0,e1)Comment:

1205	-  Perhexiline hydrogen maleate  or  MAO-inhibitors  (with hepatotoxic potential) must not be administered together with  <e0>Bezalip</e0>  or  <e1>Bezalip retard</e1> ."
Other
Comment:


100	In vitro studies have shown  <e0>CASODEX</e0>  can displace  <e1>coumarin anticoagulant</e1> s, such as  warfarin , from their protein-binding sites."
mechanism(e0,e1)Comment:

101	In vitro studies have shown  <e0>CASODEX</e0>  can displace  coumarin anticoagulant s, such as  <e1>warfarin</e1> , from their protein-binding sites."
Other
Comment:

102	In vitro studies have shown  CASODEX  can displace  <e0>coumarin anticoagulant</e0> s, such as  <e1>warfarin</e1> , from their protein-binding sites."
mechanism(e0,e1)Comment:

200	It is recommended that if  <e0>CASODEX</e0>  is started in patients already receiving  <e1>coumarin anticoagulants</e1> , prothrombin times should be closely monitored and adjustment of the  anticoagulant  dose may be necessary."
advise(e0,e1)Comment:

201	It is recommended that if  <e0>CASODEX</e0>  is started in patients already receiving  coumarin anticoagulants , prothrombin times should be closely monitored and adjustment of the  <e1>anticoagulant</e1>  dose may be necessary."
advise(e0,e1)Comment:

202	It is recommended that if  CASODEX  is started in patients already receiving  <e0>coumarin anticoagulants</e0> , prothrombin times should be closely monitored and adjustment of the  <e1>anticoagulant</e1>  dose may be necessary."
Other
Comment:



100	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  <e1>AKINETON</e1>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

101	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e1>narcotic analgesics</e1>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

102	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e1>meperidine</e1> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

103	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e1>phenothiazines</e1>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

104	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e1>antipsychotics</e1> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

105	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

106	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

107	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
effect(e0,e1)Comment:

108	Drug Interactions: The central  <e0>anticholinergic</e0>  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
effect(e0,e1)Comment:

109	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e1>narcotic analgesics</e1>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

110	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e1>meperidine</e1> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

111	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e1>phenothiazines</e1>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

112	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e1>antipsychotics</e1> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

113	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

114	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
effect(e0,e1)Comment:

115	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
effect(e0,e1)Comment:

116	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  <e0>AKINETON</e0>  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
effect(e0,e1)Comment:

117	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  <e1>meperidine</e1> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

118	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  <e1>phenothiazines</e1>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

119	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  phenothiazines  and other  <e1>antipsychotics</e1> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

120	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

121	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

122	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

123	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  <e0>narcotic analgesics</e0>  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

124	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  <e1>phenothiazines</e1>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

125	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  phenothiazines  and other  <e1>antipsychotics</e1> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

126	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  phenothiazines  and other  antipsychotics ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

127	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

128	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

129	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  <e0>meperidine</e0> , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

130	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e0>phenothiazines</e0>  and other  <e1>antipsychotics</e1> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

131	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e0>phenothiazines</e0>  and other  antipsychotics ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

132	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e0>phenothiazines</e0>  and other  antipsychotics ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

133	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e0>phenothiazines</e0>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

134	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  <e0>phenothiazines</e0>  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

135	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e0>antipsychotics</e0> ,  <e1>tricyclic antidepressants</e1> , certain  antiarrhythmics  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

136	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e0>antipsychotics</e0> ,  tricyclic antidepressants , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

137	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e0>antipsychotics</e0> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

138	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  <e0>antipsychotics</e0> ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

139	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e0>tricyclic antidepressants</e0> , certain  <e1>antiarrhythmics</e1>  such as the  quinidine  salts, and  antihistamines ."
Other
Comment:

140	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e0>tricyclic antidepressants</e0> , certain  antiarrhythmics  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

141	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  <e0>tricyclic antidepressants</e0> , certain  antiarrhythmics  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

142	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e0>antiarrhythmics</e0>  such as the  <e1>quinidine</e1>  salts, and  antihistamines ."
Other
Comment:

143	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  <e0>antiarrhythmics</e0>  such as the  quinidine  salts, and  <e1>antihistamines</e1> ."
Other
Comment:

144	Drug Interactions: The central  anticholinergic  syndrome can occur when anticholinergic agents such as  AKINETON  are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain  narcotic analgesics  such as  meperidine , the  phenothiazines  and other  antipsychotics ,  tricyclic antidepressants , certain  antiarrhythmics  such as the  <e0>quinidine</e0>  salts, and  <e1>antihistamines</e1> ."
Other
Comment:


100	 <e0>ZEBETA</e0>  should not be combined with other  <e1>beta-blocking agents</e1> ."
advise(e0,e1)Comment:

200	Patients receiving catecholamine-depleting drugs, such as  <e0>reserpine</e0>  or  <e1>guanethidine</e1> , should be closely monitored, because the added beta-adrenergic blocking action of  ZEBETA  may produce excessive reduction of sympathetic activity."
Other
Comment:

201	Patients receiving catecholamine-depleting drugs, such as  <e0>reserpine</e0>  or  guanethidine , should be closely monitored, because the added beta-adrenergic blocking action of  <e1>ZEBETA</e1>  may produce excessive reduction of sympathetic activity."
effect(e0,e1)Comment:

202	Patients receiving catecholamine-depleting drugs, such as  reserpine  or  <e0>guanethidine</e0> , should be closely monitored, because the added beta-adrenergic blocking action of  <e1>ZEBETA</e1>  may produce excessive reduction of sympathetic activity."
effect(e0,e1)Comment:

300	In patients receiving concurrent therapy with  <e0>clonidine</e0> , if therapy is to be discontinued, it is suggested that  <e1>ZEBETA</e1>  be discontinued for several days before the withdrawal of  clonidine ."
Other
Comment:

301	In patients receiving concurrent therapy with  <e0>clonidine</e0> , if therapy is to be discontinued, it is suggested that  ZEBETA  be discontinued for several days before the withdrawal of  <e1>clonidine</e1> ."
Other
Comment:

302	In patients receiving concurrent therapy with  clonidine , if therapy is to be discontinued, it is suggested that  <e0>ZEBETA</e0>  be discontinued for several days before the withdrawal of  <e1>clonidine</e1> ."
advise(e0,e1)Comment:

400	 <e0>ZEBETA</e0>  should be used with care when  <e1>myocardial depressants</e1>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

401	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e1>calcium antagonists</e1>  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

402	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e1>phenylalkylamine</e1>  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

403	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e1>verapamil</e1> ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

404	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  <e1>benzothiazepine</e1>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

405	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

406	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
advise(e0,e1)Comment:

407	 <e0>ZEBETA</e0>  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
advise(e0,e1)Comment:

408	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  <e1>calcium antagonists</e1>  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

409	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e1>phenylalkylamine</e1>  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

410	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e1>verapamil</e1> ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

411	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  <e1>benzothiazepine</e1>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

412	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

413	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

414	 ZEBETA  should be used with care when  <e0>myocardial depressants</e0>  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

415	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  <e1>phenylalkylamine</e1>  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

416	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  phenylalkylamine  [ <e1>verapamil</e1> ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

417	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  phenylalkylamine  [ verapamil ] and  <e1>benzothiazepine</e1>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

418	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

419	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

420	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  <e0>calcium antagonists</e0>  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

421	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e0>phenylalkylamine</e0>  [ <e1>verapamil</e1> ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

422	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e0>phenylalkylamine</e0>  [ verapamil ] and  <e1>benzothiazepine</e1>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

423	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e0>phenylalkylamine</e0>  [ verapamil ] and  benzothiazepine  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

424	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e0>phenylalkylamine</e0>  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

425	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  <e0>phenylalkylamine</e0>  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

426	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e0>verapamil</e0> ] and  <e1>benzothiazepine</e1>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

427	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e0>verapamil</e0> ] and  benzothiazepine  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

428	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e0>verapamil</e0> ] and  benzothiazepine  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

429	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ <e0>verapamil</e0> ] and  benzothiazepine  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

430	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  <e0>benzothiazepine</e0>  [ <e1>diltiazem</e1> ] classes), or  antiarrhythmic agents , such as  disopyramide , are used concurrently."
Other
Comment:

431	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  <e0>benzothiazepine</e0>  [ diltiazem ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

432	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  <e0>benzothiazepine</e0>  [ diltiazem ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

433	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ <e0>diltiazem</e0> ] classes), or  <e1>antiarrhythmic agents</e1> , such as  disopyramide , are used concurrently."
Other
Comment:

434	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ <e0>diltiazem</e0> ] classes), or  antiarrhythmic agents , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

435	 ZEBETA  should be used with care when  myocardial depressants  or inhibitors of AV conduction, such as certain  calcium antagonists  (particularly of the  phenylalkylamine  [ verapamil ] and  benzothiazepine  [ diltiazem ] classes), or  <e0>antiarrhythmic agents</e0> , such as  <e1>disopyramide</e1> , are used concurrently."
Other
Comment:

500	Concurrent use of  <e0>rifampin</e0>  increases the metabolic clearance of  <e1>ZEBETA</e1> , resulting in a shortened elimination half-life of  ZEBETA ."
mechanism(e0,e1)Comment:

501	Concurrent use of  <e0>rifampin</e0>  increases the metabolic clearance of  ZEBETA , resulting in a shortened elimination half-life of  <e1>ZEBETA</e1> ."
Other
Comment:

502	Concurrent use of  rifampin  increases the metabolic clearance of  <e0>ZEBETA</e0> , resulting in a shortened elimination half-life of  <e1>ZEBETA</e1> ."
Other
Comment:

700	Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including  <e0>thiazide diuretics</e0> ,  <e1>digoxin</e1> , and  cimetidine ."
Other
Comment:

701	Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including  <e0>thiazide diuretics</e0> ,  digoxin , and  <e1>cimetidine</e1> ."
Other
Comment:

702	Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including  thiazide diuretics ,  <e0>digoxin</e0> , and  <e1>cimetidine</e1> ."
Other
Comment:

800	There was no effect of  <e0>ZEBETA</e0>  on prothrombin time in patients on stable doses of  <e1>warfarin</e1> ."
Other
Comment:


200	If you are also using a  <e0>steroid</e0>  inhaler, take  <e1>bitolterol</e1>  first and then wait about 15 minutes before using the  steroid  inhaler."
advise(e0,e1)Comment:

201	If you are also using a  <e0>steroid</e0>  inhaler, take  bitolterol  first and then wait about 15 minutes before using the  <e1>steroid</e1>  inhaler."
Other
Comment:

202	If you are also using a  steroid  inhaler, take  <e0>bitolterol</e0>  first and then wait about 15 minutes before using the  <e1>steroid</e1>  inhaler."
advise(e0,e1)Comment:

300	This allows  <e0>bitolterol</e0>  to open air passages, increasing the effectiveness of the  <e1>steroid</e1> ."
effect(e0,e1)Comment:


200	In clinical trials in patients undergoing PTCA/PCI, co-administration of  <e0>Angiomax</e0>  with  <e1>heparin</e1> ,  warfarin ,  thrombolytics  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
effect(e0,e1)Comment:

201	In clinical trials in patients undergoing PTCA/PCI, co-administration of  <e0>Angiomax</e0>  with  heparin ,  <e1>warfarin</e1> ,  thrombolytics  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
effect(e0,e1)Comment:

202	In clinical trials in patients undergoing PTCA/PCI, co-administration of  <e0>Angiomax</e0>  with  heparin ,  warfarin ,  <e1>thrombolytics</e1>  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
effect(e0,e1)Comment:

203	In clinical trials in patients undergoing PTCA/PCI, co-administration of  Angiomax  with  <e0>heparin</e0> ,  <e1>warfarin</e1> ,  thrombolytics  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
Other
Comment:

204	In clinical trials in patients undergoing PTCA/PCI, co-administration of  Angiomax  with  <e0>heparin</e0> ,  warfarin ,  <e1>thrombolytics</e1>  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
Other
Comment:

205	In clinical trials in patients undergoing PTCA/PCI, co-administration of  Angiomax  with  heparin ,  <e0>warfarin</e0> ,  <e1>thrombolytics</e1>  or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications."
Other
Comment:

300	There is no experience with co-administration of  <e0>Angiomax</e0>  and plasma expanders such as  <e1>dextran</e1> ."
Other
Comment:

600	Among 494 subjects who received  <e0>Angiomax</e0>  in clinical trials and were tested for antibodies, 2 subjects had treatment-emergent positive  <e1>bivalirudin</e1>  antibody tests."
Other
Comment:


100	Certain  <e0>antibiotic</e0> ,  <e1>cisplatin</e1> ,  cyclosporine ,  diuretic ,  foscarnet , and  vaccines ."
Other
Comment:

101	Certain  <e0>antibiotic</e0> ,  cisplatin ,  <e1>cyclosporine</e1> ,  diuretic ,  foscarnet , and  vaccines ."
Other
Comment:

102	Certain  <e0>antibiotic</e0> ,  cisplatin ,  cyclosporine ,  <e1>diuretic</e1> ,  foscarnet , and  vaccines ."
Other
Comment:

103	Certain  <e0>antibiotic</e0> ,  cisplatin ,  cyclosporine ,  diuretic ,  <e1>foscarnet</e1> , and  vaccines ."
Other
Comment:

104	Certain  <e0>antibiotic</e0> ,  cisplatin ,  cyclosporine ,  diuretic ,  foscarnet , and  <e1>vaccines</e1> ."
Other
Comment:

105	Certain  antibiotic ,  <e0>cisplatin</e0> ,  <e1>cyclosporine</e1> ,  diuretic ,  foscarnet , and  vaccines ."
Other
Comment:

106	Certain  antibiotic ,  <e0>cisplatin</e0> ,  cyclosporine ,  <e1>diuretic</e1> ,  foscarnet , and  vaccines ."
Other
Comment:

107	Certain  antibiotic ,  <e0>cisplatin</e0> ,  cyclosporine ,  diuretic ,  <e1>foscarnet</e1> , and  vaccines ."
Other
Comment:

108	Certain  antibiotic ,  <e0>cisplatin</e0> ,  cyclosporine ,  diuretic ,  foscarnet , and  <e1>vaccines</e1> ."
Other
Comment:

109	Certain  antibiotic ,  cisplatin ,  <e0>cyclosporine</e0> ,  <e1>diuretic</e1> ,  foscarnet , and  vaccines ."
Other
Comment:

110	Certain  antibiotic ,  cisplatin ,  <e0>cyclosporine</e0> ,  diuretic ,  <e1>foscarnet</e1> , and  vaccines ."
Other
Comment:

111	Certain  antibiotic ,  cisplatin ,  <e0>cyclosporine</e0> ,  diuretic ,  foscarnet , and  <e1>vaccines</e1> ."
Other
Comment:

112	Certain  antibiotic ,  cisplatin ,  cyclosporine ,  <e0>diuretic</e0> ,  <e1>foscarnet</e1> , and  vaccines ."
Other
Comment:

113	Certain  antibiotic ,  cisplatin ,  cyclosporine ,  <e0>diuretic</e0> ,  foscarnet , and  <e1>vaccines</e1> ."
Other
Comment:

114	Certain  antibiotic ,  cisplatin ,  cyclosporine ,  diuretic ,  <e0>foscarnet</e0> , and  <e1>vaccines</e1> ."
Other
Comment:


500	Patients on oral  <e0>antidiabetic agents</e0>  receiving  <e1>VELCADE</e1>  treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their  antidiabetic medication ."
advise(e0,e1)Comment:

501	Patients on oral  <e0>antidiabetic agents</e0>  receiving  VELCADE  treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their  <e1>antidiabetic medication</e1> ."
Other
Comment:

502	Patients on oral  antidiabetic agents  receiving  <e0>VELCADE</e0>  treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their  <e1>antidiabetic medication</e1> ."
Other
Comment:


700	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  <e1>Contraceptives</e1> : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

701	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  <e1>bosentan</e1>  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

702	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  <e1>hormonal contraceptive</e1>   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

703	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   <e1>Ortho-Novum</e1>  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

704	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  <e1>norethindrone</e1>  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

705	 <e0>Hormonal Contraceptives</e0> , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

706	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  <e0>Contraceptives</e0> : An interaction study demonstrated that co-administration of  <e1>bosentan</e1>  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

707	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  <e0>Contraceptives</e0> : An interaction study demonstrated that co-administration of  bosentan  and the oral  <e1>hormonal contraceptive</e1>   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

708	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  <e0>Contraceptives</e0> : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   <e1>Ortho-Novum</e1>  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

709	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  <e0>Contraceptives</e0> : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  <e1>norethindrone</e1>  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

710	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  <e0>Contraceptives</e0> : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

711	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  <e0>bosentan</e0>  and the oral  <e1>hormonal contraceptive</e1>   Ortho-Novum  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

712	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  <e0>bosentan</e0>  and the oral  hormonal contraceptive   <e1>Ortho-Novum</e1>  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
mechanism(e0,e1)Comment:

713	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  <e0>bosentan</e0>  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  <e1>norethindrone</e1>  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

714	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  <e0>bosentan</e0>  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  norethindrone  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

715	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  <e0>hormonal contraceptive</e0>   <e1>Ortho-Novum</e1>  produced average decreases of  norethindrone  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

716	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  <e0>hormonal contraceptive</e0>   Ortho-Novum  produced average decreases of  <e1>norethindrone</e1>  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

717	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  <e0>hormonal contraceptive</e0>   Ortho-Novum  produced average decreases of  norethindrone  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

718	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   <e0>Ortho-Novum</e0>  produced average decreases of  <e1>norethindrone</e1>  and  ethinyl estradiol  levels of 14% and 31%, respectively."
Other
Comment:

719	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   <e0>Ortho-Novum</e0>  produced average decreases of  norethindrone  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

720	 Hormonal Contraceptives , Including Oral, Injectable, Transdermal, and Implantable  Contraceptives : An interaction study demonstrated that co-administration of  bosentan  and the oral  hormonal contraceptive   Ortho-Novum  produced average decreases of  <e0>norethindrone</e0>  and  <e1>ethinyl estradiol</e1>  levels of 14% and 31%, respectively."
Other
Comment:

900	Therefore,  <e0>hormonal contraceptives</e0> , including oral, injectable, transdermal, and implantable forms, may not be reliable when  <e1>TRACLEER</e1>  is co-administered."
effect(e0,e1)Comment:

1100	Specific interaction studies have demonstrated the following:  <e0>Cyclosporine A</e0> : During the first day of concomitant administration, trough concentrations of  <e1>bosentan</e1>  were increased by about 30-fold."
Other
Comment:

1200	Steady-state  <e0>bosentan</e0>  plasma concentrations were 3- to 4-fold higher than in the absence of  <e1>cyclosporine A</e1> ."
mechanism(e0,e1)Comment:

1300	The concomitant administration of  <e0>bosentan</e0>  and  <e1>cyclosporine A</e1>  is contraindicated."
advise(e0,e1)Comment:

1400	Co-administration of  <e0>bosentan</e0>  decreased the plasma concentrations of  <e1>cyclosporine A</e1>  (a CYP3A4 substrate) by approximately 50%."
mechanism(e0,e1)Comment:

1500	 <e0>Tacrolimus</e0> : Co-administration of  <e1>tacrolimus</e1>  and  bosentan  has not been studied in man."
Other
Comment:

1501	 <e0>Tacrolimus</e0> : Co-administration of  tacrolimus  and  <e1>bosentan</e1>  has not been studied in man."
Other
Comment:

1502	 Tacrolimus : Co-administration of  <e0>tacrolimus</e0>  and  <e1>bosentan</e1>  has not been studied in man."
Other
Comment:

1600	Co-administration of  <e0>tacrolimus</e0>  and  <e1>bosentan</e1>  resulted in markedly increased plasma concentrations of  bosentan  in animals."
mechanism(e0,e1)Comment:

1601	Co-administration of  <e0>tacrolimus</e0>  and  bosentan  resulted in markedly increased plasma concentrations of  <e1>bosentan</e1>  in animals."
Other
Comment:

1602	Co-administration of  tacrolimus  and  <e0>bosentan</e0>  resulted in markedly increased plasma concentrations of  <e1>bosentan</e1>  in animals."
Other
Comment:

1700	Caution should be exercised if  <e0>tacrolimus</e0>  and  <e1>bosentan</e1>  are used together."
advise(e0,e1)Comment:

1800	 <e0>Glyburide</e0> : An increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with  <e1>glyburide</e1> ."
Other
Comment:

1900	Therefore, the concomitant administration of  <e0>TRACLEER</e0>  and  <e1>glyburide</e1>  is contraindicated, and alternative  hypoglycemic agents  should be considered."
advise(e0,e1)Comment:

1901	Therefore, the concomitant administration of  <e0>TRACLEER</e0>  and  glyburide  is contraindicated, and alternative  <e1>hypoglycemic agents</e1>  should be considered."
Other
Comment:

1902	Therefore, the concomitant administration of  TRACLEER  and  <e0>glyburide</e0>  is contraindicated, and alternative  <e1>hypoglycemic agents</e1>  should be considered."
Other
Comment:

2000	Co-administration of  <e0>bosentan</e0>  decreased the plasma concentrations of  <e1>glyburide</e1>  by approximately 40%."
mechanism(e0,e1)Comment:

2200	 <e0>Bosentan</e0>  is also expected to reduce plasma concentrations of other oral  <e1>hypoglycemic agents</e1>  that are predominantly metabolized by CYP2C9 or CYP3A4."
mechanism(e0,e1)Comment:

2400	 <e0>Ketoconazole</e0> : Co-administration of  <e1>bosentan</e1>  125 mg b.i.d. and  ketoconazole , a potent CYP3A4 inhibitor, increased the plasma concentrations of  bosentan  by approximately 2-fold."
Other
Comment:

2401	 <e0>Ketoconazole</e0> : Co-administration of  bosentan  125 mg b.i.d. and  <e1>ketoconazole</e1> , a potent CYP3A4 inhibitor, increased the plasma concentrations of  bosentan  by approximately 2-fold."
Other
Comment:

2402	 <e0>Ketoconazole</e0> : Co-administration of  bosentan  125 mg b.i.d. and  ketoconazole , a potent CYP3A4 inhibitor, increased the plasma concentrations of  <e1>bosentan</e1>  by approximately 2-fold."
Other
Comment:

2403	 Ketoconazole : Co-administration of  <e0>bosentan</e0>  125 mg b.i.d. and  <e1>ketoconazole</e1> , a potent CYP3A4 inhibitor, increased the plasma concentrations of  bosentan  by approximately 2-fold."
mechanism(e0,e1)Comment:

2404	 Ketoconazole : Co-administration of  <e0>bosentan</e0>  125 mg b.i.d. and  ketoconazole , a potent CYP3A4 inhibitor, increased the plasma concentrations of  <e1>bosentan</e1>  by approximately 2-fold."
Other
Comment:

2405	 Ketoconazole : Co-administration of  bosentan  125 mg b.i.d. and  <e0>ketoconazole</e0> , a potent CYP3A4 inhibitor, increased the plasma concentrations of  <e1>bosentan</e1>  by approximately 2-fold."
Other
Comment:

2500	No dose adjustment of  <e0>bosentan</e0>  is necessary, but increased effects of  <e1>bosentan</e1>  should be considered."
Other
Comment:

2600	 <e0>Simvastatin</e0>  and Other  <e1>Statins</e1> : Co-administration of  bosentan  decreased the plasma concentrations of  simvastatin  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
Other
Comment:

2601	 <e0>Simvastatin</e0>  and Other  Statins : Co-administration of  <e1>bosentan</e1>  decreased the plasma concentrations of  simvastatin  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
Other
Comment:

2602	 <e0>Simvastatin</e0>  and Other  Statins : Co-administration of  bosentan  decreased the plasma concentrations of  <e1>simvastatin</e1>  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
Other
Comment:

2603	 Simvastatin  and Other  <e0>Statins</e0> : Co-administration of  <e1>bosentan</e1>  decreased the plasma concentrations of  simvastatin  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
Other
Comment:

2604	 Simvastatin  and Other  <e0>Statins</e0> : Co-administration of  bosentan  decreased the plasma concentrations of  <e1>simvastatin</e1>  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
Other
Comment:

2605	 Simvastatin  and Other  Statins : Co-administration of  <e0>bosentan</e0>  decreased the plasma concentrations of  <e1>simvastatin</e1>  (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%."
mechanism(e0,e1)Comment:

2800	 <e0>Bosentan</e0>  is also expected to reduce plasma concentrations of other  <e1>statins</e1>  that have significant metabolism by CYP3A4, such as  lovastatin  and  atorvastatin ."
mechanism(e0,e1)Comment:

2801	 <e0>Bosentan</e0>  is also expected to reduce plasma concentrations of other  statins  that have significant metabolism by CYP3A4, such as  <e1>lovastatin</e1>  and  atorvastatin ."
mechanism(e0,e1)Comment:

2802	 <e0>Bosentan</e0>  is also expected to reduce plasma concentrations of other  statins  that have significant metabolism by CYP3A4, such as  lovastatin  and  <e1>atorvastatin</e1> ."
mechanism(e0,e1)Comment:

2803	 Bosentan  is also expected to reduce plasma concentrations of other  <e0>statins</e0>  that have significant metabolism by CYP3A4, such as  <e1>lovastatin</e1>  and  atorvastatin ."
Other
Comment:

2804	 Bosentan  is also expected to reduce plasma concentrations of other  <e0>statins</e0>  that have significant metabolism by CYP3A4, such as  lovastatin  and  <e1>atorvastatin</e1> ."
Other
Comment:

2805	 Bosentan  is also expected to reduce plasma concentrations of other  statins  that have significant metabolism by CYP3A4, such as  <e0>lovastatin</e0>  and  <e1>atorvastatin</e1> ."
Other
Comment:

3000	Patients using CYP3A4 metabolized  <e0>statins</e0>  should have cholesterol levels monitored after  <e1>TRACLEER</e1>  is initiated to see whether the  statin  dose needs adjustment."
advise(e0,e1)Comment:

3001	Patients using CYP3A4 metabolized  <e0>statins</e0>  should have cholesterol levels monitored after  TRACLEER  is initiated to see whether the  <e1>statin</e1>  dose needs adjustment."
Other
Comment:

3002	Patients using CYP3A4 metabolized  statins  should have cholesterol levels monitored after  <e0>TRACLEER</e0>  is initiated to see whether the  <e1>statin</e1>  dose needs adjustment."
Other
Comment:

3100	 <e0>Warfarin</e0> : Co-administration of  <e1>bosentan</e1>  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  S-warfarin  (a CYP2C9 substrate) and  R-warfarin  (a CYP3A4 substrate) by 29 and 38%, respectively."
Other
Comment:

3101	 <e0>Warfarin</e0> : Co-administration of  bosentan  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  <e1>S-warfarin</e1>  (a CYP2C9 substrate) and  R-warfarin  (a CYP3A4 substrate) by 29 and 38%, respectively."
Other
Comment:

3102	 <e0>Warfarin</e0> : Co-administration of  bosentan  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  S-warfarin  (a CYP2C9 substrate) and  <e1>R-warfarin</e1>  (a CYP3A4 substrate) by 29 and 38%, respectively."
Other
Comment:

3103	 Warfarin : Co-administration of  <e0>bosentan</e0>  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  <e1>S-warfarin</e1>  (a CYP2C9 substrate) and  R-warfarin  (a CYP3A4 substrate) by 29 and 38%, respectively."
mechanism(e0,e1)Comment:

3104	 Warfarin : Co-administration of  <e0>bosentan</e0>  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  S-warfarin  (a CYP2C9 substrate) and  <e1>R-warfarin</e1>  (a CYP3A4 substrate) by 29 and 38%, respectively."
mechanism(e0,e1)Comment:

3105	 Warfarin : Co-administration of  bosentan  500 mg b.i.d. for 6 days decreased the plasma concentrations of both  <e0>S-warfarin</e0>  (a CYP2C9 substrate) and  <e1>R-warfarin</e1>  (a CYP3A4 substrate) by 29 and 38%, respectively."
Other
Comment:

3200	Clinical experience with concomitant administration of  <e0>bosentan</e0>  and  <e1>warfarin</e1>  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3201	Clinical experience with concomitant administration of  <e0>bosentan</e0>  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  <e1>warfarin</e1>  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3202	Clinical experience with concomitant administration of  <e0>bosentan</e0>  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  <e1>warfarin</e1>  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3203	Clinical experience with concomitant administration of  <e0>bosentan</e0>  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  <e1>bosentan</e1> - and placebo-treated patients."
Other
Comment:

3204	Clinical experience with concomitant administration of  bosentan  and  <e0>warfarin</e0>  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  <e1>warfarin</e1>  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3205	Clinical experience with concomitant administration of  bosentan  and  <e0>warfarin</e0>  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  <e1>warfarin</e1>  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3206	Clinical experience with concomitant administration of  bosentan  and  <e0>warfarin</e0>  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  <e1>bosentan</e1> - and placebo-treated patients."
Other
Comment:

3207	Clinical experience with concomitant administration of  bosentan  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  <e0>warfarin</e0>  dose (baseline vs. end of the clinical studies), and the need to change the  <e1>warfarin</e1>  dose during the trials due to changes in INR or due to adverse events was similar among  bosentan - and placebo-treated patients."
Other
Comment:

3208	Clinical experience with concomitant administration of  bosentan  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  <e0>warfarin</e0>  dose (baseline vs. end of the clinical studies), and the need to change the  warfarin  dose during the trials due to changes in INR or due to adverse events was similar among  <e1>bosentan</e1> - and placebo-treated patients."
Other
Comment:

3209	Clinical experience with concomitant administration of  bosentan  and  warfarin  in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or  warfarin  dose (baseline vs. end of the clinical studies), and the need to change the  <e0>warfarin</e0>  dose during the trials due to changes in INR or due to adverse events was similar among  <e1>bosentan</e1> - and placebo-treated patients."
Other
Comment:

3300	 <e0>Digoxin</e0> ,  <e1>Nimodipine</e1>  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3301	 <e0>Digoxin</e0> ,  Nimodipine  and  <e1>Losartan</e1> :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3302	 <e0>Digoxin</e0> ,  Nimodipine  and  Losartan :  <e1>Bosentan</e1>  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3303	 <e0>Digoxin</e0> ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  <e1>digoxin</e1>  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3304	 <e0>Digoxin</e0> ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  <e1>nimodipine</e1> , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3305	 <e0>Digoxin</e0> ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3306	 <e0>Digoxin</e0> ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3307	 Digoxin ,  <e0>Nimodipine</e0>  and  <e1>Losartan</e1> :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3308	 Digoxin ,  <e0>Nimodipine</e0>  and  Losartan :  <e1>Bosentan</e1>  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3309	 Digoxin ,  <e0>Nimodipine</e0>  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  <e1>digoxin</e1>  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3310	 Digoxin ,  <e0>Nimodipine</e0>  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  <e1>nimodipine</e1> , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3311	 Digoxin ,  <e0>Nimodipine</e0>  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3312	 Digoxin ,  <e0>Nimodipine</e0>  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3313	 Digoxin ,  Nimodipine  and  <e0>Losartan</e0> :  <e1>Bosentan</e1>  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3314	 Digoxin ,  Nimodipine  and  <e0>Losartan</e0> :  Bosentan  has no significant pharmacokinetic interactions with  <e1>digoxin</e1>  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3315	 Digoxin ,  Nimodipine  and  <e0>Losartan</e0> :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  <e1>nimodipine</e1> , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3316	 Digoxin ,  Nimodipine  and  <e0>Losartan</e0> :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3317	 Digoxin ,  Nimodipine  and  <e0>Losartan</e0> :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3318	 Digoxin ,  Nimodipine  and  Losartan :  <e0>Bosentan</e0>  has no significant pharmacokinetic interactions with  <e1>digoxin</e1>  and  nimodipine , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3319	 Digoxin ,  Nimodipine  and  Losartan :  <e0>Bosentan</e0>  has no significant pharmacokinetic interactions with  digoxin  and  <e1>nimodipine</e1> , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3320	 Digoxin ,  Nimodipine  and  Losartan :  <e0>Bosentan</e0>  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3321	 Digoxin ,  Nimodipine  and  Losartan :  <e0>Bosentan</e0>  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3322	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  <e0>digoxin</e0>  and  <e1>nimodipine</e1> , and  losartan  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3323	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  <e0>digoxin</e0>  and  nimodipine , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3324	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  <e0>digoxin</e0>  and  nimodipine , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3325	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  <e0>nimodipine</e0> , and  <e1>losartan</e1>  has no significant effect on plasma levels of  bosentan ."
Other
Comment:

3326	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  <e0>nimodipine</e0> , and  losartan  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:

3327	 Digoxin ,  Nimodipine  and  Losartan :  Bosentan  has no significant pharmacokinetic interactions with  digoxin  and  nimodipine , and  <e0>losartan</e0>  has no significant effect on plasma levels of  <e1>bosentan</e1> ."
Other
Comment:


100	Co-administration of  <e0>BOTOX</e0>  and  <e1>aminoglycosides</e1>  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  toxin  may be potentiated."
advise(e0,e1)Comment:

101	Co-administration of  <e0>BOTOX</e0>  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  <e1>curare-like compounds</e1> ) should only be performed with caution as the effect of the  toxin  may be potentiated."
advise(e0,e1)Comment:

102	Co-administration of  <e0>BOTOX</e0>  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:

103	Co-administration of  BOTOX  and  <e0>aminoglycosides</e0>  or other agents interfering with neuromuscular transmission (e.g.,  <e1>curare-like compounds</e1> ) should only be performed with caution as the effect of the  toxin  may be potentiated."
Other
Comment:

104	Co-administration of  BOTOX  and  <e0>aminoglycosides</e0>  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:

105	Co-administration of  BOTOX  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  <e0>curare-like compounds</e0> ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:

300	Excessive neuromuscular weakness may be exacerbated by administration of another  <e0>botulinum toxin</e0>  prior to the resolution of the effects of a previously administered  <e1>botulinum toxin</e1> ."
effect(e0,e1)Comment:


100	Co-administration of  <e0>MYOBLOC</e0>  and  <e1>aminoglycosides</e1>  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  toxin  may be potentiated."
advise(e0,e1)Comment:

101	Co-administration of  <e0>MYOBLOC</e0>  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  <e1>curare-like compounds</e1> ) should only be performed with caution as the effect of the  toxin  may be potentiated."
advise(e0,e1)Comment:

102	Co-administration of  <e0>MYOBLOC</e0>  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:

103	Co-administration of  MYOBLOC  and  <e0>aminoglycosides</e0>  or other agents interfering with neuromuscular transmission (e.g.,  <e1>curare-like compounds</e1> ) should only be performed with caution as the effect of the  toxin  may be potentiated."
Other
Comment:

104	Co-administration of  MYOBLOC  and  <e0>aminoglycosides</e0>  or other agents interfering with neuromuscular transmission (e.g.,  curare-like compounds ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:

105	Co-administration of  MYOBLOC  and  aminoglycosides  or other agents interfering with neuromuscular transmission (e.g.,  <e0>curare-like compounds</e0> ) should only be performed with caution as the effect of the  <e1>toxin</e1>  may be potentiated."
Other
Comment:


100	 <e0>Digitalis</e0>  toxicity may be aggravated by the initial release of norepinephrine caused by  <e1>Bretylium Tosylate</e1>  Injection."
effect(e0,e1)Comment:

200	The pressor effects of  <e0>catecholamines</e0>  such as  <e1>dopamine</e1>  or  norepinephrine  are enhanced by  Bretylium Tosylate ."
Other
Comment:

201	The pressor effects of  <e0>catecholamines</e0>  such as  dopamine  or  <e1>norepinephrine</e1>  are enhanced by  Bretylium Tosylate ."
Other
Comment:

202	The pressor effects of  <e0>catecholamines</e0>  such as  dopamine  or  norepinephrine  are enhanced by  <e1>Bretylium Tosylate</e1> ."
effect(e0,e1)Comment:

203	The pressor effects of  catecholamines  such as  <e0>dopamine</e0>  or  <e1>norepinephrine</e1>  are enhanced by  Bretylium Tosylate ."
Other
Comment:

204	The pressor effects of  catecholamines  such as  <e0>dopamine</e0>  or  norepinephrine  are enhanced by  <e1>Bretylium Tosylate</e1> ."
effect(e0,e1)Comment:

205	The pressor effects of  catecholamines  such as  dopamine  or  <e0>norepinephrine</e0>  are enhanced by  <e1>Bretylium Tosylate</e1> ."
effect(e0,e1)Comment:

400	Although there is little published information on concomitant administration of  <e0>lidocaine</e0>  and  <e1>Bretylium Tosylate</e1> , these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy."
Other
Comment:


100	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  <e1>CNS depressants</e1>  ( alcohol ,  barbiturates ,  opiates ,  sedatives , or  anesthetics ) should be considered."
advise(e0,e1)Comment:

101	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  CNS depressants  ( <e1>alcohol</e1> ,  barbiturates ,  opiates ,  sedatives , or  anesthetics ) should be considered."
advise(e0,e1)Comment:

102	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e1>barbiturates</e1> ,  opiates ,  sedatives , or  anesthetics ) should be considered."
advise(e0,e1)Comment:

103	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e1>opiates</e1> ,  sedatives , or  anesthetics ) should be considered."
advise(e0,e1)Comment:

104	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  <e1>sedatives</e1> , or  anesthetics ) should be considered."
advise(e0,e1)Comment:

105	Although specific drug interaction studies have not been conducted with  <e0>ALPHAGAN P</e0> , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  sedatives , or  <e1>anesthetics</e1> ) should be considered."
advise(e0,e1)Comment:

106	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( <e1>alcohol</e1> ,  barbiturates ,  opiates ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

107	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  <e1>barbiturates</e1> ,  opiates ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

108	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  <e1>opiates</e1> ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

109	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  opiates ,  <e1>sedatives</e1> , or  anesthetics ) should be considered."
Other
Comment:

110	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  <e0>CNS depressants</e0>  ( alcohol ,  barbiturates ,  opiates ,  sedatives , or  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

111	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  <e1>barbiturates</e1> ,  opiates ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

112	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  <e1>opiates</e1> ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

113	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  opiates ,  <e1>sedatives</e1> , or  anesthetics ) should be considered."
Other
Comment:

114	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( <e0>alcohol</e0> ,  barbiturates ,  opiates ,  sedatives , or  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

115	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  <e1>opiates</e1> ,  sedatives , or  anesthetics ) should be considered."
Other
Comment:

116	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  opiates ,  <e1>sedatives</e1> , or  anesthetics ) should be considered."
Other
Comment:

117	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  <e0>barbiturates</e0> ,  opiates ,  sedatives , or  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

118	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e0>opiates</e0> ,  <e1>sedatives</e1> , or  anesthetics ) should be considered."
Other
Comment:

119	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  <e0>opiates</e0> ,  sedatives , or  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

120	Although specific drug interaction studies have not been conducted with  ALPHAGAN P , the possibility of an additive or potentiating effect with  CNS depressants  ( alcohol ,  barbiturates ,  opiates ,  <e0>sedatives</e0> , or  <e1>anesthetics</e1> ) should be considered."
Other
Comment:

300	Caution in using concomitant drugs such as  <e0>beta-blockers</e0>  (ophthalmic and systemic),  <e1>anti-hypertensives</e1>  and/or  cardiac glycosides  is advised."
Other
Comment:

301	Caution in using concomitant drugs such as  <e0>beta-blockers</e0>  (ophthalmic and systemic),  anti-hypertensives  and/or  <e1>cardiac glycosides</e1>  is advised."
Other
Comment:

302	Caution in using concomitant drugs such as  beta-blockers  (ophthalmic and systemic),  <e0>anti-hypertensives</e0>  and/or  <e1>cardiac glycosides</e1>  is advised."
Other
Comment:

400	 <e0>Tricyclic antidepressants</e0>  have been reported to blunt the hypotensive effect of systemic  <e1>clonidine</e1> .It is not known whether the concurrent use of these agents with  ALPHAGAN P  in humans can lead to resulting interference with the IOP lowering effect."
effect(e0,e1)Comment:

401	 <e0>Tricyclic antidepressants</e0>  have been reported to blunt the hypotensive effect of systemic  clonidine .It is not known whether the concurrent use of these agents with  <e1>ALPHAGAN P</e1>  in humans can lead to resulting interference with the IOP lowering effect."
Other
Comment:

402	 Tricyclic antidepressants  have been reported to blunt the hypotensive effect of systemic  <e0>clonidine</e0> .It is not known whether the concurrent use of these agents with  <e1>ALPHAGAN P</e1>  in humans can lead to resulting interference with the IOP lowering effect."
Other
Comment:


100	 <e0>AZOPT</e0>  ( <e1>brinzolamide</e1>  ophthalmic suspension) 1% contains a  carbonic anhydrase inhibitor ."
Other
Comment:

101	 <e0>AZOPT</e0>  ( brinzolamide  ophthalmic suspension) 1% contains a  <e1>carbonic anhydrase inhibitor</e1> ."
Other
Comment:

102	 AZOPT  ( <e0>brinzolamide</e0>  ophthalmic suspension) 1% contains a  <e1>carbonic anhydrase inhibitor</e1> ."
Other
Comment:

300	However, in patients treated with oral  <e0>carbonic anhydrase inhibitors</e0> , rare instances of drug interactions have occurred with high-dose  <e1>salicylate</e1>  therapy."
int(e0,e1)Comment:

400	Therefore, the potential for such drug interaction should be considered in patients receiving  <e0>AZOPT</e0>  ( <e1>brinzolamide</e1>  ophthalmic suspension) 1%."
Other
Comment:


100	The risk of using  <e0>bromocriptine mesylate</e0>  in combination with other drugs has not been systematically evaluated, but  <e1>alcohol</e1>  may potentiate the side effects of  bromocriptine mesylate ."
Other
Comment:

101	The risk of using  <e0>bromocriptine mesylate</e0>  in combination with other drugs has not been systematically evaluated, but  alcohol  may potentiate the side effects of  <e1>bromocriptine mesylate</e1> ."
Other
Comment:

102	The risk of using  bromocriptine mesylate  in combination with other drugs has not been systematically evaluated, but  <e0>alcohol</e0>  may potentiate the side effects of  <e1>bromocriptine mesylate</e1> ."
effect(e0,e1)Comment:

200	 <e0>Bromocriptine mesylate</e0>  may interact with  <e1>dopamine antagonists</e1> ,  butyrophenones , and certain other agents."
int(e0,e1)Comment:

201	 <e0>Bromocriptine mesylate</e0>  may interact with  dopamine antagonists ,  <e1>butyrophenones</e1> , and certain other agents."
int(e0,e1)Comment:

202	 Bromocriptine mesylate  may interact with  <e0>dopamine antagonists</e0> ,  <e1>butyrophenones</e1> , and certain other agents."
Other
Comment:

300	Compounds in these categories result in a decreased efficacy of  <e0>bromocriptine mesylate</e0> :  <e1>phenothiazines</e1> ,  haloperidol ,  metoclopramide ,  pimozide ."
effect(e0,e1)Comment:

301	Compounds in these categories result in a decreased efficacy of  <e0>bromocriptine mesylate</e0> :  phenothiazines ,  <e1>haloperidol</e1> ,  metoclopramide ,  pimozide ."
effect(e0,e1)Comment:

302	Compounds in these categories result in a decreased efficacy of  <e0>bromocriptine mesylate</e0> :  phenothiazines ,  haloperidol ,  <e1>metoclopramide</e1> ,  pimozide ."
effect(e0,e1)Comment:

303	Compounds in these categories result in a decreased efficacy of  <e0>bromocriptine mesylate</e0> :  phenothiazines ,  haloperidol ,  metoclopramide ,  <e1>pimozide</e1> ."
effect(e0,e1)Comment:

304	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  <e0>phenothiazines</e0> ,  <e1>haloperidol</e1> ,  metoclopramide ,  pimozide ."
Other
Comment:

305	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  <e0>phenothiazines</e0> ,  haloperidol ,  <e1>metoclopramide</e1> ,  pimozide ."
Other
Comment:

306	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  <e0>phenothiazines</e0> ,  haloperidol ,  metoclopramide ,  <e1>pimozide</e1> ."
Other
Comment:

307	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  phenothiazines ,  <e0>haloperidol</e0> ,  <e1>metoclopramide</e1> ,  pimozide ."
Other
Comment:

308	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  phenothiazines ,  <e0>haloperidol</e0> ,  metoclopramide ,  <e1>pimozide</e1> ."
Other
Comment:

309	Compounds in these categories result in a decreased efficacy of  bromocriptine mesylate :  phenothiazines ,  haloperidol ,  <e0>metoclopramide</e0> ,  <e1>pimozide</e1> ."
Other
Comment:

400	Concomitant use of  <e0>bromocriptine mesylate</e0>  with other  <e1>ergot alkaloids</e1>  is not recommended."
advise(e0,e1)Comment:


100	 <e0>Dexbrompheniramine</e0>  can interact with  <e1>alcohol</e1>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
effect(e0,e1)Comment:

101	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  <e1>CNS depressants</e1>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
effect(e0,e1)Comment:

102	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e1>antihistamines</e1> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

103	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e1>anticholinergics</e1>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
effect(e0,e1)Comment:

104	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

105	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
effect(e0,e1)Comment:

106	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

107	 <e0>Dexbrompheniramine</e0>  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

108	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  <e1>CNS depressants</e1>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

109	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e1>antihistamines</e1> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

110	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e1>anticholinergics</e1>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

111	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

112	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

113	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

114	 Dexbrompheniramine  can interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

115	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  <e1>antihistamines</e1> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

116	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e1>anticholinergics</e1>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

117	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

118	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

119	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

120	 Dexbrompheniramine  can interact with  alcohol  or other  <e0>CNS depressants</e0>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

121	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e0>antihistamines</e0> ),  <e1>anticholinergics</e1>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

122	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e0>antihistamines</e0> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

123	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e0>antihistamines</e0> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

124	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e0>antihistamines</e0> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

125	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e0>antihistamines</e0> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

126	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e0>anticholinergics</e0>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

127	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e0>anticholinergics</e0>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

128	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e0>anticholinergics</e0>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

129	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e0>anticholinergics</e0>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

130	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e0>antihistamines</e0> ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

131	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e0>antihistamines</e0> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

132	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e0>antihistamines</e0> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

133	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e0>monoamine oxidase (MAO) inhibitors</e0>  (concurrent use with  <e1>antihistamines</e1>  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

134	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e0>monoamine oxidase (MAO) inhibitors</e0>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:

135	 Dexbrompheniramine  can interact with  alcohol  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  <e0>antihistamines</e0>  may prolong and intensify the anticholinergic and CNS depressant effects of  <e1>antihistamines</e1> )."
Other
Comment:


100	This drug may interact with  <e0>alcohol</e0>  or other  <e1>CNS depressants</e1>  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

101	This drug may interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  <e1>antihistamines</e1> ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

102	This drug may interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  <e1>anticholinergics</e1>  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

103	This drug may interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  <e1>antihistamines</e1> ), and  monoamine oxidase (MAO) inhibitors  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
Comment:

104	This drug may interact with  <e0>alcohol</e0>  or other  CNS depressants  (may potentiate the CNS depressant effects of either these medications or  antihistamines ),  anticholinergics  or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with  antihistamines ), and  <e1>monoamine oxidase (MAO) inhibitors</e1>  (concurrent use with  antihistamines  may prolong and intensify the anticholinergic and CNS depressant effects of  antihistamines )."
Other
